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ABSTRACT 
Aim 
This paper reports a study exploring the lived experience of fifteen men and women treated 
with allogeneic stem cell transplant (SCT) for haematological malignancy. 
Background 
Evidence suggests that treatment of haematological malignancy including allogeneic stem 
cell transplant has a significant impact on the quality of life (QoL) of recipients and 
quantitative studies have measured dimensions such as physical function and psycho-social 
and spiritual domains. Fewer studies have considered individual’s lived experience of 
allogeneic stem cell transplant (SCT) and their subsequent recovery. 
Methods 
The study followed an interpretive phenomenological methodology using semi-structured 
interviews.  Fifteen participants aged between 22-68 years were purposively recruited from 
two specialist treatment centres and were interviewed within three months to one year post 
SCT between April and September 2013. Data were then analysed using interpretive 
phenomenological methodology to gain insights into their lived experience including their 
personal and social experience of the world following treatment.  
Findings 
Two overarching themes emerged from the data: The Immediacy of Illness & Existential 
Crisis and The Recovery Journey.  The Immediacy of Illness and Existential Crisis illustrate 
the participants’ experiences of critical events in relation to disease onset, diagnosis and 
treatment and the enduring uncertainty which continues into recovery including facing their 
own mortality.   Participants suffer major disruption to their lives physically, psychosocially 
and emotionally as a result of illness without a sense of when they may resume the 
normality of their former life.  
 
Returning home after several months of hospitalisation is a particularly daunting and 
challenging time for patients. Participants expressed their fear of being suddenly left in 
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charge of their own health needs and the stark reality of the outside world compared to 
being cared for in the relative safety of their protective isolation facility in hospital. The 
responsibility for self monitoring and vigilance in the light of on-going treatment effects such 
as graft versus host disease (GVHD) and the threat of viral infections warrants increased 
support from health care professionals.  Social support in order to cope with isolation, 
financial hardship and employment issues similarly deserves attention.  
 
Processing traumatic experiences such as life threatening diagnoses, critical events and 
harsh treatments can be difficult when faced with the immediacy of illness. Participants feel 
guilty of burdening their loved ones but could benefit from the opportunity to talk to other 
patients in order to gain perspective and share strategies for coping and adjustment.  
 
Conclusion 
Ambiguity and uncertainty characterise the illness and recovery journey for those with 
haematological malignancy.  Whilst participants have access to specialist teams, there are 
opportunities for health and social care professionals to provide more support for individual’s 
returning home after prolonged hospitalisation and in the months that follow. In particular the 
development of a community based Advanced Nurse Practitioner, skilled in early recognition 
of treatment effects, could significantly enhance the care of patients in their first year post 
SCT. 
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Glossary of terms 
 
Androgen: is the broad term for any natural or synthetic compound, usually a steroid 
hormone that stimulates or controls the development and maintenance of male 
characteristics 
 
Aplastic Anaemia: is a disease in which the bone marrow and the blood stem cells are 
damaged causing a deficiency in all three blood cell types (pancytopenia);  red blood cells 
(anaemia), white blood cells (leukopenia) and platelets (thrombocytopenia). Aplastic refers 
to the inability of the stem cells to generate mature blood cells   
 
Acute Lymphoblastic Leukaemia: is an acute form of leukaemia, or cancer of the white 
blood cells, characterized by the overproduction of cancerous, immature white blood cells 
known as lymphoblasts. In ALL, lymphoblasts are overproduced in the bone marrow and 
continuously multiply, causing damage and death by inhibiting the production of normal red 
and white blood cells and platelets in the bone marrow and infiltrating to other organs  
 
Acute Myeloid Leukaemia: is a cancer of the myeloid line of blood cells, characterized by 
the rapid growth of abnormal white blood cells that accumulate in the bone marrow and 
interfere with the production of normal blood cells. AML is the most common acute 
leukaemia affecting adults 
 
Autologous stem cell transplant (AHST):  transplantation in which stem cells 
(undifferentiated cells from which other cell types develop) are removed, stored, and later 
given back to the same person through a transfusion 
 
Allogeneic stem cell transplant: transplantation in which stem cells donated from another 
individual are provided to the recipient through a transfusion 
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Antithymocyte globulin: is an infusion of horse or rabbit-derived antibodies against human 
T cells used in the prevention and treatment of acute rejection in organ transplantation and 
therapy of aplastic anaemia 
 
Blasts: new immature blood cells 
 
Bone marrow transplant (BMT): the original term used for a stem cell transplant when 
stem cells are collected from the bone marrow itself by aspirating stem cells from the hip 
bone using a specially designed needle and syringe 
 
Cognitive Behavioural Therapy: types of therapy, often delivered by psychologists, usually 
based on talking and practising specific types of voluntary activity. This group of 
interventions can include relaxation training, counselling and psychological approaches to 
pain control 
 
Cyclophosphamide: an agent used to treat cancers and autoimmune disease 
 
Cyclosporin: a drug widely used in organ transplantation to prevent rejection by reducing 
the activity of the immune system 
 
Cytogenetics: a branch of genetics concerned with the study of the structure and function 
of the cell, especially the chromosomes 
 
Cytology: the study of cells in terms of structure, function and chemistry 
 
Granulocyte colony stimulating factor (G-CSF):  used to stimulate the production of stem 
cells in the bone marrow 
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Graft versus host disease (GVHD): occurs when particular white blood cells (T cells) in the 
tissue (the graft) recognize the recipient (the host) as "foreign". The transplanted immune 
cells then attack the host's body cells 
 
Acute graft versus host disease aGVHD: Acute GVHD usually happens within the first 3 
months after a transplant. Common acute symptoms include: 
 
 Abdominal pain or cramps, nausea, vomiting, and diarrhoea 
 Dry or irritated eyes 
 Jaundice (yellow colouring of the skin or eyes) 
 Skin rash, itching, redness on areas of the skin 
 
Chronic graft versus host disease (cGVHD): Chronic GVHD usually starts more than 3 
months after a transplant, and can last a lifetime. Chronic symptoms may include: 
 
 Dry eyes or vision changes 
 Dry mouth, white patches inside the mouth, and sensitivity to spicy foods 
 Fatigue, muscle weakness, and chronic pain 
 Skin rash with raised, discoloured areas, as well as skin tightening or thickening 
 Shortness of breath 
 Vaginal dryness 
 Weight loss 
 
Haematopoietic cell transplant (HCT): stem cell transplant using blood stem cells 
(haematopoietic stem cells are produced in the bone marrow and either divide to form more 
blood-forming stem cells, or mature into one of the three types of blood cells 
 
Haematopoietic stem cell transplant (HSCT): as above 
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Health Related Quality of Life (HRQoL): a multi-dimensional concept that includes 
domains related to physical, mental, emotional and social functioning. It goes beyond direct 
measures of population health, life expectancy and causes of death, and focuses on the 
impact health status has on quality of life. A related concept of HRQoL is well-being, which 
assesses the positive aspects of a person’s life, such as positive emotions and life 
satisfaction 
 
Histology: a branch of anatomy concerned with the study of microscopic structures of 
human tissue 
 
Hodgkin Lymphoma: is a cancer that develops in the lymphatic system (part of the immune 
system). In Hodgkin lymphoma, B-lymphocytes (a particular type of lymphocyte multiply in 
an abnormal way and collect in certain parts of the lymphatic system such as the lymph 
nodes (glands). The affected lymphocytes lose their immune properties increasing 
vulnerability to infection 
 
Human leukocyte antigen tissue types: genes that encode for proteins on the surface of 
cells responsible for regulation of the immune system 
 
Imaging: making a visual representation with an electromagnetic beam 
 
Immunophenotyping: a technique used to study the protein expressed by cells. This can 
be performed on tissue section or cell suspension. An example is the detection of tumour 
marker such as the diagnosis of leukaemia and involves the labelling of white blood cells 
with antibodies directed against surface proteins on their membrane. The labelled cells are 
processed in a flow cytometer, a laser-based instrument capable of analysing thousands of 
cells per second  
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Intrathecally: route of administration for drugs via an injection into the spinal canal 
(subarachnoid space) 
 
JAK2 gene: a gene present in the bone marrow, a mutation of which can cause 
myeloproliferative neoplasm 
 
Myelodysplastic Syndrome: a group of diverse bone marrow disorders in which the bone 
marrow does not produce enough healthy blood cells. MDS is often referred to as a bone 
marrow failure disorder. 
 
Myelofibrosis: a bone marrow disorder disrupting the body's normal production of blood 
cells. It causes extensive scarring in the bone marrow 
 
Myeloablative therapy: Conventional full intensity therapy aimed to kill as many cancer 
cells as possible and to suppress the immune system of the recipient to allow engraftment of 
the donated stem cells 
 
Non-myeloablative transplants: reduced intensity transplant using less aggressive 
chemotherapy and radiation. This treatment aims to suppress the immune system of the 
recipient to allow engraftment of the donated stem cells and relies on the graft versus host 
reaction to kill cancerous cells 
 
Peripheral blood stem cell transplant (PBSCT): stem cells are collected from the 
peripheral blood 
 
Peripheral T Cell Lymphoma:  a group of rare and usually aggressive Non Hodgkin 
Lymphomas that develop from mature T-cells 
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Quality of life (QoL): An evaluation of health status, relative to a person’s age, expectations 
and physical and mental capabilities 
 
T cells: a type of lymphocyte (white blood cell) that play a central role in cell-mediated 
immunity 
 
Thalidomide: is in a class of medications known as immunomodulatory agents and can be 
used to treat certain cancers by strengthening the immune system 
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CHAPTER 1 
 
 
Introduction 
 
 
1.1 This introductory chapter begins to build the rationale for the thesis including its 
contextual and clinical origins. An explanation of the researcher’s role and interest in this 
area is followed by a short summary of the background to the study and an outline of the 
chapters.  
 
1.2 Researcher’s role and personal transcript 
My initial fascination regarding the experiences of patients undergoing stem cell transplant 
(SCT) for haematological malignancies began when I became a Matron in Haematology in 
2008. It is where I learned about this specialised field for the first time and was responsible 
for the in-patient ward, the haematology day unit and associated out-patient clinics. Once a 
decision has been made to treat the patient with SCT they spend several weeks in a 
protective isolation facility receiving high dose chemotherapy, radiotherapy and sometimes 
total body irradiation prior to undergoing their SCT. Whilst my role combined both clinical 
and managerial components, I was conscious not only of the impact of a long period of 
hospital stay on in-patient bed capacity but most importantly to the individuals’ experience of 
treatments, the impact of chemotherapy and radiotherapy, associated side effects, social 
isolation and their subsequent recovery.  
 
I found it hard to decide which part of the patient’s journey would form the focus of my 
research since the progression from diagnosis through treatment to returning home were all 
areas of significant interest to me. In particular, my attention was drawn to people’s ability to 
cope with life threatening diagnoses, toxic and invasive treatments and the experience of 
receiving often “last chance” life saving treatments when these were not necessarily 
guaranteed.  This in turn led me to consider the challenges lying ahead for these patients 
after hospital treatment, for example physical effects, psychosocial adaptation and the 
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adequacy of on-going support and after much deliberation chose this area for my research. 
What has been rewarding is that participant’s narratives have incorporated significant 
experiences from their initial symptoms, diagnosis, treatment and recovery phases through 
to their return home resulting in unique accounts of their individual journey. 
 
1.3 Background  
Initially, a literature review was conducted examining studies published between 1995 and 
2012. Rationale for this is because HSCT was becoming increasingly the treatment of 
choice for patients with haematological malignancy in the 1990’s. In the United Kingdom 
haematopoietic stem cell transplants using donor cells were progressively more prolific 
following the establishment of a stem cell donor registry in the mid 1980’s. As will be seen in 
the literature review a host of quality of life studies emanated from stem cell transplant 
centres and therefore served as a useful background to this study. The search was 
subsequently narrowed down to focus on the period between 2000 to 2012 for a number of 
reasons. Firstly, patients’ need for support in their cancer journey was highlighted by 
Sanson-Fisher (2000), corroborated by Cardy (2006) in a large scale study of the emotional 
impact of cancer, sponsored by Macmillan Cancer Support, where a quarter of the 
participants reported feeling “abandoned” and unsupported by the health system when they 
are not receiving care in hospital. Specific to haemato-oncology the government paper, 
Improving Outcomes in Haematological Cancers (NICE 2003) called for particular attention 
to be given to helping patients to adjust back to daily life, and to management and 
monitoring long-term side effects.  Issues relating to cancer survivorship and on-going care 
for all cancer survivors have also gained attention in recent years and led to policy 
development (DoH 2010, DoH 2007). Secondly, researchers began to consider the wider 
context of the psychosocial and emotional impact of stem cell transplant as patients’ survival 
rates improved.  Finally, nurse-led follow-up arrangements are evolving (Beaver 2005, Cox 
et al 2008, Cox & Wilson 2003) and it is pertinent to investigate how nurses and other health 
 
17 
and social care professionals can best support patients in the aftermath of lengthy and 
aggressive treatments involving stem cell transplantation. 
 
1.4 Overview of Chapters 
Literature review 
Chapter 2 presents the current knowledge and substantive findings relating to patients 
under-going haematopoietic stem cell transplantation and their subsequent recovery.  
Consideration is given to the theoretical and methodological contributions within this field 
and also to the wider related literature concerning cancer and survivorship. 
 
Methodology and methods 
 
Chapter 3 provides an overview of interpretive phenomenology and the rationale for it’s 
choice as a suitable methodology for this study in eliciting patient’s experiences of stem cell 
transplant. The research methods are outlined including the ethical considerations. 
 
Findings and analysis 
 
Chapter 4 presents the findings in two overarching themes; the immediacy of illness and 
existential crisis and the recovery journey. The participant narratives are analysed and 
supported by in vivo data extracts to provide evidence for the themes which emerged.  
References are also made to relevant research in the field.  
 
Discussion 
 
Chapter 5 presents a discussion of the findings.  
 
Conclusion 
 
Chapter 6 concludes the study making recommendations for informing clinical practice and 
future research. The limitations of the study are discussed. 
 
1.5 Summary of Chapter 
 
This introductory chapter has presented the rationale for this study by providing a synopsis 
of its context and background. The researcher’s clinical and managerial experiences have 
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been described to illustrate how the research idea evolved from observations in practice. 
The chosen methodology has been identified with a brief overview of the forthcoming 
chapters. 
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CHAPTER 2 
 
 
Literature Review 
 
 
2.1 Introduction 
This chapter presents an overview of the supporting literature for this study. The review 
summarises the current incidence and treatment of haematological malignancies including 
haematopoietic stem cell transplantation (HSCT). Studies evaluating quality of life during 
and after HSCT treatment are presented followed by research exploring the patient 
experience.  A major complication associated with the treatment, that is, graft versus host 
disease is also discussed. Key texts from the cancer literature are reviewed to inform and 
illustrate a broader focus to the patient’s illness and recovery experience. The limitations of 
current knowledge are described to provide the rationale for this study.   
 
2.2 Search strategy 
The databases used to obtain relevant studies between1995-2012 for this review are: The 
Cochrane Controlled Trials Register; Medline; CINAHL; British Nursing Index and 
PSYCHLIT. The search strategy  utilised for this review included the use of key words and 
phrases in each database: autologous stem cell transplant, allogeneic stem cell transplant, 
haematopoietic stem cell transplant (HSCT), bone marrow transplant (BMT). All of these 
terms were used singly and in conjunction with health and quality of life, patients’ attitudes 
and experiences, coping and psychosocial factors, survivorship, follow up, consultations, 
out-patient appointments, post discharge care, transition care, home care and hospital at 
home using Boolean operators.  The search revealed limited publications relating directly to 
follow up after stem cell transplantation and patient experience therefore literature focussing 
on quality of life and post-transplant experience was reviewed. Reference lists of all studies, 
reviews and articles obtained were checked for secondary references.  
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Allogeneic haematopoietic stem cell transplantation is often referred to as allogeneic HSCT, 
HSCT, HCT, SCT, peripheral blood stem cell transplant (PBSCT) or bone marrow transplant 
(BMT). When studies are referenced, the author’s abbreviation will be utilised but in the 
main body of this thesis the term HSCT and SCT will be used interchangeably. A glossary of 
terms is presented to explain medical and technical terminology on page 7. 
 
2.3 Classification and incidence of haematological malignancy 
Haematological malignancies are tumours affecting the haematopoietic and lymphoid 
tissues affecting the bone marrow, blood, and lymph nodes (Vardiman et al 2009, World 
Health Organisation 2014). A disease affecting one of these areas often affects the others 
due to their intimate connection through the immune system. Lymphoma, a disease of the 
lymphoid system often spreads to the bone marrow, thereby also affecting the blood. 
According to the World Health Organisation (WHO 2001) classification of haematological 
malignancy is dependent on cell lineages, that is the myeloid and lymphoid lines. 
Lymphomas and lymphocytic leukaemias are derived from the lymphoid line whilst acute 
and chronic myelogenous leukaemia, myelodysplastic syndromes and myeloproliferative 
diseases are myeloid in origin. 
 
A quality appraisal comparing data from the National Cancer Data Repository with the 
population-based Haematological Malignancy Research Network (2012) states that there 
are no precise or reliable figures for incidence and survival rates for the range of 
haematological cancers in England and Wales. Complexities surrounding the multiple 
parameters required for diagnosis are considered key to this problem such as a combination 
of histology, cytology, immunophenotyping, cytogenetics, imaging (see glossary of terms) 
and clinical data (Swerdlow 2008). However, according to Leukaemia and Lymphoma 
Research (2014) around 30 000 people in the United Kingdom from infancy to adulthood are 
diagnosed with a haematological malignancy (blood cancer) every year. Cancer Research 
UK (2014) report average survival statistics for certain haematological malignancies 
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acknowledging that individual cases vary significantly according to stage and severity of 
disease, type of blood cell affected and age. Treated at an early stage, survival of at least 
five years is reported as 91-94% for Hodgkin lymphomas, 40% for acute lymphoblastic 
leukaemia and 25% for acute myeloid leukaemia. In the latter case survival for more than 
five years in those under 45 years is 50% reducing to only 12% for those over 65 years. 
 
2.4 Initial treatment of haematological malignancy 
The primary aim of treatment for haematological malignancies is to achieve disease 
remission. For diseases such as lymphoma, leukaemia and Hodgkin lymphoma the 
instigation of a suitable chemotherapy regime is commenced as soon as possible after 
diagnosis and a requirement for radiotherapy may also be indicated. The duration of this 
treatment, referred to as induction therapy can take up to a month and aims to destroy all of 
the malignant cells (Cancer Research UK 2014). This is proceeded by consolidation therapy 
consisting of more chemotherapy aimed to prevent malignant cells from returning and 
subsequently maintenance treatment consisting of low dose chemotherapy and short 
courses of steroids for up to two years or stem cell transplant (Cancer Research UK 2014). 
Both induction and consolidation therapy regimens are intense and require periods of 
hospitalisation in a protected isolation facility due to the risk of infection caused by the 
disease and the treatment.  The intensity of therapy is necessary to destroy the rapid 
production of immature and ineffective white blood cells which in turn limit the production of 
normal functioning white and red blood cells and platelets. Chemotherapy is administered 
through an indwelling intravenous device placed into one of the larger ‘central’ veins or in 
the case of acute lymphoblastic leukaemia, intrathecally when malignant cells have 
penetrated the central nervous system.  It is often necessary to also give blood and or 
platelet transfusions due to the depletion of red blood cells and platelets resulting from both 
disease and treatment.  For other malignant diseases, different treatments are indicated 
prior to consideration of allogeneic SCT. Myelofibrosis is treated with medications that target 
the JAK2 gene mutation thought to be responsible for the disease combined with steroids, 
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androgen (male hormone) therapy and thalidomide related medications (Killick et al 2013). 
The main treatment for myelodysplastic syndrome is supportive care including the use of 
antibiotics, blood transfusions to treat severe anaemia and in some cases growth factors to 
promote normal blood cell production in the bone marrow (Killick et al 2013). In more severe 
or progressive disease, chemotherapy may be used to control a rising blast count and allow 
the bone marrow to resume normal blood cell production. This can involve low dose oral 
chemotherapy or more intensive treatment using a combination of drugs given 
intravenously, similar to those used to treat acute myeloid leukaemia. Medical therapy for 
aplastic anaemia involves suppression of the immune system and in more severe cases, a 
stem cell transplant (Locasciulli et al 2007). 
 
2.5 Haematopoietic stem cell transplant 
Haematopoietic stem cell transplant (HSCT) is increasingly considered the treatment of 
choice for patients with a range of malignant haematological diseases including leukaemia, 
non-Hodgkin lymphoma, Hodgkin lymphoma and myeloma (Rizzo et al 2006). Globally, 
10,000 patients are treated in this way annually (Gratwohl et al 2008). As mentioned above, 
HSCT is also used to treat patients with aggressive forms of aplastic anaemia, 
myelodysplastic syndrome and myelofibrosis.  Significant morbidity and mortality are 
associated with the underlying diseases and their treatments, including transplantation, and 
extend well into the post transplant recovery phase (Lee et al 2001, Andrykowski 2005).  A 
study (Hahn et al 2013) included 38,060 patients with haematological malignancies or 
disorders who underwent a first allogeneic HSCT in a United States or Canadian Centre 
between 1994-2005 and were reported to the Centre for International Blood and Marrow 
Transplant Research. Diseases included acute lymphoblastic leukaemias, myeloid 
leukaemias, myelodysplastic syndrome and Hodgkin and non-Hodgkin lymphomas. Survival 
rates for those undergoing allogeneic SCT from both related and unrelated donors have 
shown an overall increase since the inception of this procedure. This can be largely 
attributed to advances in HLA tissue typing, improved supportive care and earlier treatment 
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with transplantation. Yet Hahn et al (2013) advocate further development of innovative 
approaches to increase the overall survival to more than one year. 
 
The decision to undertake HSCT is taken when attempts to otherwise treat the disease have 
failed or when certitude that this will ultimately be the case exists.  The purpose of HSCT is 
to replace the recipient’s diseased or damaged stem cells by replacing them with healthy 
ones. Haematopoietic stem cells are the blood forming component of bone marrow 
responsible for the production of red blood cells, white blood cells and platelets which in turn 
carry oxygen to body tissues, prevent infection and prevent bleeding respectively. There are 
two main types of stem cell transplantation. The first is autologous - when the patient’s own 
stem cells are collected during a period of disease remission, stored and re-infused at a later 
time. The second is allogeneic - when the stem cells are obtained from a related or 
unrelated donor. Once the decision is made to progress to an allogeneic SCT the process of 
establishing a donor of a tissue type compatible with the recipient commences.  A related 
donor is more likely to have matching human leukocyte antigen tissue types (see glossary 
on p 7) to that of the recipient which plays a significant role in transplant success (US Bone 
Marrow Transplantation and Peripheral Blood Stem Cell Transplantation National Cancer 
Institute 2015).  Historically the stem cell collection involved aspirating the bone marrow but 
has largely been replaced by a process known as apheresis. The donor is treated with the 
hormone, granulocyte colony stimulating factor (G-CSF) to increase the production of their 
stem cells (Cancer Research UK 2015). The apheresis procedure involves being attached to 
a machine with an intravenous device which draws off and filters the donor’s blood in order 
to preserve the stem cells for transplantation to the recipient. Stem cells may also be 
collected from umbilical cord blood (Cells4life 2015). 
 
2.6 Conditioning therapy 
Conditioning is the term used to describe the chemotherapy or irradiation regimen employed 
to eradicate the patient’s disease and to suppress immune reactions preceding the infusion 
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of healthy stem cells. The bone marrow is ablated with dose levels that cause minimal injury 
to other tissues. In allogeneic SCTs a combination of cyclophosphamide or similar agent in 
addition to total body irradiation is conventionally employed Socie et al (2001).  Whilst SCTs 
allow higher strength conditioning treatments to treat aggressive disease, the associated 
toxicities can result in painful stomatitis, chemotherapy induced colitis and life threatening 
infections (Larson et al 1993). More recently, novel treatment approaches use lower doses 
of chemotherapy and radiation and whilst insufficient to eradicate all the bone marrow cells 
of the recipient, non-myeloablative transplants reduce the risk of serious infections and 
transplant related mortality and instead rely on the graft versus tumour effect to resist the 
inherent risk of cancer relapse (Alyea et al 2005, Aleya et al 2006). Also, whilst requiring 
elevated doses of immuno-suppressive agents (drugs used to prevent rejection of the 
donated stem cells) in the early stages of treatment they are less than for conventional 
transplants (Mielcarek et al 2003). This results in a state of dual chimerism1 in the early 
stages following transplant where both host and donor stem cells are present in the marrow 
space. By decreasing doses of immuno-suppressant’s the donor T-cells are allowed to 
eradicate the remaining recipient’s stem cells and to induce the graft versus tumour effect. 
The relatively common appearance of mild graft-versus-host disease is indicative of the 
more desirable graft versus tumour effect and serves to inform future dosage levels of 
immuno-suppressive agents. Less aggressive conditioning regimes tend to be undertaken in 
elderly patients or for those considered too high risk for conventional allogeneic STC (Alyea 
2005). 
 
2.7 Graft-versus-host disease 
Graft-versus-host disease (GVHD) commonly occurs in people undergoing allogeneic HSCT 
for haematological malignancies with 30-70% suffering an acute or chronic form (Lee et al 
2003). The disease occurs as a result of the donors stem cells recognition of host tissues as 
antigenically foreign. Although the risk of GVHD is reduced by deoxyribonucleic acid (DNA) 
                                                 
1 Chimerism is the term normally used to describe the status of donor marrow in the patient 
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based tissue typing, allowing for more precise matching between donors and transplant 
patients, it can still manifest. Even human leucocyte antigens (HLA) identical unrelated 
donors have genetically different proteins known as histocompatability antigens causing the 
donors T-cells to mount an immune response. The acute form of GVHD is typically 
experienced in the first one hundred days post-transplant (National Marrow Donor 
Programme 2014) and poses a major challenge associated with morbidity and mortality 
(Goker, Haznedaroglu & Chao 2001). The chronic form normally occurs after a hundred 
days and can present on-going challenges to transplant patients long into their recovery 
phase, adversely affecting long term survival (Lee et al 2003). The clinical manifestations of 
acute GVHD include selective damage to the liver, lungs, skin and mucosal membranes and 
the gastro-intestinal tract. Chronic GVHD also attacks these organs and over the longer term 
can cause damage to the connective tissue and exocrine glands. Patients can experience 
rashes, itching, diarrhoea, nausea, mucositis, loss of appetite and jaundice. Standard 
treatment of both acute and chronic GVHD is the administration of intravenous 
glucocorticoids such as prednisolone designed to suppress the T-cell-mediated immune 
response of host tissues. Risks associated with the treatment are infections due to this 
immune suppression. Depending on the severity of the GVHD, quality of life may decrease 
significantly (Pidala et al 2009) and exacerbation result in hospitalisation for therapeutic 
intervention or dose adjustment of the patient’s existing medications (Grant et al 2005). 
 
2.8 Quality of Life Measures 
For patients undergoing HSCT there are numerous severe physical, psychological, social 
and emotional challenges to be faced (Cooke et al 2009, Sherman et al 2005, Hacker & 
Ferrans 2003, Hacker et al 2002, Hendricks & Schouten 2002, Fife et al 2000). 
Considerable attention has been dedicated to the assessment of quality of life (QoL) for 
patient’s undergoing HSCT and is important in order to compliment data regarding survival 
statistics, treatment outcomes and disease free intervals. Conceptualising QoL, however, is 
not straightforward since definitions vary (Ferrans 2000) and researchers strive to identify 
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and develop the most appropriate instrument to reflect their own conceptualisation.  Clearly, 
the validity and reliability of the measurements used in relation to QoL is imperative but 
equally if an agreed definition of quality of life is not reached, interpretation, comparison and 
synthesis of research findings will be compromised (Hacker 2003). In the thirty-two studies 
included in an integrative review (Hacker 2003) investigating quality of life in adult patients 
undergoing bone marrow transplant or peripheral blood stem cell transplant over a decade, 
only five stipulated a definition of quality of life. Liptrott (2007) similarly acknowledges the 
difficulties of applying quality of life assessment to clinical practice in view of the wide 
variation of measures used and the relative importance attached to their specific domains. 
Her review (Liptrott 2007) examines both the qualitative and quantitative methods of 
assessing the impact of HSCT on QoL and notes both the multidimensional nature of the 
measures and the multiple separate scales. The outcomes of the studies appear to be 
influenced considerably by the context of the methodology and perception of quality of life 
from the instruments used.  Table 1 summarises a range of QoL studies a number of which 
are reviewed in more detail in the following sections. 
 
 2.9 Table 1: Quality of life studies and reviews during haematopoietic stem cell transplantation 
 
Authors Objective of study Sample Measures Results 
Anderson et al 
2010  
To describe health related QoL  
(HRQoL) after autologous versus 
allogeneic SCT during the first year 
post transplant. Also to compare 
allogeneic SCT after reduced  
intensive conditioning (RIC) and 
allogeneic SCT after myeloablative 
conditioning (MAC) 
139 patients between  
2000-2004  
European Organization for Research and 
Training for Quality of Life Questionnaire-
Core30. (EORTC QoLQ-C30) 
Questionnaires completed on six occasions
from inclusion to 12 months post SCT 
The RIC group recovered in a similar way  
to the autologous group and were closer in 
scoring compared with the MAC group.   
After 1 year levels of symptoms and 
functioning were back to baseline or better 
for the autologous and RIC group. The  
MAC group perceived more symptoms and 
lower levels of functioning during the whole 
period and were still impaired in 10 out of  
29 scales 1 year after SCT 
 
Andrykowski et a
2005 
To examine health-related quality of 
life (HRQoL) and growth, and  
spiritual well-being in adult survivors 
of hematopoietic stem-cell 
transplantation (HSCT) for a  
malignant disease 
HSCT survivors (n = 662)  
recruited through the Inter- 
national Bone Marrow Trans- 
plant Registry/Autologous  
Blood and Marrow Transplant 
Registry from 40 transplant  
centres  
Age- and sex-matched healthy 
comparison (HC) group (n =  
158) 
Mean age approx 50 yrs in  
both groups 
Breast cancer (n=154) and 
haematological malignancy  
(n= 497) 
Autologous (n=386) 
Allogeneic (n=267) 
A variety of standardized measures of  
HRQoL and growth and spiritual well-being:
Physical Functioning (SF-36-PF) and pain 
(SF-36-Pain) subscales of the SF-36 
Physical Well-Being subscale of the  
Functional Assessment of Cancer therapy 
scale (FACT-PWB) 
Functional Assessment of Cancer Illness 
Therapy Fatigue subscale (FACIT-Fatigue)
Medical Outcomes Study Sexual Problems 
(MOS-Sex) and Sleep Problems (MOS- 
sleep) scales 
Alertness Behaviour subscale of the  
Sickness Impact profile (SIP-AB) 
Mean 7 years post HSCT (range 1.8-22.6) 
HSCT survivor group reported poorer  
status relative to the HC group for all  
HRQoL outcome clusters including  
physical health, physical functioning,  
social functioning, psychological  
adjustment, and dyadic adjustment. 
HSCT survivor group reported more 
psychological and interpersonal growth 
Bevans 2010 To define HRQL, highlight the major 
HRQL during allogeneic HSCT and 
discuss the clinical application of the 
evidence and gaps that require  
further research 
Case study of one 28 year old 
female  
Patient reported outcomes (PROs)   Inclusion of PROs should be incorporated  
into patient assessment and clinical care. 
Psychological and social needs are less  
often addressed than physical function and 
symptoms  
 Bird et al 2010 Randomised controlled trial (RTC) to 
compare the effect of two methods of 
rehabilitation after SCT on health and
QoL 
58 patients between  
2005-2006. Median age  
55 years. Autologous and 
allogeneic. 
28 randomised to intervention 
and 29 control patients 
36-item Short Form Health Survey. 
General Health Questionnaire 
Graham and Longman QoL Scale 
Shuttle Walk Test 
Data collected at baseline, 12 weeks and 6 
months  
There was no difference in Short Form 36 
physical functioning scores between the  
two groups at follow-up. No evidence of a 
difference between the two modes of 
rehabilitation was observed for any of the  
trail outcomes 
 
Byar et al 2005 To evaluate QoL 5 or more years  
post autologous HSCT 
197 individuals post BMSCT 
between 1983-1992 for 
haematological malignancy 
Medical Outcomes Study-Short Form (MOS
SF-36);City of Hope-Quality of Life-Bone 
Marrow Transplant (COH-BMT) and the 
Functional Assessment of Cancer Therapy-
Bone Marrow Transplant (FACT-BMT) 
 
MOS-SF-36 scores for physical functioning,
role-physical, bodily pain and general  
health sub-scales lower than values for the 
general population 
Frick et al 2004 To compare individual QoL (iQoL)  
with health related QoL (HRQoL) and 
functional status of patients before  
high dosed therapy/PBSCT  
79 patients aged between  
10-70 years 
Schedule for the Evaluation of Individual 
Quality of Life-Direct Weighting (SEIQoL- 
DW) and the EORTC QLQ-C30 
Patient nominated domains included family 
(89%0, hobbies/pastimes (74%), health 
(physical including mobility) (70%), 
profession/occupation (51%), social life/ 
friends (47%) and marriage/partnership  
(33%). Patient perceived iQoL depends on 
areas other than health and physical 
functioning 
 
Hacker & Ferran
2003 
To investigate the QoL among  
patients immediately after 
undergoing peripheral blood stem 
cell transplantation 
16 patients Autologous and 
allogeneic 
European Organization for Research and 
Training for Quality of Life Questionnaire-
Core30 and the Ferrans and Powers  
Quality of Life Index.  
Assessed before transplantation (n=16), 
immediately before hospital discharge  
(n=10), 2 weeks after hospital discharge 
(n=10), and at 6 weeks post hospital 
discharge. 
Brief telephone interview at 6 weeks after 
discharge from hospital 
Patients experienced diminished functional 
ability, increased symptoms and poorer  
quality of life immediately after the marrow 
ablative regimen. Deviations from pre 
transplantation functioning did not  
necessarily result in life dissatisfaction. 
Findings suggest some patients can return  
to baseline status in terms of perceived  
health and functioning, decreased  
symptoms and overall QoL 6 weeks after 
hospital discharge 
 
  
Hacker 2003 To critically evaluate a decade of 
quantitative QoL measurement in  
adult patients undergoing bone  
marrow transplant (BMT) or  
peripheral blood stem cell transplant 
(PBSCT) 
Quantitative research studies 
published between 1990-2000 
in the nursing and medical 
literature (N=32) 
Single or multiple instruments to assess  
QoL 
Nurses can select from a variety of tools to 
measure QoL in the BMT and PBSCT  
patient populations. No gold standard  
exists for measuring QoL in research or  
clinical practice. Clinicians must consider  
the clinical meaningfulness of changes in  
QoL before implementing changes in their 
practice 
 
Hendriks & 
Schouten 2002 
To measure QoL after stem cell 
transplantation from a patient,  
partner and physician perspective 
SCT survivors with no  
recurrent disease. 
Autologous and allogeneic 
EORTC QLQ-C30 at 2.5 years (n=52) and 
at 4.5 years (n=33) post SCT 
SCT has long term impact on QoL issues  
such as fatigue, sleep disturbance,  
dyspnoea and financial problems. Partner’s 
assessment of the patient’s QoL was more 
aligned with the patient’s own assessment. 
Physicians tend to overestimate QoL and 
underestimate symptoms in their patients 
 
Jarden et al  
2009 
Randomised controlled trial (RTC) 
to explore the effect of a 
multimodal (exercise, relaxation 
training and psychoeducation) 
intervention on treat-related 
symptoms in patients undergoing 
allogeneic haematopoietic SCT 
42 patients aged 16-65 years 
Allogeneic. 
21 randomised to intervention 
21 control 
24 item symptom assessment 
questionnaire weekly in hospital and at 3 
and 6 months post SCT 
Overall significant decrease in symptom 
intensity in all but the affective symptom 
cluster (affective symptoms = 
nervousness, anxiety and stress). The 
study begins to support an exercise-
based multi-modal intervention 
programme 
 
Lee et al 2006 To measure QoL of patients 
undergoing allogeneic 
transplantation 
96 subjects between 1999-
2004. Median age 46 years  
Self assessment surveys pre HCT and at 
6 months and 1 year post HCT including 
the Medical Outcomes Study Short From 
12 (SF12) and the Functional 
Assessment of Cancer Therapy-Bone 
Marrow Transplant scale (FACT-BMT) 
Physical and mental functioning 
assessed by the SF12 was not 
associated with acute or chronic GVHD. 
In contrast the trial outcome index (TOI) 
of the FACT-BMT was sensitive to 
occurrence of acute and chronic GVHD. 
GVHD is a major determinant of the QoL 
of survivors. Chronic GVHD is most 
strongly correlated with worse QL after 6 
months post transplantation 
  
Liptrott  2007 To provide an overview of themes 
and issues arising from a  literature 
review of QoL for patients 
undergoing HSCT 
Qualitative and quantitative 
QoL studies 
Single or multiple instruments to assess 
QoL 
Definitions of QoL variable; instruments 
used to measure QoL variable. 
Aspects of QoL identified as both 
positive and negative at varying times 
throughout the HSCT journey. Few 
studies report interventions and 
outcomes 
 
Mosher et al  
2008 
To review current literature on 
adult’s QoL following HSCT 
Review of 22 prospective 
reports with 20 or >20 
participants between 2002-
2007 
Single or multiple instruments to assess 
QoL at baseline and post HSCT 
Although physical, psychological and 
social aspects of QoL improve over the 
years following HSCT, survivors 
experience persistent anxiety and 
depressive symptoms, fatigue, sexual 
dysfunction and fertility concerns. 
Despite ongoing treatment side effects, 
the majority of HSCT survivors resume 
work, school or household activities 
 
Pidala et al 
2009 
To review the current literature on 
QoL following allogeneic HCT in 
adults 
Review of 37studies 
examining QoL after HCT 
Single or multiple instruments to assess 
QoL 
Statistically and clinically significant 
adverse impact of allogeneic HCT on 
QoL. Improvements over time from 
baseline. Some studies suggest greater 
impairments to QoL in allogeneic HCT 
compared with autologous HCTH and 
chemotherapy but others do not. Acute 
and chronic GVHD pose threats to QoL. 
Behavioural interventions have 
demonstrated efficacy in improving QoL 
 
  
Saleh & 
Brockopp 
2001 
To examine a comprehensive view 
of QoL post BMT and to evaluate 
the psychometric properties of an 
instrument designed to measure 
QoL in this population 
41 BMT survivors with an 
age range of 18-71 years 
Autologous and allogeneic 
BMT 
Quality of Life in Bone Marrow 
Transplant Survivors Tool (QoL-BMT-ST) 
An average of 30 months post-BMT 
 
Global QoL good (x=6.7 on 0-10 scale. 
Subjects experienced long-term areas of 
concern including physical strength, 
sexual activities, fear of cancer 
recurrence, fear of developing a 
secondary cancer, unemployment, family 
distress and uncertainty toward the 
future. Psychometric testing of the QoL-
BMT-ST revealed adequate to excellent 
reliability and validity 
 
Schulmeister 
et al 2005 
To expand the limited body of 
knowledge of the perceptions of 
QoL, quality of care and patient 
satisfaction among patients 
receiving high-dose chemotherapy 
with an autologous SCT on an out-
patient basis 
36 patients  FACT-BMT before chemotherapy and 2-
4 weeks and 6 months post 
chemotherapy and SCT 
FACT-BMT scores were lower 1 month 
post-treatment than at baseline and 
highest six months post treatment. 
Subjects with progressive disease 
reported lower QoL at one and six 
months post treatment and ranked 
satisfaction with care lower than subjects 
with no evidence of disease 
 
Tierney et al 
2007 
Exploration of the theoretical 
model of response shift in relation 
to QoL following HSCT 
Review of 25 QoL studies Only 3 studies stated the theoretical 
framework on which the study was 
grounded 
HSCT recipients report good to excellent 
QoL following treatment despite ongoing 
physical and psychological sequelae. 
The theoretical model, response shift 
offers a compelling explanation for the 
paradoxical findings. Response shift 
proposes that individuals redefine QoL 
based on alterations in health status 
 
Wettergren et 
al 2008 
To prospectively measure QoL in 
patients with malignant blood 
disorders following SCT using an 
individualised and a standardised 
measure 
22 patients assessed  Schedule for the Evaluation of Individual 
Quality of Life-Direct Weighting (SEIQoL-
DW) and the EORTC QLQ-C30 
Before and 1 year post SCT and the 
standardised measure was compared to 
Swedish norm values 
The majority of patients reported 
concerns related to health before and 1 
year post SCT recorded by both 
instruments. QoL improved after a year. 
SCT recipients reported worse 
functioning in comparison to Swedish 
norm values  
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2.10 Patient’s experience and QoL including the period of undergoing SCT 
This section reviews a qualitative study of patients undergoing allogeneic and autologous 
stem cell transplant in hospital (Shuster et al 1996), a personal account of the stem cell 
transplant experience (Morstyn 2009) and a descriptive longitudinal study (Schulmeister et 
al (2005) exploring patients’ perceptions of QoL, quality of care and patient satisfaction 
whilst undergoing autologous SCT for a variety of conditions including haematological 
malignancy on an outpatient basis. The studies are summarised in Table 1. 
Shuster et al (1996) interviewed patients (n=11) during their hospitalisation for SCT 
including one who had an autologous and ten who had an allogeneic SCT. Informants were 
interviewed between one and four times a week whilst in hospital and once a week for four 
weeks post discharge. Five themes emerged from the study which were physiological 
functioning, alertness, attitude, social relationships and spirituality. Physiological functioning 
concerned numerous severe challenges such as pain, nausea, itching, fevers, sweats, chills 
and seizures along with difficulties in eating and the discomfort of tubes such as intravenous 
devices.  The authors (Shuster et al 1996) identified a thread between all five core themes 
which led them to describe the ‘dialectic of patient coping experience’ (Shuster et al 1996 p 
5). In essence the informant’s vacillated between two poles; a desire for connectedness and 
a sense of disconnection in order to deal with their experience. For example they alternated 
between striving to be alert and the desire to sleep through unpleasant events, or a desire to 
plan for the future countered with dealing with the immediacy of daily life.  
 
Making sense of the transplant experience is eloquently described by Morstyn (2009) in his 
personal reflections of his bone marrow transplant. As a practising psychiatrist, he 
endeavours to conceptualise his experiences of diagnosis and treatment within a medical or 
psychiatric framework but finds neither of these approaches suitable in addressing his 
feelings or understanding. Spending weeks in isolation under-going harsh treatments 
Morstyn (2009) found that he was no longer able to consider the world as a separate entity 
from his own existence in it. Whereas his body was largely taken for granted and generally 
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invisible to him, the threat of death and deterioration coupled with physical changes, 
disruptions, pain and fatigue necessarily created a new and frightening awareness. He 
describes new forms of spacial and temporal experience such as noticing the ceiling as he 
spent hours staring up at it as if re-learning to look at the world. Further discomfort was 
suffered by self-alienation resulting from physical pain and the ambiguity of existence and 
solitude experienced at this very difficult time. He describes how Merleau-Ponty’s (2002 
p237) explication of the phenomenology of perception helped him to make sense of his 
“overwhelming existential crisis” and as a consequence felt better able to understand his 
own experience. Furthermore, he could identify individuals who were able to relate to him in 
his altered existential state and contribute invaluably to his recovery. Whilst a number of 
these were health care professionals, he found that their ability was variable and that the 
most significant person  to understand his predicament was his wife. 
 
A descriptive longitudinal study (n=36) was carried out by Schulmeister et al (2005) to 
explore patients’ perceptions of QoL, quality of care and patient satisfaction whilst 
undergoing autologous SCT on an outpatient basis. Of the thirty-six patients, twenty one 
had breast cancer, one ovarian and fourteen haematological malignancy and whilst 64% 
lived at home, 3% stayed in a residential facility and 33% in an apartment near to the out-
patient site. Subjects completed the Functional Assessment of Cancer Therapy-Bone 
Marrow Transplant (FACT-BMT) before high-dose chemotherapy, four to six weeks after 
and six months post-chemotherapy.  In addition, telephone interviews were conducted to 
gain the patient’s perspective on their treatment experience, quality of care received and 
satisfaction of care and the qualitative data were analysed using Giorgi’s methodologic 
reduction.  Findings revealed that those reporting a negative experience were associated 
with severe or life threatening effects including neutropenic sepsis as a result of high dose 
chemotherapy and almost half of the patients in the study required hospitalisation 
(Schulmeister et al 2005). Recommendations for improvement of the autologous SCT 
programme included more effective communication, better information and implications for 
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nursing care, ancillary needs and survivor support. Specific comments relating to 
communication and information related to offering rationales for symptom management 
advice and offering personalised information tailored to an individuals’ needs. Participants 
also suggested that they would appreciate conversations regarding spirituality, sexuality, 
effects of treatment on fertility, long-term effects and complementary therapies 
(Schulmeister et al 2005 p64). 
 
2.11 Quality of Life Studies post stem cell transplant 
This section reviews a number of studies investigating QoL pre SCT up to twenty two years 
post SCT. It should be noted that patients involved in the studies have a range of diseases 
including breast cancer and haematological malignancy and are treated with both 
autologous and allogeneic SCT. Patients undergoing autologous SCT do not suffer from 
GVHD and therefore this potentially reduces the number of side effects post SCT.  A study 
by Wettergren et al (2008) found that quality of life improved a year post compared to pre-
transplant state. Most notable were improvements in the domains of role function, social 
function and physical function.  The authors advocate the use of a standardised instrument 
to measure QoL in combination with an individualised measure. The latter allows 
participants to nominate preference-based domains, thereby increasing the likelihood of 
reflecting a patient’s personal perceptions and priorities at specific times. In an earlier study, 
carried out by Whedon et al (1995), the QoL-BMT-ST was supplemented with an open-
ended qualitative questionnaire allowing patients to report additional data which highlighted 
additional themes of pain, uncertainty and fear of disease recurrence. 
 
Saleh and Brockopp (2001) examined a comprehensive view of quality of life post BMT and 
evaluated an instrument to measure quality of life in this population. The Quality of Life in 
Bone Marrow Transplant Survivors Tool (QoL-BMT-ST) was found to be reliable and valid 
through comparison and high correlation with similar measures and the authors (Saleh & 
Brockopp 2001) promote its value over other instruments for two reasons. Firstly, its design 
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is specific to BMT survivors on previous QoL evaluation and secondly, certain questions are 
generated directly from the content analysis of interviews with BMT survivors though the 
authors do not state specifically what these questions were. The study included patients 
who had been treated with either allogeneic or autologous transplantation. The BMT 
survivors (n=41) with an age range of 18-71 years who were an average of thirty months 
post BMT in Saleh & Brockopp’s (2001) study reported good quality of life. However, areas 
of concern included physical strength, sexual activities, fear of cancer recurrence, fear of the 
development of a secondary cancer, unemployment, family distress and uncertainties about 
the future and are reported with high incidence during the first year post transplant. 
Uncertainty was found to be conceptually distinct from fear of recurrence but closely 
associated with the unpredictable nature of their primary cancer. 56% of the allogeneic BMT 
survivors experienced graft versus host disease, causing changes in physical appearance 
accounting for the psychological distress reported. 
 
Tierney et al (2007) note the paradoxical findings of a large number of QoL life 
investigations where SCT recipients report good to excellent QoL following treatment 
despite ongoing physical and psychological sequelae. Corroborating this evidence are 
studies reporting positive outcomes such as enhanced appreciation of life and relationships, 
personal growth and a re-ordering of life priorities as perceived by the individual 
(Andrykowski et al 2005, Dew et al 1997, Fromm et al 1996). The theoretical model of 
response shift into QoL research (Sprangers & Schwartz 1999) helps to explain how 
patients redefine their quality of life based on alterations in health status.  The response shift 
model offers an explanation of how individuals perceive their quality of life in the face of on-
going physical and emotional sequelae. The concept of response shift accounts for a 
change in meaning an individual assigns to their own perception of their QoL resulting from 
a reappraisal of values, internal standards or re-conceptualisation of the target construct.  
Similarly, Tierney et al (2007) acknowledge that social factors may also affect individuals’ 
perceptions of their QoL and for some, survival itself, given the limited treatment options 
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available, may be synonymous with life quality. Tierney et al (2007) effectively demonstrate 
the phenomena of response shift in their case study. Despite enduring problems with 
chronic GVHD following STC, resulting in significant physical manifestations, loss of sexual 
desire and eventually abandoned sexual activity the individual studied rated her QoL higher 
at these times than at others when health issues were not so challenging.  
 
In a large (n=662) multi-centre study Andrykowski et al (2005) compared patients who had 
received an HSCT with a healthy control group to illicit their health related QoL (HRQoL) a 
mean of seven years post treatment. The HSCT survivor group reported poorer status 
relative to the healthy control group for all HRQoL outcome clusters including physical 
health, physical functioning, social functioning, psychological adjustment, and dyadic 
adjustment. In contrast, the HSCT survivor group reported more psychological and 
interpersonal growth corroborated by Tierney et al’s (2007) findings. A study investigating 
quality of life after SCT at around 2.5 (n=52) and 4.5 (n=33) years, Hendriks & Schouten 
(2002) found that survivors experienced  long term impact on QoL issues such as fatigue, 
sleep disturbance, dyspnoea and financial problems.  Whilst recognising the value of the 
tool in analysing overall quality of life the authors (Hendriks and Schouten 2002) point to the 
importance of factors such as sexuality and unemployment which are not included but 
potentially have significant impact on quality of life.   
 
Although increasing data are available addressing QoL issues after stem cell 
transplantation, a number of important challenges remain for investigators. Whilst the 
concept of QoL is an important consideration in the aftermath of arduous treatments for life-
threatening illness (Pidala et al 2009), its definitions remain varied, synonymous with the 
heterogeneity of the instruments utilised to measure it. These range from general quality of 
life instruments such as the 36-item Short Form Health Survey to cancer-related measures 
such as the Functional Assessment of Cancer Therapy General and disease specific and 
treatment related measures such as the FACT-BMT outcome measures. Whilst the disease 
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specific and treatment related measures are more sensitive to specific patient groups, 
interpretations and comparisons of studies using heterogenous instruments are problematic. 
Patient attrition can also affect the validity of longitudinal studies along with potential 
response shift in relation to self-reported QoL. It is also recognised that further work is 
required to enhance the researchers, clinicians and patients understanding of the clinical 
relevance of QoL throughout the treatment and recovery trajectory (Pidala 2009, Bevans 
2010).  
 
2.12 Social context of quality of life 
In their study of forty-four cancer patients in two treatment centres, Schou and Hewison 
(1999) examine factors affecting quality of life whilst undergoing radiotherapy and or 
chemotherapy. Unlike other studies which, they argue, ignore or under-examine the social 
nature of treatment Schou and Hewison (1999) draw attention to the importance of the 
individual’s social reality in relation to their experience. Contrary to the perception of 
patients’ being passive recipients of treatment Schou and Hewison (1999) highlight the 
significant, interpretive and practical work that patients undertake in order to manage 
complex treatment and their daily lives. The important role of language in the social 
construction of treatment and patients’ accounts of treatment experience places social 
context as an integral part of their cognitive-behavioural mechanisms and processes. 
Therefore the authors caution against assumptions being made regarding patients’ coping 
and adjustment styles in isolation of their social context and reality. Developing this 
argument further, Schou and Hewison (1999) explore the concept of time and treatment 
calendars in relation to experiencing cancer. Surviving a cancer diagnosis for five years or 
more whilst living with the effects of treatment and the possibility of recurrence has led to it 
being considered a chronic illness (Witter & LeBas 2008).  As a consequence there is a 
requirement for patients to reconstruct their personal calendars according to frequent 
disruptions and deviations from their pre-diagnostic situation. 
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In terms of developing strategies to deal with their cancer experience, Corbin and Strauss 
(1988) refer to three focal areas for patients and families, these being illness related, 
biographical and everyday life-work. Schou and Hewison (1999) conceptualise these three 
areas in terms of organisation of time so that the work of patients and families is to balance 
the illness and treatment calendar with their biographical life calendar and their personal or 
private calendar. The authors contend that that this work is hindered by the ambiguity of 
dialogue between health care professionals where prognostic and treatment detail is rarely 
discussed and the language used is tempered to inspire the notion of cure and survival. Van 
der Waal (1996) found continuity of care to be one of the most important aspects of QoL for 
patients with chronic illness, whilst this appeared to be a lower priority to providers. Changes 
in schedules or alterations to treatment plans gave rise to patients’ anxiety, particularly when 
news of these was delivered by a junior or unknown person. Concurring with this evidence, 
Schou and Hewison (1999) found that lack of a dependable contact with an identifiable 
central treatment professional or professional treatment team is a distinct feature of a 
confusing treatment context. The lack of a central figure gave rise to communication deficits 
and interfered with relationship building between professionals and patients. Questions 
regarding treatment and surveillance as well as explanations regarding test results and 
procedures tended to be unaddressed by the less experienced clinical staff and impacted on 
patient choice and consequent control of their treatment programme. Patients commented 
on the confusion caused by receiving conflicting information. An example of this arose when 
a patient reported fatigue and received a lecture on the benefits of positive thinking at one 
consultation, but at the next was told that this was understandable (Schou and Hewison 
1999). 
 
The displacement of the personal and life calendar is arguably the most important effect of 
the treatment calendar and the disease process on the ill person’s Quality of Life, (Schou 
and Hewison 1999). To this end, they argue the importance of professional contact and 
advice in managing the treatment calendar and rehabilitation phase so that patients and 
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families can assess if and when normality will be resumed.  In summary the illness calendar 
and treatment calendar expressed by the term ‘patienthood’ (p153) is considered by Schou 
and Hewison (1999) to be key to illness related quality of life but is often underestimated 
and overpowered by the functional living perspective associated with the biomedical model.  
Whereas QoL in oncology originated in ideas about impairment and disability and their 
assessment, treatment processes themselves impact seriously on social functioning. 
 
2.13 The lived experience of autologous stem cell transplantation 
Two studies (Jones & Chapman 2000, Stephens 2005) are discussed here exploring the 
lived experience of patients undergoing SCT, (see Table 2).  A third study is presented in a 
later section examining patient’s coping strategies (Cohen & Ley 2000).  At the beginning of 
the 21st century Jones and Chapman (2000) acknowledged that stem cell transplantation 
was still in its relative infancy and therefore attention necessarily focussed on the technical 
and scientific aspects of the treatment. Whilst medical research was concerned with the 
biological efficacy of this treatment for an increasing number of haematological and other 
cancers, nursing studies sought to address the multiple side effects of treatment. The 
authors highlight a paucity of research uncovering the lived experiences of patients 
undergoing stem cell transplantation and the associated physical, psychosocial and 
emotional consequences and implications. Jones and Chapman (2000) own small in depth 
study of seven individuals undergoing autologous stem cell transplantation seeks to address 
this gap through hermeneutical phenomenological enquiry. The aims of the study were to 
elicit, value and learn from their personal experiences and thereby inform nursing practice 
regarding appropriate support and care. Themes that emerged from the participants’ stories 
included changing concepts of self, the significance of relationships, being different from the 
past and temporality. The changing concept of self resulted from physical and emotional 
changes including the recognition of their own mortality often in alien environments due to 
treatment in specialist centres.  The narratives of two patients speak powerfully about their 
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experience and fight for survival as demonstrated in the following concluding statements 
from patients in the study: 
 
“If I had to describe in one sentence what it was like, it was like a sheer trip to hell and back. 
A very quick trip there and an awfully slow trip back”  
 
And, 
 
“I’ll tell you what boys, you’ve got to be awful bloody sick before you die.” 
(Taken from Jones & Chapman 2000 p159) 
 
The importance of close connection with significant family and friends provided strength and 
comfort during treatment and extended during the transition from hospital to home.  
Participants in this study reported feelings of uncertainty and turmoil in trying to resume their 
normal lifestyle characterised by the theme of ‘being different from the past’. The theme of 
temporality found by Jones & Chapman (2000) refers to the lived time connecting past, 
present and future experiences giving meaning to our being-in-the-world and according to 
Heidegger(1962) gains meaning in the face of a finite future. 
 
Certain limitations are highlighted (Jones & Chapman 2000) acknowledging that critics of 
phenomenology may question how an understanding of patient experience can translate 
into changes in practice. However, the authors demonstrate how a number of 
recommendations to change and support practice were accepted locally on the basis of the 
study and it can be argued that these valuable findings are transferable to other transplant 
centres.  Recommendations included active measures to reduce patient and family anxiety 
including orientation to personnel and the environment in the treatment facility, inclusion of 
family members and friends in the care of patients whilst in hospital and support for these 
individuals too. Trust in people and processes were recognised as all important particularly 
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when test results went missing or the competence of practitioners was called into question. 
This latter finding had implications for staff education and training both within the transplant 
centre and in diagnostic departments in the hospital.  
 
In a subsequent phenomenological study, Stephens (2005) interviewed five patients 
following autologous stem cell transplant. Findings illustrated that the transplant experience 
impacted on their lives for an undetermined time and that through experiencing physical, 
psychological and emotional changes felt they had altered as people supporting the findings 
of Jones and Chapman (2000). All five participants described reprioritisation and changes in 
their outlook and values and whilst this was perceived as positive in some cases, two 
participants described an increase in emotional vulnerability (Stephens 2005). An emergent 
theme from the participants (Stephens 2005) was one of discovering the gift of a new life 
and not wanting to waste it. Whilst this view is upheld by a number of participants in the 
study by Jones and Chapman (2000), emotions are adversely affected in the analysis of 
why their cancer developed, reflections on the aggressive treatment regimens and a 
resulting anger and bitterness towards life articulated by one of the participants. 
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2.14 Table 2: Patients lived experience of autologous stem cell transplant 
 
Authors Study aims and design Sample  Data collection and analys Results 
Cohen and Ley 
2000 
To describe patients’ 
experience of having an 
autologous bone marrow 
transplant 
20 adults; 15 females, 5 
males; mean age 46 years  
Interviews and 
hermeneutic 
phenomenological 
analysis (descriptive and 
interpretive). 
Mean number of months 
post autologous BMT 16 
months (range 2-49.5) 
Patients experienced fears including 
that of death, recurrence of disease and 
being physically and emotionally 
unprepared. Loss of control and trust in 
one’s body was experienced. Fear was 
associated with leaving hospital and not 
having someone ‘constantly looking at 
you to make sure the cancer isn’t back’  
 
Jones & Chapman 
2000 
To explore the lived 
experience of people treated 
with autologous bone 
marrow/peripheral blood 
stem cell transplant 
7 people; 2 females, 5 males Interviews and 
hermeneutic analysis. 
At least one year post 
autologous SCT 
Four themes identified: 
Changing concepts of self 
Significance of relationships 
Being different from the past 
Temporality 
 
Stephens 2005 To explore the lived 
experience of people treated 
with autologous HSCT 
5 informants; 2 males, 3 
females; mean age 53.8 
years 
Interviews and analysed 
using Giorgi’s method of 
phenomenological 
analysis. 
At least 6 months post 
HSCT 
Nine themes identified: 
Changes on various levels; fear; 
isolation; concern about others’ well 
being and coping skills; adaptation, 
adjustment and recovery; changes in 
values, outlook and priorities; transplant 
is a separate and discrete experience 
from that of diagnosis and initial 
treatment; new life; bereavement 
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2.15 Survivorship 
Definitions of survival following cancer vary. For the purpose of statistics oncologists 
consider survival as commencing from the time of cancer diagnosis and henceforth defined 
as disease-free survival or survival with recurrence (Little et al 2000). Others use the term 
survivor to refer to those for whom treatment has been successful and there is no evidence 
of the original malignancy and no recurrent disease. Increased survival rates largely due to 
screening and improved treatments have resulted in research statistics reporting survival 
periods of five and ten years from the time of diagnosis. A number of adult patients with 
cancer survived because of the aggressive nature of treatment including HSTC and the 
subsequent screening and preventive practices for long term survivors (Rizzo et al 2006). 
The experiences of cancer survivors include a number of physical, social and psychological 
challenges relating to their altered life circumstances (Welch-McCaffrey et al 1989). Studies 
reveal some of the challenges faced by cancer survivors for example, those with colorectal 
cancer (Beech et al 2012, Little et al 2000), breast cancer (Crouch & McKenzie 2000) acute 
leukaemia and Wilms’ tumour (Mackie et al 2000). Other illnesses can develop as a result of 
treatment including heart disease, renal impairment, hypertension, osteoporosis and sexual 
dysfunction (Dubbleman et al 2006, Tichellie & Socie 2005), and cognitive impairments 
(Tannock et al 2004). Altered physical functioning and fatigue can have a major impact on 
resuming normal activity post allogeneic SCT (Anderson et al 2010, Syrjala et al 2004) and 
cancer related fatigue can increase in severity when other chronic conditions are present 
(Wright et al 2014). Psychosocial challenges include uncertainties about the future (Holland 
& Reznik 2005), feelings of isolation (Little et al 2000) and an inability to return to work 
(Short et al 2005, 2007).    
 
Cancer survivorship research aims to identify diagnosis and treatment related outcomes to 
contribute to a knowledge base informing appropriate follow up care including screening and 
surveillance, thereby optimising the future health of cancer survivors (Aziz 2002).  These 
authors (Aziz 2002) acknowledge that for patients with malignant haematological disease 
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the most significant treatment related therapies affecting health status in long-term survivors 
are irradiation, chemotherapy and allogeneic stem cell transplantation. The so called ‘late 
effects’ manifest in specific organ or tissue complications requiring on-going monitoring and 
interventions as required. For patients with acute and chronic graft versus host disease, late 
effects are associated with long term high-dose glucocorticoid treatment. This prolongs the 
period of immunosuppression with consequent adverse effects on health and survival 
(Tichelli & Socié  2005).  
 
Fatigue is one of the most prevalent and distressing symptoms experienced by those 
treated for cancer (Barton-Burke 2006, Lawrence et al 2004) including haematological 
malignancy (Jarden 2009, Hacker et al 2011). Whilst Hacker et al’s (2011) study involved 
the immediate post transplant period they highlight the fact that decreased activity may 
result in long-term functional consequences affecting patients’ ability to return to their 
previously held roles.  
 
Saegrov & Halding (2004) conducted a three part investigation in Norway to ascertain the 
experiences of twelve adults living with cancer and diagnosed six months to three years 
earlier. The informants aged from 43-70 years included those diagnosed with breast, 
prostate and colon cancer, non-Hodgkin lymphoma and myeloma. Initially a mapping 
process identified the follow up and post treatment programmes offered in the region closest 
to the patients’ home. The second part of the investigation involved mapping how the 
participants evaluated their own health, quality of life and views regarding their post 
treatment programmes and follow up. Finally, in depth interviews were carried out to gain 
further insight into how the individuals experienced having cancer. The major findings 
highlighted three specific times of stress and difficulty; that of awaiting a definitive diagnosis 
following a suspicion of cancer, waiting for treatment to commence and the period following 
treatment. Participants felt that this latter phase of recovery and rehabilitation was neglected 
and would have welcomed the opportunity to discuss their new and altered life situation as a 
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result of the disease and associated challenges faced. They highlighted the need for a 
rehabilitation programme to provide information regarding physical activity and fatigue 
management and the opportunity to address psychological and social issues with a health 
care professional. Consultancy follow ups tended to focus on the medical themes as 
opposed to health related quality of life issues.  
 
2.16 Therapeutic rehabilitation intervention 
Bird et al (2010) compared the effect of a professional-led and a self-managed rehabilitation 
programme after stem cell transplantation on health and quality of life. The randomised 
controlled trial incorporated exercise, relaxation and information. No evidence of a difference 
in outcomes between the programmes was observed using a number of trial outcome 
measures.  One of the limitations identified was the small sample size and is synonymous 
with earlier studies investigating the effectiveness of exercise programmes to maintain 
physical functioning both during and following SCT (Courneya et al 2000, Hayes et al 2003). 
In Bird et al’s study (2010) recruitment was adversely affected by the entry criteria which 
meant that potential participants who felt that they did not require rehabilitation were 
excluded at a later date when this may have been beneficial. The most frequently cited 
reasons for declining to take part were the distance from home to the hospital and that the 
programme did not feel relevant for their needs. The authors conclude that programmes with 
variable content to suit individual requirements at a time appropriate to them and with 
creative methods of evaluation appropriate to increasingly complex and less standardised 
interventions are required in the future. Conversely, Jarden et al’s study (2009) found overall 
significant decrease in symptom intensity with a supervised structured exercise programme, 
relaxation training and psycho-education intervention compared with standard treatment.  
However, symptom intensity in the affective cluster, including nervousness, anxiety and 
stress was not decreased and fatigue was reported most frequently as the most distressing 
symptom in both the intervention and control groups (Jarden at al 2009).  Findings (Jarden 
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et al 2009) do however provide some evidence of the efficacy of an exercise-based 
multimodal intervention.   
 
2.17 Psychosocial issues and survival 
The areas of distress most common amongst individuals undergoing treatment for cancer 
include uncertainty regarding treatment outcome, recurrence and mortality; acute symptoms 
such as nausea, vomiting, mouth sores and pain; reduced functional status; changes in 
appearance and sexuality; family distress; contact with health services including 
communication and information sources and financial considerations (Syrjala et al 2004).  
There is currently a growing body of research focussing on the psychological aspects of 
SCT, particularly in the post-transplant rehabilitation phase (Table 3). A pilot study by De 
Marinis (2008) aimed to compare the presence of post-transplantation depression disorders 
by gender and to compare the outcomes amongst those with and without depressive 
disorders from a health psychology standpoint. Twenty three adult participants completed a 
number of self-report measures including the Short Form (SF)-12 Health Anxiety Inventory 
(HAI) and Somatosensory Amplification Scale (SAS) and this data was supplemented with 
medical and psychiatric records detailing medical problems and medications. Findings 
showed that female survivors have a higher rate of depressive disorders and that survivors 
with treated depressive disorders are similar to those without depression based on the 
outcome measures of health related quality of life and health anxiety due to success of their 
anti-depressant treatment. A number of limitations were highlighted including sample size, 
sample bias, uncertainty regarding definitive diagnoses and adherence to treatments in 
addition to the validity of the instruments used to measure anxiety and distress. However, 
the findings were consistent with Syrjala et al’s (2004) findings, where those suffering 
depressive disorders were significantly more likely to be female.  
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2.18 Table 3: Studies investigating the physical, psychological and psychosocial sequelae of HSCT 
 
Authors Study aims and design Sample  Data collection and analysis Results 
Coolbrandt & 
Grypdonck 
2010 
 
 
To explore how patients  
undergoing SCT keep courage  
and pull through the demanding 
therapy 
15 patients 
from three 
hospitals,  
8 males and 7 
females.  
8 nurses 
Grounded theory 
Participant observation 
Patient interviews 
Nurse interviews 
 
Prior to discharge from hospital to during 
the first few weeks afterwards 
 
Patients ‘keep courage’ by protecting their positive 
story from the assaults of negative information and 
threatening signals. The most vulnerable time is 
during aplasia (following conditioning therapy) when 
physical and mental strength are lost. Doctors and 
nurses help them to muster up courage and nurses 
carry them through the most despondent moments 
 
De Marinis et 
al 2009 
To compare the presence of post-
transplantation depression 
disorders by gender and to 
compare outcomes amongst those 
with and without depressive 
disorders using a health 
psychology focus  
 
23 HSCT 
recipients 
Cross-sectional pilot study. 
Depression disorders health status  
measure (Short Form-12) 
Health Anxiety Inventory (HAI)  
Somatosensory Amplification Scale  
(SAS) 
At mid-term survivor stage 
Females had a higher rate of depression  
disorders. Those with treated depressive  
disorders were similar to those without  
depression on health-related quality of life and health 
anxiety. Neither age nor time since  
HSCT was associated with depressive  
disorders 
 
Gruber et al 
2003 
To identify long-term psychosocial 
effects of allogeneic, syngenic and 
autologous HSCT 
163 patients   Herschbach Questionnaire on Stress in 
Cancer Patients (QSC). Three additional 
items added specific to HSCT. 
Up to 16 years post HSCT between  
1979-1996 
Somatic and psychosocial problems of HSCT  
can have long-term effects on patients’ QoL. Serious 
problems were associated with fitness, 
pain and fear/emotional stress. Professional 
reintegration is an important factor in patients’  
well-being 
Hochhausen 
et al 2007 
To examine whether three 
psychosocial variables (social  
support, self-efficacy and 
optimism) assessed prior to BMT 
predicted physical and emotional 
well being  
one year post BMT 
87 participants Rand Medical Outcomes Study Social 
Support Survey 
Life Orientation Test (LOT) to measure 
optimism. 
Cancer Behaviour Inventory Long From 
(CBI-L) to measure self-efficacy. 
HRQL assessed with the Functional 
Assessment of Cancer Therapy General 
(FACT-G) and the FACT-BMT disease 
specific outcome measures  
Social support, self-efficacy and optimism 
significantly predicted emotional and physical  
well being one year post BMT 
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Jenks Kettmann & 
Altmaier 2008 
 
 
To assess prevalence of 
depression among patients 
receiving an allogeneic 
transplant over a 1 year  
period. 
To investigate the role of  
social support in mitigating 
depression. 
To assess whether age  
and/or gender influenced 
depression or its relationship 
to social support 
 
86 
participants, 
47 males and 
39 females 
between the 
ages of 18-55 
at the time of 
transplant 
Medical Outcomes Study Social Support 
Scale (MOS-SSS) 
Centres for Epidemiological Studies of 
Depression Scale (CES-D) b 
Before transplant and one year post 
transplant 
Patients experienced a reduced level of depression 
post compared to pre-BMT.  
Females reported more depression than males. 
Social support pre-BMT predicted depression  
levels post-BMT 
Sherman et al 
2005 
 
To describe issues  
discussed by participants in 
a monthly post-HCT 
6-8 
participants 
each month 
but not 
necessarily 
the same 
people; males 
and females; 
1-12 years 
post HCT. 
Young adults 
to middle age. 
Autologous 
and allogeneic  
 
Topics of discussion emanating from a 
monthly support group over a two year 
period. Issues raised were accompanied 
by examples from participants 
Issues raised were categorised into three major 
themes: physical, psychological and social with sub-
themes and specific examples 
Siegal  2008 To review the evidence 
regarding psychosocial 
considerations in HSCT and 
implications for patient QoL  
and post transplant survival 
Literature 
review 
Studies investigating psychosocial 
considerations in HSCT. 
Evidence reviewed points to the need for 
psychosocial services on transplant units and 
psychological evaluations in the pre-transplant 
workup. Psychosocial screening and intervention 
should be offered early in the treatment process 
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Siegal (2008) reviewed evidence of psychological considerations of haematopoietic stem 
cell transplantation in relation to patient’s quality of life and post-transplant survival and 
concluded that psychosocial services should be available on transplant units offering 
screenings and interventions early in the treatment process. Psychosocial factors have been 
shown to predict health outcomes and mortality in chronic illnesses such as heart disease 
and immune-deficient disorders (Schneiderman et al 2005). Though such an association 
has proved controversial in cancer, studies have supported a link between psychosocial 
factors and survival (Foster 2004, Hoodin 2006). Whilst Foster’s (2004) study produced 
significant data showing a correlation between in-patient lay carer presence and survival, a 
limitation was that the quality of the relationship between the care-partner was not 
considered. Frick et al (2005) demonstrated a relationship between problematic support and 
increased risk of mortality in a prospective study of patients before and four years following 
autologous stem cell transplantation. The psychosocial sequelae associated with HSCT can 
extend to the patient’s informal caregiver, partner or spouse as evidenced in a study by 
Langer et al (2003).  This prospective longitudinal investigation revealed higher levels of 
depression, anxiety and marital dissatisfaction in caregivers compared to the patients as 
long as one year post transplant (Langer et al 2003). 
 
A prospective longitudinal cohort study, Syrjala et al (2004) examined the course of recovery 
and return to work after haematopoietic cell transplantation for leukaemia and lymphoma 
patients (n=335).  Findings show that cancer treatment distress peaked prior to and up to 
ninety days post transplant. Whilst declining steadily over subsequent assessments 
however, 79% of patients reported a clinically significant level of cancer treatment distress at 
1 year follow-up assessment. The authors conclude that physical recovery occurred earlier 
than psychological or work recovery and that recovery might be accelerated by more 
effective interventions to increase work-related capabilities, improve social support and 
manage depression.  
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A study by Sherman et al (2005) elicited themes generated from dialogue among survivors 
of HSCT in a designated patient support group. The purpose of this investigation was to 
provide a foundation regarding long term effects that can be investigated more closely in 
order to develop interventions to assist in improving quality of life. Sherman et al’s (2005) 
findings concord with quality of life research eliciting patients’ concerns within the spheres of 
physical, psychological and social changes. In particular a discordance between pre-
transplant expectations for returning to normal and the reality of altered functional status 
associated with greater psychological distress was indentified. However, both positive and 
negative post-transplant issues were highlighted by participants. Physical themes included 
coping with long-term physical changes or complications, fatigue, cognitive changes, 
medications and side effects and sexuality. Psychological themes comprised of feelings of 
uncertainty and the search for meaning and whilst many expressed a struggle relating to 
redefining themselves and a sense of identity, there was also acknowledgement that they 
had received a second chance and an increased ability to deal with other life stresses. 
Depression occurring many months after discharge from hospital was also experienced. The 
social themes discussed related to roles and relationship changes, work and study issues 
and interpersonal communication. Recommendations from this study (Sherman et al 2005) 
include the promotion of support groups to provide information and contacts for patients, an 
explanation of the normal disease trajectory and emotional support. An earlier study, (Weis 
2003), demonstrated the benefit of learning strategies for coping with long term effects of 
SCT within a patient support group. 
 
In a study of eighty-seven participants receiving allogeneic stem cell transplantation for 
leukaemia in a multi centre randomised controlled trial, Hochhausen et al (2007) found a 
correlation between social support, optimism and self-efficacy and post transplant emotional 
well-being one year post procedure. Limitations to the study include the poor representation 
of diverse racial and ethnic groups and potential selection bias resulting from potentially 
physically healthier patients agreeing to participate. Whilst social support and self-efficacy 
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may be enhanced through intervention Hochhausen et al (2007) advocate that future 
research should explore the predictive value of optimism further along with other 
psychosocial factors such as coping style. 
 
In a longitudinal prospective study, Jenks Kettmann & Altmaier (2008) considered the role of 
social support in mitigating depression among bone marrow transplant patients pre and post 
hospitalisation and up to a year into the recovery phase. Eighty-six patients completed the 
Medical Outcomes Study Social Support Scale (MOS-SSS) and the Centres for 
Epidemiological Studies of depression Scale (CES-D) before and one year post-transplant. 
The authors (Jenks Kettmann & Altmaier 2008) acknowledge that whilst this was part of a 
larger study (n=398) a relatively low number of patients were able to complete both social 
support and depression measures at pre-BMT and one year later mainly due to death and 
severe illness. Results showed moderate levels of depressive symptoms with 29.1% and 
27.6% meeting the suggested criterion for clinical depression at pre and post BMT 
respectively. Females reported more depression than males pre BMT, though this levelled 
out at one year post BMT. Social support status pre BMT influenced depression levels post 
BMT controlling for existing levels of depression. The authors recommend that health care 
professionals encourage patients to build social support pre-transplant and to maintain this 
post BMT. Although Jenks Kettmann & Altmaier (2008) acknowledge the challenges of 
maintaining social support during weeks of hospitalisation in an isolation facility and 
advocate inclusion of informal caregivers, family and friends, this does not necessarily 
address the challenges throughout the disease trajectory. BMT often follows months of 
treatments which have already impacted on the patients’ ability to sustain a social network 
or employment and Grassi et al (1996) found that post-transplant depression is linked with 
pre-transplant depression, low social support and external locus of control.  
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2.19 Patients’ coping strategies 
Several authors endeavour to distinguish strategies used by patients to cope with their 
diagnosis and ensuing disease trajectory (Cohen & Ley 2000, Bulsara et al 2004, Frick et al 
2005, Shuster 1996, Coolbrandt & Grypdonck 2010). Cohen & Ley’s (2000) study of twenty 
adult survivors of autologous stem cell transplant (see Table 2) begins to explore the 
relationship between hope and fear and the role that nurses can play in preparing and 
supporting patients throughout their journey. Although the twenty patient interviews were 
conducted a mean number of sixteen months post-transplant, the focus was their reflections 
of undergoing the treatment as opposed to their return home. The patients’ need for realistic 
information was countered by a fear of knowing too much and potentially diminishing their 
hope of survival. 
 
In a study of haematological cancer patients (n=7) Bulsara et al (2004) set out to identify the 
common factors which patients and spouses believed would enable them to achieve a level 
of control in managing their illness. Interviews included patients and three spouses included 
at the discretion of the patients. Findings highlighted the importance of feeling in control of 
their illness and treatments, acceptance of their condition, maintaining hope and the support 
of family and significant others as fundamental elements for their sense of empowerment. 
 
Frick et al (2007) sought to determine associations between health locus of control, causal 
attribution and coping prior to stem cell transplantation using three questionnaires to 
measure these factors (Lohaus & Schmitt 1989, Muthny 1998, Muthny 1992). In addition, 
ratings of Karnovsky’s index was used to measure performance status (Karnofsky & 
Burchenal 1949). Frick et al (2007) identified four homogenous subgroups of patients (total 
n=126) in respect to their locus of control convictions which are outlined in Table 4 below: 
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2.20 Table 4: Adapted from Frick et al (2007 p159) 
 
1. ‘not internal’ (n=30) patients seem to believe that situations relevant to their health or 
illness are not under their control   
 
2. ’powerful others’ (n=21) patients seem to perceive that doctors, nurses, spouses and 
others are relevant for managing their disease 
 
3. ‘yeah sayer’ (n=35) patients score highly on all three internal, external and fatalistic 
subscales 
 
4. ‘double external’ (n=38) patients have very high external expectations relating to powerful 
others and fate control 
 
Frick et al’s (2007) findings support the theory that adjustment to cancer can be related to 
external factors such as medical care, financial stability and social integration alongside 
internal factors such as coping resources or spirituality supported by other studies (Folkman 
& Greer 2000, Grulke et al 2005, Farsi 2010).   
 
Research into patients’ coping mechanisms during stem cell transplantation (Coolbrandt 
Grypdonck 2010) explores the concept of keeping courage in order to pull through the 
considerable physical, emotional and psychological demands of their treatment. A distinction 
between this active strategy and the purveyance of a ‘positive story’ (p218) as opposed to 
the passive concept of hope is recognised. Patients were found to think only optimistic 
thoughts believing that a positive attitude may affect the outcome of their treatment 
(Coolbrandt & Grypdonck 2010). Interestingly, Morstyn (2009), in his personal reflection of 
stem cell transplant experience describes his feeling of anger towards a nurse’s 
recommendation to ‘think positive’, an approach also questioned by McGrath et al (2004). 
Farsi et al (2010) uphold the notion that nurses should actively seek to understand their 
patients’ coping strategies and also be cognisant as to how these vary according to 
individuals at different stages of the disease. The authors recommend further research to 
investigate the effect of religious and cultural orientation in relation to coping with life 
threatening and challenging situations.  
 
54 
 
2.21 The paediatric and adolescent experience 
This section reviews three studies pertaining to the experiences of children under the age of 
eighteen and their parents to illustrate some of the psychological issues raised throughout 
stem cell transplant treatment. Parental experience of family stress during HSCT of 
paediatric patients is examined by Wu et al (2005). Eleven parents of children under the age 
of eighteen were interviewed and through content analysis four emergent themes were 
identified including parental psychological distress, family lifestyle disturbances, parents’ 
coping patterns and family resources. Though a small study (n=11) the effects on direct 
family care-givers at the beginning of the transplant process are worthy of consideration in 
the arena of adult HSCT and the potential effects of carer distress during the recovery 
phase. Wu et al (2005) highlight the role of the nurse in teaching parents about the potential 
reactions of their children during the transplant process. Guidance is recommended 
concerning adjustment and coping of both parent and child with a focus on sharing 
experiences with other families and health and social care professionals. It is pertinent to 
consider the cumulative effects of being a care-giver from disease onset, diagnosis, 
treatment and recovery trajectory since care-giver support is an important factor affecting 
SCT recipient’s recovery (Bulsara 2004). 
 
The importance of considering both parental and child assessments of quality of life is 
advocated by Feichtl et al (2010). Longitudinal quality of life data were obtained from sixty-
eight paediatric patients-parent dyads prior to and up to two years post-transplant. Findings 
showed that children typically rated their quality of life as high at all time points and virtually 
all domains. Quality of life agreement was less aligned where dyads did not speak the same 
language and concordance was more disparate among female-patient dyads than male-
patient dyads. 
 
In a retrospective study of seven adolescents Forinder and Posse (2008) examined data 
collected from the patient’s medical records pertaining specifically to psychosocial 
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interventions and their subsequent responses to these. The theoretical frame of reference 
used was Erikson’s (1968) socio-emotional model for psychological development. Erikson 
(1968) upholds the notion that each phase of a person’s development is associated with an 
inherent crisis to be managed. For adolescents, he argues, it is a conflict between plural 
identities which need to be untangled. Seeking an identity is considered a basic human 
need by Erikson (1968) where identity is defined as a subjective experience consisting of 
three components: biological identity, psychological identity and social identity. Interacting 
with peers is seen as critical to this development as young people compare themselves to 
others and endeavour to find social roles and groups compatible to their own biological and 
psychological make-up. 
 
Literature concerning adolescent development describes a process of psychological 
emancipation from parental dependence through to independence and adulthood (Erikson 
1968, Marcia 1994). The seven adolescents in Forinder & Posse’s (2008) study had sought 
psychotherapeutic support several years after HSCT and were identified as being a 
particularly vulnerable group. The participants’ describe how they are affected by the feeling 
of being different, suffer isolation from their peers and have an on-going dependence on 
their parents. The authors suggest that the loneliness and in some cases fear disclosed by 
these young people could represent a grieving process associated with the limitations 
imposed by illness and also the loss of an imagined future. Conversely, other studies have 
demonstrated the positive outcomes experienced by children and adolescents who have 
suffered from cancer including valuing life in a more positive way, achieving emotional 
growth, life satisfaction and hope for the future (Meeske et al. 2001, Zebrack & Chesler 
2002, Chao et al 2003, Patenaude & Kupst 2005)  
 
It is useful to consider the paediatric and adolescent literature because the experience of 
paediatric haematopoietic stem cell transplant preceded that in the adult field. Whilst there 
are specific issues relating to younger people such as a disturbance to identity development, 
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it can be argued that biographical disruptions caused by illness have a similar effect on adult 
self perceptions and identity. Valuable knowledge may therefore be transferable across the 
age groups. Considering this literature is also important because the effects of HSCT on 
paediatric patients can be long lasting and may inform implications for adults post treatment. 
Two participants in the current study experienced isolation from their peers during their 
young adult years and significant uncertainty related to resuming their future plans.   
 
2.22 Summary of chapter 
This chapter has reviewed the literature regarding haematopoietic stem cell transplant and 
the associated physical and psychosocial sequelae both during and following treatment.  
Some studies adopt a biomedical framework to measure patient’s quality of life at certain 
time points throughout their journey and form an extremely valuable body of knowledge for 
understanding the implications for patients of haematological disease and both autologous 
and allogeneic stem cell transplants. Physical symptoms such as fatigue and susceptibility 
to infections are common and persist for many months post SCT. In spite of this on-going 
disruption and challenging side effects such as GVHD patients often report an acceptable 
quality of life. At the time of commencing the current research relatively few studies explore 
the patient’s lived experience. Whilst psychosocial issues such as depression, uncertainty, 
fear of disease recurrence, isolation and financial insecurity have been highlighted 
exploration of how patients experience returning home following treatment with allogeneic 
SCT has not been specifically addressed. It is therefore important to elucidate participant 
responses regarding this transition and their initial recovery journey in order to identify their 
longer term health and social needs.  
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CHAPTER 3 
 
Methodology and Methods 
 
3.1 Introduction 
This chapter provides a rationale for the methodology chosen for the study. The 
philosophical and theoretical underpinnings of interpretive phenomenology are presented 
including its antecedents. Decisions regarding the study design, choice of sample sites, 
recruitment strategies, participant inclusion and exclusion criteria, data collection and ethical 
considerations are discussed. 
 
3.2 Study Design  
This study is designed to explore the experiences of fifteen adult participants who were 
treated with allogeneic stem cell transplantation (cells from a donor) for haematological 
cancer.  The focus of the study is concerned with participants’ experiences of returning 
home following this treatment.  Participants were recruited from two major specialist 
treatment centres and the study followed an interpretive phenomenological methodology 
using semi-structured interviews on one occasion only between three months and one year 
post transplantation.  Data were then analysed using interpretive phenomenological 
methodology to gain insights into participants lived experience following the transplant 
including their personal and social experience of the world following treatment.   
 
3.3 Research Methodology 
Interpretative phenomenological analysis (IPA) is a qualitative approach committed to the 
examination of how people make sense of major life experiences (Smith et al 2009). It is 
phenomenological because it allows expression of things in their own terms (Husserl in 
Smith 2009) as opposed to attempting to fit them into predefined categories. Since individual 
interpretation of an event is both personal and dependent on many contextual factors (Scott 
1990), this feels to be a highly appropriate philosophical stance for the current study.  Whilst 
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all participants underwent allogeneic stem cell transplant, their diseases varied in type, 
complexity and onset and their ages and social circumstances varied considerably. A major 
theoretical axis of interpretative phenomenological analysis is hermeneutics (Smith et al 
2009), that is, the theory of interpretation, where both participants and researcher reflect on 
and make sense of events and experiences. It is argued (Smith et al 2009) that the active 
thinking involved in this sense making is applied in a self-conscious and systematic fashion 
in order to reach a deeper level of understanding. The idiopathic nature of IPA recognises 
the uniqueness of an individuals’ experiences as interpreted by themselves whilst 
acknowledging the researchers contribution as second order. The term second order is used 
since the researcher only has access to the participants’ experience through their personal 
account of it. Thus, IPA can be viewed as a shared process of researcher and participant 
seeking to shed light on an experience through story telling and active listening. 
 
In the analysis of patient stories, Van Manen (1990) argues that similarities and differences 
between cases may be explored but only for comprehensive interpretations of individual 
accounts. The overall aim is not to generalise (Van Manen 1990 p22) as this may distort the 
uniqueness of the events. Conversely, Smith et al (2009) advocate the study of a 
homogenous sample so that convergence and divergence can be examined in some detail. 
Whilst immediate claims are bounded by the group of participants under study Smith et al 
(2009) support the notion that these may be extended through theoretical generalisability, 
where the reader of the research is able to consider the evidence in relation to their existing 
professional and experiential knowledge. As noted earlier, the participants in this study 
formed a homogenous sample by virtue of their treatment with SCT whilst their experiences, 
personal characteristics and contexts were unique. It was therefore envisaged that there 
may be some common themes and others that would be exceptional. 
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3.4 Antecedents of interpretative phenomenology 
As an academic discipline, philosophy is ‘the study of the fundamental nature of knowledge, 
reality and existence’ (New Oxford Dictionary 2010). In turn, phenomenology forms a broad 
philosophical movement having at its core, the study of the structure of experience.  The 
prime concern of phenomenology is the systematic reflection on and study of the structures 
of consciousness Husserl (1970). The technical term ‘intentionality’ is invoked by Husserl 
(1970) to describe the process occurring in consciousness and the object of attention for 
that process (Smith et al 2009). Phenomenologists assume human existence is meaningful 
and interesting as a result of this consciousness and that ‘being’ in the world or embodiment 
is a concept of acknowledging peoples’ ties with their world (Polit & Hungler 1997). A clear 
differentiation exists between Husserl’s conception and the Cartesian method of analysis 
which sees the world as objects, sets of objects and objects acting and reacting upon one 
another. The Husserlian approach to phenomenology adopts a descriptive stance where the 
process of bracketing off the outside world and subsequent phenomenological reduction 
supports the notion of objectivity towards the study subjects. In direct contrast, Heidegger 
(1954) asserts the importance of man’s capacity to understand himself and the world and 
thereby introduces the notion of interpretation.  This ontological position is responsible for 
the shift from description to that of social constructivism and IPA is therefore the chosen 
methodology for this study.  
 
3.5 Embodiment 
The concept of embodiment has recently gained focus in a range of human sciences 
including sociology and qualitative approaches to psychology (Finlay & Langdridge 2007, 
Nightingale & Cromby 1999, Burkitt 1999). In sociological terms the concept is useful in 
developing social constructions of the human condition such as disability and gender issues 
whilst for psychologists it is critical to understand embodied experiences on an individual 
level. From a phenomenological perspective, embodiment encapsulates the physical and 
biologic body at the same time as recognising its inherently individual expressive and 
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experiential potential (Smith et al 2009). As suggested by Ratner (2000) emotional qualities 
and expressions are determined by cultural rather than biologic processes. The body is 
therefore perceived as a vehicle through which individuals actively engage with the world 
both physically and emotionally (Merleau-Ponty1962). IPA research has addressed the 
notion of embodiment in terms of the ailing body and how individuals endeavour to 
understand their altered bodily state. As articulated by Ainley (1989): 
 
“A person’s experience of the world and self are bound up with her/his body...The 
body anchors the individual in a world of things and other people...A person’s ties to 
her/his body are perhaps made most clear when something about the body goes 
awry...Most people are aware then - whether they view their bodies as enabling or 
limiting – of both being and having a body”. (Ainley 1989 pp21-22).  
 
This concept of developing an increased consciousness of the body as a result of illness 
resonates with the experiences of individuals undergoing haematopoietic stem cell 
transplantation found in the literature (Morstyn 2009, Stephens 2004, Jones & Chapman 
2000). As highlighted in the literature review, participants in Stephen’s (2004) and Jones and 
Chapman’s (2000) studies underwent autologous stem cell transplants and in Morstyn’s 
(2009) personal account the type of transplant is not specified. 
 
3.6 Methodological choice 
Academic teaching and authors of research methodology promote the notion that research 
questions should guide decisions about research design and methods (Blaikie 2000, de 
Vaus 2001, Mason 2002). In a paper addressing the role of the research question in social 
research, Bryman (2007) poses challenges to this conventional view and how this position 
pertains to actual research practice. Citing the example of Glaser and Strauss’ (1967) 
original formulation of grounded theory approach, she acknowledges that research 
questions are necessarily secondary to the course of this type of investigation. Whilst 
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advocating the naturalistic paradigm, Kleinman and Kopp (1993) recognise the uncertainty 
experienced by even experienced fieldworkers when challenged to define their research 
question at the outset. In such cases, however, the research topic is identified and specific 
questions emerge as the study progresses. Beyond the methodological debate in its own 
right exist other tensions and factors influencing the ultimate choice of research design. 
Included are issues of research credibility or preference in relation to policy gate-keepers, 
journal referees and editors, chosen audience and funding bodies (Bryman 2007). Likewise, 
an important consideration is the epistemological beliefs of the researcher and their own 
strengths and analytical skills. Whilst the author is a relative novice in pure research terms, 
she is aware of the relatively low value that some critics would attach to the chosen 
methodology particularly in the hierarchy of research acclaim. However, as advocated by 
Frank (1995) the importance of listening to patients stories is one which is worthy of 
renewed focus in the post modern era.  Further, the advancement of communication and 
interpretive skills from a philosophical and ethical viewpoint through the research process 
itself can only serve to enhance a deeper understanding of the patient’s lived experience.  
 
Phenomenology does not argue for the abolition of traditional science (Benner 1994) but 
rather for its apposite use. Clearly, where a study does not seek to examine or make sense 
of the human experience a different approach will be more appropriate, for example, a study 
researching the efficacy of a novel therapy for malignant conditions demands scientific 
investigation. As Baron (1985) argues however, accomplishments of traditional science 
derive their significance from what this means for human beings. Consequently, it could be 
argued that research conducted with both positivist and social constructivist paradigms may 
be viewed as complimentary as opposed to diametrically disparate. Scientific knowledge 
and medical know-how regarding stem cell transplantation (SCT) for haematological 
malignancy is an experimental and highly technical developing field of medicine. As new 
treatment regimens are developed and their efficacy tested with traditional positivist 
scientific methods, it is important that qualitative methods are used simultaneously to 
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explore the effects that such treatments have on patients’ lives. The current study is 
concerned with participant's lived experience of life-threatening illness, arduous treatments 
and its long term effects. Consideration of blood cancer as both an acute and chronic illness 
further recognises the value of medical and social research in gaining a greater knowledge 
of novel treatments for haematological malignancies alongside developing an enhanced 
understanding of people's health and social needs.  
 
3.7 Data collection 
Data collection is usually through semi-structured interview or can arguably take place with 
an interview guide rather than formal questions. Since the essence of interpretive 
phenomenological enquiry is to understand the experience through participants accounts 
(Smith & Osborne 2007) an opening question could be all that is required supported by 
probes and affirmations of understanding  (Kvale 1996) as the dialogue progresses. The role 
of the researcher is to check out meanings with the respondents by seeking examples and 
clarification of their feelings towards the experience. Subsequently adding their perspective 
and subjective judgement (Polit & Hungler 1991) is considered an important element of the 
research process. Conversely, this perspective is contended by Jasper (1994) who 
challenges the skilled researcher adopting a phenomenological approach to avoid 
contamination of the data in their pursuit of the true lived experience. Proponents of this 
latter view advocate the descriptive form of phenomenology where the system of bracketing 
is undertaken so that preconceptions and presuppositions are put aside (Crotty 1996). 
 
The adoption of a detached position where a priori assumptions are suspended has a 
parallel to the grounded theory methodology of Glaser and Strauss (1967) whereby 
emerging theory drives the inquiry and emanates directly from the participant. In contrast, 
however, the phenomenologist centres on eliciting the experience of individuals to identify 
the phenomenon whereas the grounded theorist seeks to develop the emerging theory using 
interviews and other data collection methods (Wimpenny & Gass 2000). Whatever the 
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ontological perspective, the skilled interviewer should be sensitive to the respondent to 
ensure important data is not missed and be aware when to provide direction such as probing 
or asking the participant to give an example. As cautioned by Charmaz (1994), however, 
being too directive and basing questions on assumptions should be avoided. Similarly, a true 
representation of the interview data is dependent on the integrity of the researcher ensuring 
important detail is not overlooked in favour of biased selection of material for personal gain. 
 
3.8 The study population 
The population for this study are patients who have been treated with allogeneic SCT for 
haematological malignancy. The participant cohort (see Table 5) were recruited from two 
major treatment centres in South East England referred to as Centre A and Centre B. Each 
centre treats approximately one hundred and fifty people with this procedure annually and 
therefore provided a sufficient number of participants, despite the possibility of attrition 
during the study for reasons such as ill health, fatigue or death. A sample of up to twenty 
patients was intended with the final number being fifteen in all. Rationale for choosing the 
two specialist centres was two-fold. Firstly, each is a designated facility for SCT and 
secondly, the researcher has professional contacts at both centres and it was anticipated 
that their support would impact on gaining access to potential participants. Gaining access to 
institutions for the purpose of research is important since professional gate-keeping has 
been noted to restrict access for a number of reasons including that of protecting patients 
and staff groups (Holloway & Wheeler 2002). Conversely however, other studies (Corbin & 
Morse 2003, Alexander 2010) have demonstrated the willingness of vulnerable patients to 
participate in research with the potential to benefit others. The therapeutic value of 
articulating physically and emotionally painful experiences is powerfully described by 
Kleinman (1998: xiii) subsequently corroborated by researchers in palliative care (Barnett 
2001: 158, Dickson-Swift et al 2006: 859, Alexander 2010). 
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3.9 Sample size 
Sandelowski (1995, p180) points out that any hard and fast rules concerning sample size is 
inappropriate given the inquiry nature of qualitative research, and states that: “A good 
principle to follow is: An adequate sample size in qualitative research is one that permits - by 
virtue of not being too large - the deep, case orientated analysis that is the hallmark of all 
qualitative inquiry, and that results in – by virtue of not being too small - a new and richly 
textured understanding of experience”. Smith and Osborne (2007 p56) concur with this view 
and state that ‘there is no right answer to the question of the sample size’ and that it is 
dependent on factors such as availability and willingness of participants, the richness of the 
individual cases, the depth of analysis and the constraints of the study’s resources. 
Rationale for aiming to interview up to twenty participants in this study is based on a number 
of factors including the likelihood of gleaning sufficient in depth data in order to answer the 
research questions; time resource to conduct this number of interviews given the 
geographical location of the specialist centres and participants homes and also the time 
taken to analyse the data in sufficient depth. Many more experienced researchers postulate 
their opinions as to sample size in a paper written by Baker & Edwards (2012) supporting 
the notion that ‘how many qualitative interviews is enough’ is dependent on a range of 
arguments including those stated for this current study.  
 
3.10 Inclusion and exclusion criteria 
Participants in this study had returned home following hospitalisation for allogeneic SCT for 
between three months and a year. Eligibility was also dependent on the participant being an 
English speaking adult (or the availability of a translator), aged eighteen or above and with 
capacity to provide informed consent and to participate in an interview process.  Patient 
exclusion criteria includes those who have any cognitive dysfunction, impairing their ability to 
provide informed consent or respond to questions. The full inclusion and exclusion criteria 
are summarised in Figure 1 below: 
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Figure 1: Inclusion and Exclusion Criteria 
 
 
Inclusion criteria 
 
1. Male or female patients who have undergone allogeneic stem cell transplant  
for haematological malignancy between 3 months-1 year previously. 
2. Adult patients above the age of eighteen. 
3. Able to understand the participant information provided. 
4. Capacity to provide informed consent and to participate in the interview process. 
5. English speaking or translator available. 
6. Patients have sufficient time to read the information sheet and to ask any questions 
prior to agreeing to participate. 
7. Patients whose hospital teams and General Practitioner had been informed of their 
participation in the study and consideration given to any concerns to be raised. 
 
 
Exclusion criteria 
 
1. Patients who lack capacity. 
2. Patients who were too weak or unwell to participate. 
 
 
Whilst sixteen patients were interviewed, it transpired that P13 had received an autologous 
SCT and therefore did not fit the inclusion criteria. His data was therefore excluded from the 
study. 
 
Methods 
3.11 Recruitment of participants 
The clinical nurse specialists and the consultant haematologists at each specialist centre 
were named on the site specific information of the ethical application for the study and were 
kept informed of its progress. Site visits provided the opportunity to meet members of the 
team and discussions took place regarding recruitment strategies. Permission to attend the 
patient support group at Centre B was initially requested in order for the researcher to 
introduce the idea of the study and potentially recruit participants. However the group had 
made a decision to exclude external speakers at that time. The clinical nurse specialist sent 
a flyer explaining the research to all the stem cell transplant patients eligible to take part as 
she was posting other information to them regarding the support group she led. The Matron 
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for stem cell transplant at Centre A displayed research flyers at the out-patient clinic and 
agreed to answer questions on behalf of the researcher. Those who were prepared to 
participate were requested to inform a member of their clinical team or to contact the 
researcher directly. Rationale for recruiting potential participants to the study through their 
clinical teams included the following considerations: 
 
(i) The researcher felt that patients would be reassured by research that was approved 
by their clinicians. 
(ii) That patient’s would feel confident about the credibility and authenticity of the 
researcher if endorsed by their clinical team. 
(iii) That potential participant’s would feel better able to decline inclusion following 
discussion with a third party rather than directly with the researcher.  
 
After several weeks, when this strategy yielded no patient interest, two former haematology 
consultant colleagues were approached at Centre B to ask if they would promote the study 
at their SCT follow up clinics which they readily agreed to do. Reminders were sent a day 
before their clinic at their request along with flyers and participant information sheets. The 
researcher also made contact with their secretaries in the case of busy schedules 
preventing information transmission by e-mail. Again, this strategy did not result in patient 
interest being communicated to the researcher. It was at this point that the researcher 
requested to attend the out-patient follow up clinics at centre A and following excellent 
recruitment replicated this strategy at centre B. 
 
Potential patient participants were identified during a pre-clinic multidisciplinary meeting at 
both hospital sites to which the researcher was invited. The researcher was introduced 
acknowledging her professional relationship with colleagues in the hospital and wider 
network which undoubtedly had a positive impact on the researcher’s inclusion within the 
clinical team. Following the conclusion of the meeting, one of the clinical nurse specialists 
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volunteered to make introductions to the patients though very quickly this proceeded to the 
researcher introducing herself due to clinical staff being busy and feeling at ease to do so. 
The clinic administrative staff were invaluable in identifying the patients in the clinic to the 
researcher and assisting in communicating what stage they were at in their appointment in 
order to minimise disruption. The potential participants were approached by the researcher 
and the purpose of the research explained including the intention to conduct recorded 
interviews and how long these may last. Initial questions were answered and they were 
supplied with the participant information sheet (Appendix I) with an arrangement for the 
researcher to make contact at a mutually convenient time to establish if they were happy to 
take part. Apart from one gentleman who entered the clinic and expressed his requirement 
to rest, all of the patients approached agreed to consider participation. Over the subsequent 
few days follow up calls were made to the potential research subjects and their willingness 
to participate established. The researcher offered to interview patients on a day that 
coincided with their clinic appointment or in their own homes depending on their preference. 
Several potential participants began to tell their story right away which was promising and 
they were asked to retain their thoughts or to make some notes as an interim measure to 
inform the interview. Often several calls were necessary due to scheduling of the 
participant’s clinic and other hospital appointments, health status, work and other 
commitments which served to enhance an initial relationship and rapport between the 
participants and the researcher.  
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Figure 2: Flow Chart of Recruitment Process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Potential participants identified during haematology clinic 
multi-disciplinary meeting 
Potential participant approached by researcher in the 
out-patient clinic and the aims of the study are explained 
Patient expresses willingness to participate and a patient 
information sheet is supplied 
Arrangement made for the researcher to contact the 
patient to establish if they are still willing to participate 
Interview arranged at the venue convenient to the 
participant (at the treatment centre to coincide with the 
participant’s follow-up appointment or in their home) 
Written consent obtained on the day of the interview 
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3.12 Table 5: Participant details  
 
Fifteen participants aged between twenty two and sixty eight years who were treated with allogeneic stem cell transplantation were recruited to the study. Eight participants were 
treated at specialist centre A and seven at specialist treatment centre B. Details of the sample are given in the following table and brief pen portraits of each of the participants 
can be found in Appendix II.   
 
Key: Gender: M = male, F = female; STC A = specialist treatment centre A, STC B = specialist treatment centre B; Status: Ma = married, S = single, W = widow; Diagnosis: AML = 
acute myeloid leukaemia, ALL = acute lymphoblastic leukaemia, AA = aplastic anaemia; Interview location: STC A = specialist treatment centre A, STC B = specialist treatment centre 
B, H = home, W = work 
Partici- 
pant 
Age Gender Specialist 
Treat- 
ment  
Centre 
Marital 
status 
Living 
Context 
Diagnosis Date of  
Transplant 
Time Since 
T’plant at Time of
Interview 
Donor and GVHD Status Interview  
Location 
1* 22 M A S With mother Hodgkin  
Lymphoma 
29.11.2012 (2nd transplant) Unrelated donor 
Gut GVHD May 2013  
now resolved 
STC A 
2 67 F A Ma With husband AML 22.08.2012 8 months Unrelated donor No GVHD H 
3* 29 F A S On own/ 
boyfriend 
AML June 2012 11 months Unrelated donor 
Skin GVHD now resolved 
STC A 
4* 59 F A Ma  
on own 
With son ALL Feb 2013 3 months 
(2nd transplant) 
Sibling donor 
Chronic GVHD gut and liver 
STC A 
5* 24 F B S On own/mother AA 01.08.2012 9 months Sibling donor No GVHD STC B 
6* 63 M B Ma With wife AML Feb 2013 3 months Son donor GVHD STC B 
7 68 M A Ma With wife and 2  
adult daughters 
AML August 2012 11 months  
nearly 12  
Cord x 2 Skin GVHD  H 
8* 63 F B Ma With husband AML (from CML) 17.01.2013 4 months  
11days 
Unrelated donor  GVHD  STC B 
9 68 F B W On own but  
son in adjoining 
house 
AML (from MDS) 12.07.2012 11  months Unrelated donor No GVHD H 
10 62 M B Ma With wife Myelofibrosis 20.09.2012 8 mths 14 days Unrelated donor GVHD STC B 
11* 50 M B Ma With wife and  
son 
Myelodysplastic  
syndrome   
19.02.2013 
 
3  months  
18 days 
Unrelated donor GVHD H 
12* 28 or 
38 
M A Ma With wife and 2 
children 
Lymphoma  
peripheral T cell  
15.03.2013 
 
3  months Sibling donor No GVHD STC A 
14 67 M A Ma With wife Myelofibrosis 
 
01.11.2012 
 
8  months Unrelated donor GVHD STC A 
15* 33 Ma A M With wife and 2 
children 
ALL 13.12.2012 
 
6 months 21 days Unrelated donor No GVHD W 
16* 62 Ma B M With wife AML 23.02.2013 7  months Unrelated donor      No GVHD  STC B 
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3.13 Narrative interviews 
Narrative inquiry aims to elicit the participant’s story, incorporating ‘plots and structures’ 
(Kvale & Brinkmann 2009) and their interpretation of these through temporal and social 
frameworks (Mishler 1986). Whilst Mishler (1986) supports the view that narratives are one 
of the cognitive and linguistic forms through which individuals attempt to organise and 
express meaning and knowledge, Riessman (2008) alludes to the complex relationship 
between narrative, time and memory in an individual’s attempt to reify their past and present 
identity.  For an interview to be truly narrative in nature, the interviewer seeks information 
from the participant in the form of an initial question (Kvale & Brinkmann 2009). Thenceforth, 
the interviewer will actively listen to the account using verbal and non-verbal signs to 
encourage the storyteller. It may be necessary to pose an occasional question to seek clarity 
or further information whilst noting the content, structure and potential tensions and 
resolutions within the story. If a situation arises where a participant experiences difficulty in 
telling their story, gentle probing based on the topic guide or non-directional facilitative 
support is employed (Wengraf 2001). Gordon, (1980 in Sorrell & Redmond 1995) suggests 
two forms of probing: recapitulation – where the respondent is taken back to the beginning 
of their story to re-establish their flow of narrative or to add more detail and silence – 
allowing the interviewee time to gather their thoughts and formulate the next stage of their 
account.  Probing is also an important aspect for the researcher in that it serves to clarify 
understanding and to resist making assumptions (McConnell-Henry et al 2011). 
 
Questions may include the following: 
Could you remind me about how you felt when….? 
How did you come to terms with that? 
Was there anyone there to support you? 
 
The opening question used for this study was “Could you tell me about your experiences of 
undergoing a stem cell transplant and in particular about returning home from hospital”.  
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Although a topic guide was devised (Appendix III), subsequent questions and probes 
followed the content and issues raised by the participant’s in their narrative. 
 
The interview was non directive other than the opening question “Can you tell me about your 
experience of being treated with allogeneic SCT for your blood disorder and what it’s been 
like trying to resume a normal life at home?” supported by probes and affirmations of 
understanding (Kvale1996) . The narrative style of interview enabled the participants to tell 
their story and to talk about experiences which are important to them in relation to the 
overall purpose of the study. Whilst the lack of structure poses certain risks, for example, 
participants veering away from the phenomena being studied, the benefits are a collection of 
unique accounts borne out of their willingness to reconstruct and attempt to ascribe meaning 
to their experiences. The validity of such data may be called into question, since participants 
have a choice what to disclose or not as the case may be and their accounts change over 
time. However, it is argued by Frank (1995 p22) that there is no such thing as a false 
account: 
 
“If calling stories true requires some category of stories called false, I confess to being 
unsure what a ‘false’ personal account would be. I have read personal accounts I 
considered evasive but that evasion was their truth. The more reconstructed the story 
the more powerful the truth of the desire for what is being told, as the corrected 
version of what was lived.” 
 
In accordance with this view, Charmaz (1997 p219) conceives that the telling and retelling of 
stories by those suffering illness serves to solidify and reify their stance on the event, 
themselves and their future selves.  Observations and field notes accompanied each 
interview and were reflected upon alongside analysis of the interviews. Following the 
interviews when points of clinical clarification were required the researcher sought this 
information from the Clinical Nurse Specialists for example their GVHD status immediately 
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post SCT (acute GVHD) and at the time of the interview (chronic GVHD) as this could have 
an impact on their physical and psychological state. 
 
Five participants requested family members to be present during the interview and their 
contributions are recognised in the analysis. A pilot interview was undertaken involving a 
volunteer following his experience of head and neck cancer and the challenges he faced 
during his recovery phase. This served as valuable practice for the researcher of narrative 
interview technique and familiarity with the electronic recording device. 
 
The interviews took place over a period of six months and each one lasted between thirty 
five minutes and one hour and fifteen minutes. On initial meeting to conduct the interview, 
there was a period of preamble including the purpose of the study, consent and general 
conversation aimed at gaining a rapport and putting the participants at ease. 
 
3.14 Follow up to interviews 
At the end of the interview participants were asked if they were willing to be contacted at a 
later date for the purposes of verification, and clarification of points within their narrative.  
Initially it was planned that the participants would be supplied with a short summary of the 
interview transcript and asked to comment on its validity. However after much discussion, 
deliberation and reading on this strategy a decision was made not to do so.  The reasons 
were both ethically and methodologically motivated. Ethically, the participants interviewed 
had already given a significant amount of their time to be interviewed during the early stages 
of their recovery and the researcher did not want to add to this burden. Whilst some authors 
(Lincoln & Guba 1985, Colaizzi 1978) advocate the process of checking interpretations of  
data between researchers and participants as a final step in data validation, Giorgi (2006) 
adopts the view that the use of participants as evaluators of findings is theoretically flawed. 
He argues that whilst participants describe their experiences from the perspective of a 
natural attitude, analysis is conducted from the perspective of the phenomenological 
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attitude.  Central to his concerns (Giorgi 2006) are firstly that if precedence is given to the 
individual undergoing the experience then the rationale for analysis is invalid and secondly 
that if discrepancy exists between the researcher and the participant, problems arise in 
determining which perspective takes priority. He therefore proposes a greater trust in 
subjectivity and the safeguards that the method and phenomenological attitude provide.  
Whilst this view could imply an imbalance of power between the researcher and the 
participant Giorgi’s (2006) reference to method and phenomenological attitude are crucial in 
dispelling this notion. Proponents of interpretive phenomenological method and analysis, 
Smith and Osborne  (2007 p53) argue that whilst IPA is concerned with ‘trying to understand 
what it is like, from the point of view of the participants, to take their side’, of equal 
importance is the interrogation of the text and asking critical questions to establish deeper 
meaning. By combining these two aspects of understanding through empathy and 
interpretation Smith & Osborne (2007) suggest that the inquiry is likely to achieve a richer 
analysis at the same time as respecting the totality of the person. In this study, the 
researcher had the opportunity to check meanings with participants at the time of the 
interview and witnessed participants making sense of their experiences through their 
narratives. All participants were invited to contribute further thoughts if they recollected any 
detail they considered relevant and important during the period of the study, though no 
further contact was made.  
3.15 Demographic and clinical data 
Demographic and clinical information was obtained from the participants and access to their 
medical record was granted if required. The participant’s age, marital and employment 
status, their underlying disease, date of their SCT and GVHD status are collated in Table 5.  
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3.16 Ethical Considerations 
Ethical approval for the study was obtained following submission to the National Research 
Ethics Committee, Surrey University Ethics, and the local Research and Development 
Departments at the two specialist treatment centres in accordance with the NHS Research 
Governance Framework. The researcher obtained an honorary contract from specialist 
centres A and B for the duration of the study involving employment checks including 
occupational health clearance, Criminal Record Bureau checks and references. The chief 
focus of the occupational health check was to ensure the researcher had no infections which 
could have posed a risk to the participants.  The patients’ general practitioners were notified 
(Appendix IV) and asked to inform the researcher of any contraindications to their 
participation, though no concerns were raised. 
 
Each potential participant was comprehensively informed of the aims, methods, anticipated 
benefits and risks of the research and any discomfort it may entail prior to seeking written 
consent. Participants were assured that any issues of concern that may be raised would be 
communicated to their clinical teams or relevant agencies as required and in discussion with 
them. The procedure for making complaints or raising concerns independently including 
those concerned directly with the researcher was communicated to all participants with 
details of who to contact on the participant information sheet. 
 
The primary ethical issue which was considered in relation to the purpose and design of the 
study concerned the possibility of causing distress to a vulnerable group of people. The 
researcher was mindful that recollection of events throughout their illness trajectory from 
disease onset through to chemotherapy, radiotherapy, stem cell transplantation and 
rehabilitation could potentially be challenging to the participants and require an intervention 
to alleviate the anxiety caused. A significant number of studies suggest that people treated 
for cancer including blood cancers fear the recurrence of disease (Stephens 2005, Cesario 
et al 2010, Williams 2012) and suffer on-going side effects relating to treatments in addition 
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to facing a slow and debilitating recovery (Sherman et al 2005). Since participants were 
recruited between three months and a year post SCT it was envisaged they would still be 
experiencing the physical, psychological and emotional effects of their harsh treatment 
regimes and be in the stage of relatively early recovery. Conversely however, studies have 
demonstrated that whilst telling stories of illness can be painful, it may be a unique 
opportunity to share the emotional burden of such experiences and to endeavour to make 
sense of them as well as providing an opportunity to help somebody (Alexander 2010) . In 
accordance with this view Frank (1995) advocates listening to illness stories as a 
fundamental moral act, a duty and as such refers to a post-modern requirement for an ‘ethic 
of listening’ (Frank 1995 p 25). 
 
The most important strategy put in place to mitigate distress is the researcher’s sensitivity in 
recognising verbal and non-verbal signs of distress and in being prepared to discontinue the 
interview in such circumstances. The participant’s specialist teams were aware of the 
research and details of the study were communicated to their general practitioners in order 
that any concerns could be raised by the participants or by the researcher on their behalf.  
The participant information sheet stated that the researcher could make referrals for 
professional support should this be required. Two participants were visibly distressed during 
the interview. One young gentleman signalled for the recording to be stopped temporarily 
and apologised for being upset. However, he was subsequently keen to resume despite 
reassurances that he should not continue if he felt uncomfortable to do so. He had made 
notes about the areas he wanted to cover in the interview in the days leading up to meeting 
and it was suggested that these could be used rather than continuing but he was earnest in  
his desire to continue. A second gentleman had experienced significant health challenges in 
the week before the scheduled interview and had to cancel it once. Despite this, he also was 
insistent on fulfilling his commitment to share his experiences. 
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As Kvale & Brinkmann (2009 p 74) note, ‘morally responsible research behaviour is more 
than abstract ethical knowledge and cognitive choices; it involves the moral integrity of the 
researcher, his or her sensitivity and commitment to moral issues and action’. Field notes 
were kept relating to each interview in order to learn from each what went well and not so 
well including contextual factors such as how the participant appeared in terms of their 
health and general demeanour. The researcher’s years of nursing experience were of value 
in making these physical and psychological assessments and in respecting each individual’s 
circumstances. Environmental factors such as securing a comfortable venue for the 
interviews or arranging to visit the participant at their home were also important factors. 
 
3.17 Consent 
Participants were asked to sign a consent form and advised again that they could withdraw 
at any time without giving a reason nor affecting their future care (Appendix V). Verbal 
consent was repeated at the beginning of the taped interview. The participant information 
sheet stated that the research would not result in a direct benefit to them but that it could 
help others undergoing SCT in the future. 
 
3.18 Confidentiality 
The participants were assured that all data would be treated as confidential unless it was 
disclosed that they or another person was at risk of serious harm. The electronic recordings 
and interview transcripts were kept securely in a locked place when not being used solely by 
the researcher for the purpose of analysis. 
 
3.19 Anonymity 
The participants were assured that their interviews would not be related to their personal 
identity nor discussed with anyone other than anonymised versions being discussed with the 
researcher’s academic supervisors prior to dissemination of the findings to themselves, 
presentation at conferences and publication in an academic journal. 
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3.20 Potential risks and learning for the researcher 
There is a possibility that the researcher may be affected by the narratives told by the 
participants or if she feels that they have been adversely affected by the process. Reflecting 
on the interviews including reference to the transcript and field notes helped to further refine  
the art of effective listening and genuine solicitude. Sharing data excerpts with academic 
supervisors also helped to point to instances where a leading question was asked or an 
opportunity to probe missed.  A second issue for the researcher concerned interviews 
conducted in the participant’s home.  The principles outlined in the Hospital Trust and 
University of Surrey Lone Worker Policies were applied to ensure safety in entering an 
unknown environment and informing a colleague or family member of her whereabouts. 
 
3.21 Data Analysis  
The researcher made the decision to transcribe the interviews herself for several reasons. 
Firstly to gain familiarity and subsequent in depth knowledge of each participant’s interview 
by repeated listening which was ensured due to the slow speed of typing relative to the 
spoken word. Secondly, in order to pick up any nuances such as silences, pauses, laughter, 
repetition of certain words and tone as advocated by McLellan et al (2003) which may 
otherwise have been overlooked and finally because this formed the first stage of data 
analysis. Whilst developing a heightened consciousness of both content and context, the 
process of transcription can also be viewed as a function of reflexivity, uncovering more 
detail and thereby increasing the depth of understanding (McLellan et al 2003).  
 
Transcribing the interviews without involving a third party also supported the ethical 
principles of confidentiality of the data, though the possibility of doing so was built into the 
ethics application for the study in the event of constraints on time resources. Although the 
researcher undertook training in the software package NVIVO on two separate occasions, 
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and the transcripts uploaded, capabilities within other more familiar programmes proved to 
be sufficient for the organisation of data. 
 
In order to enhance the depth and quality of the data analysis three approaches were 
considered valuable. Thematic analysis of the interview transcriptions was conducted using 
the procedural steps outlined by Colaizzi (1978) and Smith et al (2009) as a guide. Rationale 
for this method is twofold. Firstly that a logical procedure is followed so that all interviews are 
subjected to the same steps to identify statements and significant phenomena which could 
then be drawn together across all participant data. Secondly, adopting interpretive 
phenomenological analysis recognises and accepts that a researcher’s previous knowledge 
and experience are included as part of the analysis (Colaizzi 1978, Crist & Tanner 2003, 
Smith 2009).   
 
1. Read all of the participants descriptions of their experiences to acquire an overall 
feeling for them 
2. Return to each transcript and extract phrases or sentences that directly pertain to the 
investigated phenomena, that is, extract significant statements. Acknowledge 
common themes and condense responses by eliminating repetition. 
3. Formulate meanings from the significant statements. The result should be closely 
connected to the original accounts whilst illuminating meanings hidden in the various 
contexts and horizons of the investigated phenomenon. 
4. Repeat step three for each transcript and organise the aggregate formulated 
meanings into clusters of themes. Refer these back to the original transcripts to 
validate them. 
5. Integrate the results into an exhaustive description of the investigated topic. 
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6. Formulate the exhaustive description of the investigated phenomenon in as 
unequivocal a statement of identification of its fundamental structure as possible. 
7. A final validating step may be achieved by returning to the participants. 
 
Adapted from Colaizzi’s procedural steps in Valle & King 1978 
 
3.22 Reading the participants descriptions of their experiences 
As mentioned earlier, the participant interviews were listened to in detail whilst being 
transcribed verbatim.  Following each interview notes were made contemporaneously and 
whilst these included demographic data, the venue and context of the meeting, an initial 
overall sense of meaning was ascribed (see Pen Portraits Appendix III). During the process 
of the initial line by line analysis, comments and themes were annotated in the margin of 
each interview transcript (Appendix VI). On subsequent readings preliminary interpretations 
of the data were also noted and summarised in table format (Appendix VII). The box below 
shows an example of one of the participant transcripts with preliminary themes identified: 
 
Themes: physical manifestations, identity and self-image 
“I was really puffed out and my arms were like sausages. I was quite a keen gym goer 
before I went in (to hospital) ’cos I wanted to be really fit and I was going in three times a 
week doing weights and cardio and its just all gone (laughs), you know it’s like being the ten 
stone weakling on the beach again.” (P11) 
“You don’t even want to watch TV because you compare yourself with the people who are 
well and you think look at me, I’ve blown up and I’ve got no hair and I’m not the way I should 
be.” (P1) 
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Theme: facing own mortality and therefore feeling grateful for any hope regarding 
treatment options. 
“I feel quite lucky ‘cos you know, on the 1st January the doctors in Brighton essentially said 
game over, you know, you’ve had this seizure so if it’s in your spine or central nervous 
system … nothing’s going to happen, we won’t be doing the transplant.” (P12) 
 
This process was performed for each interview and a further table designed to represent 
some of the cross cutting themes (Appendix VIII). At each stage of the analysis the 
preliminary findings were discussed with academic supervisors and excerpts of the data 
shared to promote consistency of interpretations. When these differed, in depth discussions 
ensued allowing possible construals of meaning to be considered. This process was 
invaluable in achieving consensus with the researcher being able to lend context to the 
narrative and the academic supervisors to challenge unintentional but none the less 
potential bias and preconceptions to influence the interpretation. An example of such 
discussion related to the researchers interpretation of a number of participants appearing 
positive about their experiences. Whilst there were data to support their adoption of this 
attitude it was perhaps more of a conscious strategy to deal with experiences which were on 
many occasions overwhelming.  It is important therefore that the researcher’s interpretations 
were questioned and that a deeper level of understanding achieved.  In this way the 
researcher acts as a resource to make sense of the data thereby increasing the reliability of 
the findings.  As Hammersley and Atkinson (2007) state:  
 
“This requires the exercise of some analytic nerve, tolerating uncertainty and  
ambiguity in one’s interpretations and resisting the temptation to rush to determinate 
conclusions” (Hammersley and Atkinson 2007 p163) 
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Since the foundations of the analysis lies deep within the data, re-visiting and re-checking 
interpretations with the original data is an important and repetitive process as the findings 
emerge.  
 
3.23 Extracting Significant Statements 
A process was followed for each interview transcript which involved extracting significant 
statements (Appendix IX). This differed from the line by line analysis because it allowed for 
larger pieces of text to be examined. In a number of interviews these statements were 
repeated but in a slightly different way allowing the researcher to discover events which 
were particularly significant for the participant or that they appeared to be making sense of. 
An example of this related to the theme of uncertainty which had already emerged in one 
form or another in all the participant’s narratives. The example shown in the box below 
catalogues significant statements relating to the uncertainty about whether a second stem 
cell transplant had been successful for a particular lady. 
 
Significant statements relating to uncertainty about disease recurrence: 
“If I have a pain, I think oh, is that the leukaemia back as soon as I get sort of over tired like I 
have been recently, I immediately think it’s back, you know” (P4) 
“I’m still at the stage where I’m waiting for it to come back and I think I’ve got to really sort 
of get over that. The doctor said today my blood levels are fine. There’s one or two things 
that are slightly out of kilter but they’re not worried so, so I think it’s, it is good because I 
trust them” (P4) 
 
A subsequent method of analysis advocated the viewing of data through four lenses 
McCormack (2000a, 2000b) including language, narrative processes, context and significant 
moments in order to uncover different aspects of understanding resulting in a contextually 
rich interpretation. An explanation of the lenses is outlined below: 
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(i) The lens of language guides the researcher to focus on the specific words used 
by participants in the telling of their unique story. 
(ii) The lens of narrative process focuses on the structure and pattern of words used. 
Noting a hesitant, disjointed use of words may suggest a different meaning than 
an easier, flowing account and enables the researcher to sense emotions and 
meaning attached to what is being discussed. 
(iii) The lens of context acknowledges the individual’s understanding of how their 
experience is influenced by the context in which the experience takes place. In 
this study, contextual factors include the researchers understanding of the 
aggressive treatments undertaken by the participants through clinical experience 
and review of the literature. 
(iv) The lens of moments refers to a new understanding of an event or experience 
captured through the process of storytelling.  
 
Whilst this process was rigorously applied to several interview transcripts thenceforth the 
overarching principles were applied in a more general way as the researcher became 
familiar with the analytical method.  For example, a heightened awareness of language and 
the structure of the narratives such as the repetition of certain events and feelings led to an 
enhanced understanding of the participant’s experience. A male participant who 
experienced significant physical challenges stated that he was not depressed “just hugely 
pissed off” which revealed his strength of feeling but his language also characterises a 
masculine tendency to display anger rather than distress.   
 
Furthermore, increased attentiveness and sensitivity to the participant’s discursive style 
enabled a deeper level of analysis of the data and the meaning attached to it. McCormack’s 
(2000a) lens of significant moments refers to a person’s new understanding of an event or 
experience, also referred to as an epiphany captured through the process of storytelling 
83 
 
whilst Colaizzi’s (1978) collection of significant statements implies interpretation by the 
researcher. The researcher’s experience was that both processes occurred, that is, during 
participant’s story telling when it was evident that they gained new understanding and again 
as the researcher analysed these statements in the context of the whole narrative.  
 
The use of metaphor has also been suggested as an effective vehicle both to communicate 
and present human experience (Wiklund 2010). Their use may originate from the 
participants within their narrative (Jairath 1999) or be applied by researchers (Kangas, 
Warren & Byrne 1998, Wiklund 2010). Since metaphors were apparent in the language of 
participants in studies reviewed in the literature the use of such an approach was considered 
appropriate if they arose in the current study. According to Lakoff and Johnson (2003) 
Western philosophy and language is often inadequate in expressing the meaning of 
everyday realities and argue that the use of metaphor plays a critical role in purveying 
meaning and understanding of our stories: 
 
“Metaphor is for most people a device of the poetic imagination.... a matter of the 
extraordinary rather than ordinary language.” (p3 Lakoff and Johnson 2003) 
 
Participants in the current study used metaphors such as ‘in limbo’ or ‘having no satnav’ to 
describe the uncertainty they felt about their recovery experience and these are discussed 
further in the findings. One of the participants used the following metaphor to illustrate how 
he felt about being told that he could go home revealing the enormity of how this felt to him:  
 
“you’re being given a key that unlocks certain doors back to your normal life but not 
fully understanding the consequences of being left to stand on your own two feet 
after such a journey. It’s a huge, huge thing”. 
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3.24 Rigour 
Whilst quantitative research is dependent on the reliability and validity of the instrument 
(Polit & Hungler 1997) qualitative research is judged in terms of trustworthiness, 
transferability, transparency and depth of analysis to uphold its rigour. Van Manen (1990 
p22) argues against generalisation as an aim of phenomenological research in favour of 
capturing the uniqueness of the individual and associated events. However, Van Manen 
(1990) also cautions against reflection on such events whereas Conroy (2003) advocates 
the incorporation of Heideggerian (1954) philosophy into an interpretive phenomenological 
research design. Qualitative methodology involving such an interpretive naturalistic 
approach to its subject matter is considered by Denzin & Lincoln (1994) to be more valid and 
less reliable than quantitative methods. Establishing rigour in both methodological 
congruence and in the interview process is one of the principle tenets of phenomenological 
inquiry (Wimpenny & Gass 2000). Kvale & Brinkmann (2009) promote the concept of 
interviewing as a craft whereby the interviewer becomes skilled with practice and is 
subsequently able to apply educated judgements to inform the data collection process. This 
contrasts with the positivist approach advocating formulaic ‘rule-governed’ methods (Kvale & 
Brinkmann 2009). Burns (1989) outlines the requirements for procedural rigour in qualitative 
research consistent with Glaser & Strauss’ (1967) view that the researcher should describe 
the social world with such vividness that you could almost believe you were there. 
 
3.25 Researcher credibility 
Researcher credibility (Patton 1990) as the data collecting instrument and analytic agent is 
dependent on their knowledge, qualifications, skills and experience. Any connection to the 
topic and the participants should also be transparent as recommended by Koch (1994) 
outlining how a decision trail can assist the reader to regard the interview in its wider 
context. All of these factors are important in establishing confidence in the data (Polit & 
Hungler 1997 p306) and are incorporated into the final thesis and related publications. The 
researcher’s professional role at the time of undertaking this study was largely a managerial 
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one and also the area of specialism relatively new. This has distinct advantages in that 
knowledge in the field was gained through working in the area and by what was learnt from 
the participants throughout the duration of the study as opposed to having any preconceived 
ideas or views.  This position of naivety in relation to the speciality reduced the risk of bias 
and any associated conflict of interest pertaining to clinical and managerial matters. 
 
3.26 Trust in narrative inquiry 
As mentioned earlier the researcher gained access to patients through a network of 
professional colleagues. It is hoped that patients were reassured regarding the authenticity 
of the researcher since the study was approved by their clinical team.  Establishing a 
relationship of trust with participants throughout the inquiry is critical (Cartwright & Limandri 
1997, Polit and Beck 2004), particularly when emotive topics may be discussed (Speziale & 
Carpenter 2003). The researcher remained cognisant of her responsibility to protect the best 
interests of participants and to consider the needs of those who may be more vulnerable, for 
example, those with a limited social support network, advanced age and compromised 
functional or psychological status (Castledine 2003). The concept of trust has implications 
for the nature and quality of information participants are willing to disclose and the 
researcher made every effort to ensure that their shared experiences were valued. Certain 
characteristics are advocated for the investigator such as reliability, the ability to inspire 
confidence and consistency (Meize-Grochowski 1984), empathetic understanding 
(Cartwright & Limandri 1984) and the ability to work in partnership with participants (Shuster 
1984). The initial face to face contact and thereafter by telephone or text message 
communication between the researcher and the participants led to a shared familiarity, trust 
and respect. 
 
3.27 Reflexivity 
The role of reflexivity in qualitative methodologies is highly significant (Dowling 2006) 
refuting the belief that distance between researcher and participant is paramount. Whilst 
86 
 
some authors promote its value in sustaining objectivity in phenomenological methods (Koch 
& Harrington 1998), others acknowledge the participatory nature of narrative research 
whereby reflexivity embraces a reciprocal process of interpretation between researcher and 
the researched (Fontana 2004). From an epistemological standpoint reflexivity encourages a 
critical appraisal of the research design and methods in conjunction with the investigators 
reflections on their prior assumptions about how knowledge and truth are acquired. In 
philosophical hermeneutics Gadamer (1989) asserts that predispositions are an essential 
component of interpretation and should be recognised accordingly (Pascoe 1996).  A 
number of strategies were employed to support the authenticity and trustworthiness of the 
interpreted data. As mentioned earlier, the researcher kept field notes to record nuances and 
impressions from the narratives directly after the interviews were completed to support the 
subsequent interpretation and analysis. A research log was maintained to record the 
researcher's reflections on the interview process and to maintain a decision trail thereby 
ensuring transparency of the research process and the analysis.  
 
3.28 Confirmability 
Confirmability refers to the neutrality or objectivity of the data achieved through an 
agreement between two or more independent people about the relevance and meaning of 
the data (Polit & Hungler 1997). In this study, the researcher’s academic supervisors worked 
collaboratively with the researcher in the analysis and interpretation of the data.  
 
3.29 Transferability and implications for practice 
Lincoln & Guba (1985) utilise the term transferability to denote the applicability of the data to 
other contexts. The clarity of the research design and sampling will influence this in 
combination with the thick or rich description provided by the investigator. Whilst critics of 
phenomenology argue that gaining insights into the lived experiences of the participants 
does not result in practice change, as highlighted in the literature review Jones & Chapman 
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(2000) claim that recommendations to change and support practice were accepted on the 
basis of their phenomenological inquiry. 
 
3.30 Dissemination and reporting 
Preliminary findings from this study have been shared with a group of Doctoral students and 
academic staff and a poster was presented at the post-graduate conference in February 
2014 at the University of Surrey.  An abstract was accepted for an oral presentation at the 
British Sociological Association conference in September 2014. Following a travel 
scholarship awarded by the European Bone Marrow Transplant European Bone Marrow 
Transplant (United Kingdom) Nurses and Allied Professions Group in 2009 to attend the 
annual conference, presentation at a subsequent European Bone Marrow Transplant 
meeting has been invited. A paper has been submitted to the Journal of Advanced Nursing. 
Appropriate methods of dissemination to the patient groups and staff at both specialist 
treatment centres will be discussed with the clinical teams on completion of the thesis.   
 
3.31 Summary of chapter 
This chapter has offered a rationale for the chosen methodology of interpretive 
phenomenology in order to investigate participant’s experiences of returning home following 
allogeneic stem cell transplant. Since interpretive phenomenological methodology is based 
on an acceptance that the researcher is able to consider the evidence in relation to their 
existing professional and experiential knowledge, it is not value free. IPA acknowledges the 
human contribution to the process which would not be acceptable to researchers favouring a 
positivist paradigm. In order to gain a greater insight and understanding of what patients go 
through and what life holds following SCT it is important to explore the issues directly from 
the patient’s perspective. The study methods and the procedural steps followed for analytical 
purposes have been outlined and the emergent themes will be discussed in the findings 
chapter. 
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CHAPTER 4 
 
 
Data Analysis and Findings 
 
4.1 Introduction 
The purpose of the following chapter is to present the findings from the study in accordance 
with interpretive phenomenological method (Munhall 2012, Smith 2009). The two 
overarching concepts which emerged from the data are: The Immediacy of Illness and 
Existential Crisis and The Recovery Journey.  Arriving at this conceptual stance was a 
lengthy and complex process of analysis, moving backwards and forwards between the data 
and what was emerging. The aim was to narrow the scope of enquiry to the most significant 
convergent characteristics of the participant’s experiences, whilst endeavouring to preserve 
some of their unique features. As mentioned in the previous chapter, the early themes were 
assembled in a series of mind-mapping diagrams and tables (Appendices VII & VIII). 
Revisiting the data and looking for relationships between the emerging themes and sub-
themes was an iterative - inductive process (Ezzy 2002).  Excerpts from participant 
narratives are used to illustrate the themes with data extracts denoted in speech marks and 
italic and the participant number in brackets, for example participant 1 is (P1). Where a 
spouse or parent were present and contributed to the interview the participant to whom they 
relate is entered into the brackets with a W for wife, an H for husband and M for mother for 
example the wife of participant 14 would be shown as (P14W). Words or statements 
specifically emphasised by participants are shown in bold type within the data extracts. 
References are made to the literature to support the findings, some of which originated from 
the primary literature review and others introduced as themes from the data emerged and 
further reading took place.  
 
4.2 The Immediacy of Illness and Existential Crisis 
This overarching concept illustrates the immediacy of illness and existential crisis 
experienced by the participants in relation to disease onset, diagnosis, treatment and 
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continuing into recovery.  The sudden or insidious onset of haematological malignancy 
throws the participant’s lives into an existential crisis in both an immediate and enduring 
sense.  Challenges include their literal fight for survival through uncompromising 
chemotherapy and radiotherapy treatments with stem cell transplantation as the only 
remaining option available to them to treat aggressive or relapsing disease.  The 
participant’s experiences have resonance with Bury’s suggestion that “illness and especially 
chronic illness is the kind of experience where structures of everyday life and the forms of 
knowledge that underpin them are disrupted” and that “chronic illness involves a recognition 
of the worlds of pain and suffering, possibly even of death which are normally only seen as 
distant possibilities or the plight of others” (Bury 1982 p169). The immediacy of illness and 
existential crisis includes themes of: critical events and uncertainty (Table 6). 
 
Table 6: Themes and subthemes of the immediacy of illness and existential crisis 
 
Themes Subthemes 
Critical Events Onset of illness and diagnosis 
Disease and treatment effects  
Uncertainty Safe in the bubble and being left to stand on your own two feet 
Progress isn’t linear, waiting for it to come back 
I can never relax: the emotional strain of caring 
Left to fight and fend and work it out for yourself: financial issues 
 
4.3 Critical Events  
The illness journey is characterised by critical events resulting from the underlying disease 
and the effects of treatments including impaired immunity, damage to vital organs and the 
possibility of stem cell rejection.  Systemic infections and in some cases reaction to trial 
chemotherapeutic agents pose life threatening risks with the pre-transplant conditioning 
therapy being one of the most physically and  mentally challenging. This section will follow 
the participants chronologically through these stages commencing with their diagnosis.  
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4.3.1 Onset of illness and diagnosis 
Several participants described how feelings of tiredness and weakness (p 11, p14 and p16) 
and symptoms suggestive of viral illness (p12, p14, p16) precipitated their decision to seek 
medical help. Participants 3, 12, 14 and 16 acknowledge the speed of events following their 
diagnosis and the experience of participant sixteen, a sixty three year old man, employed on 
a full time basis until his illness serves to illustrate this point. Both this gentleman and his 
wife were increasingly concerned about symptoms such as “pains in his stomach, incredible 
night sweats and the fact that he was getting weaker and weaker and sleeping constantly 
and stopping breathing.” Initially told that they he could see a doctor “in a fortnight” prompted 
his wife to “row with the receptionists” in order to have her concerns taken seriously and 
expedite an emergency appointment. Her concerns were well founded as she describes 
below: 
 
“they actually told my husband when he was brought into the hospital he had a 
fortnight, it was that close. I mean we just about got him out of the car into the hospital 
before he collapsed, it was that bad.” (P16W) 
 
In this data extract the patient’s wife is describing how close to death her husband was 
before he was admitted to hospital where he was confirmed to have acute myeloid 
leukaemia.  At the specialist treatment centre, developments progressed rapidly as 
demonstrated in his wife’s explanation of the situation and his affirmation (in brackets) in the 
following quote: 
 
“It was like being thrown into a cement mixer and wondering what was going to come 
out at the other end (it was just a haze really, yea, so much going on P16).”  (P16W) 
 
The “cement mixer” analogy portrays a sense of the complete disruption that was occurring 
with little conception of what was going to happen at the other end of treatment.  Participant 
91 
 
twelve, a thirty-eight year old gentleman described the shock of learning that he had a 
diagnosis of peripheral T cell lymphoma having experienced several weeks of respiratory 
symptoms prior to his GP organising investigations at the hospital: 
 
“It was a bit of a shock, I wasn’t expecting it at all.  I’d had trouble breathing and 
sweats, like a virus and then they called me next day and I thought right, well that’s not 
good and I thought it was because of the chest x-ray, probably because of the 
wheezing, I couldn’t properly inflate my lungs I was thinking this is like lung cancer or 
something like that but then they took me away to the quiet room as they do and sort 
of mentioned it but it was kind of like a whole new world it’s not something I was, blood 
cancers isn’t anything I know anything about”  (P12) 
 
Though he had not anticipated a serious cause for his symptoms, assuming he had a virus, 
his suspicions were aroused when he was called back to the hospital urgently following 
diagnostic investigations. The immediacy of the life and death situation and the complete 
uncertainty was an overwhelming experience.  Not only was the diagnosis a surprise but the 
nature of the disease itself was not one which was familiar to him. Since haematological 
malignancies are relatively rare it is not surprising that lay knowledge is sparse in 
comparison to the more common forms of cancers. The urgency of this call alerts him to 
contemplate a more sinister explanation for his condition coupled with the severity of his 
pain and breathing difficulties. Reaching a conclusion that something is seriously wrong 
suggests that he is processing external cues at the same time as beginning to interpret 
changes in his altered bodily state. These interpretations signal his heightened awareness 
and resonate with the notion of embodied intelligence as described by Benner (1994) and 
the primacy of embodiment proposed by Merleau-Ponty (2002).  His lack of awareness 
about blood cancers is apparent in his articulation “a whole new world” encapsulating the 
notion of entering the world of the sick (Bury 1982, Mishler 1994, Frank 1995). Participant 
four was similarly shocked to learn of her diagnosis of acute lymphoblastic leukaemia: 
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“I was actually in denial at first. I mean I even told the consultant that he’d got it wrong. 
I said people in my family don’t get things like this, I think you’re wrong. Bless him, he 
just smiled nicely at me and said, no I think I’m right.” (P4) 
 
In searching for the meaning of illness events, there is evidence that patients consider 
possible causes for disease incidence including familial transmission (Bury 1982 p 174). 
This particular lady articulates disbelief at her diagnosis because there is no family history of 
“things like this”.  
 
For the participants treated with supportive therapies for myelodysplastic disorders (P11 and 
P 14) there is a period of a less critical nature following diagnosis as symptoms are treated 
and plans for eventual SCT are made. The young lady with aplastic anaemia (P5) is also 
treated conservatively though she suffered a critical event five months after diagnosis when 
she contracted a klebsiella bacterial infection and required life support. Serious 
complications of avascular necrosis 2 and osteomyelitis rendered her severely debilitated 
and at risk of amputation of her arm and leg. Participants diagnosed with leukaemia and 
lymphoma had several months of chemotherapy or a combination of chemotherapy and 
radiotherapy prior to their SCT. Describing their experiences of chemotherapy and 
radiotherapy leading up to SCT, participants liken the time spent in a protective isolation 
facility as feeling like a ‘caged animal’ (P15) or “serving a prison sentence” (P11 and P15).  
Participant fifteen found these times particularly frustrating, “when you’re feeling mentally ok, 
it just drags” and kept a calendar to cross out the days until he was able to come out of 
isolation. The temporal aspects to which this gentleman refers accord with the ‘treatment 
calendar’ as portrayed by Schou & Hewison (1999 p49) over which he has little control and 
which conflicts with his personal and life calendar enforcing a sudden disruption to his day to  
                                                 
2 Avascular necrosis is a condition whereby a compromised blood supply results in the 
death of bone tissue and there is evidence to show that it can occur as a result of high dose 
methylprednisolone therapy used in the treatment of aplastic anaemia (Marsh 1993).  
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day plans. Conversely, for participant twelve, a thirty eight year old gentleman whose 
hospitalisation at the point of diagnosis and initial treatment lasted several weeks, the period 
in isolation during the transplant experience appeared to be less daunting. 
 
“I’d been in hospital in Brighton for seven weeks at the start, then I knew that however 
long I was in here was for less time than that, so it was doable, I know that I’d done 
worse do you know what I mean, it was almost like training” (P12) 
 
Knowing that he had managed a long period of time in hospital at the time of diagnosis 
helped him to prepare mentally for the challenges ahead coupled with the chances of 
achieving disease remission from undergoing the SCT.  
 
4.3.2 Disease and treatment effects 
Despite relatively mild physical effects during the initial two cycles of chemotherapy, which 
he described as “being in limbo” participant six acknowledges the rapid deterioration of his 
physical condition during the time of his pre-transplant conditioning. He questions whether 
his “vegetative state” was due to tiredness relating to both the treatment and the fact that he 
suffered heart failure caused by the chemotherapy or if this was a psychological reaction to 
his circumstances. He appeared to feel more comfortable with the former explanation.  His 
experience of being in hospital, characterised by his use of the metaphor “being in limbo” is 
evocative of the concept of liminality identified by Turner (1969) and encountered by cancer 
patients as evidenced in a number of studies (Little et al 1998 McKenzie 2004, Thompson 
2007, Cayless et al 2010). Turner (1969 p 97) uses the concept of liminality to explain the 
process of transition between roles and positions in society where the liminal phase is 
viewed as particularly ambiguous ‘betwixt and between structural classification’.  In the 
context of illness, Molzahn et al (2008 p15) suggests that ‘liminality refers to the ambiguous 
experience of one’s life story being interrupted by illness’. For this gentleman being “in 
limbo” relates to the time in hospital receiving his initial chemotherapy where the implications 
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of illness and uncertain outcomes are realised. A number of the participants describe the 
conditioning phase of the transplant experience as being particularly distressing and the 
inherent risk to survival is also evident. As participant sixteen explains: 
 
“I had my transplant in February but before that I had to have the conditioning 
chemotherapy and I found that the worst ... it affected me most, I was getting 
infections, also I had a problem with very low blood pressure which nearly put me into 
intensive care.”  (P16) 
 
It appears that this gentleman suffered a critical event as a result of infection and effect on 
his blood pressure caused by the conditioning therapy and that he narrowly escaped an 
episode of intensive care. Similarly, participant nine, a sixty eight year old lady, eleven 
months post SCT for acute myeloid leukaemia recalls: 
 
“And I landed up with one platelet! God knows how I survived. They’re now a hundred 
and sixty-six, whoopee! Put the flags out! I mean ok, I laugh about it but it was... I’m 
going to say this, you probably won’t put it in but I was knocking on death’s door...the 
professor said to me it’s going to be like nothing you’ve had before. I know you’ve had 
three lots of chemo, he said and in different stages it’s got stronger and stronger, but 
this one is the ultimate. He said you can never have any more. He said if this comes 
back I’m afraid it’s curtains.” (P9) 
 
Whilst this lady appears to speak fairly light-heartedly about her experience, it was obviously 
one which carried very real and potentially life threatening consequences illustrated by her 
reference to “knocking on death’s door”. Furthermore, the professor’s sobering advice that if 
the “ultimate” treatment failed it would be “curtains”. The fact that she feels able to laugh 
about it now suggests her relief to have survived or perhaps the use of humour was a 
deliberate strategy to underplay the seriousness of the situation. Fox (1979) suggests that 
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humour is a key strategy to mask the stress that uncertainty brings. Participant eleven’s 
powerful description of conditioning therapy and SCT is articulated in the following data 
extract: 
 
“you’ve had the core of your body killed and brought back to life again and you can’t 
just shrug that off and bounce back”  (P11) 
 
This gentleman’s description of “the core of your body being killed” and being “brought back 
to life again” correlates with findings in Potrata et al’s (2010) study aimed at understanding 
distress and distressing experiences in patients living with multiple myeloma.  Potrata et al 
(2010 p127) found that the conditioning phase of allogeneic stem cell transplant was 
particularly stressful and considered a ‘violation to the body’, where several participants 
associated chemotherapy and specifically the conditioning chemotherapy with the beginning 
of death. This temporary state of ‘death’ ceased when the stem cells were infused and there 
was evidence of successful engraftment. Though not specifically referring to any one part of 
the SCT process another participant in the current study affirmed “you’ve had a huge bang 
to your body” and “you’ve been stripped down from your whole”. Whilst other participants in 
the current study refer to distressing symptoms at this time, the majority also focus on the 
life giving qualities of the stem cell treatment.  This view is both significant and poignant for 
participant four who had already had a SCT and explained how she felt about undertaking a 
second one: 
 
“in a way it was easier because I knew what to expect with the transplant, having 
been through it before but also it was harder because I knew what to expect”  (P4) 
 
She described having different side effects with both lots of chemotherapy treatments in that 
pain was a feature the first time and diarrhoea the second which though “terrible” was dealt 
with well, “you only have to say, you know this hurts or I’m really feeling sick and they look 
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after you”. Clearly, prompt alleviation of unpleasant symptoms relieved the situation and as 
she explained the “reassurance” she received likewise reduced her anxiety. At the time of 
our meeting this lady was feeling concerned about a possible relapse of her acute 
lymphoblastic leukaemia. In the face of this, though the transplant experiences in their 
totality had not been pleasant, she expressed a preference for the opportunity to receive 
more treatment in order to increase her chances of survival:   
 
“they told me I couldn’t have another transplant now because I’ve had two and I think 
it’s my age and whatever, but if someone said to me ‘well we can give you another 
transplant you know, it’s come back but you can have another one’, I wouldn’t think 
twice, you know,…it wasn’t a terrible experience, you know, by any means.”  (P4) 
 
These sentiments contrast significantly with a participant with disease relapse in Potrata et 
al’s (2010) study who felt that she could not face the experience of a second SCT. Potrata et 
al’s (2010) findings however, concord with the sentiments of participant eleven who stated: 
 
“I went in there sort of you know quite roughty toughty and well muscled and weighing 
about thirteen stone and it really kicked my arse… if I’d been another twenty years 
older and known what I know now, I bloody wouldn’t have it. I’d go with transfusions.”  
(P11) 
 
The strength of his language “I bloody wouldn’t have it” reflects his emotional response to 
how challenging the experience has been for him and that he would certainly not be keen to 
contemplate a second SCT. Two participants described critical events leading to a 
significant period of time in intensive care.  Participant seven required life support due to a 
chemotherapy related infection prior to his transplant. The critical nature of his experience 
and his feelings of confusion due to lack of memory regarding how or why he was there are 
exemplified in the data extract below: 
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“That was a nightmare when I was in Intensive Care, really. I’ve got a vision, I’ve got 
memories of being aware that I was somewhere, I didn’t know why I was there, I didn’t 
know where I was. All I knew was I couldn’t move. Was I a prisoner, you know I just 
didn’t know, my mind was going round in circles and it was horrible, you know it was 
awful. All I could see was strange people walking past that I didn’t know. I could hear 
people talking occasionally but it was, well, I just couldn’t make out what was going on 
and it was frightening to me, because my mind was working normally in a sense, but I 
just couldn’t work out what was happening at all.”’   (P7) 
 
Memories remain vivid for this participant and he emphasises the magnitude, duration and 
effect that the confusion had on him. The incident clearly caused him much distress evident 
by the strength of feeling articulated in his narrative and his lasting memory of the 
experience as illustrated further in his words: 
 
“I just didn’t know what was going on and my mind was playing awful tricks on 
me and well at least I felt it was, it must’ve been because I just didn’t know what to 
think at the time and it was awful and I can’t forget that, you know, it is still stuck in 
my memory... it took me about five days to find out what had happened” (P7) 
 
The immediate effect of being provided with an explanation and making sense of the 
situation however was perceived by this participant to improve his mental attitude 
immediately: 
 
“once I knew what had happened to me, I was actually a lot happier, because,  I was 
just so confused, so confused, so confused it was awful but anyway once I knew 
what had happened to me I was, it made life a lot simpler and everything and I 
concentrated on getting better”  (P7) 
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The experience related by participant seven almost a year post transplant illustrates the 
speed at which life threatening infections can occur and also the profound and lasting effect 
of the distress he felt. Similarly participant eight, a sixty three year old lady treated for 
leukaemia recollects the time when she was “rushed” to intensive care following an acute 
reaction to a trial drug: 
 
“I was on a trial and they gave me really strong chemo and it caused monocytes in 
the skin, they were attached to my skin, they were attached to my lungs and gut and 
everything and when the chemo...worked, all that came away and it just left all my 
lungs and gut and everything and I just bled out, so I was rushed to Intensive Care 
and they had to put me on a life support machine and I was on that for three weeks.” 
(P8) 
 
Her recollections remain vivid as she went on to explain: 
 
“...and in my stupid mind I was trapped.  I mean my husband said to me, you had 
tubes everywhere and I couldn’t move. I was just on my back .. and I could hear this 
music and I could hear, very far away, people talking. And I thought, I’m a prisoner, 
somebody’s keeping me prisoner and I don’t know why they’re keeping me prisoner 
‘cos I haven’t got anything (laughs), you know, as if I’d been kidnapped and I could 
hear this music and I thought, I’m in Austria, because I kept hearing Strauss’s 
waltzes”’  (P8) 
 
It is clear that both participants had a consciousness of their experience. Participant eight 
subsequently learnt that music was played twenty-four hours a day in the intensive care unit 
and accounted for her accurate memory of hearing Austrian music. She even remembers 
thinking that everyone must be having a good time “dancing in the square”.   She was only 
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four months post transplant and she describes how “flashbacks” of this experience affected 
her during a subsequent admission to her local hospital. She had lost a lot of weight and 
was being fed by naso-gastric tube. She describes waking up in the night gasping for breath 
and likens this to the feeling of being trapped whilst in intensive care.  She alludes to the 
reassurance given to her by the night nurses and also her determination to overcome the 
feeling of panic as shown in the following data extract: 
 
“but after a few days I got through that... I’m a very logical person. I argue with 
myself. I say you’ve got to stop this. Get on with it. Face it.”  (P8) 
 
For both participant seven and eight, it appears that they can apply logic when they are able 
to make sense of their experiences. It is interesting that they appear to take a tough line with 
themselves, “you’ve got to stop this. Get on with it” despite the extremely traumatic events 
they have been through.  Conversely, an inability to interpret their situation adequately 
during their time in intensive care engendered fear and confusion. Similarly, in Parker’s (in 
Clanidin & Connelly 1999) study of patients’ recollections of their intensive care experience, 
participants reported a diminished ability to discern dreams and hallucinations from reality. 
They too told of feeling like a prisoner where their bodies had lost the capacity to move 
through paralysis, weakness and the constraint of tubes and life supporting equipment. 
Attempts to communicate were thwarted by respiratory apparatus for participants in both 
studies in addition to substitutes such as writing or touch being impaired. However, 
participants reported their awareness of and comfort derived from hearing the familiar voices 
of loved ones. This was clearly a critical moment in this lady’s treatment and the duration of 
time spent on life support emphasising the extreme seriousness of the event.  Despite the 
alarming disruption to her body this lady repeatedly spoke about how lucky she felt to 
receive the treatment and felt more concerned for her close family as shown in the following 
data extract: 
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“it obviously affects your life but I think the awful thing is that it affects your loved 
ones, because my husband and my son and my daughter-in-law really went through 
it, seeing me the way I was, I mean they say, no don’t be silly, but it makes you feel 
guilty because you feel that you can cope with it for yourself.  I don’t know if other 
people feel the same, I feel guilty that I’ve ruined their lives...they’re really hurting, 
they’re really suffering”  (P8) 
 
The emotional aspect of the suffering affecting the whole family is evident here particularly 
her suggestion that she had “ruined their lives” and caused them to suffer. In addition to 
critical events relating to chemotherapy treatments, two participants experienced atypical 
and unique complications resulting in further disruption to their physical being. Participant 
twelve, married with two small children, suffered both a brain seizure between treatments for 
his lymphoma, compromising his chances of progressing to SCT and also a perforated 
bowel. The latter was thought to be related to the effect of steroids on a previously 
weakened area of the lining of the bowel and happened when he was in a neutropenic state 
following chemotherapy. As he explains: 
 
“I ended up having bowel taken out as well. I had raging lymphoma and they were 
doing a fairly major operation and when it happened I was neutropenic so they had to 
wait and once they’d done it the lymphoma came back very quickly so there was this 
battle about, so well we want to give him treatment, we want to give him steroids and 
steroids plus healing bowel is not a good combination”  (P12) 
 
The careful timing and titration of treatments for conditions with competing requirements and 
priorities is palpable.  From his diagnosis onwards this gentleman suffered a series of life 
threatening complications and the “battle” he alludes to over what course of action to take in 
addition to the “raging lymphoma” would inevitably have added to his anxiety. However, the 
calm attitude displayed by this gentleman as he told his story belied the enormity of what he 
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had experienced and was perhaps explained by the very fact that he had survived. In his 
words: 
 
“I’ve actually felt very lucky to be..., there’s been plenty of times when I’ve wondered if 
I’ll see the end of the football season.” (P12) 
 
Similarly, participant fifteen, a thirty three year old gentleman with acute lymphoblastic 
leukaemia experienced an extremely rare complication. Despite being treated aggressively 
with both chemotherapy and radiotherapy, he developed a tumour on his optic nerve:  
 
“I was on chemotherapy and I developed really bad headaches but it was a 
headache that was all day, all night, every minute, every hour of the day...they were 
giving me pain killers which didn’t even touch the sides. After about seven to ten 
days the consultants were doing the rounds and I just had my head under the 
blanket and I said I can’t see and I couldn’t read text messages on my ‘phone 
anymore, the room went a bit hazy and then I woke up another day and I couldn’t 
see anything”  (P15) 
 
This participant was newly married in the same year that his illness became apparent. He 
had two small children and after years of working in larger companies had recently set up 
his own business. The enormous disruption this situation had on his entire family was 
evident from his narrative. Coming to terms with his underlying diagnosis and subsequently 
facing possible loss of his sight was clearly an event of inordinate magnitude.  He explained 
that when he was seen by a specialist ophthalmologist, she acknowledged that in her many 
years in the speciality, she had never seen nor treated a case such as his.  Not only was it 
unusual to experience disease relapse whilst still being treated with chemotherapy but the 
tumour itself was particularly uncommon. Threatened with the loss of sight in both eyes, his 
stunned reaction is evident in the following narrative extract: 
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“but I’ve got two young children and I can’t see anything, I can’t see and I could just 
hear her talking and she said I think you’ll never be able see again and I was sat with 
a nurse ‘cos the nurse had to walk me to my ward because I couldn’t see where I 
was going and I was just thinking, I just couldn’t get my head round it.”  (P15) 
 
Whilst the shock of this news and all its implications was difficult to absorb, his immediate 
thoughts involved not being able to see his children. Not only was this a critical event in this 
gentleman’s treatment phase but held devastating consequences for his future. As he 
explained however, after several scans he started targeted radiotherapy to the optic nerve 
the following day which resulted in a successful outcome: 
 
“the next day I woke up and I could see but only like 10% but I could start to make 
shapes and over about four or five days it, I came back and I got complete eyesight 
again.”  (P15) 
 
It is worthy of note that the experience of the actual SCT was an anti-climax for the 
participants directly contrasting with that of the conditioning treatment. The following data 
extract is testimony to the way several of them viewed the experience:  
 
“Then it was the big day... and I had twenty minutes on one bag (of stem cells) and 
then twenty minutes on the next bag and they said ‘that’s it, you’re all done’ and you 
sort of look round, am I in any pain, nothing’s you know, what do you mean, they said 
that’s it, done and I couldn’t believe it” (P15) 
 
This young man expresses surprise that the experience was different to that which he 
anticipated imagining the SCT to be a more invasive procedure than it actually is. As 
mentioned previously, participant four had been treated with a second STC and her 
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acknowledgement that the cells were literally life giving and her gratitude are evident as she 
explains:   
 
“one of the things that really shocked me was when I had the transplant, when they 
actually brought in those stem cells and they treated them sooo carefully as if they 
were so precious and I thought gosh they really are precious, this is sort of my chance 
at life...and they treated the whole situation like that and it was quite humbling really. It 
was really quite a shock for me, it wasn’t just an everyday thing, you know it was really 
important”  (P4)  
 
This lady’s articulation and repetition of how “precious” the stem cells are and how 
“humbling” the experience felt emphasises the importance of this event, “it wasn’t just an 
everyday thing”.  Overall, it seems that whilst the physical experience of receiving the stem 
cells was relatively straightforward for the recipients who articulated it, the personal meaning 
ascribed to it is one of significant magnitude and potentially life changing. In reality, 
however, many of the participants’ post-transplant experiences illustrate that having a new 
“chance at life” is not as easy as these words of hope might suggest.  
 
This section has presented the first of the two themes, ‘critical events at diagnosis’ and 
‘critical events related to disease and treatment effects’ under the overarching concept of 
‘The immediacy of illness and existential crisis’. The second of the themes, ‘uncertainty’ will 
now be presented.  
 
4.4 Uncertainty 
4.4.1 Safe in the bubble and being left to stand on your own two feet 
This section focuses on the uncertainty described by participants commencing with their 
transition from hospital to home, the immediate post transplant period and for others in a 
more enduring sense.  The majority of participants relayed their experiences of leaving the 
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safety of the hospital to returning home and how it felt.  The sense of uncertainty 
experienced by the participants was particularly acute when they were ready to go home.  
Some felt psychologically unprepared for making this transition. These feelings are captured 
in the opening statement of participant three’s narrative: 
 
“I think the first reaction I guess was oh no, I’m leaving hospital, what’s going to 
happen, because you’re in a very safe environment and as soon as you leave that 
environment you start to worry, you know any little thing, you check your temperature 
a few times a day just to make sure because although you really don’t want to go back 
into hospital, that’s the primary concern.”  (P3) 
 
This young lady’s feeling of uncertainty “what’s going to happen” appears to contrast 
significantly with the feeling of safety within the hospital environment. Nevertheless, she 
alludes to worrying about little things and checking her temperature “a few times a day” 
suggesting an increased level of vigilance regarding bodily changes.  Her “primary concern” 
however, is to avoid returning to hospital at all costs. In accordance with this view, 
participant four refers to the safety of the hospital both in terms of being cared for but also 
sheltered from life in the outside world.  
 
“It was (pause) all the time I was in hospital actually, it was like you are protected from 
everything else. Even if I wanted to do something for people at home I couldn’t 
because I was, you know in some ways it was really nice because I was protected 
and I was being looked after, you know, I was safe in this bubble, but I also felt a little 
bit trapped, I couldn’t do things that I wanted to do, you know, try and sort things out at 
home but it was very nice in some ways, I did feel very protected and very safe”  (P4) 
 
Whilst she appreciates feeling “protected...looked after” and “safe in this bubble” these 
emotions are countered with a sense of duty to “sort things out at home” and result in her 
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feeling “a little bit trapped”.   In the context of her narrative, this dichotomy appears to centre 
principally on the enormous responsibility she feels towards caring for her mother with 
dementia and her son with mental health illness versus her own needs in illness and the rare 
privilege of being cared for herself, “I was being looked after.” Emphasis on the word I and 
her repetition of how “nice” that felt illustrate this point.  Participant sixteen similarly refers to 
the relative safety of the hospital environment: 
 
“I felt myself very vulnerable. Under the protection of the hospital you feel relatively 
safe but once you’re put out into the big open world and our local hospital is about half 
an hour’s drive away I suppose so if anything went wrong,  I’d have to be rushed to 
hospital,  so I did feel vulnerable, and I did think that something would go wrong 
because they, they’d told me many times that I could get infections, high temperature, 
diarrhoea loads of different things that would be quite serious”  (P16) 
 
This gentleman’s prime concern appears to rest on his feeling of vulnerability, “that 
something would go wrong” and in the event of needing to be “rushed to hospital” the time 
that this would take. These worries stem from advice that has been given to him “many 
times” and relate to a multitude of possible complications preparing him for this likelihood. 
The following extract from participant one’s story illustrates comparable feelings of anxiety 
and uncertainty about leaving hospital: 
 
“when they tell you to go, that you’re ready to go home you need that psychological 
support, as soon as they said that your counts have gone up and they tell you that 
you’re ready to go you get that almost overwhelming feeling inside that you can’t wait 
to leave the hospital and you almost wonder whether it’s staying in one place all the 
time that makes you feel weak or if it’s still the treatment that’s kicking in, you’re still 
not sure, as soon as they tell you you can go home where do I start from there? 
That’s, a huge, huge thing and being by yourself and being told that, sometimes you 
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can take those things for granted that you’re being given a key that unlocks certain 
doors back to your normal life but not fully understanding the consequences of being 
left to stand on your own two feet after such a ... journey.”  (P1) 
 
However, for this gentleman it is the “overwhelming” sense of anticipation about going home 
coupled with feeling weak and not knowing ‘where to start’ psychologically that make the 
transition difficult to contemplate. When he says he was told by clinicians that “your counts 
have gone up” and that he is “ready to go”, it is the physiological parameters of his blood 
test results informing this decision to which he refers.  The disparity between the 
physiological and psychological reality is tangible and powerfully expressed. Whilst 
acknowledging metaphorically that he is being given a “key that unlocks certain doors back 
to your normal life” he nonetheless conveys the uncertainty and insecurity he feels.  In his 
work the Wounded Storyteller (Frank 1995 p18) testifies to the importance of people telling 
stories of illness in order to give voice to an experience that medicine cannot. Reading the 
professional literature after having cancer himself compounded his belief that the language 
used failed to describe the immediacy of the embodied suffering he had recently 
experienced. This notion has a significant resonance with the experience articulated by 
participant one where the simplicity of the declaration that he is ready to go home, 
particularly as he was alone when this occurred, totally underestimates the enormity of its 
implications for him “after such a journey”. These findings concord with Jones and Chapman 
(2000) where a participant similarly described her emotional turmoil on being discharged 
home:  
 
“I think it was the fear of facing life again after what you’d been through, because one 
minute you think you’re so near death and then you’re forced back into society.”  
(Jones & Chapman 2000 p157) 
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“All the instructions, so many things”: the worry about taking responsibility  
 
Participant sixteen comments on the weight of responsibility he felt when he returned home 
and the uncertainty as to whether he was following instructions correctly: 
 
“I suppose a mental aspect of it was slight paranoia to start with. I just thought, is that 
an infection, in goes the thermometer. Have I done that right have I done this right. 
When I’d left hospital it was then my responsibility to keep myself you know within that 
bubble of you know all the instructions that they gave me when I left hospital and of 
course you tend to take things by the letter”  (P16) 
 
The use of the word “paranoia” suggests the strain he felt regarding self-monitoring his 
condition and the interpretation of symptoms.  Also how diligent he was in following the 
instructions he was given to the letter.  In accordance with this participant’s experience, 
participant one describes similar feelings as follows: 
  
“Obviously there are infections but here there are many things, it could be GVHD, 
could be infection,  you could have different variables of, different types of medication 
that you need to  go and take, whether you’re taking too much or whether your body’s 
not absorbing it, or if it’s how severe your GVHD is in your gut or on your skin, 
anything.  There’s so many more things, so many warning signs and on top of that 
you have to worry about the disease as well.”  (P1) 
 
At seven months post SCT he appears to feel overwhelmed by the number of complications 
requiring his vigilance in addition to being alert for signs of disease relapse.  He was 
suffering both peripheral and systemic effects of graft versus host disease at the time of the 
interview and mentioned feeling nauseated that morning. Since his gastro-intestinal tract 
was involved it is understandable that he was also concerned about the absorption of his 
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medications.  Whilst the majority of participants talked about the uncertainty and fear of 
disease recurrence and other complications post SCT participant three was an exception. 
Apart from her increased vigilance in monitoring her temperature when she initially returned 
home she focused on regaining her physical strength. This lady was one of the younger 
participants and described herself as physically fit prior to developing leukaemia. She had 
managed to return to work and resume many of her normal activities, albeit in a limited or 
less strenuous sense than before her illness. In view of this progress and having almost 
reached one year post SCT   her anxieties may well have diminished in comparison with 
some of the other participants.        
 
4.4.2 Progress isn’t linear, waiting for it to come back 
Once the participants return home, challenges associated with a more chronic state become 
evident with the threat of acute events ever present.  As stated by participant six, a sixty 
three year old gentleman three months post stem cell transplant for leukaemia: 
“I’ve been warned by lots of people that progress isn’t linear with this and it’s not, so 
going through, you think everything’s well not ok because there’s something wrong, 
but that you’re going in the right direction and then you have a setback, you get a bit 
lower, then it picks up again, so you pop up and down the change curve several 
times.”  (P6) 
Similarly, other participants in this study report fluctuating physical and psychological effects 
throughout their illness, treatment and post treatment phases which are not necessarily 
related to the disease itself. Though temporarily reassured by acceptable blood test results, 
in many cases doubts prevail that this situation may be short-lived due to the possibility of 
stem cell rejection and disease relapse in addition to longer term side effects and the 
continued risk of infection. The experiences related by the participants are testimony to the 
reality of their anxieties resulting in an on-going state of uncertainty for themselves and their 
families. This reality is exemplified in the following narrative extract from participant one, a 
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twenty-two year old young man with Hodgkin’s Lymphoma whose initial autologous stem cell 
transplant failed to combat his disease: 
 
“I went through the first three months and the scan was clear, thank God. Then I 
started to get symptoms about a month and a half after and I started to panic. I 
started to get worried and certain diseases, they don’t show through the blood, 
especially Hodgkins, and the other signs would be sweating, lumps, feeling itchy and 
there’s only so much that bloods can do and even the chimerism3 within the bloods 
to say how much is yours and how much is the donor.”   (P1) 
 
In his account, this young man clearly faces grave concerns regarding the recurrence of 
disease related symptoms. Despite the initial clear scan and the normal reliance on blood 
tests used to monitor disease remission, he is acutely aware of the ubiquitous nature of 
Hodgkin’s Lymphoma. Undoubtedly, his previous experience of a failed stem cell transplant 
compounds his anxiety. He goes on to articulate an understandable need for his concerns to 
be believed and taken seriously following his second donor transplant: 
 
“it’s so good to be rest assured, and to have confidence in the patient that if something 
is not right at least to order an alternative scan or a CT scan or something or I don’t 
know. My disease had been acting very, very funny and to go and say’ oh you can’t 
be, you look well, you look fine’. If I relied on that then there would be no need to have 
any scans would there? And I know they cost alot of money, for the NHS to go through 
all of this but ... I need to be rest assured for their sake as well because it’s easier, it’s 
good to have the disease under control and know what exactly what is happening with 
the disease rather than ‘we don’t need one, you look fine, your bloods are fine’.”  (P1) 
                                                 
3 ”Chimaera”: creature from Greek mythology whose body is made of parts from different animals. In allogeneic 
transplantation chimerism is normally used to describe the status of donor marrow in the patient i.e. how large a 
percentage of blood cells constitute that of donor and recipient.  
 
110 
 
 
It would appear that the nature of his disease and the outcome of his stem cell transplant 
are such that he is unable to feel reassured that all is well. He infers that health care 
professionals are telling him that he ‘is fine’ based on his blood test results and his 
appearance as opposed to a diagnostic scan to confirm that his disease is ‘under control’. 
He feels that the cost is justified both to mitigate this uncertainty and to effectively monitor 
and manage disease relapse. Uncertainty illness theory (Mishel 1981) supports the concept 
that when illness events such as diagnosis, symptoms, treatments and prognoses are 
ambiguous, they are unable to be cognitively categorised adequately and uncertainty 
ensues. Being listened to and the subsequent reassurance and trust built out of this cannot 
be underestimated and is demonstrated below:  
 
“He (the doctor) made sure that he was going to do one (a PET scan) because he 
knows the prognosis of your disease and know how everything goes and it’s to rule 
out any complications, anything. And that is very, very important. Very important. And 
he did do that and everything was fine and I couldn’t thank him enough because  I 
have trust in him and he listened to me, he didn’t ignore it and that’s also important the 
doctors do not ignore even the smallest of things, the small things can turn into 
something big.” (P1) 
 
His relief that the doctor appeared to share his view that further investigations were required 
to ‘rule out complications’ is apparent and he reiterates the point several times in his account 
of events at this time. It appears that he can no longer trust in his body and needs evidence 
from various investigations to reassure him. In accordance with this young man’s 
apprehension, participant fourteen stated simply “it’s hard to understand what’s going on in 
your body”. Similarly, in their study of twenty adult survivors of autologous bone marrow 
transplantation Cohen and Ley (2000) found that patient’s fears were associated with loss of 
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both physical control and trust in their body. Participant one also alludes to his mother’s 
anxiety and the need for understanding. For example: 
 
“the worst thing is especially when your mother is there and  she’s worried because 
you know, having a child whose unwell and knowing the disease can come back, ‘oh 
she’s anxious, she’s an anxious mother, you know, don’t listen to her’. It’s not the case 
all the time. I don’t like that, I’ve absolutely hated the judgement of that. It makes me 
feel as if I’m almost paranoid, that I’m getting almost too much into it.”  (P1) 
 
In the context of his whole narrative, this participant stressed the weight of responsibility he 
felt for managing his recovery including recognition of potential problems and also the 
importance of having the unerring support of his mother.  Understandably, diminution or 
disrespect of their roles perceived as labelling them as anxious is challenging to accept, 
particularly in the light of such an uncertain future.  
 
“because it’s one thing that ‘oh you’re anxious, you’re over thinking, you’re new to this, 
it’s only been three months and you’re already thinking about this and getting too 
much into it.’ How about, how about if I’m not getting too much into it. What about if 
there really is something there? “  (P1) 
 
Participant one’s description of his need to be heard reveals how he felt that not all doctors 
or nurses were taking his and his mother’s concerns seriously, rendering them powerless, 
silenced and in turmoil. Frank’s (1995) notion of the chaos story has particular relevance 
here. His argument centres on the need for clinical staff to develop an enhanced tolerance 
for chaos as part of a person’s illness or life story rather than attempting to assuage it. This 
requires the professionals to share the burden of uncertainty by listening and resisting the 
temptation to control it. In terms of self protection and survival, qualities such as realism and 
vigilance are advocated by Ehrenreich (2010) and therefore support an attitude of alertness 
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as expressed by this young man.  Participant nine similarly reports a worry with regard to the 
difficulty of recognising if anything is wrong: 
“If that’s what’s happening with my body, I don’t know what’s happening in there, you 
know, it’s not really telling me and now they’ve found this thing to do with the liver, and 
I’m more worried about that.”  (P9) 
 
This participant feels uncertainty about the implications of a blood test when she 
experiences no physical signs or symptoms: 
 
“she said (the nurse) that yes, the counts are pretty high on your liver and that’s what 
they’re worried about, but she said it is curable so she said, don’t worry about it. She 
said don’t get all panicky and upset about it and I said no, I’ve got over that bit now. 
You know, I went for a long walk and sort of sorted it out in my head and I think that’s 
the only way I can do it, go for a long walk.”  (P9) 
 
On first meeting this lady at the specialist treatment centre she had been told that her there 
were some concerns about her liver and she expressed her own apprehension at that time.  
In this example, it appears that the nurse at her local hospital is suggesting she controls her 
emotions “don’t get all panicky and upset about it” and whilst her attempt to reassure “it is 
curable” were undoubtedly well meant, could in the circumstances have been somewhat 
premature. As this lady explained, she needed to find her own way of sorting it out in her 
head by going for “a long walk” suggesting the psychological toll this worry is having on her. 
She went on to explain:  
 
“I’ve got no husband to talk things over with. In actual fact I’ve got no one so, you 
know, it all goes through my head all the time. You know, oh God, what’s going to 
happen if I get worse than I am now, who’s going to look after me?”  (P9) 
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It appears that her worry is intensified and going through her head “all the time” because 
since she lost her husband she has no-one to talk things over with.  She also expresses 
uncertainty and fear about her future and wonders how she will cope if she gets worse. A 
significant part of her narrative was concerned with her difficult relationship with her grown 
up children and also the fact that neither could offer any help to her in the future as she said: 
 
“I’ve got a boy and a girl, and they both said oh well when you get past it Mum you’ll 
have to go in a home, we’re not looking after you. And I thought, well thank you, 
thank you very much’’  (P9) 
 
When asked how this made her feel she replied, “it gives me an awful feeling, I feel, a real 
dark feeling within myself”. Anxious to maintain her independence, this lady fears any future 
further deterioration in her health which would threaten this, as she said “ooh heck, what am 
I gonna do then?”  Her existential worries and concerns suggest a need for more support 
and reassurance at the time of meeting with her as well as in the future. Having suffered a 
seizure during the course of his treatment for T cell Lymphoma, participant twelve alludes to 
his on-going investigations in relation to suspected involvement of his central nervous 
system. The following quotes demonstrate the uncertainty experienced with elements of 
self-reassurance and hope as mentioned earlier: 
 
“actually I think I’ve got off pretty lightly I think in the great scheme of things. I haven’t, 
touch wood, I haven’t had any complications or anything. My scans came back from a 
few weeks ago that were, appeared to be clear although I’m having another one today 
so that seems to be pretty good hopefully…”  (P12) 
 
Having said that he has “got off pretty lightly” seems to be a considerable understatement in 
the context of significant life threatening situations he faced at the beginning of his treatment 
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which in itself was not guaranteed in view of the highly aggressive nature of his disease. The 
use and emphasis on the word “appeared” suggests that this young man is not convinced 
that he can rely on the latest scan results endorsed by the fact that a more specialised scan 
has been ordered for him. He articulates his doubts further in the following quote: 
 
“I’m slightly suspicious about why I’m having this scan today, I did know deep down 
I’m having a scan on my brain because neither a standard PET or MRI gives them the 
kind of comfort that they want over what’s going on in my brain, neither of them are 
quite clear enough. This particular type of choline PET scan gives them better clarity. 
I know that. Then you’re sort of thinking have they seen a shadow on a previous scan 
or something, you know, you can talk yourself into it, so I’m sure when I see them next 
week and if they say yes, your scan came back and it was fine I’ll just walk along a bit 
taller, do you know what I mean?”  (P12) 
 
This excerpt suggests that he is weighing up whether or not he is being told the truth about 
his previous scan and the rationale for performing another one. On the one hand he can 
understand the doctor’s need for assurance given that he has suffered a seizure and that 
initially this was thought to be linked with his malignancy. On the other, he toys with the idea 
that there may be something suspicious on the first scan after all. Again, like several other 
participants he seems to perceive his concerns as rather tenuous, whilst his attitude appears 
to be both reasonable and shrewd.  Despite this, he does admit to the fact that he will feel 
relieved to be in receipt of a clear scan. His reference to being able to “walk a bit taller” also 
suggests that this will have a positive effect on his self concept and underscores the effect 
that illness and uncertainty can have on one’s identity (Charmaz 1997). Reflecting on the 
uncertainty he has felt since his SCT he explained:  
 
“I imagine it’s the same as when you’ve had a heart attack or anything is, is I don’t 
have the luxury to have twinges or aches and pains..if I feel something in my head I 
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think ooh is it coming back in my head..if I feel a twinge in my stomach I don’t just 
think I might have had a dodgy prawn sandwich or something you think ooh is this 
lymphoma or something like that, but I haven’t had any of the big signs that I had 
initially which is like night sweats and fevers and that kind of thing, so, it isn’t but it’s 
hard to er, it’s only time actually heals that er, I’m a great believer you know.  The first 
couple of weeks after my seizure, anything I was just like ooh, is it another one 
coming, you know?”  (P12) 
 
Participant twelve’s experiences demonstrate his heightened awareness of any bodily 
symptoms such as “twinges or aches and pains” that could indicate that all is not well in his 
body.  His continued concerns are that any physical symptom must be related to the original 
lymphoma disease. Whilst the fear maybe unfounded, it is never the less real and given the 
multitude of possible side effects or potential relapse is highly significant. He does however 
acknowledge that these worries are lessened by the degree of symptoms and the passage 
of time. Participant four had been treated with two SCTs due to recurrence of her acute 
lymphoblastic leukaemia and following her return home explains her prevailing uncertainty 
regarding potential disease relapse: 
 
“I’m still at the stage where I’m waiting for it to come back and I think I’ve got to really 
sort of get over that because the doctor said today my blood levels are fine. There’s 
one or two things that are slightly out of kilter but they’re not worried so I think it’s 
good because I trust them and they don’t mislead you so you feel very safe in a way 
that they’re not going to tell you one thing and then you know, a surprise is going to 
pop up” (P4) 
 
At just three months after the most recent SCT this lady describes herself as “still at the 
stage” of waiting for her disease to return. Her narrative followed a consultation in the out-
patient’s clinic and she reflects back on what has been said. Here the focus is on her blood 
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results and whilst “one or two things are slightly out of kilter”, she appears reassured by the 
doctor’s assertion that her “blood levels are fine”. The notion of trust is important in helping 
her to feel safe.  She also alludes to pain and her fear that this may be linked with “your 
leukaemia or the medication or the transplant” and describes this as “quite a scary thing 
really”. She went on to assert: 
 
“I am in remission, and I have to keep telling myself that, I have to keep telling myself 
that. I am in remission, I don’t  have active leukaemia cells at the moment and so 
that’s something I need to really hold onto really, sort of, you know, keep telling myself 
that,  so I almost feel like I’ve got to stop thinking about ‘what ifs’ and  you know, 
maybe and just work with that”  (P4) 
 
Her repetition of being “in remission” and that she has to ‘keep telling herself that’ suggest 
the effort it is taking her to adequately convince herself that her disease is under control. In a 
study (Baker et al 2005) involving participants who had been diagnosed with one of the ten 
most prevalent cancers, 68% continued to fear recurrence more than one year after 
treatment was completed. Similarly, in a study of forty-three women with a diagnosis of 
ovarian cancer at some time in their lives Cesario et al (2010 p615) found that the 
‘Damocles Sword’ of ovarian cancer seems to be the constant threat of recurrence and 
subsequent health deterioration or death. Similarly, participant fourteen questions whether 
he is clear of disease declaring an ever present “element of doubt”: 
 
“Yea... there’s always that element of doubt as to whether they’ve got it all. They keep 
saying oh your blood counts are great but you know your lymphocytes... If we get rid 
of that ‘but’ we’d be a 100% you know” (P14) 
 
This gentleman’s comments infer that whilst being assured by the doctors on the one hand 
that your “blood counts are great” another level of clinical uncertainty exists in relation to his 
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lymphocytes and “whether they’ve got it all”.  An exceptional case is participant three who 
did not allude to any fear of disease recurrence and for participant two who stated: 
 
“You get confidence from the, just the time really...six months seemed to be quite a 
critical time. I think you know after that I think I started to feel more positive and able to 
do more.” 
 
This example suggests that survival time since the SCT is an all-important marker of 
recovery progress and consequent reduction in existential uncertainty.  
 
4.4.3 I can never relax: the emotional strain of caring  
The husband of participant eight echoes the sentiment of uncertainty illustrating the strain 
felt by care-givers regarding his wife’s on-going symptoms though refutes the notion that 
these feelings can be dispelled in the near future as shown in the examples below:  
 
“I can never relax, I can never feel good about things, even if there’s good news, I 
don’t feel like it is good news. The doctors say oh, everything’s going well, but as far 
as I’m concerned it’s only going well today, up to this point, tomorrow it could change, 
and so I’m just on my guard all the time.”  (P8H) 
 
These words illustrate his reasoning that he is only able to live for today and takes no 
comfort in good news as everything can change tomorrow. His reference to being on his 
“guard all the time” suggests the degree of strain he is experiencing. In the following data 
extract he expresses his concern about how quickly an infection can take hold and become 
life threatening:  
 
“I make sure she’s done the temperature and if she gets up in the night, I’m awake, I 
can hear her, I’m alert for her all the time, you know, because they say that it can 
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come on so quickly. Your temperature can go from normal to forty within such a short 
time and that’s at danger point and they said be alert, because people that aren’t 
alert don’t wake up in the morning.”  (P8H) 
 
The emotional burden felt by participant eight’s husband is evident. Because he has been 
warned how quickly an infection can develop he is constantly “alert for her” which 
undoubtedly interrupts his sleep too. He goes onto describe such an experience when his 
wife’s temperature was very high but she “felt fine” which adds another dimension of worry 
when symptoms which should be acted upon may be ignored:  
 
“That really worries me at the moment, that’s why I was checking the temperature and 
it was thirty nine point nine and I thought wow, you know and she felt fine, oh, I’ll be 
alright, you know, but we can’t take the chance, so you know normal things that your 
body would normally fight off wouldn’t it, you know, I’ve got a bit of a bit of a sore 
throat there, that’s ok, be gone in the morning, could be disastrous for her” (P8H).   
 
This gentleman was acutely aware of the risks associated with stem cell rejection, disease 
relapse and infection, taking his responsibility to act quickly extremely seriously. Given the 
life threatening complications during his wife’s treatment when he had been warned on 
several occasions that she may not survive are compounded by on-going health concerns 
and uncertainty.  In addition to the above concerns he is witness to many physical changes 
and disturbances to his wife’s bodily state and questions what these might mean: 
 
“Why’s her nose running all the time?  Why’s she blowing blood out of her nose, you 
know, this type of thing, is she breathless? Is she clearing her throat? The hearing’s 
gone a bit hasn’t it? Your eyes have gone a bit, deteriorated, your teeth, all your fillings 
in your teeth, they’re hurting... now her nails all cracked off and became brittle.”  (P8H) 
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These signs and symptoms are diverse and hard to comprehend and it is difficult for him to 
know how to react. As he continued:  
 
“then I saw this rash coming back and this big black bruise came up so I said well 
have you knocked it, no I haven’t knocked it, well why’s it come up then, why’s that, is 
it blood problems?”  (P8H) 
 
As experienced by other participants, it is unclear as to the specific cause of participant 8’s 
signs and symptoms but she did have GVHD which would account for the skin rash. It is 
likely that her platelet count was still low accounting for her bruising and it appears that her 
husband feared this was an indication of on-going “blood problems”.  He went on to explain 
that whilst some complications are outlined in the transplant information booklet others are 
not which causes more worry, particularly when experienced at home.  
 
4.4.4 You’re left to fight and fend and try and work it out for yourself: financial 
issues 
The following quote from participant four demonstrates the worry she experiences through 
lack of agency as a result of an uncertain prognosis following her second SCT: 
 
“they didn’t actually say they couldn’t hold my job any longer but they did things like 
employ someone on a long term contract to cover my class (pause) because there 
was no clear prognosis, and I realise now they can’t give you a clear prognosis, so I 
took early retirement on medical grounds but of course, then my income dropped so 
dramatically and you can’t pay your mortgage and things like that. So it’s things like 
that that have made coming home more difficult. I think that’s why in hospital, in my 
little bubble, I didn’t think about the horrors of the financial thing but when you come 
out and suddenly you’re faced with all these things to have to try and sort out and 
because you can’t give a definite, you know, well, I’m in remission and everything’s 
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going to be alright now, you can’t sort of really organise things properly so, it’s just 
difficult, it is difficult.” (P4) 
 
Her account clearly portrays the difficulties of coming home and facing the realities of a 
“dramatically” reduced income and inability to pay the mortgage and how these factors have 
added to her distress. Again this lady alludes to the protective environment she experienced 
in hospital “my little bubble” compared with “the horrors of the financial things” and the 
immediacy with which things need sorting on return home. Although she refers to her 
remission state and that “everything’s going to be alright now” it appears that her concerns 
are compounded by the uncertainty of her prognosis, “you can’t give a definite...” suggesting 
that remission itself is a fragile and uncertain position to be in. She goes on to articulate the 
seriousness of the threat to her home and her anxieties in relation to her son who is unable 
to work due to mental illness:  
 
“I think I may lose the house. I’ve written to the mortgage company again, I’ve used 
all my savings now to keep paying the mortgage, but of course, my son with his 
situation, because he is depressed, he doesn’t work and if  anything happens to me 
he’s going to be homeless, so that’s a  huge issue for me and you know I just think 
people don’t realise the impact, not just on your health, that leukaemia has such an 
effect on those around you, you know, so that’s still ongoing and I’m still trying to sort 
that out and I’m sure I will but maybe not how I want to, but get sorted” (P4) 
 
Ensuring that her son is going to be alright is stated repeatedly by this participant, 
particularly in the context of her having time to “get sorted”. The impact of her disease on the 
lives of others is powerfully described, “it’s a huge issue for me... not just on your health” but 
“those around you”.  Since her disease relapsed following her first transplant and success of 
the second one is not guaranteed she has to cope with the fact that she has reached the 
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limit of available treatments and that her future is therefore uncertain. Her effort to make 
sense of this situation is illustrated in the following extract from her narrative: 
 
“I said to them, what if this one doesn’t work because obviously the last one didn’t, 
well it did but only for a short time and they said well you couldn’t have another one so 
it would just be palliative care and you think, you know, well I’ve just been thinking, 
what happens then, you know, how, what does it all mean?” (P4) 
 
Throughout her narrative this lady reflects on her current position and seems to fluctuate 
between states of despair and hope as she endeavours to comprehend the concept of 
remission, afforded to her for a second time and eluding her so quickly previously. The 
following excerpt appears to illustrate her belief that she may have another year in which to 
leave things in order for her surviving family:  
 
“I’ve been given a chance and I’ve got at least another year I hope  that I can do 
things and try and get things sorted, you know, make sure my son’s alright, that my 
Mum’s ok. I’ve got time to do things so I am lucky.” (P4) 
 
The notion of being lucky in relation to having the SCT and in this lady’s case valuable “time” 
is alluded to by most of the participants and is discussed in a previous section. It is 
unfortunate however that whilst recognising her own and her son’s need for support on 
return home this participant was unable to access it.  
 
“I did contact Macmillan because I felt I needed support for me to deal with how I was 
feeling about the leukaemia but also to help my son cope with it all.., but apparently 
you have to be referred by the hospital. I was hoping someone would come to my 
home talk to us together, but they couldn’t do that so its, you know it isn’t that long 
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since the transplant, and I think you find it, I found it hard to cope with, really, on my 
own”  (P4) 
 
When the researcher enquired as to whether she felt able to ask the medical staff to make a 
referral she replied: 
 
“they are so incredibly busy, and I thought you know they’re really to treat my 
leukaemia, and the other problems are something that I’ve got to sort out, rather than, 
you know, try to rely on them again.”  (P4) 
 
This sentiment was echoed by many of the participants who felt they should endeavour to 
be as brief as possible at their consultation to ensure others were not kept waiting too long. 
A number of other participants mention the financial burden associated with loss of earnings, 
reliance on a single wage and the costs of travelling to a specialist centres (P5, P10, P14, 
P15, P16). The length of time they were in hospital and the intensity of follow up 
appointments had an impact on the financial and emotional strain felt by both participants 
and their family members. Participant fifteen, a thirty three year old self employed gentleman 
highlighted the considerable strain caused by sustained interruption to his employment. This 
interview took place in his business location where he and his wife were self-employed, 
though he had not yet resumed work. A significant proportion of his narrative was concerned 
with the financial problems they faced and their perceived lack of meaningful advice in this 
regard: 
 
“I honestly thought that there would be somebody, a team of people, Macmillan nurses 
or whatever who would come and sit with you and just say, tell me about your 
situation,  what do you need help with,  where are you at financially, how does this 
impact on your life... but there was nothing and you’re left to fight and fend and try 
and work it out for yourself “  (P15) 
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It appears that this young man and his wife did not receive the information they required to 
understand what if any benefits they were entitled to and were left to “fight and fend” to work 
it out for themselves. This, at a time when he felt as his most vulnerable and unsure about 
his prognosis took valuable time and added to their anxiety and uncertainty. As he stated “I 
was more stressed about the finances than I was about the treatment”. Supporting this view, 
his wife pointed to the irony of the advice they received: 
   
“that’s the one thing they say, stay as relaxed and calm as possible, no stress and 
then you’ve got other stuff like this to deal with.” (P15W) 
 
The anxiety experienced by this young man and his wife is similar to that of participant four 
and suggests a significant lack of attention to these important social aspects of illness. This 
finding reflected precisely that of an explorative study of financial concerns, advice, support 
and coping in people diagnosed with cancer and their carers carried out by Wilson et al 
(2011) on behalf of Macmillan. Whilst Macmillan grants are available, (Macmillan 2012) and 
health care professionals eligible to apply on behalf of patients, it is possible that the 
participants in the current study were either not eligible or that this aspect of support was 
overlooked.   
 
4.5 Summary of the immediacy of illness and existential crisis 
This section has served to illustrate the severe disruption caused to the participants both in 
terms of their physical, psychosocial and emotional being and their everyday lives. Critical 
events concerning diagnosis, systemic infections and the conditioning therapy including trial 
drugs remain at the forefront of their minds, with two participants describing flashbacks 
related to their intensive care experience suggestive of the negative recall associated with 
post-traumatic stress disorder. The participants also describe periods of being ’in limbo’ 
between treatment cycles and feeling frustrated about being in protective isolation, 
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particularly during periods when they feel relatively well. All of the participants describe 
significant aspects of their illness journey which relate to uncertainty. Uncertainty is evident 
at the time of becoming ill and at diagnosis and on-going insecurities are experienced on 
their return home.  Anxieties concern the responsibility for self-monitoring, the fear of 
disease relapse, the strain felt by care givers and social aspects such as employment and 
financial issues.  Though some recovery progress is acknowledged no participants have 
reached a point where the full benefits of their treatment is realised. These aspects will now 
be discussed in the recovery journey theme which follows. 
 
4.6 The Recovery Journey  
The overarching concept of the recovery journey presents the participants’ experiences of 
life following their return home after treatment between three months and a year post SCT. 
Whilst most of the participants begin to recover some physical strength, problems such as 
infections, GVHD and associated side effects prevail, giving rise to on-going health issues of 
both an acute and chronic nature. The recovery journey includes themes of physical, 
psychosocial and emotional disruption; coping strategies and communication and 
information matters (Table 7). 
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Table 7: Themes and sub-themes of The Recovery Journey 
 
Theme Sub-themes 
Physical, Psychosocial and 
Emotional  Disruption 
Treatment effects  
Groundhog Day 
Altered appearance, identity and self-concept 
Coping Strategies Keeping occupied 
Being positive and determined 
Being lucky and rethinking the way I see life 
Communication and  
information matters 
 
The desire for knowledge versus ‘not wanting to know’
Your blood counts are fantastic: the biomedical focus 
Autonomy, trust and encouragement 
 
 
4.7 Physical, Psychosocial and Emotional Disruption 
4.7.1 Treatment effects 
A common theme emerged which was the participant’s shock about the degree and duration 
of fatigue, tiredness and physical weakness they felt on return home.  Whilst some 
described feeling debilitated and sleeping for much of the day (P6, P10 and P11), one lady 
was unable to go upstairs to bed (P8) and others described limitations such as being unable 
to socialise for long (P2, P3, P4, P5, P9, P10, P11, P12, P14 and P16), do the shopping 
without feeling “dead on his feet” (P11) and unable to care for young children as they had 
previously (P11, P12 and P 15). Fatigue has been found to be a common long term effect of 
SCT (Marks et al 1999, Molassiotis & Morris 1999) and difficulties in physical functioning 
exacerbated by conditions such as GVHD, infections, secondary malignancies, organ 
damage and endocrine dysfunction (Mosher et al 2009). The intensity of fatigue experienced 
is evident from all participants and the effect that this has on their ability to contemplate the 
normal activities of daily life including social pursuits is considerable.  
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P3, the young female teacher played a lot of sport including touch rugby before her illness 
and experienced a loss of muscle tone and P2, P6, P8 and P11 were unable to pursue their 
former sporting activities including golf, keep fit, dancing and gymnastics. Symptoms 
experienced by the participants are shown in Table 8. 
 
Participant eleven, a fifty year old gentleman had experienced a steady but incapacitating 
decline in physical fitness following his diagnosis of myelodysplastic syndrome four years 
previously. He was treated with supportive therapy for some time knowing that a SCT was 
imminent and spent some time preparing for it with exercise aimed at “bulking up” and 
“improving his chances on the other side”. The following data extract illustrates the 
expectations he associates with this treatment: 
 
 “I’d only looked as far as T day, let’s get this transplant out the way and everything’s 
going to be alright. But of course everything’s not going to be alright, that’s just the 
start of it. I hadn’t really let myself look any further than that and even when I was in 
hospital I was thinking oh yea, by three months I’ll be back down the gym again and in 
six months, it’ll all be sorted, you know and of course I’ve had to come to terms with 
the fact that that’s not even slightly realistic.”  (P11) 
 
The fact that he could no longer rely on his body to respond to exercise in the same way as 
it had done prior to his illness exemplifies the disparity between his expectations and the 
reality, or in other words, what he previously took for granted (Bury 1982). His determination 
is clear along with his initial expectation that “everything’s going to be alright” following 
treatment and that he would be resuming activities in the gym within a three to six month 
time frame. He admits to the fact that these hopes were unrealistic, though at the time his 
perception was that following his SCT “it’ll all be sorted”.   
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Table 8: Participants’ self-reported symptoms  
 
 
All participants in the study reported on-going issues relating to infections (see Table 8), 
several of which necessitated admission to hospital. For some participants, though the 
duration of the disruption caused by infection was more protracted due to their immune-
compromised state, it was not severe enough to necessitate admission to hospital. In 
contrast others experienced considerable disruption to their physical state due to more 
severe infections requiring re-admission to hospital. In some cases this was to their local 
hospital and in others they returned to the specialist treatment centre where their SCT had 
been carried out.  Participant nine’s experience involved re-admission to the specialist 
hospital following assessment at one of her routine follow-up appointments. In part, she 
feels that the burden of the journey and time taken to attend these appointments is 
responsible for an infection occurring:  
 
“It was such a long day, and I think in a lot of ways that pulled me down and that’s why 
I ended up with pneumonia (pause)I had pneumonia about three weeks before they 
grabbed me and said right, you’ve got to come in and I said, no, I’m not, I’m going 
Presenting  
symptoms 
P1 P2 P3 P4 P5 P6 P7 P8 P9 P1
0 
P1
1 
P1
2 
P1
4 
P1
5 
P1
6 
Fatigue √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ 
Weight loss √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ 
Infection √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ 
Mucocitis        √ √ √ √     
Taste  
disruption 
 √   √ √   √ √ √ √ √ √ √ 
Sleep  
disturbance 
√ √        √ √     
GVHD √   √   √  √ √ √   √ √     
Pain    √            
Visual  
disturbance 
  √    √         
Depression/ 
feeling down 
√   √ √ √ √ √ √ √ √  √ √ √ 
Neuropathy           √ √    
Skin rashes   √     √   √ √    
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home and I went home. Then they did some cultures and they found out I had a chest 
infection on top of pneumonia so that’s why I got dragged in” (P9) 
 
This lady’s reluctance to be re-admitted at all costs is apparent in her initial refusal to stay in 
hospital as advised. It is possible that general fatigue in the early days post-transplant 
masked the threat of a more acute problem or that she simply underplayed her symptoms in 
order to avoid returning to hospital. A feature of most of the participant’s experiences was 
being unable to fully rely on their interpretations of what was happening to their body 
throughout their illness trajectory as stated by participant ten: 
 
“things happen, your body, everyone’s body is different, and everything changes in 
you your body, from losing your hair to growing new nails to, it er, everything 
changes.” (P10)  
 
Adapting to changes in the body and accepting limitations in recovery was found to be the 
experience of individuals following colorectal cancer (Beech et al 2011) and has resonance 
with Breadon’s (1997 p978) finding that the women in her study described a survival process 
that includes viewing ‘the body as a house of suspicion’. Participant fifteen experienced 
several infections on his return home which appeared to be linked to viruses carried by his 
small children and were complicated by other treatment side effects as illustrated in the 
following data extract: 
 
“so I went home and I was ok, not too bad and then I picked up a couple of viruses, I 
think I had  adenovirus, rhinovirus twice…so I went back in as I was ill and then all the 
side effects of treatment sort of started for me from then on ‘cos they said the 
radiotherapy, and even the chemotherapy, the methotrexate, everything, and alot of it 
you won’t get until you know, it could be three months later and something happens to 
you and it’s all at different stages and different times, so when you’re immediately after 
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transplant and you feeling ok and then another week and you’re feeling ok and you’re 
sort of like, what are they talking about, like I don’t feel too bad and then I’d pick up a 
virus that completely wiped me out”  (P15) 
 
His narrative suggests an ambiguity in the post-transplant period when the first few months 
of anticipated recovery takes on a different sequence of events and complications. 
Treatment side effects including weight loss also became a major concern “the loss of 
appetite I didn’t really expect, I lost four and a half stone”. In spite of the potentially serious 
nature of his infections, and the necessity to be readmitted to hospital they appeared to be 
relatively easily resolved with antibiotic therapy whilst his poor nutritional state persisted. As 
he went on to explain: 
 
“I knew it was a direct relation between eating a bowl of pasta or porridge and feeling 
healthy and not eating it and feeling crap, but you couldn’t physically do it. It’s like 
you’re in bed with the worst flu ever and you don’t even want to talk to anyone and 
someone’s trying to keep feeding you a bowl of porridge, you’re just like go away.”  
(P12) 
 
This gentleman had resisted having a naso-gastric tube inserted for feeding purposes 
despite advice to the contrary and at almost five months post-transplant was just beginning 
to be able to eat small but regular meals.  It appears that the lasting effects of radiotherapy 
and chemotherapy played a part in his on-going problems and recurrent viral infections 
compounded the situation. Participant ten, the sixty-two year old gentleman, eight months 
post SCT for myelofibrosis similarly experienced a number of occasions when a high 
temperature indicated underlying infection as he describes:  
 
“it was the third time I’d had the rigors which is the violent shakes that you get with 
the temperature that keeps spiking and I keep saying to the wife, I’m not going to the 
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hospital it’s gone down to 35 and then quarter of an hour later, she’d take my 
temperature again and it’s gone up to 38. I mean the highest one I’ve had so far is 
42.2 and I shook for three hours, solid.” (P10) 
 
Despite the extreme symptoms he strongly resisted going to hospital. His symptoms of 
chronic GVHD including colitis had a significant effect on his recovery at around seven 
months post SCT and regular episodes of diarrhoea throughout the day and night disturbed 
his sleep and further increased his fatigue and weight loss. His medication regime at this 
stage, up to forty tablets a day, impacted negatively on his appetite compounding an already 
extreme situation as he explains in the following moving data extract:  
 
“I think last Saturday was the first time that I’ve thought that I could just give up and 
not bother any more but you can’t go back. You’ve gone this far, there is no return. It’s 
not as if you’d say, oh I’ll go back and then I’ll be as I am because you never will be, 
because you haven’t got your own cells in you anymore. And it’s your life you’re 
fighting for so you’ve got to keep going. You know for the wife’s sake as well as my 
sake.”  (P10) 
 
This gentleman’s distress is evident and he is clearly realistic in acknowledging that it is not 
possible for him to return to his pre-transplant state. His experience appears to capture the 
notion of a ‘critical situation’ as identified by Giddens (1979) whereby the seriousness of his 
circumstance is starkly recognised. Concern for his wife and appreciation of the disruption 
caused to her life is also apparent. Pidala et al (2009) found that acute and chronic GVHD 
are associated with worse quality of life after allogeneic SCT and Syrjala et al (2004) found 
that chronic GVHD was associated with depression. 
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4.7.2 Groundhog day 
As evidenced in the previous sections all participants in this study described the significant 
physical, psychological and emotional disruptions experienced at various stages during their 
illness trajectory. However, participants also describe instances when they felt reasonably 
well and rather bored and frustrated regarding their slow progress.  The following data 
extract from participant twelve sums up the continued disruption and tedious nature of 
illness and recovery: 
 
“I mean the reality is that the day to day is, it’s very boring actually you know, it really 
is. It is groundhog day and sometimes you can struggle to remember where things 
happened because you don’t have specific reference points, you don’t have, oh yes 
that was the week before Jonny’s wedding or something ‘cos I don’t have any of that, 
it’s just, you know I have ‘countdown’ which is essentially the same every single day, 
you know, so you have no reference points and things can get a little bit bland, it just 
sort of rolls on interminably and when I come here, it’s just, it’s just early days or it’s 
only been three months and I think it just seems like so much more but obviously it’s 
on the back of another eight months before it or nine months before it but it still never 
ceases to amaze me and I can’t imagine certain things. I can’t imagine going back to 
work, that’ll be really weird.” (P12) 
 
Having “no reference points” compounds this young man’s sense of his life’s ‘blandness’ in 
the first three months post SCT particularly as this follows nine months of disruption since 
his diagnosis. This typifies the experiences of other participants whose life is on hold until 
their immunity recovers. 
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4.7.3 Altered appearance, identity and self-concept  
All of the participants made reference to altered appearance due to weight and hair loss, but 
for some also the ‘bloating’ effect of steroids and manifestations of acute GVHD. A data 
extract from participant eleven is included here to illustrate this point: 
 
“I’d say a fortnight after the transplant I started to get very ill. I couldn’t sleep which 
I’ve now been told was probably due to the steroids and I was having alot of water 
retention. I was a bit of a mess actually... I looked in the mirror and I could see 
myself falling apart. My skin was falling off my face where I was all bloated with water 
retention and my eyes were sort of sunk right back in my head and they were bright 
crimson... I had GVHD as well, very early on, which is kind of fortunate but you know, 
not so great on another level. I looked like I’d had a month’s cruise round the med or 
something. I went really, really dark brown and part of the reason I hadn’t wanted to 
eat was I had GVHD of my gut” P11 
 
Not only were the visual effects on his appearance disturbing to this gentleman but also the 
physiological consequences of being unable to eat or sleep properly. As he explained “in the 
end it got to the stage where I hadn’t really eaten or slept for six days and I looked in the 
mirror and I could see myself falling apart”.  In some cases the effect on their appearance 
was a significant issue because it signified their overall state of ill health and at others 
because it affected self-image. Accordingly, participant one, a young man whose passion 
was for design, fashion and jewellery alluded to his altered appearance: 
 
“You don’t even want to watch TV because you compare yourself with the people who 
are well and you think look at me, I’m blown up and I’ve got no hair and I’m not the 
way I should be”   (P1)  
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Comparing himself with “people who are well” appeared to compound this young 
gentleman’s feeling of being different “I’m not the way I should be” and served as an 
unwelcome reminder of his ill body. Participants also recognised how difficult it was for their 
close family and friends to bear witness to their altered physical state and appearance and 
endeavoured to protect those they felt most vulnerable. The wife of participant fourteen said: 
 
“he hadn’t seen the grandchildren for so long except for one of them, the oldest one, 
but he got so upset about it, we stopped him going but the little ones couldn’t even 
Facebook because he just looked so dreadful?”  (P14W) 
 
This lady’s efforts to minimise the distress caused to their grandchildren is evident though it 
is conceivable that both participant fourteen and the children experienced significant 
suffering as a result of the loss of close contact at this time.  Participant fifteen similarly 
wished to protect his family from distress caused by his altered appearance, as illustrated in 
the following excerpt from his narrative: 
 
“they basically came in to tell me I was going to have a tube fitted and I refused...the 
tube erm and just said I don’t, I don’t wannit and they said ‘cos I’ve got, you know I’ve 
got, I’ve lost four and a half stone, I’m bored, I’ve got no eyebrows, no eyelashes, I’ve 
got two young children, you know, it’s scary enough as it is without Daddy having a 
tube stuck to his face all the time as well. I thought it just looks horrific and I really 
didn’t wannit and so I refused”  (P15) 
 
It appears that for this gentleman, the suggestion to insert a feeding tube due to severe 
weight loss was the final assault on his dignity, as illustrated in his list of physical and 
emotional manifestations, “I’ve lost four and a half stone, I’m bored, I’ve got no eyebrows, no 
eyelashes”, in addition to recognising the potential effect on his children, “it’s scary enough 
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as it is without Daddy having a tube stuck in his face”.  Conversely, participant seven felt 
that his experience was less severe than he had imagined: 
 
“Chemotherapy didn’t affect me amazingly. I mean my hair fell out and things like that 
but I didn’t feel ill as a result of it. Other people I know have been through tremendous 
things, sickness and diarrhoea… and having terrible times. I sailed through it with 
virtually nothing at all, I have been so fortunate, and I’ll never, I’ll never forget that I’ve 
been that lucky, and, thank goodness for that really”  (P7) 
 
Comparing his experience with others, he acknowledges relatively few distressing 
disruptions to his physical state and refers to the virtue of luck. Comparing one’s experience 
favourably to others perceived to be less well off has been evidenced in other studies (Wood 
et al 1985) and is a recognised strategy for coping.  In addition to altered appearance the 
participants express their desire to resume some of their former activities such as work, 
study, exercise and leisure pursuits. Also, to fulfil their roles within the family such as caring 
for children (P11, P12 and P15), domestic undertakings and pursuing their intended life 
plans.   
 
4.8 Coping Strategies 
The participants reported a number of strategies for coping with their experiences of stem 
cell transplant and in adapting to their life back at home.  Four overriding examples of this 
are keeping occupied; being positive and determined; being lucky and rethinking life and 
communication and information matters.  
 
4.8.1 Keeping occupied  
A number of the participants described how they capitalised on time spent in hospital when 
they felt well enough. Much of this time involved keeping in touch with their families and 
using web-based technology. One gentleman endeavoured to learn a language (P6), 
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another made plastic models and gave them to the staff for their children (P7) and 
participant three, the young teacher spent time lesson planning for when she returned to 
work. Having the rare opportunity to prepare many lessons in advance seemed to preserve 
a sense of normality and identity for this participant and seemed to signify the confidence 
she felt about resuming her career and her future.  As postulated by Carricaburu & Pierret 
(1995) retaining control, being active and doing things is a way of projecting one’s life into 
the future and to refuse being taken prisoner by illness.  Sustaining a positive attitude and 
gauging her progress through incremental steps was a feature of this participants’ recovery 
strategy. For participant seven, keeping occupied was a coping strategy he said he would 
recommend to anyone as a diversion from dwelling on their disease and its implications. 
Being able to give the models to staff for their children could have also have had a positive 
effect psychologically by virtue of his ability to reciprocate for the care he received.  
According to Bury (1982) illness and particularly chronic illness disrupts the normal rules of 
reciprocity and mutual support increasing a sense of dependency on the individual involved. 
Keeping occupied was as an active strategy also adopted by this gentleman on his return 
home: 
 
“You know I needed something at that stage to do, to get back to normal life, to 
keep myself occupied because the worst thing in the world is if you’ve got nothing to 
do and of course your thoughts go to what’s been going on.”  ( P7) 
 
This gentleman decided to build decking in his garden with the help of his family in an effort 
to resume his “normal life”.  Johansson et al (2012) found that the goals of patients who had 
undergone allogeneic SCT within the past year at the time of interview were related to being 
healthy and participating in a normal life.  Whilst similar to this gentleman’s attitude, he also 
wanted to keep occupied to avoid thinking about his illness experiences. He is the 
participant referred to earlier who was reliving his memories in intensive care and was 
experiencing numerous challenges in his recovery including the development of a hernia 
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and shingles. He admitted to feeling “down”,  “depressed” and “morose”  at various points 
since his return home though reiterated the importance of trying to “keep a positive attitude” 
a number of times throughout his narrative as if challenging himself to uphold the belief that 
it will help. 
 
4.8.2 Being positive and determined 
As previously mentioned, despite apprehension about returning home all participants in the 
study were anxious to make the transition as soon as possible post SCT.  The data extract 
below reveals participant eight’s sheer determination to overcome the physically testing 
challenge of walking up stairs after her intensive care experience:  
 
“they said well you can’t go home unless you can walk upstairs... I looked at these 
stairs and I thought oh my word, it’s like Mount Everest and they said, if you can walk 
up two or three stairs we’ll let you go home. I walked to the top and back down. Don’t 
ask me how I did it, ‘cos I really don’t know but I thought, I’m determined to show them 
I can go home. And I think you’ve got to be positive, you’ve got to be determined, 
you’ve got to tell yourself that you will get through it.”  (P8) 
 
This lady’s Mount Everest metaphor captures the enormity of the task ahead of her and her 
over achievement of it, demonstrating her resolve to prove that she was mentally and 
physically able to return home. She makes the point that inner strength is something that 
must come from one’s own determination and positive attitude. Similarly participant one 
acknowledges that although he received counselling, ultimately he needed to draw on his 
own reserves to deal with his difficult situation. 
 
“I know I keep on saying, going back to my previous transplant, because I’ve gone 
through the whole works. I mean I’ve tried everything, I even tried counselling, I tried 
to have counselling before and after treatment but there is only so much you can 
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say, and you need to find in your own stride try and keep yourself busy, and try and do 
things to make you not think too much...and I had to dig up old projects that I did from 
University and try and get myself back up there again. Whether it’s just five minutes, 
ten minutes, it was something. I needed to feel normal “ (P1) 
 
For this young man, concerning himself with “old projects from University” to get himself 
“back up there again” appears to be of benefit in two ways.  Firstly, because this cognitive 
dimension enables him to identify with his life prior to illness and possibly helps him to 
visualise a future.  Secondly, that distraction prevents dwelling on less positive thoughts. For 
participant four, however, anxieties regarding her recovery from a second SCT, her 
dependent mother and son and her ability to pay her mortgage challenged her ability to think 
positively as advised by a nurse:  
 
“one of the nurses said to me that your attitude of mind is so important after something 
like this, after your transplant, you need to be really positive… but it’s really hard when 
you’ve got these things going on, that you worry about and you wake up in the night 
and you’re worried about them and I think how can I be sort of positive and think 
everything’s going to be alright and I’m going to beat this you now, when you just feel 
like you’re fighting all the time.”  (P4) 
 
Whilst, maintaining a positive attitude in the face of illness or adversity may be considered a 
desirable quality, critics raise some important points for consideration (McGrath et al 2006, 
Morstyn 2009, Ehrenreich 2009). Morstyn (2009), a consultant in psychiatry, treated with a 
SCT reflected on his experience of being advised to ‘think positive’ otherwise ‘his cancer 
would get worse’. He describes his reaction as angry. Rather than expressing resentment, 
the participant in the current study appeared to be confused about receiving such advice 
given the ambiguity of her situation. McGrath et al (2006) suggest that health professionals 
should exercise caution in both prescribing positive thinking and in responding to patients 
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and carers whose belief systems and feelings of obligation depend on it. A number of 
participants in this study stated that they tried to keep positive implying that this attitude was 
beneficial.  One gentleman’s belief in the notion that “mind over matter” was capable of 
affecting outcomes is evident as he explained:   
 
“the human brain is actually a lot more powerful than any of us give it credit for you 
know in terms of that sort of thing and a positive attitude definitely will help. You 
know, the feisty people survive better, generally speaking than those who sort of 
say oh life’s dreadful, I’m going to, you know it’s all going to fall apart on me.”  (P7) 
 
Whilst there is evidence to suggest that people with cancer who have an optimistic outlook 
may experience a better quality of life than those who feel hopeless, less empirical evidence 
supports a correlation between coping styles and survival (Petticrew et al 2002). In a study 
which aimed to identify the core strategies used to attain a strong sense of empowerment in 
coping with their condition (Bulsara 2004) twelve informants with haematological cancer 
were interviewed.  The study highlighted three main ways in which empowerment was 
achieved including fighting spirit and determination to cope with the illness; a reliance on 
significant others and acknowledgement and acceptance of their illness.  Findings in the 
current study are consistent with Bulsara et al (2004) in that the majority of participants refer 
to the importance of relationships as previously discussed and openly strive for a positive 
and fighting spirit.  However, the notion of illness acceptance for some participants is rather 
more implicit in as much as they do not explicitly articulate non-acceptance or denial of their 
condition.  Also, whilst all participants reveal ways in which they are actively managing their 
recovery several participants allude to feelings of anger or frustration and endeavouring to 
control their emotions, for example participant nine who stated: 
 
“there are times when I could scream, absolutely scream and I think oh, now come 
on you can’t do that, take yourself for a walk.” (P9)  
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Participant three on the other hand felt that being positive was an integral part of her 
approach to life and its challenges as illustrated below: 
 
“I’ve always been a positive, I’ve always looked at the positives to anything, I always 
think well, what’s the worst case scenario, can I deal with it, yes ok and let’s get on 
with it.”  (P3) 
 
Rather than dwell on the negative aspects of her treatment such as the slow re-growth of 
her hair, fatigue, her infertility and the restriction to travel to countries of her choice due to 
health risks and insurance reasons she actively pursues alternative ways to overcome them.  
Her attitude towards hair loss and the fact that she was still bald a year post SCT is 
demonstrated in the following example: 
 
“Finding the positives so my hair hasn’t grown back but that means I don’t have to 
wash my hair every day so all I have to do is get up and put my wig on and it saves 
me twenty more minutes in bed! ”  P3  
 
The mother of participant five believes that being “stubborn” and “a fighter” is what has 
enabled her daughter to survive from being a premature baby in a neonatal special care 
baby unit through to her more recent life threatening events in an adult intensive care facility: 
 
“and she’s always had that fighting spirit, otherwise I don’t think she’d have got this far, 
she really is a fighter.” (P5M)  
 
Similarly, participant nine refers to her whole experience as a “fight” and in the following 
words demonstrates the mental effort it takes to remain positive in spite of it: 
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“I’ve come through it.  But it was a fight, it is a fight all the time.  You’re forever 
thinking come on be positive, don’t get down in the dumps about this and you know, 
just hope for the best, you know, get on with your life, go out and do the things that 
you’ve always done “  (P9)  
 
This lady’s desire to return to a normal way of life is evident and whilst acknowledging the 
metaphorical battle she has been through to reach this state, her words “it is a fight all the 
time”, suggest that it is on-going in nature.  Stating that she must “hope for the best” implies 
that she is concerned about the success of her treatment and also her ability to return to her 
former role.  ‘Struggle language’ such as ‘fighting’ associated with personal testimonies of 
people surviving cancer (Seale 2001 p308) has both positive and negative connotations. On 
the one hand, Sontag (1991 p5) argues that when ‘fighting’ is associated with military 
metaphor, the resulting effect on many individuals is to view the disease as a demoralising 
‘ruthless, secret invasion’.  Conversely, however Seale (2001 p325) suggests that reports of 
heroic struggle and fighting language may in fact be experienced as inspiring and supportive 
by people with cancer.     
 
4.8.3 Being lucky and rethinking the way I see life 
As mentioned earlier, many of the participants refer to how lucky they have been to receive 
a stem cell transplant and their gratitude for being given a second chance.  Despite 
concerns about her family and her own future participant four reflected: 
 
“I do think, you know I think I’ve been really so lucky because I am in remission, you 
know, even if it comes back, the same, a year down the line, it’s still an extra year isn’t 
it?  And I think, gosh, you know, my niece’s husband just sort of literally dropped dead 
and you think gosh, I’ve been given a chance and I’ve got at least another year. I 
hope that I can do things and try and get things sorted, you know, make sure my 
son’s alright, that my Mum’s ok. I’ve got time to do things so I am lucky.  And I’m lucky 
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my sister was such a good match, and I’m lucky I’ve got a friend who lives in Epsom 
who can put me up the night before my appointments because I think I would find that 
very difficult, trying to drive in for the appointment.” (P4) 
 
This lady’s acknowledgement of how lucky she has been appeared to be a literal counting of 
her blessings from her survival “I am in remission... I’ve been given a chance” through to 
more practical aspects of her post transplant experience.  In a study of patients undergoing 
stem cell transplantation Coolbrandt & Grypdonck (2010) found that patients made 
concerted efforts to ‘keep courage’ and to sustain a ‘positive story’ in order to make sense of 
their ordeal. It was suggested that these efforts involved more active strategies than ‘the 
rather passive concept of hope’ (Coolbrandt & Grypdonck 2010 p218).  Findings from the 
current study accord with those of Coolbrandt & Grypdonck (2010) in that a number of 
proactive strategies were engaged by participants in order to cope with challenges 
throughout the illness journey.  The personal growth realised by participant one as a result 
of the experience is conveyed in the following excerpt from his narrative: 
 
“And you try to express that through your work because there’s alot of negativity in 
cancer and I try to do that as much as possible, and as much as I hate cancer, and I 
hate what I’ve gone through, it has made me rethink about many things, my work, the 
way I think, the way I communicate with people, the way I see life. It’s massive, it’s a 
huge thing.  A huge, huge thing. And no-one can take that away from me.”  (P1) 
 
For this young man, the enormity of what he has been through is absolutely life-changing, 
affecting his whole way of operating, communicating and the way he views life.  In addition 
to the four main sub-themes, all participants acknowledged the importance of support from 
loved ones.  In a moving data extract, participant sixteen articulates the encouragement he 
received from his daughter in the form of digital photographs of his Grandchildren: 
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“Well yes, the first thing my daughter did she brought in a digital photo frame with 
pictures of my Grandchildren and she said, ‘get better for them’ and erm, I‘m sorry 
(visibly very emotional). It worked.”  (P16) 
 
His daughter’s action and words are a poignant reminder to him of how important he is to his 
grandchildren encouraging him to draw strength from the relationships of those who love 
him.  Field notes made directly following the interview and notes attached to the interview 
transcript note the extent of his emotion as he related this.  
 
Field note entry 28/09/2013 
Participant 16 
He did get tearful when talking about the worst times which were birthdays and significant 
anniversaries or festivals such as Christmas.  Also, the importance of family and recovering 
for them was a particularly emotive topic.  I did not suggest turning the tape off as this was 
short lived but gave time for him to come through this and recover himself. 
 
4.9 Communication and information matters 
4.9.1 The desire for knowledge versus “not wanting to know” 
Participants had different experiences of the way in which certain information was 
communicated to them and mixed views as to what they wished to know or not know. 
Participant seven, a sixty eight year old gentleman, eleven months post SCT for leukaemia 
stressed the importance for him of gaining detailed information as articulated in the following 
narrative: 
 
“I’ve learned an awful lot over the time, you know there are things I knew nothing 
about, and now, I’m not an authority on it but I’m pretty knowledgeable… the more I 
understand, the easier I find it to deal with, for me. Everybody’s different in that 
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respect I know but I find that if I can understand what’s going on, I can deal with it 
much better.”  (P7) 
 
He appears to feel more in control with increased knowledge and understanding of the 
rationale behind his treatment and what this means in terms of his own experience. As well 
as a desire for detailed information seeming to be a natural trait for this gentleman he also 
mentions that a lack of suitable donor resulted in him having a cord transplant.  The novel 
nature of his treatment possibly increased his interest and though information was less 
readily available, he received verbal explanations from his medical team and supplemented 
this with seeking out information himself. In their study of age and gender in illness 
narratives, Seale and Charteris-Black (2008) similarly found that older men with cancer 
demonstrated a greater involvement with medicine as an expert system than younger men 
and women.  This related both to their interest in treating their illness as a problem capable 
of being fixed with technical expertise and their social confidence when interacting with 
doctors.  With regard to information supplied prior to treatment and in particular SCT, 
participant fifteen held the following view:  
 
“the information is good that you receive but I just think it’s hard, it’s a bit like reading 
a text book and then going on a field trip, and practically doing what you’ve been 
reading, you know the physical part of it, so people can talk to you and tell you and 
give you sheets of paper, but you never really know what to expect until you’ve 
experienced it.”  (P15) 
 
Whilst finding the information “good” he used the analogy of the practical experience of 
going on a field trip compared to reading about the subject under study to illustrate how 
difficult it was to imagine a transplant.  This point suggests that sharing experiences with 
those who have lived through SCT could have potential benefits in supplementing more 
factual material.  In contrast to the participants who felt their coping correlated strongly with 
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having more information and understanding of their disease and treatment, a number felt 
that the reverse was true for them.  This is demonstrated by the following extract from 
participant sixteen’s narrative: 
 
“I’m a terrible worrier, always have been and I knew that if I knew what was coming 
round the corner I’d be constantly worrying, which apart from the fact that you know, 
was I going to survive or not, I didn’t really have any other worries. I know that sounds 
strange, apart from my family, I worried about my family, what they were going through 
and how they were coping”  (P16) 
 
This gentleman uses avoidance as a conscious strategy of coping with his existential 
worries and he also adopts a strategy of living in the present.  He remembered vividly being 
asked if he wanted to know his chances of survival and although he expressly requested not 
to know his wishes were inadvertently overlooked, causing him and his family considerable 
distress: 
 
“He told me that I only had a forty per cent chance of getting through the next stage. 
That hit us all didn’t it?” (P16) 
 
Present throughout the interview, his wife did however express her exasperation at her 
husband’s lack of interest in any information and explained her own and her daughter’s 
conflicting attitude: 
 
“Me and my daughter was absolutely desperate for information..., we needed to 
know so we knew how to handle everything that was going to happen”  (P16W) 
 
An explanation for this difference in attitudes could be that when one’s existence is 
threatened there is little capacity or need for any information beyond concern for their 
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survival.  However, loved ones wish to know potential consequences and what they need to 
do to prepare for the future. His wife’s language and emphasis on the word “desperate” 
suggests the anxiety that both she and her daughter felt as a result of their lack of 
understanding of his situation.  Participant six’s attitude towards illness information was 
similar to participant sixteen in that he was happy for others to acquire knowledge on his 
behalf. This sixty three year old gentleman was three months post SCT for leukaemia with 
his son being his donor.  He acknowledged that his son received significant amounts of 
material by virtue of being a donor and that his wife “got herself signed up to receive all the 
research papers”.  As he explained: 
 
“it was just I suppose I didn’t want to be reminded of it. You know you’ve got 
something seriously wrong, you’re in good hands .. there’s not anything I can do 
that’s going to make any difference to what they know or what they can do, so does it 
help me to have detailed information about all the stuff that could go wrong and all 
the possible side effects? I don’t think it does, so that’s my opinion.  For other people 
it may be very helpful.”  (P6) 
 
It appears that his preferred way of coping with the situation is to rely on the expertise of the 
specialists rather than worry unnecessarily about his destiny over which he feels he does 
not have any control.  Employing a ‘language of probability and reasoning logic’ is 
recognised as a strategy for coping with the uncertainty of a situation (Fox 1979 p46). This 
gentleman did however acknowledge the value of his wife recognising possible 
complications once he returned home as illustrated in the following data extract: 
 
“Clearly there’s a point when you do need to know about the potential side effects 
because if something comes along, you need to know whether to worry about it…so it 
was probably quite important that she, that one of us was in touch with what could 
happen, but I preferred that it wasn’t me” (P6)  
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Again, he repeats his preference for the responsibility of knowledge acquisition to lie with 
others and was happy for his wife to take on this role. In addition to this being linked to his 
coping mechanism, he alludes to a gender distinction affecting the wish to discuss serious 
issues such as the nature of his disease and his chances of survival: 
 
“when you’ve had a dose of bad news I think there’s a bit of the men from Mars and 
women from Venus or is the other way round? My wife is certainly more likely to talk 
about things and it’s more likely to help her whereas I’m more likely to keep things to 
myself. I think it would have certainly helped her if I’d spoken more.  It might even 
have helped me, I don’t know.”  (P6) 
 
He acknowledges how expressing his emotions and perhaps a diversion from the traditional 
stoical male role could have alleviated these tensions.  He went on to convey how “difficult” 
it was to gauge what information to share with children and grandchildren, particularly due to 
the fluctuating nature of his changing condition, admitting that this was something he left to 
his wife to communicate. His own reaction to the information given to him by his consultant 
is illustrated in the following excerpt from his narrative:  
 
“it’s one of those conversations you remember in the state I was in. There was fifty per 
cent chance of living fourteen months I think it was, without a transplant, so we might 
as well go for a cure which has got a forty per cent chance of success and hope it was 
going to work. So that was the mental position we took.” (P6) 
 
Being given information comparing the percentage chances of survival both with and without 
a STC enabled him to make an informed choice regarding his treatment options. With a 
“forty per cent chance of success” he opted to “go for a cure and hope it was going to work” 
suggesting that whilst cognisant of the fact that there was no guarantee of success, he 
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consciously adopted the “mental position” of optimism. In a study investigating the process 
of maintaining hope in adults undergoing bone marrow transplantation Ersek (1992) 
identified several coping strategies including seeing the disease as a challenge and 
avoidance of negative thinking which resonate with the attitude of participant six in the 
current study. These findings are also corroborated by Saleh & Brockopp (2001) who found 
that participants hospitalised for bone marrow transplantation engendered positive attitudes 
and thoughts in the face of challenging situations in order to nurture hope. 
 
It is interesting to note that several participants admitted to deliberately avoiding certain 
information and others felt it had not been discussed.  Their rationale however is similar in 
that they felt that this was a deliberate attempt to focus on the curative aspects of the 
chemotherapy treatment and the transplant. Participant fourteen, a sixty seven year old 
gentleman eight months post-transplant for myelofibrosis commented on his perceived lack 
of information received about the treatment he would be undertaking as demonstrated in his 
words: 
 
“I’m very positive about having had it done and I got through the other side of it but 
one thing that did disappoint me. It was never really explained erm, what you have to 
go through.”  (P14) 
 
However, this did not concur with his wife’s recollections who felt that his relief at being 
given a ‘second chance’ blinded him to the information he was given: 
 
“You seemed to shut your eyes to alot of it because the doctor went into it in such big 
detail but I think P14 at that point was so pleased that they were going to give him a 
second chance that he’d shut his mind to all that.  He just knew he was going to go in 
and have it done and his brother was going to be a donor which was a really good 
match...our son was with us as well and he’d got this huge list of questions and he 
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was so patient and he answered every one of them and he told you it was going to be 
no walk in the park.”  (P14W) 
 
The relief that this participant felt once a donor was established for his stem cell transplant 
seemed to overshadow the reality of the treatment challenges ahead and in response to his 
wife’s explanation “I think in your mind you cut that bit completely out” he conceded: 
 
“Yea, I think you’re probably right, I didn’t want to think about what I was going to go 
through”  (P14) 
 
At sixty eight, this participant was of an age considered to be high risk for the type of 
treatment required which may well have increased both his gratitude and concern.  When he 
claimed it was “never really explained what you have to go through”, it is possible that this 
related to not fully comprehending the enormity of the physical and psychological challenge 
ahead, in other words what the lived experience would actually be like. His perceptions 
resonate with participant fifteen’s comments earlier, that is, that factual information does not 
fully prepare you for the experience.  This sentiment was echoed by a younger participant 
who when asked if he felt prepared for what was involved in his treatment explained:   
 
“I’m not sure I would have absorbed it. I was so relieved and so excited about finally 
getting my  stem cell transplant...I think maybe they didn’t impress upon me the 
seriousness of what could happen because you don’t really want to go in there 
knowing that. If you’ve got an expectation that you’re going to be absolutely bloody 
miserable, and, you know, all of the vomiting and all the other side effects that can 
happen, you don’t wanna know that’s coming, just let it happen, you know, rather than 
have chance to brood about it in advance.” (P11) 
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This gentleman suggests that sparing the volume and intensity of information prior to 
treatment may offer some protection to an individual in terms of reducing anticipatory dread. 
This attitude is similar to patients in studies (Cohen & Ley 2000, Tarzian et al 1999) where 
patients were found to want enough information to know what to expect though not too much 
to provoke a loss of hope. Accordingly, McVey et al (2001) suggest that an individual can 
reduce fear by limiting the amount of traumatic information processed, and in turn, maximise 
feelings of personal control.   
 
Several participants commented on the benefits of sharing experiences with others 
informally or in a patient and carer support group either in person or via the internet. Whilst 
helpful and reassuring for some, again, views were divided amongst certain participants with 
two in particular voicing their opinion. As participant six explained: 
 
“I’ve actually avoided support groups, and I keep away from medical programmes on 
the TV and all that sort of thing. I don’t think it would help me. Everyone’s got 
something slightly different so it would be a bit like looking on the internet, you’d get 
half the story and it probably wouldn’t be very helpful.”  (P6) 
 
Similarly, participant one shares a reticence to use the internet for fear that the information 
could make him “feel worse”.  He felt he had learned from the experience of his first SCT as 
illustrated by the data excerpt below: 
 
“after transplant you’re very vulnerable and you want to try and find an answer even 
after transplant, and especially when you haven’t had a PET scan you want to know 
what’s going to happen to me, find out other people’s stories and that’s a really, really 
bad thing to do. If I didn’t have a previous transplant before this one, I’d probably have 
done that again, I wouldn’t have learnt from my mistakes. I would have made myself 
even worse.”  (P1) 
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In the context of his narrative, this young man of twenty two years is reflecting on his 
previous transplant and the need for reassurance that his disease is not relapsing for a 
second time. He considers that a PET scan would confirm if this was the case as opposed to 
comparing symptoms by finding out “other people’s stories”.  Whilst admitting that looking up 
symptoms and talking to others on the internet could “scare you silly”, participant eleven did 
however start his own blog in hospital to share practical tips attracting five thousand views. 
As he explained: 
 
“I wrote it in a very black humour kind of style, you know, just little odds and sods and 
tips to bear in mind when you go into hospital.  One of the first things I picked up on is 
that you need lipsil ‘cos the air filters in that place are so concentrated and dry, your 
lips are the first thing to go, no matter how hydrated you are.” (P11) 
 
Sharing useful information from personal experiences that is easily accessible is likely to be 
extremely helpful to others and less controversial than offering advice about a particular 
disease, since everyone’s case is likely to be different.  However, participant five remarked 
on a conversation between two transplant patients which started in the out-patient’s waiting 
room.  Subsequently it extended to a group discussion where consensus was reached on 
many aspects of their individual experiences:  
 
“Last week in the waiting room and a couple of other transplant patients were just 
having a chat between themselves and it was quite comical listening to some of the 
stuff they’re going through.  Not because it’s actually funny what they were saying 
but it was like just one person said something and I’ve never sat in this situation where 
every single person can agree on so many things about going through their 
situation.”  (P5) 
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This sharing of experience as described above encapsulates Frank’s (1995 p49) notion of 
the communicative body whereby ‘when a body that associates with its own contingency 
turns outward in a dyadic relatedness, it sees reflections of its own suffering in the bodies of 
others’.  Portraying four typologies of bodies in illness (Frank 1995) the communicative body 
type is one which realises the ethical ideal of existing for the other and in so doing 
endeavours to fulfil an obligation to relieve the suffering of fellow men and women 
(Schweitzer 1933). 
 
4.9.2 “Your blood counts are fantastic”: the biomedical focus 
A number of participants remark on the nature of their information exchanges at their follow 
up appointments.  The primary focus of the consultation appears to be the blood test results 
and once discussed other concerns are either forgotten, held in abeyance because there is 
a perception that these are of secondary importance or not raised in order to minimise the 
delay for others.  These points are illustrated by participant fourteen who said: 
 
“Because the first thing that happens when you go in the room, they go oh yea, you’re 
blood counts are fantastic  so you think oh thank God for that, we’re through another 
month... and you think well I must be getting better if my counts are good and then you 
forget what you should be asking, you know, the not overly important things, well they 
are important things, from your point of view anyway aren’t they, you know, it stops 
you thinking about them, things you need to know”  (P14) 
 
This gentleman’s reference to the “not overly important things” but important “from your 
point of view” highlights the value of considering investigation results in parallel with 
complementary information related to the individual’s lived experience.  His phrase “I must 
be getting better if my counts are good” suggests that the results inform how he should be 
feeling rather than the reverse. This observation conveys the importance of sharing 
information in the context of understanding and responding appropriately to the illness and 
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recovery journey.  As Mattingly (1994) affirms, treatment that is structured narratively and 
comprehensively distinguishes it from a mere sequence of medical interventions.  However, 
as participant fourteen also observes entering into a dialogue can mean “you’re in there 
longer and you feel guilty ‘cos you’re taking up so much time”. 
 
For participant eleven, his initial reluctance to raise concerns was based on his desire to 
portray a traditionally masculine image rather than minimising his appointment time, as he 
explained: 
 
“my wife insisted on coming in to see the doctors with me because I used to do the 
typical bloke thing where, how’re doing, I’m great, I’m fine, all good, you know, no 
problem at all and then she’d pull me up and say what about this, what about that, 
aren’t you going to tell him about this and I’d think oh yea, maybe it’s not as rosy as 
I’m painting it. You know I actually had to make a conscious decision to change the 
way I portray what’s been happening with me and not try and butch it out or anything 
like that and actually just say everything that’s happening which is a little bit...erm, 
just something to get used to really”  (P11) 
 
The realisation that his strategy of saying he was fine was not necessarily advantageous 
occurred as a result of his wife’s insistence on attending his consultation to ensure he 
presented an accurate as opposed to a “rosy” picture of his situation. Though he refers to 
his conscious “decision to change” and “not try and butch it out” this was clearly an alien 
concept for him.  The approach, referred to as self-censorship is not limited to the males in 
this study, and the rationale for adopting it can vary. As previously mentioned, participant 
five was noted by her mother to not disclose information she felt may be upsetting and 
participant eight endeavoured to reduce her husband’s anxiety by reassuring him that she 
was fine. Whilst motives vary, the overarching intention of participant’s in this study appears 
to be an effort to protect others and in participant eleven’s case to present a positive macho 
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image.  In their discourse analysis of interviews with women with breast cancer Wilkinson 
and Kitzinger (2000:805) argue that ‘upbeat’ talk such as that used by participant eleven “I’m 
great, I’m fine, all good” is a conversational device used to fulfil a ‘socially normative moral 
requirement’ to be positive through the experience of cancer. 
 
4.9.3 Autonomy, trust and encouragement 
All of the participants expressed the value they attached to being listened to by the doctors, 
their trust in clinical expertise, openness and encouragement and the consistency of medical 
personnel involved in their follow up consultations. The following data extract from 
participant fourteen’s account illustrates the first of these points: 
 
“he was the one who took notice of me when I said about the cyclosporine. He went to 
see the consultant to persuade him to change me from that to another drug.”  (P14) 
 
This gentleman had deduced which drug in particular was causing his distressing nausea 
and vomiting and whilst it was important anti-rejection medication, the doctor he spoke to 
“took notice” and was able to persuade the consultant to change it. Similarly, participant one 
was able to influence his doctor to order a scan when he was concerned about disease 
relapse highlighting the importance of being listened to.  The following two excerpts from 
participant five and seven’s narratives illustrate their reaction to the encouragement they 
received from medical staff:  
 
“She said, P5, I saw you when you were on life support and I thought well this is it. 
And she said I cannot believe you are here looking so well. She said I really am 
proud of you and you know, just hearing that and that’s coming from a professor” (P5) 
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“I popped back in there and went up to the ITU to say hello to everybody there and to 
say thank you and they said ‘good heavens, you’re our miracle patient you are’ and I 
thought, that’s lovely, that is. Made me feel pretty good anyway.”  (P7) 
 
For both participant five and seven, the acknowledgement of their survival by a professor 
and intensive care staff respectively was extremely significant. There appear to be two 
specific reasons for this, one being that they are remembered so clearly as individuals and 
secondly that they are respected and admired for their endurance.  It is also worth noting 
that since this young lady and older gentleman appear to have survived these critical events 
‘against the odds’ a sense of praise for the staff themselves is implicit in their words of 
encouragement. The notion of symbiotic praise in these particular circumstances is 
noteworthy because treatments which engender both life saving and life threatening 
outcomes, staff understandably take pride in patients’ survival.  The value of knowing and 
being known by the specialist teams is seen as important to all the participants and the two 
data excerpts below reflect this: 
 
“as soon as we ‘phone she recognises his name and she realises, I know she’s got 
hundreds of  patients but I think he was in there so long she sort of knows”  (P14W) 
 
“I just think it would be nice if you could always see the same doctor because they 
know what you were like last time, so they can say ooh, you look a lot better today, or 
whatever, whereas if you have different doctors they tend to sort of ask you all the 
same questions because obviously they don’t know you”  (P8) 
 
Consistency and familiarity of medical staff inspires confidence and obviates the need to 
repeat information. Participant eight’s reference to a doctor knowing “what you were like last 
time” is also suggestive of a subjective element to their assessment which could enhance 
their evaluation of a patient’s progress. It is clear from her account that her experiences of 
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seeing the same doctor have been mixed. Supporting the notion of consistent contact with a 
given professional or group of professionals, Schou and Hewison (1999) suggest that when 
this is the case, patients and family members have a greater opportunity for a coherent 
treatment experience. Furthermore, Del Veccio Good et al (1994 p 857) advocate consistent 
contact for another important reason. This is to ensure that ‘attention to the trivia of daily 
treatment and the focus on technological requirements set the ground for more significant 
encounters, when difficulties of course and prognosis are addressed’.  Given the uncertain 
recovery journey for participants in the current study, this observation is significant. In stark 
contrast to the concept of the “miracle patient” several patients remark on less positive 
comments such as participant four being told that palliative care would be her only option in 
the case of disease relapse and as mentioned previously in the case of participant nine, that 
it would be “curtains”.   
 
4.10 Summary of the recovery journey 
This section has served to illustrate the experiences of the participants in their recovery 
journey up to one year post SCT. As physical, psychosocial and emotional disruption 
continue to affect the lifeworlds of the participants and their families, they employ a number 
of coping strategies to deal with enduring uncertainties regarding survival and their general 
health status.  Attitudes toward receiving information is varied whilst all of the participants 
value the expertise and encouragement afforded to them by their clinical teams. The notion 
of being positive and determined and information matters are explored further in the 
discussion chapter which follows.  
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CHAPTER 5 
 
 
Discussion 
 
5.1 Introduction 
This chapter builds on some of the theories and concepts emanating from the themes 
identified in the findings, drawing on relevant literature both within and external to literature 
concerning haematological malignancy and stem cell transplant. The study aimed to explore 
the patients’ experience of returning home following allogeneic stem cell transplantation.  
Research questions included how patients cope on their return home after prolonged 
hospitalisation; what physical, psychosocial and emotional challenges are faced and what 
help they require in order to overcome these and the medical, social and psychological 
support systems in place to meet these needs.  
 
5.2 Biographical disruption 
Participant’s experiences of the immediacy of illness and existential crisis have resonance 
with what Gidden’s (1979) identified as a ‘critical situation’. This critical situation is one which 
disrupts people’s beliefs and assumptions about their everyday lives and ‘involves a 
recognition of pain and suffering, possibly even death, which are normally only seen as 
distant possibilities or the plight of others’ (Bury 1982 p 169). For participants in this study, 
disease onset, the urgent requirement for medical help and subsequent treatment poses an 
existential crisis. This continues into the post treatment phase and is associated with on-
going threat to survival through infection, acute and chronic GVHD and the risk of disease 
relapse or secondary malignancy (Potter & Kerridge 2004). Whilst Bury’s (1982) 
conceptualisation of illness as a major disruptive experience was based on empirical 
evidence of those with chronic disease it is relevant to the experience of participants in the 
current study. Not only do some of the participants experience a major disruption to their 
lives at the inception of disease but this continues post SCT as survival now extends beyond 
one year (Hahn et al 2013). Their disease trajectory incorporates phases of acute and 
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critical illness situations in tandem with a slow and “non linear” recovery and enduring side 
effects of a more chronic nature such as fatigue, weight loss, loss of taste and tingling in 
their hands and feet (peripheral neuropathy).  No one participant could be sure what 
recovery really meant in terms of resuming their former life state, giving credence to 
Mukherjee’s (2011) observation that  those surviving cancer must define and live with a ‘new 
normal’. In addition to an altered bodily state prompting individuals to seek professional help, 
Bury (1982) identified two other aspects of disruption; firstly disruption in the explanatory 
frameworks normally used by people necessitating a fundamental rethinking of the person’s 
biography and self-concept and secondly the resources that people are able to mobilise in 
order to respond to the disruption. Key questions arising out of the disruption in the 
explanatory frameworks involve making sense of why the disease has occurred and why 
now? As previously mentioned, whilst participants in this study were shocked at the severity 
of their diagnosis they acknowledged the limited evidence of predisposing factors for 
haematological malignancy. In addition to the physical manifestations, participants described 
the major disruption to their psychosocial and emotional well-being. Their ability to fulfil their 
former roles within the family, resuming work or studies and participation in social activities 
including sport were significantly compromised due to infection avoidance, fatigue (all 
participants) and in some cases a loss of confidence (P2 and P5). These findings accord 
with what Little et al (1998 p1485) refer to as ‘boundedness’ whereby the individual’s social 
world contracts through an awareness of limits to space, available time and empowerment 
as a result of cancer.  
 
The mobilisation of resources referred to by Bury (1982) involves people having to 
reappraise their family and social support network and their on-going access to health 
services whilst attempting to fulfil the customary human attribute of reciprocity. In this study 
all the participants with the exception of one widowed lady express how vital family support 
has been physically, socially and emotionally. Another lady whose son and mother were 
reliant on her to support them formed a close relationship with her sister following SCT as 
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she was the sibling donor. However, illness of her own family members limited the support 
she was able to offer. Other than continuing to access specialist medical services, and one 
gentleman being involved in a post SCT physiotherapy class, the participants had no other 
support provided. One gentleman (P11) viewed ill-health retirement as a bonus as it 
provided an opportunity to leave a job he no longer enjoyed, to “get out of the rat race” and 
to avoid long commutes with their own associated disruptive effects on his family life. His 
wife was the primary wage earner and he was able to contemplate less stressful job 
possibilities in the future, while for others, enforced retirement and disruption to education 
and apprenticeship had a more detrimental effect on the participant’s lives.  
 
5.3 Haematological malignancy as a chronic illness 
Chronic illness and long term conditions are often defined as a physical or mental condition 
that demands living with disease trajectories over time (Hyman & Corbin 2001). A recent 
definition (Perrin et al 2007) suggests that any health condition lasting more than twelve 
months or likely to have a duration of at least twelve months constitutes a chronic illness. 
Whilst the initial diagnosis and treatment of cancer may be considered an acute phase of 
illness, it’s often insidious onset and continuing physical and psychological effects over time 
can define it as a chronic problem.  Contesting the notion that cancer should be defined as a 
chronic illness Tritter & Calnan (2002) argue that whilst a diagnosis of cancer similarly 
signifies a biographical disruption (Bury 1982) that the associated meaning is considerably 
different.  According to Tritter and Calnan (2002) a major difference concerns the social 
response to the stigma of cancer compared to that associated with chronic illness (Goffman 
1963). Tritter and Calnan (2002) contend that the stigma associated with chronic illness and 
disability is likely to be characterised by a sense of embarrassment as opposed to that of 
cancer which is associated with a fear of infection and death. Participants in the current 
study report very real fears regarding  infection and death but neither are they immune to 
feelings of embarrassment caused by altered appearance such as weight loss, hair loss and 
skin rashes due to GVHD and severe physical debilitation and fatigue. They too suffer a loss 
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of identity and altered self-concept as a result of their disrupted lives in a similar way to 
those with  chronic illness as portrayed by Bury (1982) and Charmaz (1991) and whilst for 
some this is temporary, for the majority of participants in this study are experienced well into 
the first year post SCT.  Most survivors have been found to experience symptoms such as 
fatigue (Jacob’s et al 2007, Lee et al 2001, McQuellon et al 1998) and up to two-thirds of 
patients undergoing allogeneic SCT develop chronic conditions including chronic GVHD 
(cGVHD), heart problems, endocrine and musculoskeletal disorders, neurocognitive 
impairment and secondary malignancies (Sun et al 2010). Perhaps the concept of chronic 
suffering more fittingly reflects how the individual experiences and lives with illness of an 
enduring nature.  
 
Whilst testifying to the insights of Strauss (1975) in drawing attention to those with chronic 
illness being forced to withdraw from the field of social interaction, Bury (1982) identifies a 
pressing need to consider the deeper implications of this phenomenon. The participants in 
this study are required to make adaptations to accommodate fatigue and infection avoidance 
and their social pursuits are therefore constrained. The implications are primarily associated 
with the person’s self-concept and identity as they endeavour to resume former roles and 
relationships both within and external to the family. Beech at al (2011) found that restoring a 
sense of wellness following surgery for colorectal cancer involves participants assessing and 
accepting physical limitations and that personal identity is recovered by achieving control 
over bodily functions. Participants in the current study similarly strive to achieve small goals 
with a belief that that there will come a time when they can more effectively predict stages of 
recovery, albeit different to how they were before the illness, whilst living with enduring 
uncertainty in the first year post SCT.   
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5.4 Physical aspects of recovery 
In relation to the severe physical disruption and fatigue during the first three months and one 
year post SCT knowing how much to ‘push themselves’ and how long symptoms will prevail 
are two of the most significant issues described by participants.  Similarly, in a study 
exploring the caregivers perspective of QoL post SCT (Jim et al 2014 ) they reported feeling 
unprepared for the severity and duration of emotional and physical changes in the patient 
and expressed difficulty determining how much they should ‘push patients to engage in 
activities’. In a matched control study (n=376), Kirsch et al (2014) compared the health 
behaviours between recipients of haematopoietic SCT and the general population. Evidence 
showed that twice as many patients in the former group were inactive leading to a 
hypothesis that the late effects of treatment and cGVHD potentially limited their physical 
performance. Whilst survivor’s fatigue can be a barrier to exercise, it can be reduced by 
regular physical activity (Persoon et al 2013). Furthermore, recent research suggests that in 
addition to regular activity reducing fatigue, the risk of developing diabetes and 
cardiovascular conditions, including hypertension following SCT may similarly be mitigated 
(Armenian & Chow 2014, Chow et al 2014). Accordingly, participants in the current study 
faced tiredness and fatigue, inhibiting their activity initially but all were keen to resume their 
former physical pursuits and endeavour to do so. Only one gentleman mentioned attending 
a physiotherapy class at the specialist treatment centre and due to geographical location, it 
may have been difficult for others to attend. Findings suggest that information regarding 
exercise would be well received by the participants.   
 
5.5 Coping 
An integrative literature review of haematopoietic SCT for haematologiocal malignancies 
(Adelstein et al 2014) illustrates contradictory evidence as to whether physical, 
psychosocial, or spiritual challenges are the more distressing concerns for patients, although 
these issues are closely related. However, coping style appears to be a significant variable 
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in patient adjustment to HSCT related to the level of distress associated with these factors.  
Meaning-making was cited by participants as having an important relationship to effective 
coping, regardless of their individual coping style and those able to find meaning in their 
HSCT experience were found to manage physical symptoms more effectively. They were 
also less likely to report pathologic depression, anxiety, and PTSD symptoms after 
transplantation than those who struggled to find meaning (Adelstein 2014). As previously 
cited, Coolbrandt and Grypdonck (2010) suggested ‘keeping courage’ through the creation 
of a positive story was an active coping strategy for their participants.  Farsi et al (2010) 
determined that finding meaning in their SCT experience formed the essence of effective 
coping for participants in their study.   As evidenced in the findings, participants in the 
current study displayed a number of coping strategies including keeping occupied, being 
positive and determined and counting their blessings evidenced by their reference to being 
lucky. They also employed strategies such as comparison of their own situation to others 
who were worse off and avoidance of certain information specifically related to survival.  
Whilst endeavouring to maintain a positive attitude concurs with the findings of Schoulte et 
al (2011), who defined positivity as emotion focussed coping there is variance with the other 
two forms of coping styles they identified. Instrumental coping (characterised by information 
gathering) was found by Schoulte et al (2011) to be an adaptive coping style employed to 
manage a variety of physical symptoms associated with SCT. As evidenced in the findings, 
participants in this study have two distinct attitudes towards information; feeling more in 
control with it and feeling threatened with too much. Avoidant coping, when patients deny 
the existence of a situation is considered maladaptive by Schoulte et al (2011) and may lead 
to behaviours such as alcohol abuse.  However, in the current study, it can be argued that 
participants adopted this strategy as an act of self protection to reduce inherent fear and 
anxiety.  Since striving to be positive and determined is important to many participants in this 
study, attention will now focus on a discussion of this finding. 
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5.6 Being positive and determined 
The meaning of positive thinking can be obscure, open to semantic ambiguities and it’s 
interpretation variable depending on people and circumstance (McGrath et al 2005). 
Furthermore, operational definitions can also vary considerably, evidenced by coding 
irregularities pertaining to the concept of positivity in qualitative studies as highlighted by 
Wilkinson & Kitzinger (2000). A recent Australian study compared patients and nurses 
understanding of positive thinking and found significant disparities between the two groups 
(O’Baugh et al 2003). Whilst patients frequently defined being positive as living as normally 
as possible, nurses made a greater association between being positive and personal 
attributes such as adopting a fighting spirit, maintaining optimism and hope.  As in Wilkinson 
& Kitzinger’s (2000) study of 77 women’s experience of breast cancer, participants in the 
current study were not directly asked about positive thinking but similar discourse about the 
benefits of being positive prevailed in several narratives. In fact, the significant number of 
references to ‘thinking positive talk’ (Wilkinson & Kitzinger 2000) led to their analytic focus 
on how women with breast cancer talk about the role of positive thinking in their own lives. 
This approach prompted the researcher to note the number of references to positive thinking 
evidenced in the data in this current study and to reflect on the meaning and context in 
which such statements were made. Thirty seven references to being positive with direct use 
of this word were found with the highest proportion of these evident in three of the narratives 
(P7, P3, and P8). The highest number was thirteen, then eight, five, three and two. Six 
participants mentioned it once whilst four did not use the word at all. Those who did not use 
the specific word made statements such as needing to “try and get myself back up there 
again” (P1) which in the context in which it was said suggests the considerable personal 
mental effort required to make the transition from a very vulnerable state to one of relative 
normality.  Extracts from another participant’s narrative whose recovery is marred by 
significant challenges also encapsulate the notion of the personal struggle and hope 
required to carry on such as: 
 
163 
 
“at least you’ve given it your best shot and tried everything possible...I’ll never give 
up, never ever give up until I get success one way or the other” and “I think the 
consultant’s got a few more things up his sleeve that can eliminate this so I’m still 
thinking it will work in the end and I think that’s what you’ve got to hang onto ‘cos if 
you don’t then you’ll just go and lay in a corner and just ...curl up” (P10).   
 
This gentleman’s words suggest a dual responsibility for a successful outcome; his 
consultant’s expertise and the capability of modern medicine, and his personal unrelenting 
determination. 
 
Whether applied to ill health or more generally, thinking positive has become a socially 
accepted and widely propagated phenomena of modern life.  The notion that mind over 
matter can result in positive outcomes is an attractive one, particularly when this signifies 
gaining control over an otherwise uncertain situation. Two broad benefits are claimed for 
positive thinking in relation to disease (McGrath et al 2006), one being that a positive 
attitude will enable the ill person to cope more effectively with the experience of illness and 
the other that it will increase the likelihood of a good outcome.  Whilst there is evidence that 
maintaining a positive attitude can influence a person’s ability to cope with treatment and 
adapt to life after treatment for cancer (Taylor et al 2000, Taylor 1983) critics suggest 
otherwise (Oakley  2010, Ehrenreich 2009). Given the high value placed on certain 
interpretations of positive thinking, it is argued that this has the potential to place an 
unnecessary burden on a patient at a time when they are already facing considerable 
trauma (Holland 2000). Furthermore, in their study exploring the role of positive thinking in 
perceptions of cancer outcomes Ruthig et al (2012) suggest that exposure to the notion of 
positive thinking could lead to cancer patients being perceived as culpable for a poor 
outcome. Whilst participants in the current study do not articulate self blame, they do 
however feel an obligation to play their part, best illustrated by one gentleman (P7). He 
acknowledges that the medical teams are doing their “darnnedest” for you and therefore “it’s 
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up to you to actually do your bit to make sure that you also do the same thing”. In terms of 
improving survival, Petticrew et al (2002) and Dyer (2012) challenge claims that positive 
thinking can improve outcomes in cancer. They also refute the suggestion that interventions 
that enhance benefit finding improve the prognosis of cancer patients by strengthening the 
immune system. Ruthig et al (2012) however, distinguish positive thinking from other 
theoretical perspectives and constructs applied to understanding positive adjustment to 
health and illness.  The definition proposed in their study (Ruthig et al 2012) is that ‘positive 
thinking’ involves intentional cognitive strategies in order to experience and express positive 
thoughts and to actively suppress negative ones, whilst ‘benefit finding’ suggests that 
something positive can be gained from adverse events (Helgeson et al 2006, Tomich & 
Helgeson 2004).  In the current study, P1 employed cognitive strategies by reviewing his 
University projects in an effort to reduce his anxiety, reclaim his identity and to realise future 
possibilities. Wilkinson and Kitzinger (2000) point to the way in which formulaic expressions 
such as ‘think positive’ can be used to summarise and underplay the seriousness of a 
situation in order to move a conversation on from a painful topic. As previously mentioned, 
health care professionals are also responsible for using such strategies as exemplified by 
the nurse advising one of the participants (P4) that it was important to be positive and 
doctors emphasising the notion of hope, “cure” and a “lovely new life”. Advising P4 to be 
positive when she was struggling to cope with members of her family who were unwell, 
financial worries and her own existential fears may not have been the most sensitive advice. 
This participant would have valued someone with whom to share her concerns but had 
limited social support at this time.  
 
In a study carried out by Coolbrandt & Grypdonck (2010), interviews with patients 
undergoing SCT demonstrated that an optimistic attitude on the part of doctors has an 
undeniable influence on the ability of patients to face arduous treatment regimens. However, 
the nurses who were also interviewed questioned the honesty of the doctors’ approach and 
felt uneasy in the painting of an overly optimistic picture of treatment outcomes. In their 
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review of this study Dierckx de Casterle et al (2011 p238) argue that ‘laying bare the function 
that optimism fulfils for patients’ allows a more contextualized and differentiated discussion 
of the ethical issues raised in these situations. In a study involving nurses caring for patients 
with haematological malignancy, Leung et al (2011) found that nurses experience internal 
conflict related to their simultaneous need to help patients fight their disease and to prepare 
them for the possibility of letting go.   The authors (Leung et al 2011 p 2175) used the terms 
'letting go', not to reflect nurses' intents to abandon life but to release patients from 
perceived norms of the 'curative culture'. They suggest enhancing nurses’ capacity to 
manage this dilemma and highlight the need for more research into educating and 
supporting nurses in work with patients who experience existential distress.  
Participants in this study who used the actual term ‘positive person’ and ‘positive attitude’ the 
most will now be considered in light of the discussions above. The young female teacher 
(P3) who described herself as a positive person, expressed it in terms of her identity before 
her SCT and how this positivity was operationalised: “I’m a naturally positive person... I’ve 
always looked at the positives to anything, erm I always think well, what’s the worst case 
scenario, can I deal with it, yes ok and let’s get on with it.” Her interpretation of being 
positive in this and other examples serves to illustrate her approach to problems or difficult 
situations which she would endeavour to find a solution to.  As evidenced in the findings, she 
also looked for the positive angle of being in hospital by making good use of her time and 
writing lesson plans when she felt well enough and also alluding to time saving by not 
having to wash her hair, the regrowth of which was delayed due to the effects of GVHD. 
These examples are more consistent with Helgeson’s (2006) notion of benefit finding as 
opposed to positive thinking per se. She also referred to focussing on something more 
positive by aiming to raise ten thousand pounds for leaukaemia research.  
In a study of media reports relating to ‘cancer heroics’ Seale (2002 p121) similarly found 
examples of men and women exemplifying considerable power over their reactions to illness 
including acts of bravery and physical and emotional challenge. One such lady began 
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climbing mountains ‘to symbolise to herself and others the personal mountain she was 
climbing’ whilst raising money for cancer research. The older gentleman (P7) who 
repeatedly made reference to the benefits of a positive attitude said it almost exclusively in 
relation to survival:  
“it helped me just to sort of be positive about what the outcome was going to be, 
erm, you picture yourself being well again (laughs) and you’re going to be well again, 
that’s the theory at least isn’t it?”  
Using positive imagery concurs with Ruthig et al’s (2012 p1245) definition of positive 
thinking where positive thoughts can include ‘positive expectations, positive healing imagery, 
and a positive attitude’.  Whilst this participant acknowledges “the theory” behind a positive 
attitude he does appear to believe it with some conviction: “if you can keep a positive 
attitude, it does help tremendously. I, I believe so, anyway”.  However, he does admit that he 
is making a conscious effort to maintain his positivity after feeling very down due to facing 
numerous setbacks in the first year following SCT. Whilst at one point he infers that a 
positive attitude and the right expertise may help to prolong life, he is careful to distinguish 
this from cases where neither of these attributes would be capable of affecting a poor 
outcome. Similarly in describing her initial and on-going reaction to her illness another 
participant (P8) advocates the adoption of a positive attitude whilst acknowledging that this 
must be self-motivated and not necessarily appropriate for everyone. A fourth participant 
(P2) who mentioned the word positive several times used it to reflect the attitude of others in 
addition to herself. In relation to her husband, it was his positive outlook and “doing so 
much” to help that was of benefit particularly when she returned home and was too fatigued 
to resume her normal domestic activities. The focus of her consultant’s positive approach 
was in direct relation to her blood results which she found very encouraging and made her 
appreciate the progress she was making biologically. Interestingly, this lady mentioned her 
general practitioner calling “not to offer anything positive, just, just support really”.  Her own 
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positive feelings were linked with being able to eat normally again without the restrictions 
imposed when on anti-rejection therapy and also the passage of time post SCT.  
 
5.7 The down side of positive thinking 
Such is the often unquestioning and widespread acceptance of the value of being positive 
that patients may feel a social and moral obligation to suppress negative feelings of anxiety 
and uncertainty (Arman et al 2002, O’Baugh et al 2003). In her study of survivor loneliness 
in women following breast cancer, Rosedale (2009) found that the participants used various 
strategies including self-censorship to ensure they projected an image that met social 
expectations to be positive. These sometimes involved a deliberate attempt to withhold the 
truth about their feelings from fellow survivors for fear of projecting ‘an insufficiency of 
fighting spirit’ (Rosedale 2009). The distress felt by the women as a result of concealing their 
fears (Rosedale 2009) is indicative of the notion of ‘communication alienation’ described by 
Little et al (1998) arising as a result of cancer sufferers being unable to relate to those who 
have not been through a similar experience themselves or the social expectations placed on 
them to get ‘back to normal’ following treatment. The only difference appears to be the 
added pressure on survivors to aspire to media induced heroic status (Seale 2001). In the 
context of significant physical, psychological, social and emotional challenges faced by 
cancer patients (Taylor et al 2000, Doyle 2008) and specifically those living through and 
following SCT for haematological malignancy (Williams 2012, Jones & Chapman 2000, 
Cohen & Ley 2000) attempts to control negative thoughts by themselves or by others may 
compound their feelings of alienation and isolation.  
In this study, participants articulated concerns for their families, knowing how stressful the 
situation was and in many cases continues to be for them.  Participant’s wives present at the 
interview described the degree of psychological impact treatments and hospitalisation had 
on their husbands, their “paranoia” on first returning home and for some, the continued 
burden of disease and treatment complications.  In addition, challenges such as changes in 
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self-concept, social role and financial strain are experienced and it is therefore not surprising 
that participants may feel a compelling obligation to put on a brave face. Given that 
participants said they found it difficult to interpret their bodies post SCT but showed 
evidence of utmost vigilance regarding their physical condition, it could be argued that what 
may be perceived as a negative attitude or “paranoia” is actually an act of self-preservation.  
This view concords with that of Ehrenreich (2009) who proposes that uncertainty and 
vigilance are important survival mechanisms more in keeping with realism than the ideology 
of positive thinking. 
Condemning what he terms ‘the present day tyranny of positive thinking’ Holland & Lewis 
(1995) encourage people to use the coping styles most natural to them and for others to 
respect and support them. He argues that attitudes towards the mind-body-cancer 
connection has more to do with a person’s belief system and are therefore more aligned to 
religion than influenced by scientific evidence. In this study, as some participants begin to 
make a gradual recovery and in some cases face considerable on-going challenges to their 
physical functioning and general well-being the issue of how to live their lives becomes 
central to their existence. As suggested by Campbell & Swift (2002) chronically ill people 
face enduring physical and mental burdens forcing them to draw upon personal and moral 
resources in the face of continuing adversity.  Findings from their study (Campbell & Swift 
2002) investigating patient’s perspectives on the role of character in illness suggest that 
patients valued qualities such as courage, realism, self-respect, a sense of humour, hope 
and the ability to maintain good relationships with others.  
 
5.8 Medical Talk 
An important aspect of all of the participant’s experiences related to medical talk.  In the 
main, these were positive, with an appreciation of expertise, being in safe hands, being 
listened to and the inherent optimism articulated to them regarding SCT.  Conversely, a 
number of participants related experiences where they felt that communication had been 
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particularly blunt and insensitive. As reported in the findings, one gentleman had expressly 
requested not to be given details of his survival chances and articulated his distress when 
this occurred. This raises an interesting ethical debate regarding how much or how little 
prognostic information should be discussed and whether a patient’s requirement regarding 
the volume and nature of information discussed should be established prior to the 
commencement of treatment.  Ernst et al (2013) found that haematology patients were often 
overwhelmed by the complexity of the illness and the therapy and did not want to assume 
any responsibility in medical decision-making. Participants in their study (Ernst et al 2013) 
reported a great deal of distress and very traditional paternalistic role expectations with 
regards to their health care providers, which limited their ability to partake in the decision-
making process. Since scientific knowledge and medical know-how regarding stem cell 
transplantation (SCT) for haematological malignancy is an experimental, highly technical 
and developing field it is unsurprising that patients are not always involved in treatment 
choices. Whilst the aim of the current study did not set out specifically to investigate 
communication and information giving, they constituted significant findings.  A number of 
participants were on trial chemotherapies and others noted the experimental nature of their 
treatments which changed course according to disease response. Although there was 
limited evidence of contributions to medical decisions about chemotherapy and stem cell 
transplantation per se one participant reported arguing his case to be treated following a 
brain seizure. There was also evidence that participants contributed to other medical 
decisions such as the example of one gentleman negotiating the discontinuation of his 
nausea inducing anti-rejection drug in favour of an alternative and the younger man wanting 
a scan to reassure himself and his clinicians that his disease had not relapsed. Other 
aspects of care when participants influenced decision making include those concerning 
admission to and discharge from hospital, declining the insertion of a naso-gastric tube for 
feeding purposes and a disinclination to discuss wig options because the timing did not feel 
right. These findings contrast with those of Seale and Charteris-Black (2008) as the 
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examples above involved a cross section of participants being involved in decision making 
irrespective of age and gender as opposed to a predominance of older men.  
 
5.9 Information 
Participants in this study and their care givers had differing attitudes towards their 
requirement for information. It appears that those wanting to know as much as possible 
gained an increased sense of control and independence with greater knowledge. This was 
particularly evident in critical situations when loss of control was felt more acutely, for 
example the two participants who related their experiences of the intensive care 
environment (P7,P8) as also found in Parker’s (in Clanidin & Connelly 1999) study of 
patients’ recollections of their intensive care experience. In direct contrast a number of male 
participants held a diametrically opposite view with regard to receiving or actively seeking 
information. As previously highlighted, explanations for adopting this latter stance varied.  
The rejection of certain web based information was linked to a fear of taking information out 
of context and subsequently increasing anxiety through misunderstanding or 
misinterpretation. This applied to both pre and post transplant situations with the prime 
concern post SCT relating to the interpretation of physical changes and signs of disease 
relapse (P1, P6, P11). However, some participants (P6, P10, P16) were happy for their 
partners to take on the role of information gathering so long as these were from established 
and reliable sources.  
As mentioned in the findings, P11 established his own blog in response to web-based 
questions from fellow sufferers on a disease specific website dedicated to practical advice 
for those undergoing SCT. Unfortunately, despite numerous efforts to access the blog, it 
was not found and therefore not possible to assess the nature of ‘conversations’ though 
from what he described they involved useful tips rather than emotional issues.  Sharing of 
personal stories and dilemmas regarding treatment modalities for ovarian cancer (Kenen et 
al 2007) was found to be of considerable support to a group of women.  Data was collected 
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from a website dedicated to women at risk of hereditary breast and ovarian cancers. 
Contradictory media information and medical uncertainty regarding the long term 
consequences of hormone replacement therapy led the women to seek additional 
resources. These included emotional support and specific experiential knowledge from one 
another engendering a unique sense of community and a high level of trust (Kenen et al 
2007). Exploring the communications between Norwegian women with breast cancer as 
self-selected members of an on-line self-help group, Sandaunet (2008) identified the 
benefits of sharing both positive and negative aspects of their experiences. Whilst she found 
that fears were shared to a degree, these were almost exclusively after the event when the 
women felt more in control and able to participate in ‘socially desirable exchanges about 
cancer’ (Sandaunet 2008 p 1638). Furthermore, the group were bound by an ‘obligation to 
be considerate’ to each other which did not deny mention of difficulties but rather 
emphasised effective management of them. She therefore suggests that creation of an 
online potential ‘space for suffering’ was one which was underutilised for this purpose 
perpetuating the expectation of stoicism in facing cancer (Sandaunet 2008). One woman 
who did admit to feeling depressed noted the limitations of the group in responding to her, a 
view endorsed by Ehrenreich (2009) who received indignation from fellow sufferers when 
she tried to express anger about her own experience of breast cancer. Conversely, 
informants in Dickerson et al’s study (2006 E14) shared anxieties and frustrations ‘if we feel 
like whining...or complaining...we will just whine to each other’.  
 
5.10 Emotional response to information 
The time when several participants expressed a more emotional response to unwanted 
information was during the treatment phase of their illness when they felt most unwell and 
their survival was uncertain. In her paper exploring aspects of living with uncertainty Penrod 
(2007) found that an individual’s sense of confidence and sense of control are primary 
essences in determining the nature of the experience of uncertainty. When participants in 
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the current study faced issues of their own mortality, it makes sense to assume that their 
confidence and control were adversely affected, thereby increasing feelings of uncertainty 
and discomfort.  In a study exploring the experiences of patients using the Internet for 
information and support to manage the self-care aspects of illness and treatment, including 
symptom management, Dickerson et al (2006) similarly found some participants who at 
times rejected certain information. One informant who had a bone marrow transplant for 
leukaemia preferred information one step at a time so she could adequately process it and 
was ‘scared away’ by statistical information whilst others found it useful to weigh up 
treatment options (Dickerson et al 2006 E12). In a study exploring the patient’s perspective 
of information needs regarding autologous bone marrow transplant (ABMT) Tarzien et al 
(1999) highlighted the complexities associated with this area of care. As one of the 
participants in their study (Tarzien et al 1999) affirmed, judging the right amount of ABMT 
information and the correct timing for giving it is "a real fine balance." Individual coping 
styles, the complex nature of the transplant process and the fact that it can pose significant 
risk to the patient whilst also providing a chance of survival are all factors for consideration 
(Tarzien et al 1999) as ‘patients themselves vacillate between wanting information about 
side effects and survival and simply wanting messages of hope and motivation’. An 
important finding in Tarzien et al’s (1999) study was that conversations between pre ABMT 
and recovered ABMT patients provided an opportunity to discuss and validate feelings 
experienced throughout the process. In the current study, participants highlighted limited 
possibilities to enter into conversations with other patients due to being in protective isolation 
facilities.  The waiting areas for follow up consultations post SCT which were observed by 
the researcher were not necessarily conducive to social interaction.  However, on the few 
occasions that interaction was possible, for example attendance at a support group and one 
occasion reported by a participant that took place in the waiting room, participants felt they 
gained much from sharing experiences.  
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Whilst for many, living through uncertainty has the potential for personal growth and a 
changed outlook on life, for others past experiences of uncertainty accentuate threats to 
confidence and controlling current situations (Penrod 2001). Illustrations of both these 
reactions are evident amongst the participants in this study and for one young gentleman in 
particular, both responses are apparent in his narrative. On the one hand he describes very 
eloquently his feelings of psychological distress in relation to disease relapse, challenging 
treatments and the momentous occasion of being told that he could go home. However, 
later in his account he acknowledges the life changing qualities of his experiences as 
evidenced in the previous chapter. 
For the two participants (P7 and P8) who described their experiences of being on life 
support in an intensive care unit, references are made to ‘flashbacks’  suggesting a high 
level of existential distress associated with these events. Similarly, in a study reviewing the 
literature pertaining to emotional outcomes after intensive care Rattray et al (2008) found 
that being in intensive care can result in on-going significant emotional and psychological 
problems for a number of patients. Those who were less aware of their surroundings or who 
had frightening experiences had more post traumatic stress disorder (PTSD) symptoms after 
discharge than did other patients (Rattray et al 2008). Post traumatic stress is often 
associated with combat, violence, abuse, or natural disaster and according to American 
Psychiatric Association (APA 2000) is a stress related anxiety disorder comprised of 
exposure to a traumatic stressor, intrusive thoughts, avoidance, arousal or reactivity 
symptoms and negative mood and cognitions. Both participants in the current study retain 
vivid memories of being in an intensive care unit and indicate that this was one of the worst 
experiences for them.  Individuals with PTSD normally avoid any stimulus that can be 
associated with the trauma, such as feelings and places (APA 2000). Whilst one participant 
(P8) suffered “panic attacks” when she had to have a naso-gastric tube for feeding purposes 
because it reminded her of feeling constricted by tubes during her intensive care experience, 
the comfort provided by the nurses who sat with her in the night alongside what she 
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expressed as applying her own logic alleviated her fright. As opposed to avoiding the place 
associated with his trauma, the gentleman (P7) pro-actively returned to the intensive care 
unit to proffer his thanks for the care he received. Nonetheless, there is no doubt that these 
events coupled with their overall illness experience have the potential to contribute to on-
going distress.  
 
5.11 Recovery and liminality 
In what he terms the remission society, Frank (1995) describes the position where people 
with diseases such as cancer and others of a more chronic nature are unable to resume 
what were once their normal obligations. Had the current study allowed for longitudinal data 
to be collected it would have been possible to assess what this meant for the participants 
further into their recovery. Frank’s (1995) use of the term remission society is exemplified by 
Sontag’s (1978) metaphor of illness as travel. She argues that people are citizens of two 
kingdoms; that of the well and that of the sick and whilst our preference is to reside in the 
former, we will all find ourselves citizens of the less desired place at some stage and 
perhaps for an undetermined time. For participants in this study, transition between states of 
feeling ill and feeling better not only fluctuate according to their disease status but also 
concern their physiological response to treatments and their undesired side effects. They 
use metaphors such as being “in limbo”, experiencing a “non linear” recovery and having “no 
reference points” to describe how this feels. Accordingly, as Andrykowski (2005) postulates, 
because HSCT survivors evidence deficits across a spectrum of physical, psychological, 
and social outcomes, it cannot be claimed that they will achieve a full restoration of health. 
This continued period of transition has resonance with the concept of liminality as described 
by anthropologist van Gennep (1960) who suggested that ‘the life of an individual in any 
society is a series of passages from one age to another and from one occupation to 
another’. Typically these rites refer to such life events as birth, marriage and death (van 
Gennep 1960 p3) where the rite of passage is characterised by ‘severing connection’ with 
an existing social state or position and re-entering or being born into a new social role 
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(Hockey 2002). The period between these two states is an ambiguous one, a liminal state, 
where an individual’s identity can be viewed as being temporarily suspended. Whilst 
participants in this study have experienced the life giving qualities of SCT it is evident that 
they have entered unknown territory in terms of understanding the extent or duration of their 
recovery. As slow recovery ensues, however, their new identity appears to be one that 
integrates their illness experience (Zebrach 2000) in order to accept a lower level of physical 
functioning and in some cases coming to terms with enduring uncertainty and coping with 
existential distress. In McKenzie and Crouch’s (2004 p140) research, an abiding aspect of 
liminality is ‘chronic suffering, a protracted condition of existence that commences abruptly 
with the cancer diagnosis’. In a later paper, Crouch and McKenzie’s (2006) analysis of three 
of their own studies drawing on the concept of liminality led them to the view that: ‘Confined 
to a borderline condition between well and unwell, surviving and being threatened, cancer 
survivors must endure the indeterminacy of both their lives and their social personae’. 
 
Little at al (1998 p.1492) suggest that liminality is experienced in two phases: ‘acute’ and 
‘sustained’. The acute phase occurs at diagnosis, characterised by disorientation, loss of 
control and uncertainty whilst sustained liminality refers to the adaptive phase involving 
reflection on life’s meaning and one’s own identity. For the participants in the current study 
there appears to be a protracted phase of ambiguity when the state of remission is not 
guaranteed and the possibility of life threatening infection or chronic GVHD pose on-going 
threats to health and recovery. Success or otherwise of SCT will determine their survival and 
subsequent experience of the adaptive phase (Little et al 1998). Whilst sustained liminality is 
not guaranteed for other patients undergoing treatment for non haematological cancer to an 
extent, they are not dependent on the receipt of donated cells for survival in addition to 
surgical, chemotherapeutic or radiotherapeutic treatments. Indeed, a unique position for the 
participants in this study is the adoption of a new biological identity by virtue of their stem 
cell donor. How this was experienced by a number of the participants varied with one lady 
blaming her short-temperedness on her donor “it’s not me, it’s her”, another questioned if 
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she should feel like a twenty three year old (the age of her donor) and in the case of the 
gentleman receiving cord cell transplants from two separate donors which genetic make-up 
would be adopted proving the efficacy and prowess of one nationality above another.  
 
5.12 Support Groups 
Patient support groups were available to patients and their families at both specialist 
treatment centres. Those who spoke about attending these sessions felt reassured by 
sharing experiences and one lady commented particularly on how encouraged she felt to 
meet longer term survivors. However, because participants lived some distance away and 
were attending out-patient appointments frequently it was difficult to build this in from a 
geographical and time perspective and also due to fatigue. The wife of one participant 
commented that the support group occurred at the same time as the follow up clinic and she 
felt it of greater importance to attend the consultation with her husband. Sherman et al 
(2005) reported on the themes generated within a support group for patients following SCT 
for haematological malignancy in existence for three and a half years. The group was borne 
out of an unmet need expressed by many patients to be educated and supported in their 
challenges post transplant. The findings were categorised into three major themes: physical, 
psychological and social many of which were similar to the experiences of participants in this 
study. Furthermore, Sherman et al’s (2005) study highlighted a similar finding in that 
participants articulated the incongruence of post transplant expectations. Not only did they 
report feeling unprepared for the life-long changes they were facing but they did not 
remember realistic discussions regarding post transplant life. This finding accords with a 
number of participants in this study who similarly had no recollection of conversations about 
the transplant experience and the post transplant experience or if they did, it did not 
adequately prepare them for what was to come.  As discussed in the findings chapter, the 
sense of feeling inadequately prepared experienced by several participants centred on two 
aspects. In some cases they were overwhelmed with the volume and complexity of 
information including discussions about survival outcomes. Others acknowledged a 
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deliberate strategy of avoidance in seeking detailed information in an effort to reduce stress 
prior to treatment. Informants in Dickerson et al’s study (2006) highlighted the benefit of 
being able to discuss symptoms that their doctors did not have time to explain with others on 
a web-site. Symptoms such as difficulty sleeping and tingling or numb fingers were 
discussed and were similarly reported by participants in the current study. However, these 
symptoms seemed to be overlooked on occasions either because they were simply 
forgotten, not considered important enough to raise or because it was felt that the 
appointment time did not allow for much more than the blood test results to be discussed.   
 
5.13 Survival 
Novel treatments for haematological malignancies have been developing at a rapid pace 
offering greater chances of survival to those who previously faced an extremely poor 
prognosis. As evidenced in the findings, several participants make direct reference to being 
given prognostic information regarding their disease at the diagnostic and initiation of 
treatment stage but more specifically in relation to the SCT. In some instances, the way in 
which prognoses were communicated compared the percentage chance of achieving 
disease remission with chemotherapy and radiotherapy with that of undergoing conditioning 
therapy and stem cell transplantation. The possibility of developing a secondary cancer as a 
result of chemotherapy was also reported as being discussed. However, the gentleman (P7) 
reporting this particular aspect of treatment complication readily dismissed any anxiety 
related to it due to the length of time post-transplant that it was predicted, “I’m sixty seven 
now so in twenty or thirty year’s time, I don’t think I’m going to be so very worried about it”.  
In view of the uncertainty experienced by all the participants in relation to survival whether 
acutely during treatment and associated with critical life threatening events or in a more 
enduring sense over the year following SCT, communication regarding prognosis is worthy 
of further discussion. In his thesis, Rich (2002) charts the progression of medical 
advancements in parallel with the relative decline in clinical prediction. Historically, the three 
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core elements of medicine involved diagnosis, prognosis and treatment (Hutchison 1934). In 
earlier times, diagnosis and prognosis were the more prominent until the advent of modern 
medicine between the 1930’s and 1980’s marking the evolution of the biomedical model and 
disease directed therapies. Significant curative advancement during this era included the 
considerable contribution associated with antibiotic therapies. Such was the effect of these 
on diseases such as pneumonia, that decreasing attention was given to prognosis in leading 
medical texts in favour of a focus on curative therapies (Christakis 1997).  Prognostication, 
as described by Rich (2002) encapsulates the formulation of a patient’s prognosis by the 
physician and its effective communication to the patient or appropriate surrogate if required. 
His argument that the medical profession demonstrate a reluctance to carry out the latter is 
centred on the basis of doctors not wishing to acknowledge the limitations of medicine and 
their aversion to seemingly fail a patient by their inability to offer a cure. Furthermore that 
they may risk harm to the patient by sharing information they may not be able to understand 
or by removing any remaining hope that they have. The requirement for informed consent 
for experimental therapies led to a step change in practice regarding communication with 
patients including the disclosure of its potential risks and benefits. Consequently, the 
continuing development of anti-cancer interventions over recent years is thought to be a 
major influence. Not only was comprehensive explanation and consent a legal requirement 
for new treatments but their introduction a promise of improved outcomes. As a direct 
consequence, it is postulated by Rich (2002) that physicians felt more able to disclose a 
cancer diagnosis. 
The relevance of the above arguments and analysis to the current study concern the nature 
of medical communication regarding treatment options reported by the participants. As 
noted by Rich (2002) it is likely that conversations regarding prognosis were instigated as 
part of the consent process and based on his argument that the ability to offer some hope of 
remission made these discussions less daunting probably contributed to their occurrence. 
Unfortunately, whilst progress has been made with new chemotherapy agents, remission 
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can still be relatively short-lived, particularly in cases of aggressive and diffuse disease 
leading to SCT being the remaining treatment option available. It is perhaps more 
understandable still in these circumstances that this highly technical and complex procedure 
is given such a high status in scientific medicine. Building on Rich’s (2002) argument that 
the act of consent and hope drives discussions about prognosis, it is perhaps unsurprising 
that participants report such phrases being used as “well, the bad news is you’ve got 
leukaemia, the good news is we’ve got the cure” and “you’ve got to think it’s a new life”, 
since the only other option would be to discuss the possibility of death and the role of 
palliative care. As highlighted by Kelly (2000) the experience of those who fail to respond to 
aggressive treatments or those who face death as a result of treatment-induced 
complications has been relatively under-researched. As one participant (P7) stated, “I mean 
I went into this knowing, I mean the very sobering thought that up to thirty per cent of 
people will be dead in the first three months”. 
In a study examining the influence of evidence based medicine in shaping the nature and 
direction of biomedical practice and organisational culture, Broom et al (2009 p 198) found 
that haematologists had a greater tolerance for ‘poor’ evidence than their medical oncology 
counterparts. It is interesting to note the stance taken by five women diagnosed with breast 
cancer in Sinding et al’s (2010) study in relation to making treatment choices. Whilst 
acknowledging the importance of an evidence base for judging the efficacy of certain 
treatments, the women’s measure of their physician’s expertise was in their clinical 
application of such evidence in individual cases, as one lady stated ‘and so I’m wanting your 
best intuition and gut even though we don’t call it that because that’s not very medical, that’s 
not professional’ (Sinding at al 2010). Indeed critics of evidence based medicine argue that it 
undermines other forms of knowledge and risks replacing professional acumen and 
decision-making with ‘formulaic’ practice (Trinder cited in Trinder & Reynolds 2000). One 
clinician in Broom et al’s (2009) study suggested that a different philosophy exists within 
haematology whereby patients are potentially over-treated in an effort to cure or at least 
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prolong life. Oncologists on the other hand were seen to ‘view themselves as palliative care 
physicians’ (Broom et al 2009 p196) and therefore perhaps more accepting of the fact that 
many patients would have relatively poor prognoses. On entry to the haematology speciality, 
the researcher of this thesis recalls the words of a clinical nurse specialist who told her ‘in 
haematology it’s lift the lid of the coffin and try one last treatment.’  It should be reiterated 
here that whilst participants in the current study were grateful for a chance of survival with 
SCT, several gentlemen alluded to being pushed to their ultimate level of physical and 
psychological tolerance during treatment, that it was “too late to go back” or that if they had 
been older, they would not have wanted to go through it. 
 
5.14 Unmet need 
As previously mentioned, all participants in this study value the expertise of their specialist 
medical teams and the opportunity to undergo life-saving treatment. There are however, 
areas which became apparent where significant distress could potentially be reduced.  The 
speed of diagnosis, initiation of treatment and lengthy hospital stay caused shock and 
confusion as their normal everyday activities were severely disrupted. Family members are 
similarly affected, whereby life becomes a continuous cycle of travelling often considerable 
distances to visit their loved ones whilst trying to care for children, maintain employment and 
maintain the home.  As one participant observed, having one day of sickness necessitates 
significant arrangements to manage work and the family, let alone a year. Many participants 
made reference to financial hardship and whilst not established if they were eligible for a 
grant or other form of support, it appeared to be a considerable worry. Concerns ranged 
from meeting the high cost of travel, parking and subsistence when visiting or attendance of 
appointments to being unable to meet mortgage payments due to loss of salary. Advice 
regarding such issues would have been welcomed during hospitalisation for treatment and 
on return home. Supporting this finding, Meehan et al’s (2006) study also highlighted the 
significant financial and time requirement on the part of caregivers of autologous SCT 
recipients during the period of hospitalisation. Similarly Hamilton et al (2014) suggest that 
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serious economic challenges can be viewed as chronic stressors capable of reducing 
survivors' mental and physical well-being following SCT. 
 
Discharge decisions are seemingly determined by satisfactory blood counts and a minimum 
level of functional ability. Whilst some participants report receiving information regarding 
diet, medication and infection avoidance, the responsibility for self-monitoring and symptom 
management felt overwhelming to some in the context of leaving the relative safety and care 
of the hospital environment. Although the participants looked forward leaving hospital it 
appears that an increased emphasis on the mental preparation required to make the 
transition could be of benefit. In their study of autologous BMT survivors Cohen and Ley 
(2000) similarly report that participants experience a fear of leaving the protective 
environment of the medical centre upon discharge home. A recent study (Cooke et al 2009) 
sought to develop an educational programme to support patients discharge from hospital 
following SCT based on topics identified by patients. The programme includes a pre-
transplant teaching session and progresses throughout hospitalisation in preparation for 
discharge and subsequent follow up. The study’s results showed that psychosocial issues 
were the most prevalent for transplantation recipients. Proponents of a survivorship care 
plan (Beavers & Lester 2010) suggest that advanced practice nurses in the ambulatory 
setting would be uniquely positioned to guide survivors from acute to short-term care, the 
sub-acute phase and successive long-term chronic phase of survivorship. Similarly Oguz, 
Akin & Durna (2014) highlight the need to provide patient-family education and psychosocial 
support for symptom management. Their study included only patients following autologous 
SCT and therefore the need for those following allogeneic SCT is likely to be greater. 
 
Participants in this study are monitored closely at the specialist treatment centres and have 
access to telephone advice for emergencies but what appears to be lacking is a semblance 
of longer term support to address the practicalities of living with enduring fatigue, weight loss 
and the fear of disease recurrence and other psychosocial issues. Although much of their 
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narrative focus relates to the acute phase of illness, there is no doubt that participants are 
endeavouring to gauge to what extent their previous life will be restored.  
 
Current policy (Macmillan 2013) highlights a deficit in knowledge regarding the longer term 
implications of cancer survival which is shared amongst health care providers and patients 
alike. Elliot et al (2011) also suggest that whilst the profiles of individuals living with and 
beyond cancer have marked similarities to those with chronic or long term conditions, there 
is little progress in designing models of cancer follow up care to meet long term needs.  
 
5.15 Storytelling as an ethical duty 
As stated in the rational for choice of methodology, researching lived experience is 
advocated by Dierckx de Casterle et al (2011) not only in its own right but for its significant 
contribution for health care ethics.  In earlier work, Frank (1995) suggested that the ethical 
imperative of illness stories are located in issues of testimony and witness, and thus, in 
‘wounded storytelling’ the physical act becomes the ethical act. He refers to a personal and 
social responsibility to share illness stories, and in so doing, ‘recover the voices that illness 
and its treatment often take away’ (Frank 1995 xii).  Participants in this study appeared to be 
endeavouring to make sense of their experiences. This was demonstrated by repetition, 
faltering speech, questioning and on occasions appearing to reach an understanding or 
realisation. Some of the narratives exhibited sticking points where a part of the story kept 
recurring, perhaps because the tellers had failed to assimilate the experience. Caruth (1996) 
suggests that unassimilated traumatic experiences are characterised through behaviour 
such as unwitting repetition referred to as ‘repetitive reporting’ by Ben Ezer (1999:35) where 
an event is recounted, usually in detail, several times during the story. Felman (1992) 
suggests that when events are extraordinary and sudden they are difficult to assimilate and 
fit into appropriate frames of reference even when reflective space is available to 
accommodate this process. The participant’s readiness to contribute to this current research 
was related to a desire to help others but could also be a desire to process their experiences 
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particularly as these involved such distress and trauma. Another reason for participant’s 
willingness to share their narratives with an ‘outsider’ could be associated with their 
reluctance to overburden loved ones who shared their suffering. Bartley et al (2013 p1) 
found that high levels of ‘holding back’ or withholding of discussing disease-related thoughts 
and emotions were significantly related to lower levels of social well-being. Reluctance to  
discuss emotive issues with his wife (P6) was described in the findings though this 
gentleman does admit that there could have been mutual benefit in doing so. His 
disinclination seemed to accord with Cordova et al’s (2001) suggestion that patients may 
limit discussions about their concerns for fear that dwelling on cancer-related thoughts  may 
increase their personal distress. It is apparent from analysis of the interview with P8 that her 
husband is experiencing acute anxiety about her condition and that she does all she can to 
reassure him. This evidence is supported by field notes and the pen portrait recorded at the 
time of data collection and concords with Gotcher’s (1995) findings that patients may hold 
back from discussing health concerns to avoid upsetting the caregiver.  
 
A number of authors suggest that storytelling may be an effective intervention for patients 
who are critically ill because it allows for positive reappraisal and regaining a sense of 
control in an out-of-control situation (Pennebaker, 2000; Polkinghorne, 1996; Sakalys, 2003; 
Sandelowski, 1994). Similarly, Hubbard & Forbat (2012) postulate that oral narratives can 
help to alleviate the distress associated with uncertainty and a disrupted biography.  As a 
consequence of their integrative literature review, Adelstein et al (2014) recommend the 
development of a structured narrative intervention designed to promote meaning-making 
amongst survivors of SCT. This view accords with Frank’s (1995) recognition that many 
illness stories allude to a sense of being shipwrecked by the storm of disease and that 
metaphorically speaking, storytelling assists in repairing the wreck. 
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5.16 Summary of chapter 
This chapter has discussed key findings of this study with reference to themes emanating 
from the data analysis and in relation to the wider literature. The findings suggest that the 
experience of treatment with allogeneic SCT and the recovery journey within the first year 
post SCT is an uncertain one. The immediacy of illness and existential crisis and recovery 
journey have conceptual links to existing knowledge of chronic illness as biographical 
disruption (Bury 1982), liminality (Little 1998)) and consideration of haematological 
malignancy as a chronic illness. Participants coping strategies, including being positive and 
determined and communication and informational matters, have been discussed and unmet 
psychosocial and emotional needs highlighted.  
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CHAPTER 6 
 
 
Conclusion 
 
This chapter concludes the thesis and presents a summary of the study findings.  The study 
adopted an interpretive phenomenological methodology to explore individual’s experiences 
of returning home following allogeneic stem cell transplantation. Whilst participants in this 
study were treated at two specialist treatment centres in the United Kingdom, key themes 
and implications for practice may be relevant to patients treated elsewhere. This chapter will 
also present the strengths and limitations of the study and propose suggestions for further 
research. 
 
6.1 Summary of existing knowledge 
Quality of life studies have highlighted physical, psychosocial and emotional domains which 
present challenges to patients following allogeneic stem cell transplantation. As discussed in 
the literature review, however, patients QoL scores often belie the overall effect that 
treatments and on-going complications can have on an individual’s ability to resume their 
previous life activities and commitments. Over recent years studies of patient experience 
have begun to highlight the challenges faced, not least to make sense of the traumatic 
events leading up to and during treatment. Less attention has focussed specifically on 
patient’s experiences of returning home following allogeneic SCT. Close monitoring and 
interpretation of the participant’s blood profile occurs frequently in the immediate post-
transplant period and continues regularly depending on recovery of ‘normal counts’ and the 
adoption of their donor’s blood group indicating successful engraftment of the donors stem 
cells in the recipient’s bone marrow. Participants also have access to their specialist teams 
for consultations and advice in emergencies. However, there is a dominant biomedical focus 
to these interactions and whilst reassuring to know that ‘blood counts are good’ this 
emphasis ignores or at least underestimates the biographical disruption that people struggle 
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with. Once patients return home research suggests that individuals and their caregivers 
endeavour to manage recovery in the face of enduring uncertainty and a significant 
alteration of previously held family roles and responsibilities. Whilst hospital follow ups are 
frequent, they do not or cannot always address relevant health and psychosocial needs 
leaving people feeling vulnerable and without adequate support. 
 
6.2 Summary of the findings of this study 
The two overarching concepts emanating from the experiences of individual’s returning 
home following allogeneic stem cell transplant are the immediacy of illness and existential 
crisis and the recovery journey. These two concepts are inextricably linked as patients 
endeavour to come to terms with an acute disruption to their bodily and biographical status. 
In the first year of returning home, participants face considerable uncertainty about their 
future in terms of survival and resuming a sense of normality. Whilst participants 
acknowledge that “everybody is different” they articulate a need to understand more about 
what their recovery would look like in the future, how long it would take and how much to 
expect in terms of returning to their previous sense of normal. From a physical point of view, 
treatment side effects such as fatigue, the constant threat of viral and bacterial infections 
and cGVHD hamper recovery and render the participants in a state of sustained liminality.  It 
is interesting to note however, that it is sometimes the less immediately life threatening side 
effects that cause most concern such as recovering taste after radiotherapy. As the 
participant who experienced enduring loss of taste and significant weight loss explained, at 
least infections could be treated quickly and effectively with antibiotics (such had been his 
experience to date). From a social perspective, whilst one participant made the decision to 
retire, others had no idea what their future held in respect of returning to paid work, or in the 
case of the youngest participants, if and when they would be able to pursue their chosen 
careers. Support from family members was highlighted as being crucial at the time of 
discharge from hospital and participants felt both surprised and guilty at the length of time 
they continued to depend on them.  Household tasks and contributing to childcare were the 
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two main concerns but participants were also conscious of the effect their situation had on 
their family’s social pursuits. Even going out for a meal was difficult due to dietary 
restrictions in the first 3-6 months post SCT.  
 
For those with less family involvement, participants felt alone and isolated with their worries 
and lacked support even in having someone with whom to talk.  Nonetheless participants set 
themselves small goals to achieve such as being able to pull the starter motor on the lawn 
mower in one case and being able to help with cooking, shopping, other activities around the 
home and resuming gentle exercise in others. One participant, a keen sportswoman felt 
comfortable with pacing herself and found herself alternative forms of activity such as 
cycling instead of touch rugby. However, others would have appreciated direction as to how 
much to ‘push themselves’. In spite of these challenges, participants believe that being 
positive and determined in the face of adversity can help them to remain focussed on 
recovery, though caution is advised regarding health care professionals prescription of it.  
 
6.3 What this study adds to existing knowledge 
This study highlights the need for increased attention to the physical, psychosocial and 
emotional effects of haematological malignancy. The social needs of the participants are 
evident at disease onset as they endeavour to organise their life situation to accommodate 
the severe disruption caused by their illness. As arduous treatment regimens commence the 
participant’s concerns for their loved ones run in parallel with fears for their own survival.  
Consideration of the concepts of biographical disruption and liminality have assisted 
exploration of the participant’s experiences of returning home following allogeneic stem cell 
transplantation from a sociological perspective. There is some evidence that having an 
opportunity to assimilate traumatic events could be of benefit and enable participants to 
transcend the physical, psychological and social losses experienced through illness and to 
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redefine themselves. Exploration of the participants coping strategies has raised interesting 
arguments both for and against the virtue of positivity.  
 
Evidence of financial hardship and the stresses associated with loss of earnings and 
navigating the benefit system concur with other research. Whilst policy (NCSI 2013, 
MacMillan 2013) aims to mitigate against such difficulties it is evident that there is a need to 
improve processes and access to relevant agencies. 
 
6.4 Researcher lessons learned 
A favourable ethical opinion was obtained through a National Research Ethics Service 
(NRES) committee in London following minor changes to the participation information sheet 
and data storage arrangements. The Research and Development (R & D) approval process 
at the specialist centres was perhaps one of the most challenging areas to achieve and 
impacted on timescales envisaged for the project. There were two elements of significance; 
one concerning the requirements for approval in addition to it being my first experience of R 
& D since 2001 and the other concerned severe staffing issues within the R & D 
departments at both specialist centres. Provision of a comprehensive list of the information 
required by the R & D committee would have been helpful and this will be suggested to 
departments at both centres. The research ethics review procedure proved straightforward, 
once all required documents were submitted though the process did take eight months to 
complete. Honorary contracts were obtained at both centres and involved very thorough 
processes including occupational health checks and assessment of infection risk. I was 
particularly impressed with this level of surveillance since I was interviewing participants who 
were still immune-compromised. However, the checks all took valuable time to complete.  
Defining a research question earlier in the programme and subsequent development of a 
study proposal could have helped to mitigate against R & D delays allowing collection of 
data to commence earlier. However, the time taken to thoroughly review the literature and to 
identify a gap in knowledge was time well spent.    
189 
 
Undertaking the Doctorate in Clinical Practice has allowed me to combine a clinical and 
managerial role in acute care with an unparalleled opportunity to extend my knowledge base 
and to conduct research in a highly specialised area.  The modules undertaken served as a 
basis for the research and also influenced the way in which I have developed as a 
practitioner.  Having a greater political awareness and the ability to source and appraise 
evidence effectively has led to successful practice change within the haematology speciality.  
Similarly, my experience as a practitioner and manager undoubtedly served as a sound 
basis on which to further develop my interviewing skills and to organise and structure my 
thesis. Having a wide network of colleagues both within and external to my place of work 
was paramount in achieving access to patients and of significant value in planning and 
completing the project. Some of the most challenging times faced on this journey as I have 
strived to achieve the required level of academic work have been the most developmental 
and of significant personal gain.  I feel that I have developed the ability to manage more 
complex tasks than previously and a greater resilience to face the inevitable self-doubt 
associated with research and operating outside of one’s own usual ‘comfort zone’. (see 
Research Log and Overview of the Integration of Knowledge, Research and Practice for 
more detail). 
 
6.5 Strengths and limitations of the study 
The small sample of participants in this study were recruited from two specialist treatment 
centres in the United Kingdom and therefore reflect the experiences of these specific 
populations. It is feasible that experiences could be different for those treated in alternative 
treatment centres in other geographical locations and cultural contexts. However, 
recruitment from two centres guaranteed sufficient participants for the study and as stated 
previously, having a community of practice assisted with access to patients and collegiate 
support for the study.  It is conceivable that the findings in this study could be transferable to 
other settings and may have resonance for other patient groups facing a protracted and 
uncertain course of recovery from illness. Had the current study allowed for longitudinal data 
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to be collected it would have been possible to assess what this meant for the participants 
further into their recovery.  
 
One of the major strengths of the study was the willingness of the participants to share their 
stories and because of the qualitative nature of the study, the rich source of data gained. 
Whilst some of the findings concurred with data from quantitative quality of life studies, such 
as the participant’s fatigue and other physical and psychological manifestations of treatment, 
a deeper understanding of how these experiences effect the life worlds of the participants 
has been possible through their narratives. Although the number of participants was only 
fifteen, the volume of rich data obtained from their narratives was substantial.  Any more 
data would have been overwhelming and any less would not have captured the spectrum of 
participants from the point of view of age, disease, symptoms, contextual factors and 
experience.   
 
6.6 Table 9.  Recommendations for practice 
Issue Recommendation Action 
Lack of preparation to 
return home 
Specialist treatment centres to offer a 
structured but individualised education 
programme for patients pre and post SCT. 
Develop an educational programme 
and support programme for patients 
which commences at the beginning of 
their stem cell transplant experience. 
Lack of support at home Provide on-going support for patient’s 
physical, psychological and social needs 
on discharge home. Include proactive 
telephone contact and home visits to 
monitor and assess including late effects 
of treatments such as GVHD post SCT. 
Promotion of interventions to prevent 
unplanned hospital admissions. 
Consideration of telemedicine. 
Develop a business case to support a 
community based Advanced Nurse 
Practitioner role. Seek charitable 
funding to set up the post and 
evaluate after six months. 
Financial hardship To provide patients with information 
regarding financial support early in their 
diagnosis and treatment period. 
To provide information for patients and 
employers regarding preparation and 
options for returning to work. 
Develop comprehensive patient 
information of benefits and charitable 
organisations.  
Consider the role of occupational 
health to support vocational 
rehabilitation. 
Isolation due to immune-
suppression and 
geographical distance 
from specialist treatment 
centre 
To provide a means for patients to keep in 
contact with each other for support. To 
provide an additional forum to enable 
patients to process critical events and the 
on-going uncertainty that they experience. 
Investigate ways to enable patients to 
share their experiences with each 
other.  e.g. creation of a website 
linked to the specialist centre. 
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6.7 Table 10.  Recommendations for Education 
Issue Recommendation Action 
Biomedical focus during 
and post treatment 
To raise awareness amongst staff to 
provide psychological and social support by 
signposting patients to appropriate services 
when required 
Effective use of the Holistic Needs 
Assessment (HNA) document as 
promoted by the Cancer Alliance 
Dissemination of study 
findings 
To provide a forum for patients to meet and 
explore some of the themes raised in the 
study and through their individual 
experiences. To explore possibilities that 
the arts could have on patient experience 
and recovery. 
 
 
 
To pursue the opportunity to present the 
findings at the European Cancer Congress 
 
To continue the collaboration between 
the Arts & Music and Health & Social 
Science Faculties instigated at 
through the viva process by arranging 
an event for patients, academic and 
clinical staff at the University of Surrey 
in 2015 
 
 
Submit abstract by April 2015 
 
 
6.8 Implications for further research 
Whilst the aim of this study was to understand the experiences of patients returning home in 
the first three months to a year post SCT a qualitative longitudinal study examining patient’s 
recovery and on-going health and social needs warrants further attention.  Further 
exploration of the uncertainty, coping strategies and information themes from the health care 
professionals and care giver perspective would be of benefit. 
In summary future studies could consider: 
 
 implementation and evaluation of an education programme pre SCT during the 
treatment phase and post SCT to better prepare individual’s for the experience from a 
medical and social perspective  
 a longitudinal study to explore patient experience 1-5 years post SCT 
 exploration of the provision of an advanced practice nurse in the community to support 
transition home following allogeneic SCT and future monitoring of treatment 
complications 
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 the introduction of telemedicine and locally supported follow up to reduce fatigue and  
infection risks to patients when attending follow up appointments a long way from home 
 introduction and evaluation of locally provided exercise programmes  
 an ethnographic study to explore the discourse between patients and health care 
professionals in the in-patient, out-patient and haematology day unit settings 
 
6.9 Recommendations for clinical practice 
Advising and educating health care professionals about how they can most effectively 
address the pressing psychosocial needs of patients and their families whilst also providing 
highly specialised and technical medical care could have a positive impact on their overall 
experience. As suggested by authors of recent research and in accordance with findings in 
the current study, interventions such as an educational programme commencing prior to 
SCT organised in a quality of life framework, that is: physical, psychological and social 
domains including spiritual and survivorship aspects would be of assistance to both patients 
and caregivers. Given the issues relating to fatigue and an excess of medical appointments 
the use of social media such as skype could be employed to access educational sessions in 
real time and enhance patients’ ability to support each other. Early intervention to prepare 
patients for life beyond treatment for cancer is supported by recent policy and aligns with the 
notion of ‘prehabilitation’ (NCSI 2013).  There are also implications for managing both the 
immediate and longer term effects of treatment including support of those with disease 
relapse and consideration of palliative care.  
 
Employment of an advanced level practitioner to support patients in their transition home 
following allogeneic SCT and on-going management of acute and chronic symptoms could 
provide significant reassurance to patients and their families. This degree of surveillance 
alongside the provision of specialist blood testing locally could also reduce the number of 
hospital attendances required for follow up. Administration of intravenous antibiotics at home 
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could be considered in some cases reducing the need for readmission to hospital though 
this may be judged too high a risk for some patients.  
 
Survivors of allogeneic stem cell transplant are likely to have a requirement for supportive 
care for some months or possibly years after treatment as they exist in a state of sustained 
liminality, between illness and wellness, facing complications of an acute and chronic nature.  
Post treatment threat of disease recurrence and the associated uncertainty is a key feature 
of the liminal life (Little 1998).  Nurses and health care professionals can provide support for 
patients by having an understanding of liminality, listening to patient anxieties and providing 
information and symptom control as required. For those who cannot return to their former 
employment or educational pathway there is a requirement for vocational rehabilitation and 
a robust system for welfare advice and guidance. 
 
6.10 Dissemination of findings 
The aim of undertaking the Doctorate Study was to combine considerable experience of 
clinical practice with an academic programme capable of furnishing me with the skills to 
undertake research of a sufficiently high quality to contribute to a growing body of 
knowledge in health care. In the event, since blood cancers and their treatment was not my 
area of expertise this thesis has enabled me to learn an enormous amount in this 
specialised field. A summary of this research has been submitted to a national peer 
reviewed academic nursing journal and has recently been presented at the British 
Sociological Association conference. It will be shared amongst health care professionals 
working in cancer care and more specifically those working in stem cell transplant centres 
through presentation at a European Bone Marrow Transplant conference (as agreed on 
receipt of a travel scholarship to attend the 2011 conference at the start of this research 
journey). Findings will also be shared with patients undergoing SCT, possibly through 
involvement in patient support groups. 
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My aim is to influence others to consider the social implications of ill health as I have been 
influenced through observations in clinical practice and a considerable number of 
inspirational scholars, academics, researchers, sociologists, anthropologists, clinicians and 
patients themselves. 
 
6.11 Summary of chapter 
This chapter has presented a summary of the study findings. Implications for clinical practice 
have been suggested which could have a positive impact on supporting patients transition 
home following treatment for haematological malignancy. The limitations of the study have 
been discussed and recommendations for future research proposed. The original aim of the 
study was to explore the experiences of individuals returning home in the first year post-
allogeneic stem cell transplantation.  The themes which emerged lead to consideration of 
haematological malignancy and its associated treatment side effects as a chronic illness and 
participant needs equivalent to with those who face other long term conditions. 
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8.0 Appendices 
 
Appendix I: Participant Information Sheet 
 
 
 
 
 
 
 
 
 
PARTICIPANTS INFORMATION SHEET 
 
 
Research Study: To explore the patients’ experience of returning home following 
allogeneic stem cell transplantation. 
 
You are invited to take part in a research study relating to your recent experience of 
returning home after treatment. I am a nurse and researcher and this project is part of my 
doctoral, higher degree studies. Please read this sheet before deciding whether or not to 
take part in the study. 
   
What is this research study about? 
 
I am trying to find out about your experience after your return home following your stem cell 
transplant. I am interested to find out how you are managing at home, and what kind of 
support you are getting. 
 
Why have I been invited to take part? 
 
Because you have returned home following a stem cell transplantation within the last three 
months to one year. 
 
Do I have to take part? 
 
No, you do not have to take part. If you agree to take part, you can keep this information 
sheet. We will also ask you to sign a consent form. You can change your mind at any time, 
and you will not be asked for a reason. If you do not wish to take part, or change your mind 
later, it will not affect your treatment or care in any way.  
  
What would I have to do? 
 
If you agree to participate you will be invited to talk to me about your experiences. You will 
be asked to speak about anything you think is important about having a stem cell transplant, 
returning home, any follow up care and support you receive and the challenges you face. 
The interview will last between 45minutes and 1 hour and the conversation will be recorded. 
The researcher will be happy to come to your home, or meet you at your hospital, or 
anywhere else convenient. If you decide to travel, your expenses will be paid.  You may be 
contacted after the interview to check that the researcher has understood what you have 
said and to ask further questions if required. The researcher will ask for your permission to 
obtain clinical details from your medical team and if necessary from your medical record. 
This will provide valuable information regarding your treatment. The researcher will also ask 
your permission to inform your GP that you have agreed to take part in this study. 
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What are the possible benefits of taking part? 
 
It is unlikely that taking part in the study will help you directly, however, some people find 
that talking about their situation can make it easier to deal with. It is hoped that the 
information gained will contribute to research that may help those undergoing stem cell 
transplantation in the future.  I will provide you with a summary of the findings of the 
research study if you would like one. 
 
What are the risks?   
 
It is not anticipated that there will be risks to your well-being by taking part in the research. 
However, if you felt distressed at any time when relating your experiences, the interview 
would be stopped and immediate support offered. It would be your decision as to whether 
you wished to continue. If you felt that you would like to contact your clinical team or be 
referred for professional support, the researcher can arrange this for you with your 
permission. 
 
Will my information remain confidential? 
 
Anything you say will not be linked to your name or personal details. The recording and any 
written material will be stored and destroyed in accordance with the Data Protection Act 
1998. The only exception to this confidentiality would occur if anything came to light which 
was linked with unethical practice. In such a case the researcher would have a duty to 
disclose this information but would discuss this with you. 
 
What if there is a problem? 
 
If you felt there was a problem or have a complaint about any part of the research process 
or the researcher please contact the researcher’s supervisors at Surrey University: 
 
Dr Anne Arber or Dr Ann Gallagher 
Duke of Kent Building 
Surrey University 
Guildford 
Surrey 
 
Dr Anne Arber      Tel: 01483 686768 
Dr Ann Gallagher Tel: 01483 686711 
 
Contact Details 
 
If you would like to discuss any of the information provided here, please feel free to contact 
the researcher, Liz Dunn at Guys & St Thomas’ Hospital on 0207 188 2792 or 0207 188 
7188 and ask for bleep 0813. Alternatively please speak to your Clinical Nurse Specialist or 
Consultant Haematologist. 
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Taking Part in the Research 
 
If you would like to take part in this research, please fill in your details below and give the 
tear-off part of this information sheet to your Clinical Nurse Specialist or Medical Consultant. 
Alternatively, please send directly to Liz Dunn in the pre-addressed and stamped envelope 
provided: 
 
Liz Dunn 
c/o Haemophilia Reference Centre 
1st floor North Wing 
St Thomas’ Hospital 
Westminster Bridge Road 
London 
SE1 7EH 
Liz Dunn, researcher from the University of Surrey will then contact you to answer any 
queries and if you are happy to proceed, arrange a suitable time for the interview to take 
place. 
 
 
 
 
 
 
Name:  ------------------------------------------------------------------------------------- 
 
 
Tel:  ------------------------------------------------------------------------------------- 
 
 
Mobile: -------------------------------------------------------------------------------------- 
 
 
Email:  ------------------------------------------------------------------------------------- 
 
 
Address: ------------------------------------------------------------------------------------- 
 
Please * your preferred method of contact. 
 
 
Signature ------------------------------------------------------------------------------------- 
 
 
Signature of Referring Clinical Specialist Nurse/and Medical Consultant  
 
 
      ------------------------------------------------------------------------------------- 
 
 
The study has been reviewed by the National Research Ethics Service Committee – 
London Queen Square. 
 
 
 
Thank you for taking the time to read this Information Sheet 
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Appendix II: Pen Portraits  
 
Participant 1 
Participant 1 was extremely keen to participate in the study from the outset of meeting him 
with his mother at the post-transplant clinic. He said he felt he had so much to say that he 
wanted to tell me there and then. When I rang a week later, he was making notes in 
preparation. On the day of the interview he was not feeling great – nauseous and on high 
dose steroids due to diarrhoea over the past week. However, he was determined to go 
ahead. The overall sense of his story is that the transplant experience is one of great 
magnitude referring to it as ‘a big thing’, ‘a huge thing’ and one that has had a profound 
effect on his life and also on his work.  
 
The massive step of leaving ‘your cocoon’ and beginning to build up your life again brings 
with it the overwhelming responsibility of suddenly having to ‘take charge’ again when you 
are feeling at your most physically and mentally vulnerable. You are weak, there’s so much 
to be ‘on top’ of and you need your wits about you.  
 
In spite of this however, he feels that his experience has enabled him to share a different 
view of cancer, opening his mind and others through his artistic work and expression.  ‘You 
can’t express your feelings, you need objects’. Positive aspects of his experience include 
age appropriate care, support and respect for his concerns from his mother and the health 
carers, the ability to express feelings through art and an opportunity to pursue a life’s 
ambition. 
 
Aged 22 years. Art school studies interrupted due to Hodgkin’s Lymphoma. 
 
Participant 2  
Participant 2 described her treatment experience for.... as being fairly straightforward and 
wondered if she had enough to say that would be useful to others. She mentions on many 
occasions throughout the interview the extreme tiredness she has felt and that she had 
never expected it to continue for this long. She also mentions several times that advice 
about how far to push herself would be useful and also to have a point of reference, 
including meeting someone else in a similar position.  
 
She concentrated predominantly on the physical aspects of her experience but on gentle 
enquiry does mention how emotionally tough it was to be isolated from her new Grandson at 
the time of her treatment and early recovery. She appears to have a very stoical attitude 
towards her illness and suffering and repeatedly acknowledges the enormous support she 
has received from her husband – in fact that she could not have got through it without him 
particularly in relation to the domestic chores. She also acknowledges the support of her 
friends and wider family and the importance of receiving encouraging words from the 
consultant. 
 
Aged 67 years, married and retired. 
 
Participant 3 
The main feature of Participant 3’s narrative was her motivation and determination to make 
the best of her experiences, resume her previous life with some adjustments and take on 
new pursuits  i.e. fund raising to ‘give something back’ marking her thirtieth year - one which 
at diagnosis she was not guaranteed to survive. She describes her diagnosis and treatment 
as fairly straightforward though there were potentially devastating consequences during this 
journey, for example the speed of treatment required and subsequent effect on reproduction, 
an extreme reaction to a trial drug and on-going infection risks. As a teacher, she spent time 
in hospital preparing lessons in an effort to retain some normality in her life.  
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She describes positive aspects regarding relationships – wonderful support from her 
parents, a new partner who ‘stuck with it’ and a friend who ‘came back’ after a major fall out. 
At the time of the interview she was approaching the anniversary of her stem cell transplant. 
She had returned to work quickly and successfully, maintaining a reduced timetable but 
engaging in extra-curricular activities such as the school play, sporting activities, applying for 
promotion and similarly resuming personal exercise and travel pursuits.  
 
She described full confidence in her medical teams both locally and at the specialist centre 
and had full confidence in their knowledge whoever she asked for information. Throughout 
her narrative, this participant displayed incredible strength and resolve which she attributes 
to her inherent optimism: 
‘I’ve always looked at the positives to anything. I always think well, what’s the worst case 
scenario, can I deal with it, yes ok and let’s get on with it.’ 
 
Aged 29 years teacher – had returned to work. 
 
Participant 4 
Participant 4 described her experience of returning home as a little extreme since her 
situation was complicated by her mother suffering from dementia and her son from a long-
standing depressive illness. Both members of her family depended on her a great deal so 
she was extremely anxious about them whilst in hospital. She describes the hospital as 
providing a safe cocoon from the outside world which was both a relief and frustrating since 
she was not able to care for them. She had arranged respite care for her mother though due 
to her own uncertain prognosis she was advised to consider this as a permanent 
arrangement. 
 
She describes a strengthened relationship between herself and her sister developed as a 
result of her being the donor of her stem cells. Unfortunately her sister’s husband was 
diagnosed with cancer and her niece’s husband died suddenly preventing further support on 
her return home.  
Participant 4 states how grateful she is for the treatment she has received and appears to be 
reconciling herself to living with a degree of uncertainty regarding her future. She has been 
told that if the disease relapses, there are no further treatment options available to her. 
 
Her prevailing worry is for her son as she feels unable to provide security and psychological 
support for him since due to the uncertainty of her treatment outcome it was necessary to 
take early ill-health retirement. She is struggling financially and the future of her home is at 
risk due to her inability to meet mortgage payments. 
 
She comments on the care she has received and the encouragement she receives from her 
consultant. She does however mention how beneficial it would be to share experiences with 
others but has not been able to source a relevant support group or to receive psychological 
assistance from MacMillan. 
 
Participant 5  
Participant 5’s mother was present at this interview and at certain points the narrative is 
largely dominated by her. This did not appear to be a problem for her and when she wanted 
to make a point or to disagree, she did so and made her point very clearly. Participant 5 was 
a pastry chef and her apprenticeship in patisserie and confectionery was brought to an 
abrupt halt when she was diagnosed with aplastic anaemia. Suffering numerous episodes of 
critical illness she remained in hospital for many weeks waiting for her condition to be stable 
enough to receive chemotherapy conditioning prior to transplant. She felt cheated of an ever 
diminishing opportunity to return home for a brief period prior to the transplant itself.  
She relates her observations of good and bad care practice throughout her hospital stays 
highlighting the positive effect of genuine caring received. Her debilitating illness results in 
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her being dependent on a wheelchair for outings and she comments on the poor attitudes 
and stigma displayed by certain people in relation to her disability. Both she and her mother 
have a heightened awareness of the benefit of bone marrow donation and are campaigning 
for more Afro-Caribbean donors.  
 
Aged 23 years, single, pastry chef 
 
Participant 6  
Participant 6 describes his journey as relatively straightforward though does refer to various 
ups and downs and a non-linear disease and treatment experience. He states his reluctance 
to receive too much information whilst acknowledging that he and his wife have ‘Venus and 
Mars’ attitudes toward discussing the implications of his illness.  
He seemed a little uncomfortable to talk about his feelings but when asked what he would 
tell others about the experience he described his emotional response of ‘shutting down’ and 
assuming a vegetative state as the intensity of his chemotherapy and radiotherapy 
treatments progressed.  
He states that his wife would have appreciated him being prepared to discuss his feelings 
more openly and admits that this may have been beneficial for him too. At the end of the 
interview he mentions the difficulty of knowing how much information to share with his 
children opting for honesty and a focus on positive aspects. 
After the interview, he said he attended an exercise programme run by physiotherapists in 
the gym where strengthening exercises were performed. This was run 6 weekly and he 
mentioned that the attendance did not seem to match the number of patients undergoing 
transplant. 
 
Aged 63 years married and retired. 
 
Participant 7 
Hope and a positive attitude were the prevailing themes of this interview. Participant 7 felt 
that keeping busy, having knowledge and feeling in control were his ways of coping. He had 
prepared for his hospital stay by taking model kits which he made and gave to staff for their 
children. 
He played down the critical points throughout his journey including his life-threatening chest 
infection, a hernia operation and an episode of shingles. He did admit to feeling anxious 
when in the Intensive Care Unit as he did not remember going there and did not understand 
where he was and why.  He also mentions on-going visual problems related to the shingles 
that sometimes cause him to feel down and as if there is no end to the complications. 
He maintains that being positive and keeping occupied have a positive effect on recovery 
and this is enhanced by the encouragement and expertise of the medical team. 
Aged 68 years married with two daughters and retired. 
 
Participant 8 
Participant 8 was interviewed with her husband present. She repeatedly acknowledges her 
gratitude for the treatment she has received. Despite a difficult time including critical 
episodes threatening her survival during her treatment she remains largely positive. She 
states how ill she was on her return home and that she remained upstairs for some while, 
unable to manage the stairs. She is indebted to her husband and admits that she could not 
have coped without his help. 
 
She had experienced a critical point during her treatment when she bled into her lungs and 
this necessitated Intensive Care. She states that her husband was warned on several 
occasions that she may not pull through.  
 
Her husband reports a change in her temperament where she displays an uncharacteristic 
impatience and irritability in certain situations. Participant 8 jokes that she blames this on the 
223 
 
character of her donor but admits that in reality, it is a response to her stress. Despite being 
told to be extremely careful about picking up an infection, the out-patients waiting area is 
cramped and she feels surrounded by people coughing and sneezing.  
 
Her major concerns are for her family and loved ones whose lives are affected by her illness 
and her husband feels that he can never relax for fear of disease relapse or another 
complication. He is aware of how life threatening infection can be and is constantly on his 
guard and ready to react as appropriate. 
 
Aged 63 years, married and retired. 
 
Participant 9 
Participant 9 described her fortune of surviving leukaemia against all the odds. She had 
been told that there were no further treatment options following the final chemotherapy and 
stem cell transplant. She acknowledges difficulties arising within the relationship with her 
son. This is a recurrent theme within her narrative along with the loss of her husband and 
the challenge of coping alone on her return home. She alludes to arduous journeys to and 
from the hospital post-transplant and feels that this contributed to her contracting pneumonia 
and being re-admitted to hospital. 
 A strong sense of identity is portrayed in the narrative where independence, bravery and a 
fighting spirit are depicted whilst also acknowledging her difficulties and worries in relation to 
her disease and her adult children.  She tells a number of stories within the main story which 
gives voice to her life as a whole including past, present and future possibilities. 
 
Participant 10 
Having felt well up to 100 days after his treatment this gentleman had reached a particularly 
low point during his post-transplant experience. He was showing signs of stem cell rejection 
and was facing numerous complications including severe weight loss recurrent infections 
requiring hospitalisation, fatigue and debilitation. He admitted to having a terrible week 
exacerbated by poor planning by the hospitals whereby an investigation was delayed twice 
due to lack of platelets which he required in order to undergo it. His physical state was so 
severe that his wife had obtained a wheelchair for him. Despite feeling poorly, he insisted 
that he was still willing to take part. 
He did not make eye contact a great deal during the interview and is visibly upset when 
talking about the effect his illness has on his wife. He notes the physical, psychological and 
social impact his illness has had on both of them highlighting simple pleasures such as 
going out for a meal that have had to be abandoned due to his inability to eat without 
retching.  
 
He talked about the financial burden caused through his illness. His wife had increased the 
days she worked to accommodate an early finish in order to come home and care for him 
and he said they received no benefits due to her working. The Masonic group had helped 
with transport which reduced the financial burden incurred attending appointments at his 
local hospital and the specialist treatment centre. 
 
Towards the end of the interview he reflects on his illness experience and his current 
position. He is able to put the recent challenges into a perspective whereby he finds strength 
to carry on: 
‘when you’ve gone as far as I’ve gone, there is no going back, so therefore I’ll keep going.’ 
 
Aged 62 years, married, employed part time but not currently working. 
 
Participant 11 
Participant 11 explained that since being diagnosed in 2008, he was aware that due to the 
nature of his disease he would eventually become blood transfusion dependent. He knew 
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that at this point a stem cell transplant would be performed and acknowledges that this had 
been his major focus without looking beyond it. He states that he though he may have been 
told about what it entailed, he had not prepared himself for the arduous journey to come. He 
developed GVHD and became very ill two weeks following the transplant suffering skin and 
hair loss, an inability to eat, infection and difficulty sleeping. Once these symptoms were 
under control, his return home was delayed by an infection, the source of which was difficult 
to identify.   
 
At home, his weight continued to drop and he felt extremely debilitated, sleeping sixteen to 
seventeen hours a day.  
 
‘It’s when you leave hospital and return home, that the personal work has to start, and I had 
to go through a period of sort of wallowing in it and feeling very, very down and very, very 
tired and erm, you know, a bit of a ghost until.. I, I, I don’t know exactly what it was but I had 
some kind of internal re-set happened.’ 
 
He reports reaching a point where he started to feel frustrated with his on-going fatigue and 
seemed to make a conscious effort to overcome it. Once he was feeling slightly stronger he 
started to make progress with resuming his role of ‘house husband’ which he had adopted 
following his diagnosis. He reported having no financial worries due to retirement on medical 
grounds and his wife being the major wage earner. He stated that he had time to re-evaluate 
the important things in life and was pleased to be out of the rat race and able to consider 
more interesting job prospects closer to home. 
His ambition is to continue to recover physically in order to contribute fully to managing the 
home and also to resume his activities in the gym. He had endeavoured to keep as fit as 
possible throughout his illness and especially pre-transplant and stated that he would return 
with realistic expectations for his future fitness.  
 
Whilst in hospital he set up a blog offering practical advice as to how to cope with various 
aspects of the treatment which had proved extremely popular. 
 
Aged 50 years, married with one son, employed but not currently working.  
 
Participant 12 
Participant 12 explained that when he was initially diagnosed with an aggressive form of T 
cell Lymphoma, he was forced to face his own mortality. The serious nature of his disease 
was compounded with numerous life-threatening complications including involvement of his 
central nervous system and a perforated bowel. However, having survived this he felt that 
this experience served as training, preparing him to cope with what was to come. 
 
In hospital he appeared to prepare his entertainment and be relatively self-sufficient, 
particularly following his previous experience within an isolation facility.  
 
On returning home he relished the change of environment and independence, choosing 
when and what to eat and commencing the slow journey of recovery. His goals were to 
spend time doing ‘normal’ things like playing with his children and mowing the lawn.   
 
He felt that providing care for his father, recently diagnosed with prostate cancer had offered 
a different focus and it felt good to be able to share his own knowledge and lend practical 
support. 
 
Aged 28/38, married with two young children and employed as an accountant but not 
currently working. 
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Participant 14 
Participant 14 was interviewed with his wife present and she provided some insight which 
was helpful in portraying the impact of the chemotherapy and stem cell transplant on her 
husband. He feels she will remember things to say where he may forget. 
 
He begins by relating events leading up to his transplant and felt ‘in quite a state’ after the 
chemotherapy. He lost a lot of weight and found taking the medications difficult. He was 
extremely grateful that a doctor listened to him when he managed to elicit the tablet 
responsible for his vomiting. 
 
His wife explained that when he felt unwell after his return home, he had a tendency to panic 
and to feel very unsafe.  She felt that it was usually for a good reason and they telephoned 
for advice on numerous occasions. She also commented on the fact that he was depressed 
and reluctant for his friends to see him looking very underweight and ill. He describes his 
emotional state as frustrated rather than depressed and whereas his wife feels he has 
changed, he feels that he has just changed his outlook as a result of his experience.  
 
He makes reference to the fact that he cannot remember being told what the treatment 
would be like though his wife points out that they received a full explanation and felt that he 
focussed on the transplant as a cure and therefore ignored the warnings: ‘our son was with 
us as well and he’d got this huge list of questions and he (the doctor) was so patient and he 
answered every one of them and he told you it was going to be no walk in the park.’ 
 
Participant 14 returned to work part time with his brother and nephew working alongside him 
ensuring he did not overdo things. Both he and his wife alluded to the financial burden and 
stated that their hospital insurance policy was halved due to his being over sixty-five. He 
jokes that his wife will allow him to ‘down tools’ when he’s ninety-five.  He mentions several 
times that he feels he is over the worst of it now. 
 
Aged 67 years, married with three adult children, working part time as a plumber with his 
brother and nephew. 
 
Participant 15 
The interview with participant 15 was conducted in a public area in his business property. 
His wife worked there too and arrived back from taking the children to nursery. She carried 
on with her work and joined in later to comment on the difficulties they faced regarding 
finances and benefits and particularly the lack of information available. 
 
He described his experience of being in isolation as feeling like a ‘caged animal’ particularly 
when feeling mentally and physically reasonable and he kept a calendar to cross off the 
days. He referred to receiving information about the treatment effects and actually 
experiencing it as being like reading a textbook compared to going on a field trip. He felt 
unprepared for the reality of the post-transplant journey and stated that he often felt more ill 
at home than he had done in hospital.   
 
A critical time for him was when his disease spread to his optic nerve whilst receiving 
chemotherapy. This was extremely rare and the prospect of losing his sight on top of all the 
existing challenges was too much to bear.  
 
After the recorder was switched off he said the following. Everyone is focussed on 
depression and feeling sorry for you because you have cancer. They offer you counselling, 
massage and diversion therapy but what you really need is advice re benefits and financial 
aid in the very first part while you are adjusting to months of treatment. His wife said that 
there were weekly support groups for spouses but these ran when clinics took place and she 
wanted to be with her husband to hear what was being said by the doctor. 
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The financial difficulties experienced were a major theme for this couple. Newly married 
when the disease struck with two young children to support plus a new business of their own 
to run caused enormous anxiety and both were disappointed in the information available to 
help them. Without financial help from their parents and friends who raised money for them 
they feel they would have lost their home and business. As a result of this he had set up a 
charity to help others in a similar situation. 
 
Aged 33 years, married with two young children, self-employed as an estate agent. 
 
Participant 16 
Participant 16 stated that he was very willing to participate in the research study as he 
wanted to give something back, also reinforced by his wife. She said she did not mind being 
in or out of the room but her husband said she may remember something he did not and in a 
similar way to other spouses she added certain details, particularly about him being down 
and not wanting to know or discuss details of the illness or treatments. 
 
He relates how severely the conditioning chemotherapy affected him prior to the transplant 
including infection which almost put him into Intensive Care. Regarding his return home, he 
repeats several times how vulnerable he felt out of the relatively safe environment of the 
hospital. His wife agrees stating how terrified he was of doing anything that may necessitate 
returning to hospital. She actively encouraged him to get out a bit more and their love of the 
countryside meant this was an activity that they could do whilst avoiding crowded places as 
advised by the medical staff. 
His wife referred to the strain she felt visiting and making long journeys to the hospital. She 
stated that she was exasperated that her husband did not want to receive detailed 
information about his treatments and the possible effects, nor discuss this with herself and 
her daughter.  Whilst they craved information, his rationale for not wanting it was that he was 
afraid he would dwell on it and therefore not cope as well.  
 
He did get tearful when talking about the worst times which he stated were birthdays and 
significant anniversaries or festivals such as Christmas.  His wife stated how important their 
Grandchildren were to them and that she reminded him often of how he must get better for 
their sakes. He acknowledged how small gestures made a big difference such as the nurses 
bringing him a Birthday cake when he had been devastated at the news of not being able to 
go home as planned.  
At the time of the interview he felt that he had made good progress and although he may 
never resume his former state of fitness, he could manage most things as long as he rested 
adequately. Prior to his illness both he and his wife were going to retire, sell the house and 
go touring so their plans had to be abandoned. He was in a demanding job and despite an 
offer to return part time, he decided to retire which his wife feels has helped to reduce his 
work related stress and improve the quality of both their lives. 
 
Aged 62 years, married with two adult children, retired as a result of illness. 
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Appendix III 
 
Interview Topic Guide 
 
Opening question: Can you tell me about your experience of being treated with  
allogeneic stem cell transplant for x (blood disorder if known)  
and what it's been like trying to resume a normal life at home? 
Probing questions: What has gone well? 
 What has gone not so well? 
 Why do you think that is? 
 Have you had any help from family, friends or others? 
 What has had the biggest impact on you being able to get through  
this experience? 
 
 Is there anything you would have appreciated to help you get by?  
In hospital? At home? 
 
 How do you cope as a person? 
 What is the most important thing to you now? 
 How are you feeling? 
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Appendix IV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dear Doctor 
 
Re patient:  
 
I am currently carrying out a study to investigate patient’s experiences within the first year of 
returning home following stem cell transplantation for haematological malignancy. This will 
involve interviewing patients treated at Hospital A, and Hospital B. The study forms part of a 
Doctorate of Clinical Practice which I am undertaking at the University of Surrey and has 
been approved by the National Research Ethics Committee and the relevant Research and 
Development committees. 
 
I have provided the patient named above with an information sheet and they have 
consented to participate and for me to contact you regarding the study. If you have any 
concerns about this individual participating, or questions in relation to the study I would be 
grateful if you would contact me by telephone or letter by … 
 
Liz Dunn, Matron Haemostasis & Thrombosis 
Haemophilia Reference Centre 
1st floor North Wing 
St Thomas’ Hospital 
Westminster Bridge Road 
London 
SE1 7EH 
 
Yours Sincerely 
 
 
 
 
 
Liz Dunn 
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Appendix V 
CONSENT FORM FOR INTERVIEWS WITH PATIENTS 
 
Project title:   Patient’s experience of returning home following   
                                               allogeneic stem cell transplantation 
Names of researchers: Liz Dunn (Guys and St Thomas’ Hospital), Dr Anne Arber 
and Dr Ann Gallagher, University of Surrey 
Name of local Principal        Liz Dunn 
Investigator:  
    
Description of research project:  
 
1. Participants are being asked to take part in an interview which will last between 
45 minutes and one hour. This interview will be recorded and transcribed.   
2. The transcriptions of the interview will be coded and kept at the work place or 
home of Liz Dunn where only she will have access to them. They will be stored 
and destroyed in accordance with the Data Protection Act 1998. 
3. Only the Research team on this project will have access to this material. 
 
I have been given information about the research project and the way in which my 
contribution to the project will be used. 
 
Please tick the boxes below. 
 
  I confirm that I have read Information Sheet for the above study, I have had the 
opportunity to consider the information, ask questions, and have had these 
answered satisfactorily.   
 
  I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my employment or legal 
rights being affected.  
 
  I understand that the information I provide during my interview will be looked at by 
responsible individuals within the Research team named at the top of this form. I 
give permission for these persons to have access to the information I have given 
today.   
 
  I give permission for the researcher to speak to my medical team about my clinical 
condition and treatment and if necessary to access my clinical record.  
 
  I give my permission for my GP to be informed that I am taking part in the study. 
 
  I agree to take part in the above study 
 
  I give my permission for the information I am about to give/have given to be used 
anonymously for research purposes only (including research publications and 
reports)  
 
I hereby assign the copyright in my contribution to the researchers for research 
purposes only. 
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Signed Participant  
 
_____________________________________Date_______________ 
 
 
Signed Researcher 
_____________________________________Date_______________ 
 
 
 
This information will be retained separately and securely from the information 
given during the process of the research. 
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Appendix VI 
Sample of participant interview transcript line by line analysis 
Narrative processes, Participant 12, 18.06.2013 
 Initial interpretations
I  Right, er, P12, I’ve just switched the tape on now and thanks so much 
for being part of the research, (ok) I really appreciate it, particularly you 
just seeing a flyer and ringing me, it was really good of you.  Erm, so what 
I’m really interested today is to hear about your experiences of returning 
home after your stem cell transplant (mm mm) anything that you think’s 
important.  I just want to check you’ve had the information sheet so you’ve 
read through that (yep), you know that you can withdraw from the study 
any time (I do) without giving a reason (yep) and that’s absolutely fine, 
erm, I asked you if I can contact you afterwards if there’s anything that’s 
not clear (yep, that’s fine) or just to give you a summary as I understand it 
and erm, you’ve also signed the consent form today 
 
Clarification of the research 
question. 
P12  Yep, all fine yea. 
 
I  Ok (that’s fine) so over to you. 
 
 
P12  Over to me, ok, so er, yes, I had a er, stem cell transplant from my 
brother on the 15th March, erm, because I’ve got peripheral T cell 
lymphoma and there was a suspected CNS involvement ‘cos I’d had a 
seizure on New Year’s Day, erm, a one off, (mmm) then erm I had pretty 
strong conditioning beforehand so I had cranial radiotherapy, I had er TBI 
and I also had erm one er high dose of atoposide as well, chemo, as well 
as all the usual Chem Path and stuff like that. 
Orientation: temporal in 
terms of diagnosis and 
transplant date followed by 
treatment regime for 
lymphoma. Intensive due to 
CNS involvement. 
Demonstrates good 
understanding. 
 
So, I think alot of my experiences after I’ve left hospital have actually been 
informed by the degree of conditioning I had.  Initially I was planned to 
come in for a transplant and it would have been maybe a chemo course or 
a lighter radiotherapy course beforehand but because I had the TBI, I think 
that’s impacted alot on how I’ve felt since.  Erm, so essentially er, getting 
out was good.  After a few weeks in hospital it’s nice to get out. 
 
The conditioning was strong 
including cranial 
radiotherapy and TBI due to 
severity of the disease. Good 
to get out of hospital. 
 
I’d kept myself in isolation.  I told my wife not to come in, I’ve got two little 
kids so I deliberately kept myself in isolation here, because I knew it was a 
sort of one off and there was no point having a cold or anything, it was 
only going to be dreadful and previously I’d been hospitalised for like 
seven weeks in Brighton, so five weeks was doable, you know, I could do 
it in my head so it was fine (yea). 
He comments on the fact 
that it was good to be out of 
hospital after a few weeks. 
His description of the 
hospital stay suggests that 
he had planned quite 
meticulously and had 
prepared himself mentally to 
cope. He knew the infection 
risk and therefore decided it 
was best to isolate himself 
from his 2 small children to 
protect himself. He suggests 
that previous experience 
involving a 7 week stay 
made him know it was 
‘doable’. 
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(Intake of breath), er, when I got home, erm, I guess the first thing is just 
relief to be at home, not to be eating meals at half past five which they 
make you do here, you feel like you’re being fattened up for Christmas in 
the middle of the day and then they leave you from half five until half eight 
the next day you know,(I laughs) so it’s er, it can be a bit frustrating there, 
so, erm, got home and felt good to be out ‘cos I was out, you know, I could 
see the kids, see the wife, just in comfortable surroundings. I can make 
myself a cup of tea when I wanted to and things like, just those little things 
that’s what counts, just being able to walk upstairs or downstairs or 
whatever you know (yea) or sit on the sofa, just a change of scenery, that 
was vital,  
Independence, choice and 
control over what and when 
to do things e.g. mealtimes. 
Also environment was 
important. Relief to be home. 
Re-establish family life and 
relationships.  
Themes: Independence, 
choice, control, family 
relationships and 
environmental factors. 
erm, but pretty soon, I can’t remember exactly when but I did feel very 
tired and I guess for the majority of the three months post-transplant 
fatigue has been what er, characterised my experience (mm) if you like, 
and I’ve heard that everyone, everyone that I’ve spoken to who has had 
various forms of cancer always go, oh yea, you’ll be tired and I was yea, 
ok, but I, I actually wasn’t quite prepared for the degree of tiredness. 
He says that fatigue has 
characterised his experience 
during the first 3 months 
post-transplant. Speaks of 
his unpreparedness for the 
level and duration of 
tiredness despite expecting it 
e.g. needed to sleep after a 
jigsaw. 
Theme: extent and duration 
of post-transplant physical 
effects.  
 
I did a jigsaw the other week and I had to go for a sleep afterwards you 
know, (ahh) that’s the kind of level of tiredness we’re talking about (yea), 
erm and that’s taken quite a long time to er, to shift and I wouldn’t say it’s 
shifted yet but the last couple of weeks, yea, I wouldn’t say I feel as 
though I’ve turned a corner but maybe the corner’s appeared on my 
satnav and I can sort of, (I laughs) anticipating it coming up ahead, you 
know.  Definitely the past couple of weeks have felt different to the 
previous er, three months. 
The last 2 weeks have been 
different from the previous 3 
months ‘the corner’s 
appeared on my satnav’ 
says it with caution. Again, 
the recovery journey is an 
unknown quantity. 
Theme: uncertainty. This 
could be due to the number 
of setbacks or side effects 
which characterise the 
recovery period resulting in 
an uncertain course of 
rehabilitation. 
 
Erm, the other thing that’s characterised it beyond the fatigue, and 
probably that’s been more frustrating for me because actually during the 
day the kids are at nursery or my wife might be at work, so actually I’ve 
got time to sleep and do whatever but erm, er is changes in my mouth.  
Again another thing lots of people had warned me about but I actually 
never fully appreciated er how bad it would be, I had a degree of mucositis 
when I was in hospital but it actually didn’t last very long, it only lasted for 
a couple of days I was NG fed and stuff like that but it wasn’t, it was 
nowhere near as bad as I was expecting.  However, since coming out, 
then I’ve ended up with eer, er, sweet things were hypersweet, so my tea 
which had like half a sugar in was just like ugh, strawberries even now still 
taste alot sweeter (oh gosh) than they did.  I’m a massive fan of snacks, 
chocolates, crisps biscuits and they were all off the agenda.  Chocolate 
just tasted and still generally does taste pretty bad, erm, biscuits, well 
usually they’ve got chocolate in so they taste bad because of that but also 
anything starchy, so biscuits, pasta erm, like monster munch corn snacks, 
anything like that, erm, just would absorb all the moisture in my mouth and 
become really, really hard to eat (oh right) and like bread as well, anything 
that was like carbohydrate based is just very, very difficult.  So erm, and 
Oral changes have been 
more frustrating than 
tiredness. The taste is 
exaggerated and textures 
difficult due to a dry mouth. 
He feels mentally willing to 
eat anything that will help re-
gain severe weight loss but 
finds it difficult. His 
expectations re eating were 
that it would be bad initially. 
However, it was cope-able 
with in hospital even though 
he had to have NG feeding, 
it is more the longer term 
effects. 
Theme: late effects, enduring 
effects. 
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still now I, I do still find that, er I’m just starting to get back and everyone’s 
saying to me ‘cos I lost alot of weight, I lost, I’m two and a half stone 
lighter than I want to be, than I was before the disease, although pre-
transplant I wasn’t at that weight but erm, you know, everyone’s imploring 
me to eat rubbish and I really want to eat rubbish and generally speaking 
I’m pretty good at eating rubbish (I laughs) but I er, it’s been a struggle. 
 
I  Just not the same? 
 
 
P12 Mm, there’s a funny taste in my mouth, my tongue is er coated, you 
know I, they were talking about whether or not it was like a thrushy type of 
thing.  I mean I’ve been er taking itraconazole, fluconazole, nystatin, you 
know, it doesn’t , nothing’s shifting it really, but again and I’m sure this is 
allied to the fact that I don’t feel so fatigued in the last couple of weeks it 
has been easier for me to even force things down.  Like before everyone 
was saying just force it down you, just get it down you, you know, it’s like I 
really want to don’t think I’m not hungry ‘cos I’m absolutely starving, I 
physically can’t manage this, you know, chewing, I’d chew a piece of meat 
for like you know a hundred times before it goes down, you know, just, it’s 
that kind of thing but more recently I have actually been able to just force 
things down, I was, I’ve always been very conscious of the importance of 
nutrition in all of this, in the whole health (mm) part anyway and 
particularly in this recovery but, and I’ve always tried to keep to eating 
three meals but it might have been that in the early days I would be eating 
at dinner time, it would be like rice crispies and a yoghurt, just because, 
you know, the yoghurt’s soft, smooth, easy to eat , rice crispies are light, 
they come with milk so it’s very moist, you know, I’d have to rely on those 
things that are giving me, you know, very low nutritional content, or 
certainly a low fat content (mm) erm, but it was just to keep it ticking over 
but I really, you know I’d loved to have just sat there and eaten a fillet 
steak or something but it just wasn’t, it wasn’t going to happen.
Describes feeling of hunger 
and awareness of 
importance of good nutrition 
but physically difficult. Foods 
with lower nutritional value 
easier to eat and at least 
maintained the ‘routine’ of 
eating three meals a day e.g. 
‘keep it ticking over”. 
Soooo, yea, that’s kinda been the d ... and I think that’s probably been the 
difficult bit I’ve never felt er, downbeat or depressed or anything like that in 
terms of my experience with it , erm, I feel quite lucky ‘cos you know, on 
the 1st January the doctors in Brighton essentially said game over, you 
know, you’ve, you’ve had this seizure so if it’s in your spine or central 
nervous system you’re, it’s, nothing’s going to happen, we won’t be doing 
the transplant. 
Has been forced to face his 
own mortality particularly due 
to CNS involvement and 
therefore feels grateful to 
have received treatment. He 
thinks this is why he has not 
felt downbeat or depressed. 
Theme: facing own mortality 
and therefore feeling grateful 
for any hope re treatment 
options. 
 
Managed to get them to give me some methatrexate and that seemed to 
get me into a decent enough position to attempt a transplant, so I, you 
know, I’ve actually felt very lucky to be … there’s been plenty of times 
when I’ve wondered if I’ll see the end of the football season you know, that 
kind of thing erm, you know and we’ve had to do all the usual you know, 
making wills and all those kind of bits that you try and, not to think about 
(mmm mm) so post transplant I feel very lucky to have had the transplant 
and to be in the position I’m in so I’ve never felt down. 
It sounds as if he negotiated 
his treatment, persuading 
doctors to treat him and was 
listened to.  
He has considered his 
survival/mortality in a 
temporal context e.g. in 
relation to the football 
season and also in practical 
terms such as making a will, 
despite this being a difficult 
concept to face.  
Phenomenon: control and 
ability to plan for possible 
outcome. 
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but the only thing, the thing that has made me least happy has been just, 
you know, not being able to eat, if you like, eat what I want, when I want, 
(mm) er, and, and because also with erm, er, previous chemo cycles that 
I’d had in Brighton would be ok once you’ve had it once you get used to 
the routine, so I’d be in for a few days, I’ll probably feel alright while I’m 
actually having the chemo when I come out I feel alright for a week, I feel 
rubbish for a week when I go into neutropoenia and then I’ll be fine again 
a week later and then we’ll go through the cycle again so you know what’s 
happening but I think with this, it’s, it’s interminable, there’s no obvious er, 
point at which dips are going to be, you’re going to come out of dips 
 
Reiterates eating problem.  
He highlights the benefit of 
being able to anticipate the 
ups and downs e.g. with 
chemotherapy at initial 
diagnosis. At least you know 
how you’ll feel. 
Themes: Choice, 
independence and ability. 
I  Yea, you think good I’ve only got to get till June or July.
 
 
P12  Exactly, if somebody could say it’s going to be rubbish but on June 
the 6th you’ll start feeling better (you can eat a Mars bar) and on July the 
2nd yea, exactly, exactly, you can do it and you speak to the doctors and 
they’re, I couldn’t expect, I want them to be but I can’t expect any more of 
them, they’re very vague, you know, I mean everyone’s different, er, you 
know, and they’re treating people over a huge range of physicalities, age 
range, you know gender (mm) , ethnicity, so all these different factors that 
apply, underlying histories, erm, er, you know so yea, it could be six 
months, it could be you know, no one can ever say, they all go yea that’s 
terrible but it doesn’t help actual with the practical day to day dealing with 
it and so probably after two months or something you just start thinking, is 
this gonna end.  I mean I know, I know in the back of my head I know it is 
going to end and I know I will be able to eat these things and they will give 
me the pleasure that they used to, do you know what I mean and I will be 
able to mow the lawn or take the kids out or whatever you know, or go 
swimming with the kids all those kind of things but, you just can’t see 
when that’s going to be and no one can help you when you come into 
clinic for five minutes no one can help you see when those flags are when 
they, (yea) when they’re likely to be so, is that waffling enough for you 
would you say? 
Appreciates the difficulty of 
being specific about degree 
and duration of symptoms 
but feels it would be easier to 
cope with if you knew.  
Demonstrates this by 
comparing the uncertainty of 
resuming normal eating 
habits with the 
chemotherapy where at least 
you have an expectation and 
lived experience of what will 
happen. 
Theme coping with 
uncertainty in relation to 
recovery/eating. You never 
know when a ‘dip’ will occur.  
This sounds more general 
than just eating, though 
eating is a major issue for 
him. 
Acknowledgement that it is 
difficult for doctors to predict 
recovery points on an 
individual basis but that a 
timescale would help.  If you 
know how long something 
will last it’s easier to deal 
with.  Theme: severity and 
duration; uncertainty. 
A “road map” of physical 
recovery would help e.g. 
resuming normal activities 
such as mowing the lawn 
and taking the kids out. 
No-one can ”help you see 
when those flags are”.  5 
mins in an appointment v 
dealing with the 
practicalities.  Still, despite 
the difficulties he maintains 
hope and tells himself there 
will be improvement ”I know 
in the back of my head I 
know it is going to end”. 
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I  That’s, that’s great.  I wanted to ask you a bit more about, when you 
said, so that was fine I knew it was going to x number of weeks in hospital 
and you got yourself (yep) mentally satnaved to (yea, yea) get through it, 
how have you gained, ... how have you got that attitude, do you think it’s 
something that you’ve approached that way anyway whatever comes or … 
sounds like a very brave…? 
 
 
P12  I dunno, I think (attitude) a little bit of it, yea (sounds contemplative), I 
suppose I’m a bit of, not really an island, I don’t want to sound like some 
sort of emotional retard (slight laugh) or something but you know, I 
suppose I can be quite content within myself so long as I’ve got enough 
DVD box sets (mm) you know, essentially erm, so that doesn’t bother me.  
As I said I felt quite, I probably had more of a positive attitude because I 
felt lucky to be having the transplant and I could, as I sort of mentioned 
about the eating thing, if someone could say to me listen, you’re going to 
feel rubbish for five weeks but then it’s alright, I can cope with that (yes) 
and probably because I’d been in, as I say, Brighton for seven weeks at 
the start, then I knew that however long I was in here was for less time 
than that, so it was doable, I know that I’d done worse do you know what I 
mean, it was almost like training. 
He feels that being content 
with his own company and 
ability to entertain himself 
coupled with a positive 
attitude at being treated at all 
in the face of a life 
threatening illness. He 
restates how much easier 
things are when you know 
what you need to cope with 
and for how long.  He feels 
his previous hospital stay at 
diagnosis was ‘training’ and 
he was therefore able to plan 
and control. 
Theme: prior knowledge/ 
experience. 
I  But that had been unrelated? 
 
 
P12  No, no, no, that was when I was initially diagnosed and was going 
through my first series of CHOP chemotherapy (ah ok) but what happened 
is, I ended up with a couple of, so there was a whole period where there 
was the diagnosis ‘cos it takes a while, er, and then there was er, further 
complications in so far as erm, the very first dose of CHOP, erm, 
perforated my bowel, I think, ‘cos I’d had previously I’d had ulcerative 
colitis in the past and I think there was a weakened part of the bowel 
where the er, nodule had detached itself and then when they gave me the 
steroids and it had shrunk it, it just tore basically and so then I ended up 
having bowel taken out as well and that again was like one of these ones 
whereby I had raging lymphoma and they were doing like a fairly major 
operation erm, and you know within a couple of days of doing, and when it 
happened I was neutropoenic so they had to wait and when, once they’d 
done it then the er, the lymphoma came back very quickly so there was 
this battle about so well we want to give him treatment, we want to give 
him steroids and steroids plus healing bowel is not a good combination. 
Had faced life threatening 
disease in view of 
aggressive lymphoma plus 
the severe complication of a 
perforated bowel.  It was 
therefore necessary to weigh 
up the priorities of treatment. 
(no) basically, so I’d been through alot of rubbish before and again it was 
like well you know, ok so we’ve got through that then five week isn’t (iron 
man) is kinda well it’s, it’s a bit like training for a hundred metres by doing 
two hundred metres all the time or something you know, er , I dunno, you, 
you kind of over train and so I just feel as though we’d just sort of gone 
through enough then that it was, it was doable 
Repeats that this was easier 
due to previous experience 
and helped him to cope 
particularly as it had been so 
serious: “it’s a bit like training 
for a hundred metres by 
doing two hundred metres all 
the time or something you 
know, er, I dunno, you, you 
kind of over train and so I 
just feel as though we’d just 
sort of gone through enough 
then that it was, it was 
doable”.  
Theme: previous experience 
of severe illness.  Mental and 
physical tolerance had been 
tested in the face of 
uncertainty re survival. 
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and you know in this day and age we’ve got erm, you know, skype or 
whatever and I could still see the kids, in fact I saw the kids more than 
whenever, you know I was also very conscious, we’ve got a two year old 
and a three year old, for my wife to come up it’s a long trip, she’s got to 
worry about the erm nursery and stuff like that, doesn’t want to bring up 
the kids because they’re just riddled with infection all the time at that age 
so actually, it was a nice way to do it, you know, I made sure I had enough 
things to entertain me, I was in touch with enough people, you know, I’ve 
got an iPad so Facebook, I can watch videos, I can watch (mm) speak to 
people, you know so I didn’t feel isolated, listen, if I was doing this five, 
five years ago I’m sure it would be a completely (wouldn’t it) kettle of fish I 
think you know because then that would be much harder to cope with ... 
you know. 
Technology helps.  He is 
conscious of the potential 
strain on his wife in terms of 
distance to travel and 
childcare responsibilities. 
 
Understands the infection 
risks so is prepared to be 
parted from family. He 
comments on the potential 
strain on his wife re distance 
to travel to visit and practical 
aspects of child care. 
Technical advances have 
made a big difference e.g. 
Skype so isolation tolerable. 
Theme: virtual social 
interaction. 
 
I  Yea, you’re still in the world now aren’t you?
 
 
P12  Exactly, I can still, I can actually see my kids and they can see me 
and you know, wave and stuff like that so it’s, it’s much easier to cope for, 
I mean obviously, I’m quite lucky in that somebody gave me an iPad but 
alot of people coming in here don’t necessarily have that you know but at 
least there are DVD players and stuff here and things like that to get 
through. 
 
Theme: maintaining visual 
contact.  Lucky to have iPad. 
I  But you literally decided you were going to have no visitors at all?
 
 
P12  No I got one person to come in and bring me, I had to have a mercy 
visit for erm, for drinks, there was a guy who lives not that far away like 
Ashstead or whatever and it was just, listen can you please, I, I’m getting 
bored of water or whatever, you know, can you just get me some iced teas 
and some you know, these vitamin water kinda drinks, just something 
different to stock up my fridge, even if I don’t drink them, just so that 
psychologically I know there’s an alternative (you’ve got a bit of variety) 
over that, you know? As I say alot of the food was, I wasn’t doing alot with 
food then or, or you now, it’d be pretty bland food (mm) and stuff like that 
but, the drinks were the only thing I could go for so you know, I wasn’t 
really eating biscuits or anything like that so, yea, so I think it helped that 
I’d had a ? before
Variety important especially 
when food and drink options 
are limited. 
Theme: choice, 
independence and control 
Language e.g. “even if I don’t 
drink them, just so that 
psychologically I know 
there’s an alternative”.  
and I think it helped that I’m lucky enough to being in contact with plenty of 
people, of an age to be in contact with plenty of people on the internet as 
well as having like access to Skype and stuff like that and I think er, er, it 
helped actually to get in just a few things of what I like, like the drinks but I 
didn’t really do that at the start so you know, well I did do at the start but 
then half way through I had to get somebody to replenish supplies (yea) 
so, so I think that was just the way, to er, to get round it actually. 
Important to have social 
contact with others via 
internet etc. 
Ability to have someone 
bring in drinks seems to 
contribute to feeling of 
control in addition to 
providing choice.  It may be 
that this became more 
important as his confinement 
continued (like a prisoner – 
limited access to anything 
other than what is supplied 
and limited belongings). 
Could be related to identity. 
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I  And in terms of now (yep) you said a couple of weeks ago (yep) you feel 
as if you’re just steadily getting there (yea) do you have a vision for 
yourself about the goals, difficult though it is to see end points of things? 
 
 
P12  Yep.  Erm, I have alot of things I’d like to do.  I don’t think this is 
going to inspire me to like climb Mount Everest or swim the channel or 
anything like that but erm, there maybe more er ..., er, maybe more 
modest goals, you know, going away on holiday somewhere, abroad is 
you know, just to be out on a sun lounger, somewhere, you know (mm) 
Majorca or so ... , I dunno wherever it is you know is, that’s the kind of 
thing, it’s a bit like torture really because actually I know it won’t happen 
for a little while but that’s the kind of thing I want to get to.  And more of 
these things in terms of I’ve not been able to do alot with my kids just 
because I get tired you know, get to Friday evening it’s like oh my God 
we’ve got the kids for the weekend and I mean it’s completely the wrong 
way around or completely different to how it was before so erm, er, we’ve 
been very lucky to have alot of support from my wife’s parents who’ve 
come down and stayed with us alot and have er, you know helped with the 
kids and taken them out and entertaining them and stuff like that,
He maybe thought I meant 
life changing goals in view of 
his illness but states that he 
has modest goals in terms of 
recovery e.g. going on 
holiday and doing things with 
the kids. 
erm, this was the first weekend when we didn’t have anything like that, no 
friends or family around or down so had to do it all and had to be involved 
the whole time and actually it was ... fine, so you know, that gives me 
hope, I mean, yes as I said earlier, I’m sort of flagging a bit now but I, that 
gives me hope, ok look I’ve done it, I’ve got through this weekend so 
hopefully we’ll keep building them up but it’s, it’s things like, I just wanna 
take them swimming and stuff like that you know, just, it’s very little things 
that I’m very conscious that I haven’t been able to do, you know er, with 
them at their age and at my time of life you know, so.  Yea, I think those 
are the kinda things we think about, going away and yea, just actually be 
enjoying the kids as opposed to feeling as though it’s, it’s a burden, which 
I’m sure it does to anyone at various points you know (yes) they’re not 
easy, but erm, you know, just to do things with them (when your energy’s 
sapped as well) exactly , exactly it’s very frustrating you know and they 
and they do not understand, they’re not of an age where they could 
understand what’s going on. 
Having coped on their own 
with the kids for a weekend 
has given him hope. 
Phenomenon: the 
importance of incremental 
goals. 
They um, they know that I, I’m in bed sometimes, you know (mm) or that 
I’ve been in hospital and stuff.  If ever they see a picture of somebody in a 
hospital bed they go oh Daddy, you know (oh how sweet) which is awful if 
that’s how they er, think of me, but erm, yes, it’s just doing, doing stuff with 
them, but as, as I say the last couple of weekends, we’ve been able to do 
more and it’s made quite alot of difference, gives you , it, it’s starting to 
become more of a virtual circle whereas er, I think in the first couple of 
months there was a danger of it being a viscous circle, you know, don’t 
eat, get fatigued, you can’t spend time with your kids, feel guilty, you 
know, never, just never quite feel up for it and I can’t
His children have recognised 
that he is unwell i.e. 
associate him with hospital. 
Articulates the vicious circle 
of not eating, fatigue and 
consequent feelings of guilt 
re his children. 
specifically say what might have made it better although I have, possibly 
coming off medication so you know I have been having cyclosporin and 
stuff like that and I think as that’s come off.  I had er, quite an upset 
stomach as well for alot of this period, now I haven’t since I came off the 
cyclosporine erm, oh great and that’s the thing, you’ve had radiotherapy, 
you’ve had chemotherapy, you’ve had a bone marrow transplant, so 
you’ve got somebody else’s stuff inside you anyway, you’re on eight 
different pills, all of which have got you know, double A4 sheets of er, side 
There are so many potential 
causes of side effects and 
symptoms that you never 
really know which it is. 
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effects, potential side effects.  That’s the other thing if anything happens, 
you can’t go well specifically, oh that’s the radiotherapy or that’s the 
cyclosporine, but it’s only as you start coming off things you realise (mm) 
that maybe, that was you know, contributing to it, but I’m sure that having 
stepped down my intake of pills has helped (must make a difference 
mustn’t it).  Yea, yea completely, and also you’re on, I think I’m 
permanently on antibiotics and they, they cause enough upsets as well. 
 
I They do and appetite (mm) doesn’t it.  When you mentioned about the, 
the erm, feeling like you’ve got something, you know, you’ve got 
somebody else’s blood (yea, yea, yea) or whatever inside you, how does 
that make you feel, does, does it have any effect at all or do you largely 
just think oh ... 
 
 
P12  No not at all, you know what I don’t give it any, I should, it’s a 
miraculous thing and a generous donation from my brother and I, I, ‘cos 
we’re not a particularly close family you know so for him to do it, not that 
I’d expect him to say no but you know, he was utterly accommodating and 
great, but I really don’t think about it at all (no) it doesn’t, I don’t go thinking 
ooh I’m like the bionic man or I’m half me and half my brother or 
something like that you know I, er, it, it doesn’t , doesn’t occur to me really, 
I, I don’t think about it. 
 
Whilst blood tests have been 
ok he has a diverse range of 
side effects to deal with. 
I  And in your blood tests have you has he, he has taken over has he? 
 
 
P12 Yea, yea it appears to be, all my blood tests have been fine the whole 
time so I mean, actually since I’ve come out I have a little list of things that 
make me sound like Dot Cotton when I reel them off to the doctor, you 
know, I go oooh my feet hurt, you know or my skin, like I had bad peeling 
on the soles of my feet (did you) and stuff like that erm, and what feels like 
erm, er, what do you call it er, when you lose the erm, feeling in your ... er, 
neuropathy (yes) in my feet as well erm you know, and as I say and a bit 
of an upset stomach and that kind of thing but actually my blood have 
always been really good.  I got let out pretty quickly after my transplant 
erm, I would have got out even quicker if it hadn’t have been like a Bank 
Holiday then as well so you know that was … 
 
 
I  Did you make it in the five weeks then?
 
 
P12  Yea, yea, yea, yea, yea it was, it was, it was, I was, as I say I was 
hoping to get out earlier but then it got to like a Friday and you know once 
it gets (I do, I understand) to the weekend you don’t want to get out at a 
weekend so it didn’t bother me that was the hardest bit probably the last 
three days when you’re just hanging around (I was going to say we don’t 
like you to) exactly (we think we know best) no and I don’t want to be at 
home thinking ooh I’ve got a twinge, got a twinge erm so eeeer, yea, what 
was I wibbling on about erm, completely. 
 
 
I  You were saying about you go in with a whole list of things you feel a bit. 
 
 
P12  Oh yea, yea, yea, exactly, exactly but actually I think I’ve got off 
pretty lightly in that, you know, I think in the great scheme of things, I, I 
haven’t, touch wood, I haven’t had any erm, complications or anything. 
By complications, I think he 
means relapse of disease or 
rejection rather than other 
side effects as above. 
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My scans came back from a few weeks ago that were, appeared to be 
clear although I’m having another one today so erm you know, that is that 
seems to be pretty good (mm mm), hopefully, we’ll see,
Phenomenon: living with 
uncertainty. 
but what you don’t get, well I suppose it’s with alot of the things, I imagine 
it’s the same as when you’ve had a heart attack or anything is, is I don’t 
have the luxury to have twinges or aches and pains ... if I feel something 
in my head I think ooh is it coming back in my head do you know what I 
mean (yea) if I feel a twinge in my stomach I don’t just think I might have 
had a dodgy prawn sandwich or something you know it’s it’s you think 
(you relate it) ooh is this you know lymphoma or something like that
You are always on your 
guard for things ”I don’t have 
the luxury to have twinges or 
aches and pains”. 
but I haven’t had any of the big signs that I had initially which is like night 
sweats and fevers and that kind of thing, so, er, it isn’t but it’s hard to er, 
it’s, it’s only time actually heals that er, I’m a great believer you know.  The 
first couple of weeks after my seizure, anything I was just like oooh, is it 
another one coming, you know (yea, yea) but you know it’s been six 
months (very understandable) and now, now I’m just thinking, oh, why 
can’t I drive you know.  I’ve got to see the neurologist so I can get my 
driving licence back and stuff like that you know. 
 
Time without recurrence 
increases confidence. 
I  Oh do you, how long is it? 
 
 
P12  Well, there’s no set time limit, they just need the neurologist to, they 
need a doctor’s opinion to say you’re fine to drive but then obviously 
everything’s been side-tracked by coming here and then recovering from 
this and it’s kind of like one, one step at a time, so, erm, those are the kind 
of things that er, er can be very irritating as well, it’s just, you know, I can’t 
just drive out to get a sandwich or pick something up that I’ve forgotten to 
pick up or, not that I’ve got any dry cleaning but dropping dry cleaning, you 
know, anything like that even going to the dentist, it’s just everything 
becomes that much more of a pain (mm) if my wife isn’t around to ferry me 
round, and I can’t take the kids into nursery or pick them up there’s no 
option (no) it’s all on her you know, so erm it’s those kind of, those kind of 
practicalities I think. 
 
The seizure resulted in not 
being able to drive, 
complicated by his 
treatment.  Phenomenon: 
lack of independence. 
I  When you very first got diagnosed (yep) did you erm, were you 
somebody that wanted to know as much as you could know about the 
whole thing? Were you warned about a transplant straight away? 
 
 
P12  Er no, no, didn’t mention a transplant and also whenever a transplant 
has been mentioned it’s never been erm and this might just be semantics 
in terms of a warning but it’s always been a positive thing (yes) it’s always 
been sold to me as a positive thing (yes)
Transplant was always sold 
as a positive thing. 
erm, but er when I was first diagnosed (sounds thoughtful) no, it’s not 
really head in the sand but I don’t you know, there’s people Iike my brother 
will just get onto doctor google and start looking, all I’ll do is I’ll see every, 
well, 95% of the stuff I won’t be able to understand ‘cos it’ll be abstracts of 
medical papers and the rest of the stuff will be people who have either had 
some miraculous cure or some horrific experience you know, it’s just not 
representative, it’s, it’s a self-selective group of people (mm) that post 
there so I wasn’t really erm, that interested you know, and there was quite 
alot of literature around, I suppose the Macmillan are quite good with their 
(yea, aren’t they) guides and stuff but I can’t say I really read it, what I 
really wanted was somebody else to read it and sort of digest it and then 
He describes himself as not 
‘head in the sand’ but he 
sounds discerning in relation 
to what information will be 
useful.  He does however 
refer to the wish for someone 
else to take charge of the 
information and to sift it for 
him informing him of the 
‘salient points’.  This 
phenomenon is mentioned 
by others: P4 wanting others 
to take charge of the 
information whilst they get 
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pass it on to me, do you know what I mean (yea) so let me know the 
salient points, not, I don’t you know as I say if you read it you end up 
thinking I’ve got everything and it could go this way it could go that way, 
you want somebody else actually to read it and then give you their version 
of it if you like.  Quite lucky in so far as I know quite a few doctors and 
medics and consultants anyway just friends from Uni (mm) so I had quite 
a base of people to speak to about it now none of them are oncologists 
and none of them specialise in it but they all have a grounding or they, 
they knew other people (yes) who you know, someone was involved in 
lymphoma research in the US, that kind of thing
through the illness and 
associated treatments. 
 
and was able to say, ‘cos you know we were saying at the start I felt as if I 
wasn’t doing that much I felt like I should be like Lorenzo’s oil and I should 
be out looking for a solution for it myself and finding out if there are erm, er 
you know, studies and research projects going on, but erm, you know, at 
least with these I was able to get kind of third party (yea) advice if you like, 
again I was quite fortunate in a way I’m quite fortunate in being able to call 
on those and they were all able to help with, well you can do this, that and 
that, this is why they’re doing it and they could interpret these things for 
me into layman’s terms, you know.  And whether or not it was right or 
wrong or whether I was being fobbed off or anything like that, so I got 
quite alot of comfort from there (mm mm)
Helpful to have friends to 
interpret information for him.  
Interesting that he refers to 
the possibility of being 
‘fobbed off’. 
Erm, er, it was a bit of a shock, I wasn’t expecting it at all.  I’d gone in and 
I’d had trouble breathing, sweats, stuff like that and it, it was like four visits 
to the GP before anyone even sent me for a blood test and a chest x-ray 
er, and then they called me next day and I thought right, well that’s not 
good and I thought it was because of the chest x-ray, probably because of 
the wheezing, I couldn’t properly inflate my lungs I was thinking this is like 
lung cancer or something like that was kind of what I was expecting, but 
then, ‘cos initially I was thinking this is some kind of virus or, you know, 
erm, but then they took me away to the quiet room as they do and sort of 
mentioned it but it was kind of like a whole new world it’s not something I 
was, blood cancers isn’t anything I know anything about (no no) you know 
at all so er probably for me it probably again was harder for my wife 
because she was having to deal with it.  I was actually in too much pain on 
morphine to do, actually be thinking about the practicalities of it, you know, 
it was more about this is, I feel rubbish you know, erm (yes yea)so, so 
even now I haven’t really probably read all, I’ve sort of over the course of a 
year probably out of boredom ended up reading most of the brochures I’ve 
been given but I didn’t really do it at the time and I didn’t necessarily seek 
it out I thought the er, oncologists were pretty good in explaining stuff to 
me and as I say I was lucky to be able to just have informal chats with 
friends who could (mm) actually kinda give me the lowdown. 
 
Diagnosis came as a shock 
and he feels it was worse for 
his wife as he was too ill and 
on strong analgesia so did 
not consider the practicalities 
at this stage. 
I  Was that oncologists at Brighton?
 
 
P12  At Brighton, the haemonc team at Brighton.  I mean I was with them 
all the way until the very end of February when I came here so they’ve 
been completely looking after me for the first eight months or so. 
 
 
I  And when you said if you get erm, if you get twinges now you’re sort of 
on the alert a bit (yea) if you were worried about something who would you 
contact, would it be GP or here or Brighton? 
 
 
P12  It wouldn’t be the GP ‘cos after, although they’re very attuned to me Lack of confidence in GP 
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now but after four failed attempts to get anything out of them er I don’t 
think they’re necessarily the best place.  Erm, my tendency would be, 
really now it would be, is actually to speak to here (yea) but I’ve spent so 
much more time at Brighton as an in-patient (mm), it’s a much smaller 
Unit, there’s I don’t know, maybe a dozen beds tops, erm that I know 
those people so well 
 
since initial symptoms. 
I  And it’s a particular oncology Unit?
 
 
P12  It’s a haematology oncology unit so it’s only leukaemia, lymphoma 
and myeloma erm, they’re, that’s where I would want to go to but 
transplant isn’t their thing so I, I would come here and I, I feel alot more 
anonymous here even though again it’s relatively small unit (yea) I guess 
relative to the size of the hospital, it’s so oversubscribed up there, you 
know, you go up to clinical appointments it’s just like so packed that you 
just feel like er, a bit more of a number here than as a, than as a, than as 
a person I’d say, and, and as I say, you spend less time with it and the 
whole time I was there I was in isolation, only ever saw people with masks 
on I didn’t recognise any of the nurses if they’re not wearing masks (yes 
yes like when you’re in theatres) yea, you have to look at people like that 
and it’s oh yea ok so!  So yea. 
 
Feels treatment is more 
personal in local hospital. 
I  I wasn’t sure then, when you said you’re a bit more anonymous here 
whether you felt that was a good thing or a bad thing. 
 
 
P12  No, no, no I think it’s a bad thing.  I like the relationship I have with 
the guys in Brighton (mm) they’re really good, it was really informal, 
they’re really er, er, don’t get me wrong I think they’ve made a few 
mistakes during my treatment on the doctor side but the nurses are 
fantastic, you know, and it just feels more like er, er, I dunno, it just feels 
more kind of familial, it sounds weird I sort of look forward to going back 
there. I feel quite disappointed that I, I’m not under them anymore, do you 
know what I mean? I don’t get to see them anymore. 
 
Relationships with staff are 
important and because of 
that you can allow a few 
mistakes. 
I  I wondered whether you had, ‘cos some people have blood tests at the 
centre where they’ve had the transplant (yea) and some of their blood 
tests locally. 
 
 
P12  Yea, that might happen in future, I’ve been on a sort of weekly 
regime up here and it might be that in future. 
 
 
I  Yea, you’re still early days aren’t you, they’ll…?
 
 
P12  Yea, yea, yea, exactly I always think bloody hell I must be at the end 
of this now and they go oh, it’s only been thirteen weeks since your 
transplant, you know I think ... early days, early days ... 
 
 
I  Yea, they’ve still got their ... you’re still in their claws aren’t you?
 
 
P12  So maybe as things go on, I’ve still got a line in but that’s supposed 
to come out next week so there’s less need for just line care and basics 
like that (yea) and if it becomes, listen you need to have bloods every 
couple of months, or you know, every couple of weeks it could possibly be 
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at Brighton, yea. 
 
I  It’ll be nice ‘cos they’ll be thrilled to see you back there after you’ve ... 
 
 
P12  No, no, no it would be good to, it would be good to er, it would be 
good to go back, still here, still here gov haven’t shifted me yet!  (I laughs) 
so er so yea, no, no so yea, it’s kinda weird I’ve got a strange attachment 
to them, you spend alot of time with them, do you know what I mean, you 
go through some big things with them so(yea definitely) yea.
A closeness develops from 
going through big things. 
Erm, I’m trying to think what else has happened since I’ve come back 
(speaks slowly as if thinking), Er, I think we covered most stuff really, erm, 
as I say, yea, fatigue, upset stomachs and stuff, poor appetite they’re, 
they’re kind of the key ones. 
Reviews the information he’s 
told me so far in terms of 
side effects. 
I personally haven’t felt depression or down particularly about it.  I can 
imagine alot of other people that have been through the same have, and 
I’m not saying that’s ‘cos I’m brilliant or great but I can imagine depending 
on other things that happen, I’ve got away quite lightly as I said, I can 
imagine other people have got away less lightly or they’re older or it would 
take, you know this is the only place I come to and people go, you’ve got 
youth on your side, no-one’s said that to me for about fifteen years, so you 
know, it’s kinda good to hear it once in a while, but you know alot of 
people being treated have got thirty years on me, you know? So it’s, I can 
imagine it taking its toll (mm) er, more so on them and recovery times 
being longer and stuff like that. 
Feels his experience has 
been better than others due 
to age possibly. 
Had we had this conversation (pauses) three or four weeks ago, I think it 
would be quite it could be quite different to how it was now because I, I still 
couldn’t see (speaks thoughtfully) that ... where it was going to start 
changing but I think now, especially after this last weekend, this last few 
days I can see. 
 
Repeats that he has more 
hope as he improves 
physically and achieves 
small goals in terms of 
resuming his responsibilities 
as a father and husband. 
I  You described it as being that corner in sight.
 
 
P12  I can see it coming, I can see it coming, yea, I can see it coming and 
that gives me more hope and as I say, hopefully we’re moving from a 
viscous to a more virtual circle. 
 
 
I  Just my last couple of things …
 
P12  Yea yea. 
 
 
I  Just picking up on that, what do you think pulled you through when 
those time were pretty bleak, when you said if you’d interviewed me a few 
weeks ago I wouldn’t have felt like that (mm) would you have been saying 
then, I didn’t really, I haven’t really felt depressed or do you think at that 
stage you were feeling oh, when am I ever going to get to the end of this? 
 
 
P12  Er, maybe, I’m not sure quite what happened, as I say the reduction 
in the pills has probably helped, I think the cyclosporine was doing all sorts 
and er I think that (speaks slowly and deliberately) having had the scan, 
not that I was worried about the scans like everyone was going oh the 
scans, good luck, you know, and I didn’t , like consciously think of them as 
being like that but actually when it comes back it’s, feels (nice for you) 
better and you know although I’m slightly suspicious about why I’m having 
Reduction in medication has 
made a difference.  Admits 
to being concerned about the 
brain scan.  Theme of 
uncertainty. 
243 
 
this scan today, I did know deep down I’m having a scan on my brain 
because neither a standard PET or MRI gives them the er kind of comfort 
that they want over what’s going on in my brain, neither of them are quite 
clear enough.  This particular type of choline PET scan gives them better 
clarity.  I know that.  Then you’re sort of thinking have they seen a shadow 
on a previous scan or something, you know, you can talk yourself into it 
(yes) so I’m sure when I see them next week and if they say yes, your 
scan came back and it was fine I’ll feel (it’ll be one more thing) yea it’ll just 
be, I’ll just think ooh, I’ll just walk along a bit taller, do you know what I 
mean (I do). 
erm, er, and, what else, I think, I always try and make it very clear to my 
long suffering wife who does understand but for her, I, especially after a 
year it can get quite, it’s very wearing for her and if she’s having to 
wrangle two toddlers while I’m sat there watching Pointless or something, 
do you know what I mean it can really, I’m sure it really grates, but just 
saying to her, look, you know, if I can help I will ‘cos I do want to but if I 
can’t, I can’t and I won’t.  I can’t break that, you know.  If I need to go and 
lie down, I’ve gotta listen to what my body’s (yea) telling me, so and you 
just want everything to be normal,
Strain on his wife having to 
do everything but has to 
listen to his body and rest 
when necessary despite a 
wish to be normal. 
you want to be doing stuff because its normal, you want to do stupid 
things like mow the lawn, not because I’m particularly proud of my lawn 
but just because it’s normality (yes) it’s what people do (yea), it’s what I 
should be doing er, and I just want to be doing that kind of thing.  I want to 
carry my kids round ‘cos that’s what people do, they carry kids round, but 
actually I get pretty tired even though they’re not that big or they like sit on 
my Hickman line and like pull it down, you know, it’s just like not what I 
should be doing, but you just want to do things to, just to regain 
(mainstream) some sense of normality.  Yea, but as I say I think it was just 
physiologically, I only really felt particularly down closest to when actually 
I’d just finished coming off the cy, and they actually started taking my 
cyclosporine down pretty quickly and that was a bit of a fillip in itself ‘cos 
you just thought right I’m going to be off this in a couple of weeks (mm) 
you know and I’ sure that all helps as well as the fact that physiologically 
it’s not mucking up my body as it was (yes) before (yea) so er, yea I think 
it’s those sort of elements help. 
 
Reflecting on what normality 
means: ‘I just want to be 
doing that kind of thing’.  
Many other participants say 
this. Hickman line restrictive.  
He admits to feeling down 
whereas he has denied this 
previously in relation to the 
treatment.  Reduction of 
cyclosporine was significant 
and he felt physically and 
therefore mentally different 
“that was a bit of a fillip in 
itself”. 
I  And if you were to give anyone advice who was going to go through it, 
(yep) what would you say to them was the main … 
 
 
P12  Er, so (appears thinking, as speaks slowly) I think in terms of actually 
having the transplant it’s just preparation, mental preparation in terms of 
knowing that you’re going to be in for a while, preparation in terms of 
making sure you can keep yourself entertained erm, and realistically don’t 
be thinking, don’t take in War and Peace thinking you’re going to read it 
‘cos you read like a page or something, but you know take in DVD’s and 
things that are sort of mindless or whatever but don’t make you feel crazy 
like watching TV and take in things that are as close as you can get to 
luxuries if you like, as I say, with the eating itself then crisps and chocolate 
actually don’t do much good because you just don’t want them but 
flavoured drinks, something that stimulates the senses in some way (mm) 
is it.  For afterwards, I think it’s about having support as I say, I’ve been 
very lucky in terms of my, my wife’s family, not my family, my wife’s family 
coming down alot and you know, we have specific circumstances as 
everyone does.  We’ve got two little kids you know, so it’s, that needs 
Advice to others would 
involve: being mentally 
prepared for isolation; 
entertainment with limits i.e. 
not ‘war and peace’; luxuries 
such as flavoured drinks; 
family support; work/financial 
support both for him and his 
wife; don’t worry because it 
does get better though 
knowing it is different from 
living it. 
Theme: attend to the 
practicalities and be mentally 
prepared. 
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managing and they’ve really er, helped with that, erm, I’ve had very 
understanding work in terms of, you know, letting me off work and er, and 
still having er salary or you know like I work for a big enough company that 
has that in place and also my wife has been given quite alot of time off 
work that’s paid that I wouldn’t have expected that at all, so again we were 
quite lucky from that point of view (mm) erm, er, and I would say don’t 
worry ‘cos I think it does get better but as I’ve said to you there’s a 
difference between knowing that and living it and (yea, yes of course) I 
think that’s a circle that can never be squared or whatever, you know.  I 
think.  Yea? 
 
I  Yes absolutely I think that feels like a natural end, do you (yea) unless 
there’s anything else? 
 
 
P12  Yea, no I can’t, I can’t, I think I’ve chunted on enough.  I think I’ve 
covered all the bits that are kind of happening, I mean the reality is that 
the day to day is, it’s very boring actually you know, it really is.  It is 
groundhog day and er and sometimes you can struggle to remember 
where things happened because you don’t have specific reference points, 
you don’t have oh yes that was the week before Jonny’s wedding or 
something ‘cos I don’t have any of that, it’s just , you know I have 
countdown which is essentially the same every single day, you know, so 
you have no reference points and things can get a little bit bland, it just 
sort of rolls on interminably and when I come here, it’s just it’s just early 
days or it’s only been three months and I think it just seems like so much 
more but obviously it’s on the back of another eight months before it (yes, 
yea) or nine months before it but it still erm, never ceases to amaze me er, 
and, and I can’t imagine certain things.  I can’t imagine going back to 
work, that’ll be really weird.  I want to go back to work but I just, I don’t 
think I knew what I was doing when I was there last time so after like a 
year and a however long out, then er … 
 
Highlights the experience of 
boredom, groundhog day 
and no reference points 
because life is bland, it just 
sort of rolls interminably ‘the 
work of getting better’.  3 
months seems like more 
added onto time of diagnosis 
and treatment.  Work seems 
like miles away and can’t 
imagine returning.  Theme: 
the enormity of returning to 
mainstream. 
I  So you went back in between?
 
 
P12  No, no, no, no, no, er, before I got ill (yea) you know I was, but, but 
er now if I’ve taken a year plus out it’ll just be very strange going back but 
I, again it’s normality, it’s something that I sort of relish, you know erm, in 
terms of doing it.  Hopefully I’ll get the er the work life balance back but I’m 
sure I will but er, er, yea, erm but no I think there’s yea, yea, yea just can 
be very boring.  Jigsaws, that’s another good thing to take in.  I never 
thought I’d say it but they’re very good to focus on, I never, yea, yea. 
 
Relishes normality and sees 
regaining a work life balance 
as part of this.  He 
comments that he has 
surprised himself with 
enjoying jigsaws as a focus. 
I  As long as you’ve got a bed to lie down on afterwards.
 
 
P12  Exactly, exactly, exactly. 
 
 
I  Particularly if it’s a thousand pieces.
 
 
P12  Exactly and a big enough space to put them on, it completely threw 
me I tell you, it was a nightmare finding a board to put it on, (with two little 
kids) yea, they just say what’s that buff! Oh no! Yea (ah).  Well, if there’s 
anything else that you think of or if there’s anything else I think of you 
know, let me know and likewise I’ll let (we’ve got the numbers) yea, yea, 
yea, completely, yea. 
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I  So, I’ll type this up and July and August I’ll be getting deep into it, 
analysing it and all the rest of it so I might just send you a sheet of paper 
then just to say have I got the flavour of it. 
 
Establishing permission to 
verify data analysis. 
P12  Yea, yea, yea, yea, yea fine.
 
 
 
I  And hopefully you’ll be round that corner by then.
 
 
P12  Yea, definitely, definitely. 
 
 
I  Great, thank you very much P12.
 
 
P12  No problem.
 
 
Tape off. 
 
 
I  I’m putting the tape back on ‘cos P12 has just (he laughs) remembered 
something that he wants to say. 
 
 
P12  Well it’s very, again it’s very much down to individual, personal 
circumstances but possibly another thing (says the last two words slowly 
as if deliberating) and this might sound counterintuitive erm, that has 
helped in a way is that my Dad has become ill with prostate cancer and 
he’s quite ... he lives on his own and er, and is showing early signs of 
dementia, so I’ve had to get very involved in ... helping him with, you can 
imagine the protocols, and the things that come through, it’s a 
bombardment of information you know and if it’s not something you’re 
used to anyway it can be a bit whatever, but if you’re not completely with it 
as well, it can just be too much. 
Father’s illness has provided 
a focus. Volume of 
information overwhelming for 
both (?) for different reasons. 
We were getting to the stage whereby we would be, I have a couple of 
brothers and we’re all spread out (laughs) we would be er, we’d speak to 
him but you could never understand quite what was going on because he 
had, he couldn’t really say, oh yes I’ve got to go to the doctors here or I’m 
doing this or I’m doing that, erm, he would just sort of turn up where he 
was told to but didn’t really understand what was underlying it (yea).  I’ve 
been involved quite alot.  I had to take him up to the Churchill in Oxford 
last week for his planning meetings and speaking to GP’s and sisters and 
stuff and I’m going up to see him again tomorrow, so, actually, kind of 
bizarrely, having a different focus has, there’s always someone else for 
me to care about, ‘cos this, I have some experience I suppose of 
radiotherapy, has also in some way possibly helped.
His experience has helped 
him understand his father’s 
situation and lending support 
has diverted his attention 
and given him another focus. 
And the only reason why I mention it is the driver in the car was saying 
that exactly the same thing had happened with his brother who’s got 
myeloma but was doing alot of caring for his sister(yea) who’s got 
dementia and actually it was just giving him another focus to er, to to 
concentrate a bit on.  I’m not suggesting that everyone should go and 
(have an ill relative) (both laugh) have an ill relative in order to do it but I 
think it’s another sort of contributory factor whereby, you know, not that I 
was particularly focussed on it but it, it just gives, it’s another thing that 
keeps you focussed on something else.
Importance of having a 
focus. 
And maybe it’s, we’re new to the area where we live, so I don’t have, it’s Because of moving prior to 
diagnosis he has no local 
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not like I have a football group, all my friends are still back in London and 
stuff like that you know, or I wasn’t part of a clock repairing society or 
something, but if you had a hobby or, that’s the kind of thing that you need 
that kind of distraction I think, that other focus which I think would help.  
It’s been lacking for me, just again because of personal circumstances.  
We moved to Burgess Hill, I got ill within a month.  So we just didn’t know 
anyone.  There was none of that down there, we weren’t doing anything, 
we weren’t plugged into the community in any way, shape or form.  But for 
other people, if they are doing things, if they’re going to the University of 
the third age or whatever it is that, (mm) that interests them then I think 
those kind of distractions, diversions are possibly another good way of just 
helping you through it you know (mm mm). 
 
social network.  He highlights 
the importance of this as a 
focus.  Also, diversions such 
as learning new things. 
I  Well you’re doing children of the first age aren’t you.  (Exactly)  That’s 
your focus. 
 
 
P12  I used to like going back in for chemo ‘cos I knew I’d have four days 
without even feeling guilty about it, do you know what I mean.  I’d just be 
in bed and that was it.  People would bring me my meals and I wouldn’t 
have people clawing at me or going, can you not just look after them for 
five minutes?  (Oh P12 we won’t be playing this to them.  Can I just assure 
you that at the end of all this I destroy the tapes, it will not be available to 
your children.) 
 
Attending for chemotherapy 
was a legitimate reason for 
not playing your role in the 
family so relieved guilt.  The 
pressure was relieved and 
you were cared for. 
Theme: guilt, legitimacy. 
P12  Okay, fine.  Good, good, good!
 
 
I  Thank you for that, I think that’s a really important point actually.  
 
 
247 
Appendix VII 
Sample of preliminary interpretations for each participant 
 
P1 
Big thing, isolation, 
prison, cocoon 
Support 
Survival/recurrence 
appointments 
Anxious re coping 
feelings 
Being believed not 
labelled 
Knowledge and 
information 
Age appropriate 
care/exclusion 
Identity appearance 
Hair 
Normality 
Future goals 
Work/passion 
Expertise v lack of 
confidence 
+ve & -ve aspects 
of cancer 
Strain on others 
P2 
Gender 
Fatigue 
Appetite/weight loss 
Normality/activity/social 
Support 
Information/advice re activity 
Infection risk 
Role as Grandma 
Experts/lack of confidence/GP 
Time to recover 
Resuming activities 
Dr’s encouragement 
Donor –grateful/process 
Technology/isolation 
Carer burden/well-being 
Reflection 
Regaining self/turning points 
Sleep 
Hair& wig/turban 
Technology for keeping in touch 
P3 
Nervous 
Limited strength/pacing 
Distraction - writing 
lessons 
Making most of time/ 
interruption  
Goals – work; exercise; 
travel 
Hair 
Support from family and 
friends/students 
Effect on new 
relationship 
Delay for donor 
Expertise 
specialist/local/info 
Food choices/facilities 
Re-evaluation of 
relationships 
Trial drug 
Lucky/safe/determination
Physical effect GVHD 
Giving something back 
Fertility and sexual 
issues 
P4 
Dependents 
Big transition 
Protected/cocoon/bubble 
Psychological strain 
Macmillan and rare disease ALL 
Confidence/worry re blood 
results 
The actual transplant - +ve 
Side effects 
Age & survival 
Body wonderful and forget pain 
Family 
relationships/responsibilities 
Donor burden, procedure and 
life occurrences 
Lucky – given a chance 
Uncertain future 
Speculating/theorising/reflecting
P5 
Scary 
Side effects 
Previous treatment experience 
Fatigue 
Diet 
Infection/sepsis 
Profession 
Pain 
Isolation/confinement/embarrassment 
Panic attacks/confidence 
Re-socialisation 
Visible difference/stigma 
Give something back 
Physical impairment 
Support/counselling 
Hair loss 
Parental support groups 
Technology 
Staff knowledge/confidence or not 
Access 
Sleep problems 
Critical care 
Extra mile 
‘fighter’ 
Technical detail 
Dr encouragement 
Donor/donation 
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P6 
Support wife/sister 
Fatigue 
Exercise 
Appointments 
Donor 
Non-linear recovery 
Confidence 
local/specialist 
Uncertainty 
Heart failure 
Limbo/shut 
down/psychological 
state 
Facing own 
mortality 
Eating 
Memory of 
experience and 
dislike of fish 
Social 
Blood counts – 
monitoring 
Communication 
with loved ones 
Sharing feelings - 
gender 
 
 
 
 
 
 
 
 
P7 
Donor – cord x 2 & competition 
Survival/mortality 
Confidence in experts 
Lucky 
History relapse/chemo/infection 
including shingles 
+ve attitude 
Physical activity/effect 
‘cancer card’ 
Family strain 
Frustration 
Future 
ICU experience 
+ve attitude of Doctors 
Magnitude of it all 
+ve attitude of self 
Keep busy 
Hair 
Partnership – you do your bit 
Secondary cancer 
Memory 
Access 
Wanted information ++ 
P8 
Support 
Exhaustion 
QOL now different 
Infection worry 
Life restricted and 
disrupted 
Protecting others 
Eating terrible problem 
GVHD 
Local and specialist – 
good access 
Balance of medicine 
doses 
Donor 
Survival/mortality 
Flashbacks to critical 
care 
+ve attitude 
Contacts 
Group support 
Stress 
Physical changes 
Monitoring by husband 
Anxiety & concern for 
others  
P9 
Being alone 
Inexperienced clinicians 
Support from son 
Burden of hospital 
appointments 
Grateful for hospital transport 
as long distance from specialist 
centre but v early and results in 
fatigue and illness 
Resistance to re-hospitalisation 
plus OPD is like another world 
p14 
Survival/mortality 
Loss of husband 
Rejection of donor cells/GVHD 
Cold 
Determination 
Physical impact 
Lack of understanding from son 
Relationship thread running 
throughout 
Feels abandoned by both her 
children 
Independent 
Decrease in confidence 
(potential of loss of husband 
and illness) 
Testing herself /pride in 
achievement and own strength 
Product of her donor  
Desire to help others re 
research – bloods and this 
Hair 
Identity 
P10 
All ok till day 100 
Technical detail re engraftment 
Information booklet – all experienced 
– fatigue, weight loss, appetite 
decrease, infection 
 Transfusions 
Top up transplant transfusion 
He’s gone from good to poor – needs 
sleep+++, wheelchair, has diarrhoea, 
GVHD, medications are a problem 
Felt like giving up recently – one 
thing after another 
Huge resistance to returning to 
hospital despite potentially life 
threatening infection 
Experience of incompetent staff and 
lack of organisation 
Fluid retention 
Colonoscopy and platelet issue 
Anticlimax of actual stem cell 
transplant 
Worth it for the cure 
His condition was very painful 
Work and hopes to return 
Has had counselling – helpful. 
Physical manifestations of transplant 
make you score high on depression 
scale 
Wife and family support   
Wife altered work pattern 
Distance from specialist centre 
Financial burden 
Some local care possible & preferable 
OPD all day event 
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 Reflection on recovery 
Fighting for survival 
Some support from friends 
Specialist and local 
expertise/support 
Weight loss/appetite 
Transplant itself is not a big deal
It did guarantee longer life 
though 
She feels different as a result of 
experience 
Worry re blood results 
Dr encouragement 
Living with uncertainty re another 
transplant 
Reflects and theorises, rationalises 
his low point 
Driving affected 
Help from Masons. Previous trial 
maybe affecting engraftment 
Busy local clinic and day unit 
 
P11 
Biggest memory of 
SCT is anti-climax 
Holding treatments 
for 4 years 
No mental road 
map post transplant
Information given 
maybe but not 
absorbed 
Chemo – from 
doddle to bad side 
effects 
Medications++ 
Hair loss 
Sleep affected and 
seeping tablet 
addiction 
Water retention 
Infection 
Investigations 
++GVHD 
Visible difference 
Eating a problem 
P12 
Temporal 
Disease context 
conditioning/chemo/radiotherapy/TBI 
and lasting effects 
A real planner – prepared himself 
Freedom – lack of fixed routine 
Family 
Independence/choice/variety 
Tired – wasn’t quite prepared for this 
Orientation metaphors 
Oral changes, taste/weight 
loss/altered taste/dryness 
Less tired so can eat better 
Eating is a big issue 
Bargaining/partnership/listening to 
patient re methatrexate 
Lucky repeated 
Experiences underestimate/minimise 
Things ok when you know what to 
expect/if you can visualise a turning 
point you can deal with it 
Facing own mortality more than once
Uncertainty re timescale of recovery 
P13 
Not included as 
autologous transplant 
P14 
Temporal – date of transplant 
Chemo effects 
Identifying which med made him 
so bad 
Discussion/bargaining with Dr’s 
re cyclosporine ‘like all hell let 
loose in my stomach, it was like 
a volcano going off’ 
Weight loss/tube feed 
Persuading re letting him home 
Uncertainty/nervousness when 
first home  
Visible 
difference/embarrassment thin 
and unwell 
Fatigue and limitations 
Wife infers all not well 
Macho image depressed v 
frustrated 
Different outlook on life (Frank – 
you change and others want you 
the same p67/8) 
Wasn’t quite the doddle that I 
P15 
Temporal 
Identity of donor/match 
Anti-climax of transplant/belies what 
comes next 
Infection and wish to be in hospital v 
feel ok and stay out 
Isolation 
Metaphor/simile – caged 
animal/prison sentence 
Counting down days/living by the 
calendar (ref) 
Quick/slow dualism re post transplant 
in hospital 
\hair ref – irony of metaphor – pulling 
your hair out 
Needed transplant badly 
Sometimes felt more ill at home than 
hospital 
Immunity 
Information good but experience is 
different 
Infections 
Side effects 
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Mucositis 
Infection 
Physical 
preparation prior to 
transplant – gym 
The high of 
returning home 
Sleeping alot 
A turning point 
Resuming previous 
roles 
Support from 
friends re child care 
He had considered 
all would be well 
following transplant 
– became more 
realistic 
Painful limbs 
No financial burden 
Rethink re future 
work 
Changed view on 
work 
Holiday 
possibilities 
Strain on wife re 
work and child care 
etc 
Recovering and 
less OPA’s 
Local care – very 
convenient 
Wife plays part in 
mentioning issues 
at OPA as he is 
‘man’ about it 
– difficult to handle 
Self-sufficient/keep occupied 
Had a practice run with previous 
illness experience/mental 
preparation 
Initial diagnosis 
Serious complications - treatment v 
side effects  
Metaphors ‘battle’‘raging’ 
Technology – keeping in touch 
Concern for family 
One visitor – a mercy visit for drinks 
– needed variety of the only thing he 
could have orally  
modest goals 
Holiday 
When ‘line’ out possibility of local 
care 
Being young as a positive of getting 
through it 
Feels a turning point  - maybe aided 
by reflection on the story and talking 
about experiences 
Children and family life exhausting 
Family support 
Achievements motivating 
Image he presents to kids not great 
Radiotherapy/chemo/meds/med side 
effects/antibiotics/donor cells – what 
chance of identifying contributory 
factors to how you feel 
Danger of viscous circle of 
fatigue/guilt/time with kids 
Donor cells not a big thing 
Blood tests always good but a list of 
other issues 
Prospect of home and frustration 
thought it was 
Hair curly and different colour 
Losing battle re food 
Shut himself down 
Transplant and age 
Depression 
Experience hard but no 
alternative 
Psych help if required 
Feels for others particularly 
young (P8 and P5 re 
encouraging donors) 
Work 
Infection – things happen fast 
Backward step and effect 
expertise available 
Family illness 
Ubiquitous nature of cancer 
(the new norm) 
‘It was never really explained’ 
Maybe forgot detail when lifeline 
treatment identified 
‘I didn’t want to think what I was 
going to go through’ 
Good explanation from Dr ‘no 
walk in the park’ 
Access to experts good – good 
to be known and response 
reliable 
Acknowledgement of being 
listened to 
Long IP stay 
Seems like 5 minutes ago 
Family support 
Needs to keep occupied 
Strength for driving, lawnmower 
and work affected 
Feel better than warned then it hits 
and hits hard 
TBI 
Vision impaired and threat of 
permanent loss of sight 
Bad headache 
Relapse on treatment  
Tumour on optic nerve v rare 
Effect of this and feelings re children 
Transplant hastened 
Weight loss dramatic 41/2 stone 
He views infections as something 
easily treatable v weight loss and 
appetite  
Suggestion of tube feed led to angry 
response as all frustrations come out 
bored, no eyebrows, no eyelashes 
Bargaining re weight gain/no tube 
Visible difference and kids 
Physically incapable of getting 
nutrition in/explained in a way you 
can relate to re having flu 
Texture and consistency important 
Dietition lowered standard of 
nutrition 
Mucositis/taste/smell 
First six months are a nightmare 
Financial worries/children/work  
100 mile an hour life and just ‘taken 
out’ 
Need for someone to address how 
this impacts on your life 
Need a road map of info re 
entitlements/benefits/tax credits etc 
CAB good 
Wife highlights irony of being told to 
relax when stresses are 
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Support group – 
Macmillan group 
meets and disease 
specific e-contact 
plus own blog 
Danger of intranet 
info 
Tips e.g. lip salve 
Isolation hard 
Infection risk 
Access to 
treatment/age 
Living a day at a 
time and looking 
forward to being 
able to plan 
Rehab hard e.g. 
driving, shopping 
Feels better when 
others have similar 
issues 
 
 
 
 
 
 
 
 
 
waiting 
Recent scans and trying not to worry 
I don’t have the luxury to have 
twinges or aches and pains/fear of 
return 
Seizure – driving ban results in lack 
of freedom/independence 
Information – objective view re 
internet 
Medical friends for info – wanted 
someone else in charge of 
knowledge though thought he 
should be doing more returns to 
diagnosis and shock of it/rare 
Limited faith in GP 
Expertise of specialist centre but 
personalised care at local hospital 
Whole experience feels an age but 
medics say early days 
Subconscious anxiety re scan 
Need for others to understand his 
tiredness is genuine 
Striving for normality 
Preparation/boredom/luxuries/family 
support/financial support through 
work 
Surviving rather than living at the 
moment ‘groundhog day’, no 
‘specific reference points’, ‘things 
can get a little bit bland’ 
Surprises himself with things to 
keep him occupied. Distraction of 
father’s illness has helped in a way 
Adopting carer role 
Moved recently so no immediate 
social group 
 
Small steps raise the spirits 
Psych v physical pain 
Resuming normality curry on a 
Friday 
Social life affected 
Alcohol tolerance 
Worst is behind – focus on 
future  
It’s in the background but 
reminded just how ill you’ve 
been 
Sick role v carer role comments 
Uncertainty ‘element of doubt’, 
‘there’s  always a but isn’t there 
Trying to understand technical 
detail re transplant and blood 
results 
Top up maybe 
Lost bone marrow aspirate 
Technological advances re 
BMA’s 
Diagnosis and what led up to it 
The very beginning of 
illness/reluctance to visit GP 
Can’t fault NHS – confidence re 
speed and treatment 
Wants to contribute 
Financial hardship 
Raison d’etre re family 
Infection risk 
Internet info and technology – 
skype to keep in touch/hospital 
website info good 
Reduction in medication a sign 
of getting better 
Vaccinations 
 
medical/physically/socially 
Self-employment a particular concern 
Charity – others for him and him for 
others 
Strain on wife and family 
Expense of travel 
3-5 OPA’s a week 
Wife felt health most important but 
knew his business was of great 
importance for him 
Financial stress major issue 
His business/finances worse than 
illness 
Married just prior to illness 
You’re not depressed so much by 
cancer but all that it brings. Financial 
advice not good; need realistic advice 
particularly as recovery time 
uncertain. 
Need for someone to spell it out 
Care is the up side like a hotel 
Consistency of care highlighted 
Really looked after as an individual 
Medical/nursing care great but home 
circs neglected 
Perceives minimal impact for older 
people 
Family strain  - it would be ok if you 
could just get on with it 
It’s the speed of the crash and long 
interruption to normality 
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Almost enjoyed chemo as a rest and 
no-one had expectations 
Donor cells – an alien in your 
body 
Importance of having questions 
written down ’I think you’re so 
relieved because your counts 
are good 
Effect on fingernails 
‘there’s no hard and fast rules 
with what’s happened to me is 
there?’   
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Appendix VIII 
Cross cutting themes  
Biographical  
Disruption 
Information Fatigue and  
physical changes 
Uncertainty Identity Coping Importance of  
relationships 
Groundhog day 
Turning a 
corner 
Work 
Relationships 
Reproduction 
Social aspects 
Liminality 
Re-evaluation 
of relationships 
Distance from 
specialist 
centre 
Financial 
burden 
Re-evaluation 
of life ambition, 
work etc 
Critical illness 
events – 
trauma 
narratives 
Road map, 
viscous circle 
Not the doddle I 
thought etc 
I’ve learned alot 
I didn’t want to 
know 
Information, 
blogs, websites 
and hospital 
‘huge step’ to 
go home 
Support groups 
E-information 
and websites re 
disease info 
GP 
Access to 
experts post 
SCT 
 
Hair 
Nails 
Posture 
Pain 
Physical 
limitations, 
debilitation, 
frustration 
Muscle wasting 
Numbness 
(peripheral 
neuropathy) 
Unable to do 
‘normal’ things 
e.g. drive the car, 
mow the lawn, 
carry the kids 
Limits social 
activities 
Regaining 
independence 
Frequency of 
follow up 
appointments 
Diagnosis 
Treatment ‘in limbo, shut down; 
vegetative state 
Critical illness e.g. infection/drug 
reaction (3 & 8), heart failure (6 & 8), 
fluid overload (12) during 
chemotherapy/SCT 
Complications e.g. seizure (12), 
headache & blindness (15) 
Overall ‘big bang to your body ‘ (1) 
Survival 
No more treatment options 
Relapse 
Interpretation of blood results 
Recurrence 
GVHD and other side effects 
Infection risk 
Taking charge of their monitoring and 
self-management 
How do you know if something is 
wrong?  
Even when most things are ok there 
is always something not right. 
Hard to process information – so 
many instructions on leaving hospital.
Feeling vulnerable. 
Resuming activities - how much you 
can do? 
The future including financial 
concerns, family, employment  
Uncertainty re recovery e.g. how 
much.  
Reducing risk 
Fear; depression 
Stigma 
Hair loss 
Nails, skin 
Physical 
manifestations  
Loss of macho image 
Eating 
Normality 
Sleep issues 
Fatigue 
Importance of special 
occasions 
Regaining 
independence 
Re-establishing their 
position e.g. as 
parent, Grandma, 
wife, husband etc 
Importance of age 
appropriate care. 
Difficulty in 
expressing emotion 
or discussing 
emotive issues 
leading to feelings of 
isolation. 
 
Keeping positive and 
occupied (don’t dwell on 
things) 
Goal setting 
Being lucky  
Hope 
Optimism 
Bargaining and partnership 
with medics re decision-
making, ‘journeying with the 
team’ 
Positive attitude of doctors 
Growth through experience 
Desire to help others; 
encourage donors; money 
raising; participation in 
research 
Humour 
Reducing risk and taking care 
Vigilance re health status and 
monitoring 
‘you need to be on top of 
things’ 
 
Relationships (re-
negotiation, re-
establishment of 
existing or lapsed 
relationships) 
Family/Others 
Medical staff 
Nursing staff 
Psychologists 
Group support (or not) 
Care shown by nurses 
made a real difference 
(conversely examples 
when it did not) 
Participant’s worry for 
their families 
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Appendix IX 
Sample of meaningful statements, participant 1   
Participant 1 
 
 Initial interpretations 
I think the first thing is when they tell you Communication and information 
to er, being told that your counts are starting to go up Biomedical focus 
and you almost feel that enormous sense of relief that it’s time to go back home but after going through such a big 
transformation during transplant that you almost feel where do I start.  Telling me to go home is just such a huge step 
and there isn’t that much of a guidance that they tell you that you need to.  (stops and is visibly moved at this point) 
 
Safety of the hospital (safe in the 
bubble), lack of information 
So definitely with the first thing when they tell you to go, that you’re ready to go home you need that psychological 
support, erm, as soon as they said that your counts have gone up and they tell you that you’re ready to go you get 
that almost that, that overwhelming feeling inside that you can’t wait to leave the hospital and you almost wonder 
whether it’s staying in one place all the time that makes you feel weak or if it’s still the treatment that’s kicking in, 
you’re still not sure, as soon as they tell you you can go home where do I start from there.
 
That’s, that’s a huge, huge thing and being by yourself and being told that, sometimes you can take those things for 
granted and what I mean by that is I think that many people think that as soon as the doctors tell you you are fit to 
leave, you take this for granted that you’re being given a key that unlocks certain doors back to your normal life but 
not fully understanding the consequences of being left to stand on your own two feet after such a journey. 
 
Left to stand on your own two feet 
You’re put into a very light room from being in such a very dark room.  You get worried, you wonder how you might 
feel will I be fine, will be enough, will that ease my worry. Will I be fit enough to call, will I, what will I come across 
during that time. And the main worry for me at that time when they told me was, am I going to survive, how am I 
going to make sure that everything will be fine with me. 
 
Possibility of facing  one’s own 
mortality 
It’s ok to take the medication but you need someone there with you, behind you, I don’t think you can do that by 
yourself, at all. Yes, the nurses are there to and there’s only so much they can do, but you need that push not just 
from yourself but from other people as well and my push was my Mum. That’s what pulled me through this journey.  
It’s almost like being given the green light. You haven’t got to go through any more pain, now it’s just the recovery 
from it (right) and you’re not trapped into this room, all this time, you are set loose. You feel almost human again.
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Yes, but even that has its consequences because when you’re being told that you’re free to go, you don’t know really 
where to start to get your, you have to build up again and you’ re not at your optimum strength so you’re thinking with 
also with a weak mind as well which is dangerous I think.  Erm, the nurses and the doctors are there to tell you that 
everything will be fine and you will be monitored but that psychological part is something they can’t give to you, you 
have to give to yourself I if you haven’t got that in a way that you feel you’re ready to go. It’s just a difficult time 
 
Not knowing where to start and 
being left to stand on your own 
two feet 
 
I remember when I was given all the medication and not even, you need to understand alot you need to take in a lot, 
it’s not that they just tell you to leave, there’s alot of things that you need to remember and without having someone 
behind you, I’m not saying you know you’re in this world alone but going through cancer you need someone to be 
with you. The saying is that you shouldn’t go through cancer alone (yea) and that’s the main priority, to have 
someone with you because you can deteriorate, you can go in, they tell you that you can leave the hospital but if you 
don’t take care of yourself you go straight back in.  And that’s the worst part (quietly and meaningfully stated).
So much to remember in terms of 
self-management and monitoring.  
Importance of having someone to 
support you through the cancer 
journey. 
It is a difficult time 
Then there’s the whole idea of nutrition, dieticians, that needs to be taken care of  and with my diet that I had as well 
being intolerant to many foods, I had to take another big leap with that as well. I wasn’t really told what I should and 
shouldn’t eat, just it’s been rather difficult. You’ve already got one problem and I’ve been given another problem. 
 
 
Trying to recuperate from all the chemotherapy that you’ve had a huge bang to your body you need to be on top of 
that and if you’re not on top of that you can deteriorate as well and then that makes you wonder am I going to 
survive, am I going to recover the way I should recover, am I going to get side effects if I’m not taking care of myself. 
It’s a big, big thing for me. 
 
So much to worry about and will I 
survive? 
There was no way I could do this by myself. And I keep on saying that. It sounds like I’m really relying on my Mum 
but she was the only one there to really support me during that time. So my Mum and I, we had to rent a place near 
the hospital to make sure, because you have to come in about five or six times a week almost like a week every 
week. And to travel back and forth being nauseous, not being able to eat, feeling weak, hating the idea of travelling 
to be five minutes away for anything because there are more complications with a donor transplant than with a 
normal one because your counts just go back to normal. You can get complications of GVHD, many, many other 
things, and that was, you had to be on top of that as well.  There were sometimes I could not walk, I needed to travel 
and my Mum had to take me, er, every day to the hospital. I felt … a baby again. It’s not that you’re, it’s like you’ve 
been stripped down from your whole, your whole body’s been stripped down and you feel weak and you can’t help to 
feel almost like in a little cocoon and then they tell you to, to get out and try and do things, and you can’t. The first 
few stages you’re too weak to even think about that. You just want to go into the hospital, make it as quick as 
possible and go out.
 
 
 
 
 
Complications associated with 
allogeneic SCT e.g. GVHD. 
Increased vigilance required 
256 
 
 
I found the place myself. They did offer but sometimes you don’t want to be in hospital all the time. It’s enough to 
only go through a transplant being twenty-two and being in a hospital, it’s, among other unwell, I’m not saying that a 
hospital is a place where everything is beautiful, it’s amazing but you don’t want to be there, it’s not where you 
should be. You should be out there, I’m only twenty-two I should be able to do things, to get out there.
 
It’s almost you need to feel that little bit, a sense of normality as well during your transplant. It’s not just about being 
in hospital, because, that would be the biggest thing, the biggest worry that you spend all this time, you spend six 
months in hospital for example and if I didn’t find my own place and then they tell you to, that you’re free you’d be 
feel even more lost than before. 
 
Loss of identity 
 
I made sure that I was kept busy during this time and to avoid getting into too much detail with certain things after 
transplant avoiding going onto the internet to make yourself feel worse.  After transplant you’re very vulnerable and 
you want to try and find an answer even after transplant, and especially when you haven’t had a PET scan you want 
to know what’s going to happen to me, find out other people’s stories and that’s a really, really bad thing to do. If I 
didn’t have a previous transplant before this one, I’d probably have done that again, I wouldn’t have learnt from my 
mistakes. I would have made myself even worse.  And with time your brain becomes a little bit more stable.
Keeping occupied
You realise that everybody is different and that things will get better. But during the first three months that is definitely 
not the case. Definitely not the case.  I know I keep on saying, going back to my previous transplant, because I’ve 
gone through the whole works. I mean I’ve tried everything, I even tried counselling, I tried to have counselling before 
and after treatment but there is only so much you can say, and you need to find in your own stride try and keep 
yourself busy, and try and do things to make you not think too much.  And it’s very hard to put your head around that. 
Very, very hard. There’s only so much nurses can do.  And I had to dig up old projects that I did from University and 
try and get myself back up there again. Whether it’s just five minutes, ten minutes, it was something. I needed to feel 
normal. I had to…, and I don’t think the nurses could do anything to (pause) to make me feel that way. I needed to 
do it myself. 
 
Fear of disease recurrence 
 
 
 
Keeping occupied 
That’s also another thing that helped for young adults. It makes you look forward to something.  It doesn’t make you 
think oh I’m going back into hospital again. That was a huge huge thing, and I rejected that many, many times. Then 
it came to a point when I thought, do you know what, I’m going to do it this time because life is too short and they 
really put a smile on my face and made me think less about the whole transplant. 
 
Distraction to avoid undue worry 
But I keep on, I keep on saying this, the first three months, there’s no way you that can think all of this with a straight 
mind. 
So much to concern yourself with 
in the first 3 months post SCT 
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I think it was things these visions that things that I’ve seen before on the news, patients, young patients who have 
gone through cancer and I thought ‘the wish’ was just based on… because they’re dying. Not based on their 
moving on with their life. The media doesn’t help. The media always talks about kids who’ve had cancer and they’ve 
gone. Maybe that’s the only things I’ve absorbed and they’re the only things I’ve been seeing. And I thought the 
Willow Foundation was that, the Willow Foundation is your only opportunity to do something really great before you 
go. 
 
And once you’ve been hit too many times, you don’t care, you really don’t. I’m going to do it and I did do it. And in 
seven weeks’ time I’ll be going to do something I’ve always dreamed of which is great, really great. 
I’ll be meeting the designers of Alexander McQueen, er he’s my greatest, greatest fashion designer.  I absolutely 
love him and they invited me to go to the men’s catwalk in seven weeks to see the show. 
But those type of things are great to get back on track after transplant and you need that, and especially for someone 
who’s very young.  You definitely need that.  I can’t stress that enough.  And I was, maybe it wasn’t time for me to 
go and say yes.  Maybe it was time to say yes now.  I don’t know. 
 
Needing distraction “something to 
live for” 
You can still do it, you’re not … you’re going to the other end of the world. And these events that he creates to go out 
for like a pizza or a movie. It’s a nice thing to have because you meet other people who’ve gone through the same 
thing of your age. Going through transplant and seeing people who are about fifty or sixty years older than you or 
forty years older than you, it’s not nice, it’s not nice. You almost feel like the odd one out, you’re not at their level and 
it’s not nice at all. But being with people familiar to you, the same age, it doesn’t exclude you and another great thing 
about after transplant this time was to be with the young adults. That’s a huge thing, to, to talk to other people your 
age. 
 
Doing ‘normal’ things and sharing 
experience with others of the 
same age 
It wasn’t nice, I felt captivated Feeling  captivated  due to being 
in an isolation facility
When you are feeling better, you can go into this lovely room where you’re with other people your own age, you can 
play games, you can socialise, you can watch TV. Your own, your own little fun house and the food’s different as 
well. They offer you snacks, they stimulate your appetite which is a nice thing and the nurses are lovely, they’re all 
young, they’re all very very young, experienced and so grown up, soo on the ball. Also they allow you to bring 
your parents along, they can sleep next to you, they er, there’s a bed specially there for, for the parents which is a 
lovely thing because the last thing you want is to be by yourself and you can have your Mum, your Dad, your partner, 
whoever next to you during this difficult time. Sometimes you don’t even want to get up.   
You wrap yourself too much, because you are already in, you wrap yourself up too much in your own mind, thinking 
what’s going on, what’s happening, more medication, more lines, more this, more that and you just need someone 
Distraction is important. Teenage 
and Young Adult facility was 
appreciated.  Support of loved 
ones 
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whose there with you, like a, your family or someone who will look after you other than the nurses to give you that 
stability. 
Your body is so agitated because it’s going through so many changes once again internally, externally, visually, you 
know...(this is about…about rest). You don’t even want to watch TV because you compare yourself with the people 
who are well and you think look at me, I’m blown up and I’ve got no hair and I’m not the way I should be. 
 
Loss of identity due to altered 
physical appearance 
Some emotions you can’t even describe to someone who hasn’t gone through it. There has to be almost like a 
connection to someone else who has had cancer and would understand. There’s certain things that, no matter how 
much you describe them it will never be how you feel inside. It’s something that you can’t describe if that makes 
sense? 
You feel different because of what 
you have experienced 
It’s a heavy journey. A heavy, heavy journey. And almost after six months, it hasn’t quite been six months yet for me, 
once your brain starts to go back to that normality and you see the Doctor less, your head almost for me it’s 
expecting too much. Sometimes I almost forget that I’ve had a transplant and because you’re picking up on your own 
two feet after being protected for so long before transplant and then they tell you to leave and you’re not seeing the 
Doctors anymore, you demand too much of yourself because you’re thinking ok and you start to become something, 
someone, before it all goes again. That’s my problem now. I see it as a huge, huge problem, 
Feeling of abandonment and 
uncertainty 
when you’re putting your life in their hands and they don’t know what disease you have. Don’t treat me, you know I 
want to be somewhere where with open arms they know that they are doing. 
They took quite a long time to try and find me a donor when there weren’t any donors there.
 
I’m still not happy with the way I am. I don’t know whether this a long term thing that I’ve had or if it’s to do with 
transplant and being hit too many times, but I’m also trying to compare myself to too many people, to people who 
haven’t gone through anything. You forget that because you’re on your two feet again. Does that make sense Liz? 
It’s just that it’s almost you’re, you’re being told to go, being told to find your life again and you’re already a rare case 
at a young age to be diagnosed with cancer and you see all these other students. Obviously, I don’t know their 
history but they haven’t been through anything. You’re comparing yourself with them and they haven’t actually gone 
through any of that. 
 
Loss of identity and feeling 
different from those who have not 
experienced cancer 
 
The first time I got diagnosed was 2009, and I had just managed to start the foundation course, erm, sorry, this is 
rather upsetting. I got diagnosed with Hodgkins and had six months treatment, unfortunately the scar tissue I had in 
my body was not scar tissue it was relapse of disease. The disease was still there. So I had to go through a 
transplant and deferred my foundation for a year. Eerrrrm, going through that decided to go back to study, finish off 
the foundation. You can’t start in between years you have to start all over again.
Disruption to life plans due to 
disease recurrence 
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Got into BA course at the same University, did my exhibition and unfortunately got unwell again. So now if everything 
would have been fine and it didn’t come back I would have been studying for my three year course and finish in 
January. But that’s been on hold and now hopefully getting back to normality again. 
Loss of identity and feeling 
different from those who have not 
experienced cancer 
This is what has inspired me, because these things they don’t happen to everyone (animated)  
I’ve noticed that my work has changed alot compared to other students. Experiencing cancer has had an 
effect on his creative work 
It’s almost I have a different view on things and most of my pieces have dealt with hair. Hair has been a huge 
importance. Even before I was diagnosed hair was the main thing I was interested in, I always very much liked, very, 
very vain, very much liked doing my hair and styling it. You know as a, as a teenager, (yea, yea) but having lost it 
many times you understand the importance of, how important hair is and with jewellery, jewellery is something that 
you are bound to a , like hair is .. to you. It’s what makes you beautiful, personalises you.  I just find hair so powerful. 
After having just gone through these transplants, I find that hair is just so important as er. Because you don’t have 
any hair. When people want to feel beautiful they do up their hair. They want to have something that makes them 
feel. It’s what makes them them. 
It opens other people’s minds as well, especially the students, I mean it opens their minds. They are shocked when 
they hear the word cancer like anyone does and if you can make that cancer look something beautiful in a piece 
using hair and not judging hair as something dead. You almost like making the hair look alive again. It’s, it’s very 
hard to explain (Pauses). Like giving a new meaning to cancer. It’s not all about death.
The importance of hair as part of 
your identity 
And you try to express that through your work because there’s alot of negativity in cancer and I try to do that as 
much as possible, and as much as I hate cancer, and I hate what I’ve gone through, it has made me rethink about 
many things, my work, the way I think, the way I communicate with people, the way I see life. It’s massive, it’s a 
huge thing. A huge, huge thing. And no-one can take that away from me.
Thinking differently about life as a 
result of the cancer experience 
 
I’m very proud of that, very, very proud. No-one is ever going to take that away from me at all because it’s made me 
who I am now. It’s a growing process as much as cancer is the devil, yea, it’s the black hole but not really, it’s erm, 
it’s a whole new kind of escape, but it’s not nice to have.
Personal growth through the 
experience of cancer  
When you have cancer, sometimes you can’t express, like I was mentioning before, you can’t express your feelings, 
you need objects, you need that power, that charm, you need er, something on you to make you feel that, a bit more 
powerful because you feel so weak. 
It’s the expression, I mean this power is like a soul, speaking, if you can’t speak, your soul will speak. I had to build 
this huge transparent piece which, because you can’t see the trachea inside here, coming out then it had, it came out 
and it was made out of plastic and it had wings. Then it had, you know like a jewellery box with the key and because 
you can’t speak, it is locked within the trachea, in the middle and there are all these sharp shard like broken glass 
The use of art to express feelings 
about your experience when it is 
difficult to describe 
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that you’re trying to fit all together again like life of cancer. You have all these pieces that you need to start building 
yourself back up again, picking up of this beautiful, powerful person…it did do really well and not because it’s my 
work but once again it opened many people’s eyes and it gave a new light on cancer and the other light of cancer is 
that I’m still here. Touch wood. 
 
I went through the first three months and the scan was clear, thank God. Then I started to get symptoms about, 
sorry, I started to get symptoms about a month and a half after and I started to panic. I started to get worried and 
certain, certain diseases, they don’t show through the blood, especially Hodgkins, and the other signs would be 
sweating, lumps, itchiness, feeling itchy and there’s only so much that bloods can do and even the chimerism within 
the bloods to say how much is yours and how much is the donor. Err, it’s so good to be rest assured, and to have 
confidence in the patient that if something is not right at least to order an alternative scan or a CT scan or something 
or I don’t know.  My disease had been acting very very funny and go and say oh you can’t be, you look well, you look 
fine. If I relied on that then there would be no need to have any scans would there? And I know they cost alot of 
money, for the NHS to go through all of this but ... I need to be rest assured for their sake as well because it’s easier, 
it’s good to have the disease under control and know what exactly what is happening with the disease rather than we 
don’t need one, you look fine, your bloods are fine. 
 
Uncertainty and fear of disease 
relapse 
He made sure that he was going to do one because he knows the prognosis of your disease and know how 
everything goes and it’s to rule out any complications, anything. And that is very very important. Very important. And 
he did do that and everything was fine and I couldn’t thank him enough because he I have trust in him and he 
listened to me, he didn’t ignore it and that’s also important the doctors do not ignore even the smallest of things, the 
small things can turn into something big. 
Not all the time but to generalise someone and just say that it’s nothing without really just looking into it, going the 
extra mile to make sure that you’re fine. You need that. You definitely need that, because it’s one thing that oh you’re 
anxious, that you’re over thinking, you’re new this, it’s only been three months and you’re already thinking about this 
and getting too much into it. How about, how about if I’m not, getting too much into it, what about if there really is 
something there. And I know you can’t...you just need to find out. 
 
Trust in medical staff and needing 
to be taken seriously. 
The worst thing is especially when your mother is there and  she’s worried because you know, having a child whose 
unwell and knowing the disease can come back, oh she’s anxious, she’s an anxious mother, you know, don’t listen 
to her. It’s not the case all the time. I don’t like that, I’ve absolutely hated the judgement of that. It makes me feel as if 
I’m almost paranoid, that I’m getting almost too much into it. 
As long as you address it and do something about it. Not immediately, I’m not expecting miracles but at least they 
Uncertainty 
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don’t ignore it, and I keep on stressing that as long as they don’t ignore it and you look fine in two or three months 
and you find a lump somewhere. It’s not a good thing. 
I mean you can get worked up within, thinking this could be the disease, this could not be the disease. It’s normal. 
But, to not act upon that, it’s not a good thing. It’s not a good thing. It’s definitely not a good thing. 
 
That’s also very straining and draining coming in every day to make sure everything is fine. And then other things 
would be having your line checked. The line, that’s another thing that needs to be taken care of. There’s many, 
many, many things, and I don’t think. Some people don’t have a choice and have to do it by themselves but if you do 
have someone, if you do, yea, if you do have someone then that would be the biggest help, the biggest help, for 
anyone. 
So many things to think about and 
the importance of support from 
others 
Obviously there are infections there are many things, it could be GVHD, could be infection, could be erm, you could 
have different variables, different types of medication that you need to go and take, whether you’re taking too much 
or whether your body’s not absorbing it, or if it’s how severe your GVHD is in your gut or on your skin, anything. 
There’s so many more things, so many more things insides and on top of that you need to worry about the disease 
as well 
 
Worry about complications and 
side effects plus the possibility of 
disease relapse 
You can tell it’s a journey, it’s a big journey. And if someone says that it wasn’t, they’re lying. Laughs. They are lying.
but for now the main points are: nutrition, psychological, erm having someone to contact, being reassured by the 
doctors, doctor being on top of things to make sure everything is fine, to keep busy and my big young adult people, 
you’ve got to ...you have. That’s the biggest one. I’m not sure about the rest because this is my story, but that is the 
main thing, so you don’t feel excluded because you’re already excluded enough to not go to university like 
stereotypically everybody else does. 
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9.0 Research Log  
This research log presents the development of research skills and provides evidence of the 
research process including the rationale for decision making during the journey. 
Developing research skills 
I started the Doctorate programme with some personal research experience and having had 
the opportunity to attend conferences to learn about studies in a variety of areas of clinical 
practice. I completed my Masters in Science in 2001 when I carried out research to explore 
factors affecting the quality of life of ventilator dependent people living at home. A learning 
needs analysis was completed at the outset of this study highlighting areas for development 
(Table 1). 
Table 1: Skills and knowledge to develop (Research Log 2009) 
Skills/ Knowledge Areas to develop Notes/ action plan 
Study skills for 
Doctorate Level 
Time and project 
management skills 
Finn J.A. (2006) Getting a PhD  
An action plan to help manage your  
research, your supervisor and your project. 
 
Phillips E.M. & Pugh D.S. (2000) How to 
get a PhD A handbook for students and 
their supervisors. 
 
Dunleavy P. (2003) Authoring a PhD: how 
to plan, draft, write and finish a doctoral 
thesis or dissertation.  
Study skills seminar. 
Reflective researcher log 
Knowledge and 
Understanding 
Advanced research 
methodologies; knowledge 
of relevant policy; 
knowledge of clinical 
speciality; health service 
changes 
Modules within taught element.  
Breadth and depth of reading, regular  
review of new research 
Cognitive skills Critical reading & analysis, 
systematic review, 
synthesis, report writing. 
Advanced conceptual and 
theoretical understanding 
Library search skills; seminars; Introduction 
to Doctoral Studies module/  
Advanced Research Methods  
Presentation and 
writing skills  
Strategies for dissemination Writing skills; supervision process; wide 
reading.   
Submission to conferences; attend and 
present at post graduate seminars  
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Literature search strategies and literature management 
Literature reviews were conducted to understand more about haematological malignancy 
and its treatment including stem cell transplantation and to identify areas that were 
undeveloped. Reviewing the literature suggested less research had been conducted which 
examined what these treatments were like for patients and how they coped on return home 
after prolonged periods in hospital. Literature searches were conducted with some initial 
help form the librarians at the University of Surrey library and the Royal College of Nursing 
library. I have also found it useful to visit the Kings Fund Library and obtain certain material 
from the British Library.  
 
Supplementary information 
A number of sources of supplementary information were obtained which are outlined below: 
 
Official publications DoH 
The policy review assignment provided me with the opportunity to examine the Cancer 
Reform Strategy (2007) stemming from the original NHS Cancer Plan (2000) which aimed to 
provide a comprehensive strategy to tackle cancer across the whole patient pathway. The 
Cancer Reform Strategy (2007) and subsequent policies have started to address issues 
relating to cancer survival and are therefore relevant to this study. 
 
Websites 
I joined the James Lind Alliance (JLA) on the advice of one of my former supervisors and 
have found it helpful to refer to. The JLA facilitates priority setting partnerships and their 
belief is that: 
 
 addressing uncertainties about the effects of treatments should become accepted as 
a much more routine part of clinical practice 
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 patients, carers and clinicians should work together to agree which, among those 
uncertainties, matter most and thus deserve priority attention 
This philosophy very much supported the approach I took in my research and therefore 
helped to justify my chosen methodology. 
 
The European Bone Marrow Transplant (EBMT) website was also a source of information 
and current developments in the field. As mentioned in the overview of knowledge paper, 
this organisation awarded me the travel scholarship to attend one of the European 
conferences at the beginning of my study. 
 
Networks/communities of practice 
Having a network of colleagues in haematology was extremely helpful to gain support for the 
research and to discuss ideas and strategies. Having contacts also helped to identify the 
appropriate clinical nurse specialists, haematologists and research and development staff in 
the two specialist centres.   
 
Methodological considerations 
Because my interest arose from an interest of how patients experienced stem cell transplant 
and the challenging times post SCT a methodology used to explore lived  experience was a 
logical choice. As I read more about interpretive phenomenology and a wide variety of 
studies using this methodology it appeared to be the most suited for gathering rich in depth 
data. From a practical point of view, carrying out a pilot interview was of great value. A 
colleague’s husband had recently had extensive oral and jaw surgery for cancer and 
volunteered to be interviewed after his hospital stay. He had significant medical needs such 
as gastro-endoscopic feeding and suffered from impaired speech caused by removal of part 
of his tongue. He talked a lot about his on-going needs following his return home and his 
reliance on his wife for much of his care. The interview served to raise my awareness of the 
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potential issues faced by those returning home after cancer treatment including fatigue and 
emotional responses relating to their experiences. 
 
There are mixed views about returning to participants after the interview to discuss 
interpretations and this is something I deliberated about for some time. At the time of the 
interview I was eager to establish whether participants would mind if I contacted them 
subsequently if required to which all agreed without hesitation. However, on reflection, I 
made this provision to allow for further information to be elicited or clarified in case my 
interviewing technique was lacking in addition to the potential for interpretation checking.   
However, in the process of reading and analysing I found that I had sufficient rich data and 
whilst I recognised a number of lost opportunities to probe further in the interview transcripts, 
there were no major reasons to seek clarity. As I researched more about the merits and 
drawbacks of member checking I felt able to make the decision not to inconvenience 
participants further. Evidence is provided in the methods chapter. 
 
Sample 
Clinical staff were able to obtain details of all the patients who had undergone a SCT over 
the past year and fitted the inclusion criteria for the study. The initial strategy for recruiting 
patients was by using a flyer inviting participation in the study. The flyer was sent by post to 
all potential patients at Centre B. This was sent with information about a patient support 
group facilitated by the clinical nurse specialist for SCT. Subsequently both Centre A and B 
provided the flyers at the out-patient departments where patients attended regularly post 
SCT.  I met with the consultants leading the SCT programme and specialist nurses to seek 
their support in patient recruitment at the clinics including provision of the participant 
information sheet. My rationale for this approach was twofold. Firstly, that patients would be 
reassured about the purpose and nature of the research if explained by familiar staff and 
also the authenticity of the researcher since I had worked with many people in the clinical 
teams or met them as the research proposal and approval for the study was developed. 
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Secondly, that patients would not feel pressured into participating as the study was being 
carried out by an external researcher as opposed to their clinicians.  Endeavouring to protect 
potential participants in this way was concerned with their vulnerability following their illness 
and treatments and their continued debilitated state.  
When this approach yielded no participants I sought permission to attend a series of clinics 
at both specialist centres and did not look back. Any concerns that patients would lack trust 
or feel pressured into participating were unfounded and I met with such willingness and 
enthusiasm it was both humbling and reassuring. Humbling because the participants’ 
engagement from the outset was remarkable considering what they had been through and 
reassuring in that they were so agreeable to share their stories. 
 
Ethical approval R & D 
A favourable ethical opinion was obtained at national level following minor changes to the 
participation information sheet and data storage arrangements. Research and Development 
(R & D) approval was perhaps one of the most challenging areas to achieve and impacted 
on timescales envisaged for the project. There were two elements of significance; one 
concerning the requirements for approval which were a little unclear at times in addition to it 
being my first experience of R&D since 2001 and the other concerned severe staffing issues 
within the R & D departments at both specialist centres. Whilst the research approval itself 
proved straightforward, having limited staff to process the information led to delays of eight 
months. Honorary contracts were obtained at both centres and involved very thorough 
processes including occupational health checks and assessment of infection risk. I was 
particularly impressed with this level of surveillance since I was interviewing participants who 
were still immune-compromised. 
 
Data collection  
I thoroughly enjoyed being the research instrument and felt that I could utilise my skills as a 
clinical practitioner in building sufficient rapport with the participants and members of their 
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family to create an atmosphere conducive to narrative enquiry. Although the participants 
knew I was both a nurse and a researcher and assumed I had a degree of knowledge in the 
specialist area, it was not my perception that this created any imbalance of power between 
us.  I wanted to conduct all of the interviews myself to ensure a standard approach and also 
that I was able to start to pick up themes. Had the interviews been more structured and the 
sample size greater it would have been a consideration. However, the philosophical 
underpinnings of phenomenological methodology support the development of a relationship 
between the researcher and the participant and a shared effort in interpretation of meaning. 
Therefore consistency throughout the interviews was felt to be an important concern. I was 
keen to transcribe all of the recorded interviews time permitting, as I consider this a valuable 
way of becoming familiar with the data and to recognise the emergent themes. I did 
however, have several people who were willing to undertake audio typing if required.  
 
Challenges 
The main challenge other than the practical ones already mentioned has been achieving a 
balance between professional work, academic work and life in general. However, with 
support from people within all of these areas I have ultimately been able to overcome them.   
Prioritising work is not an unfamiliar task for many people and I am more skilled than 
previously in doing so.  
 
Writing the thesis 
One of the most noteworthy and interesting aspects of completing the thesis concerns the 
writing itself. Initially, the thought of producing a relatively long thesis in comparison with 
anything undertaken before was daunting. However, I now appreciate the importance of 
knowing when to stop writing and to concentrate on reading, revising, modifying, editing and 
finalising the thesis in order to produce a comprehensible piece of work. The volume of rich 
data and the potential for discussion emanating from it made me reluctant to leave anything 
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out. However, I now appreciate that there are opportunities to publish further findings and to 
share these with future patients and clinical staff. 
 
Constant discussions with my academic supervisors both in person and electronically were 
invaluable, particularly concerning the analysis and findings. An important development as a 
result of these discussions and those with other doctoral students has been the ability to 
defend certain actions or decisions with a greater knowledge base and confidence than 
previously. Significantly, personal and professional growth have emanated from the most 
challenging times throughout this journey, for example recognition of the breadth and depth 
of knowledge required to achieve this academic level, failure of the service evaluation and 
leadership module but a successful resubmission and times when certain chapters have 
required significant adjustments. I have learnt so much throughout these times. 
 
Finally regarding the writing element, I have had the privilege of two inspiring and dedicated 
‘critical friends’ who have constantly shown interest in this research, offered their advice and 
most importantly proof read significant parts of it to whom I am indebted.  One of these has 
no affiliation to health care but has undertaken research as part of a higher degree and is 
involved in policy development. It was extremely helpful to useful to receive her comments 
which led to a number of minor revisions. The most reassuring comment she made was ‘I 
understand exactly what's going on even though I've never heard of any of this stuff - so it's 
really clear!’ 
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Appendix I: Supervision and Progress Record  
 
The Table below charts a number of supervisory tutorial discussions and a timetable of the project and its milestones 
 
Date Discussion Action Points 
29.11.2010 
 
Returned to the programme having taken 7 months out due 
to family circumstances.  Discussed drafts for ARM 
assignment  
and advice given regarding methodology, developing more  
robust rationale for choice and expanding arguments to  
demonstrate understanding and critical thinking.   
Agreed 7-10 days to review drafts and one supervisor to 
send  
comments on behalf of both to avoid confusion. 
 
Submit ARM assignment by the 17th December 2010. 
Create a Gantt chart relating to the research project so that progress can be  
reviewed at each meeting.  Future meeting dates to be suggested by Liz in an  
e-mail to Anne and Stephanie Fuller – these will be monthly by Skype or  
conference call with quarterly face to face meetings. 
 
27/07/2011 
 
Annual review – went well.  
 
Assignments completed 23/07/2011.  
NHS Institute for Innovation and Improvement guides were  
very useful for service evaluation. 
 
Research timetable discussed: 
 
Literature review – Dec 2011 
Proposal - January 2012 
NRES application - February 2012 (discuss in more detail at  
future tutorial) 
 
Discussed project plan and advice given re timing & detail of  
actions. 
 
Lay involvement discussed and guided to INVOLVE website,  
JD’s for lay reps and lay group available at Surrey who would 
Revise Gantt chart with more detailed breakdown of actions e.g. literature  
review to include search strategy, databases used, chart of research & key findings 
including design, limitations etc. NB use this as annex to thesis. Literature flow 
chart suggested and example provided. 
 Include supervisory tutorials  and dates to send matters for discussion 
on  
the chart. 
 Training dates on Gantt e.g. GCP (December 2011) and interview 
skills/techniques (Nov 2011). 
 Provide search strategy in 2 weeks i.e. 10th August 2011. 
 Continue with opportunities to consult with patients i.e. in clinics, Day 
Unit  
and KCH/RMH patient support groups re areas worthy of research. 
 Utilise Trust library (in addition to Surrey, RCN and British Library) and  
engage with librarian. 
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be prepared to read proposal etc if local group not possible. 
Meetings are Sept and December 2011. Advised to seek  
feedback regarding potential research burden on participants 
with the user group and issues of confidentiality.  
 
Patient support groups not taken up at own place of work. 
National group attended by one family only – have  
volunteered to arrange another with European Bone Marrow 
Transplant (EBMT) committee member Michelle Kenyon, 
KCL following EBMT conference in April 2011. Include this  
information in research proposal. 
 
Consider study leave for data collection/final write up. 
 
 NHS R and D – ascertain dates of meetings. 
 Continue to read widely → hone questions.  
Follow up on recommended reading/James Lind alliance from last supervisory  
tutorial:  
Hart C. (2008) Doing a Literature Review 
Seale C., Gobo, G., Gubrium J & Silverman D. (2007)  
Publications related to lived experience of stem cell transplant for haematological  
malignancies including: QoL; hospital at home; survivorship; care giver experience; 
rehabilitation; follow up and on-going support; late effects; symptom management. 
 
Joined James Lind alliance and enjoyed website information/essence of 
patient/public involvement in guiding research required. 
 
25/08/2011 
 
Discussion: Failed evaluation/leadership assignment 44%. 
Feedback highlighted requirement for: 
Aims of evaluation design & how conducted; theoretical 
underpinnings of the evaluation model. 
Leadership type required; skills for communicating the vision; 
leading & managing. 
Assignment due to be returned with ratified mark on 
September 26th 2011. Contact Wendy Knibb and arrange 
help + re-submission. 
 
Literature search strategy does not demonstrate a proper 
plan. Redo and aim to discuss on the 13th September 2011.    
 
 
Literature search strategy: 
 
 Aims and objectives 
 Explicit statement re type of review e.g. systematic giving the rationale for  
choice 
 Include time period, eligibility criteria for studies to be included, language  
e.g. all written in English, information sources 
 Peer reviewed journals through databases: Medline, EMBASE, CINHAL,  
NHS evidence, Psychinfo.  
Be clear on the focus of interest and what is driving you. Write thoughts in simple  
language, leave for a few days and review. 
 
Many avenues to pursue but need to make a decision.  
 
Utilise librarian. 
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12/12/2011 
 
Supervisory tutorial postponed due to a pressing incident at  
work. 
October and November sessions were cancelled due to the  
requirement to work on a failed essay. Gained a great deal  
from re-submission in terms of leadership concepts and  
theoretical underpinnings of service evaluation. I had a  
helpful tutorial with Wendy Knibb and Jacky Eyers on  
October 3rd 2011. Re-submitted on November 18th 2011 as  
per regulations. Work on literature review halted temporarily  
during this period. 
 
Work on: 
 
a) A paragraph on the area/topic of interest 
b) A preliminary research question of interest 
c) What drives interest 
d) Potential impact of the research and who it would involve/benefit 
e) Identify ways the study could be  conducted 
 
29/03/2012 Feedback on initial literature review and points to expand  
e.g. survivorship, quality of life,  
 
Think of using sub headings for the section on psychosocial  
aspects. 
 
Suggested further reading. 
 
 
1. Complete literature review and include a summary at the end of literature  
review 
2. Identify research question/s 
3. Identify different possible research approaches that suit the research  
questions 
4. Use of grid to identify key research and key findings 
Beech N., Arber A., & Faithfull S. (2011) Restoring a sense of wellness following  
colorectal cancer: a grounded theory.  Journal of Advanced Nursing 2011(In press). 
Charmaz C. Good Days Bad Days The self in chronic illness and time.  Rutgers  
University Press, New Jersey 1997. 
Ehrenreich B. (2009) Smile or die. How positive thinking fooled America and the  
world. Granta Publications, London 2009. 
Willig C. Cancer diagnosis as discursive capture: Phenomenological repercussions  
of being positioned within dominant constructions of cancer. Social Science and 
Medicine 2011; 73: 897-903. 
Schou & Hewison  Experiencing Cancer.  Open University Press 
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4/10/2012 Provisional opinion from NRES committee subject to  
changes in right hand column 
Storage and disposal of data – confirmed that no data to be stored on a lap top and 
clarification of storage of data at Surrey University 
Two amendments on participant information sheet: 
1. Change ‘post graduate degree’ to ‘doctoral higher degree’ 
2. Confirmation that the study has been reviewed by the National Research Ethics 
Service Committee – London Queen Square 
9/11/2012 Favourable opinion from NREC  
25/01/2013 Research and Development  approval Centre B  
13/03/2013 Research and Development  approval Centre A Discussed recruitment strategies 
February Flyers posted to patients at Centre B. 
Distributed in clinics at Centre A & B 
 
30/04/2013  
to  
23/09/2014 
 1. Participant interviews 
2. Transcribe interviews 
3. Line by line analysis 
4. Development of themes 
November  
2013 
Post Graduate Research Conference 3rd & 4th  
February 2014 
Submit abstract   
February  
2014 
Progress on next theme. 1. Send 12.02.2014 
2. Poster presentation at PGR conference at Surrey University 
3. Presentation to fellow doctoral students 
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February/ 
March 2014 
First draft of findings Send completed draft sections to supervisors February/March 2014 
April 2014 Complete methodology chapter 1. Submit abstract for British Sociological Association Conference   
2. Continue analysis 
May 2014 Findings 1. Continue analysis   
June 2014 Discussion Send first draft to supervisors   
July 2014 Conclusion 1.  Identify examiners internal/external 
2.  Draft of conclusion for review 
August 2014 Additions/amendments/editing 
Academic paper 
1. Exam entry form 
2. Commence work on academic paper 
3. Chapters sent to proof readers 
September 
2014 
Structure of findings chapter not good 1. Oral presentation at the British Sociological Association Conference at Aston 
University. 
2. Work on structure and signposting in findings chapter 
3. Revisions to paper for publication (for submission to the Journal of Advanced 
Nursing) 
October 1st 
2014 
 Submission of thesis 
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10.0 Overview of the Integration of Knowledge, Research and Practice 
 
This paper provides an overview of the integration of knowledge, research and practice 
within the context of the four year Doctorate of Clinical Practice Programme. Taught 
modules, discussion with professional and educational colleagues, reading, thinking and 
reflection have contributed to my overall learning. Most importantly the taught elements and 
the supervisory tutorials have provided direction but also developed my ability to think 
critically, take nothing at face value and to gain deeper understanding of phenomena 
through exploration and challenge. Firstly, the strengths, opportunities, weaknesses and 
threats (SWOT) to the researcher were identified and outlined at the beginning of the study 
programme, shown in the table below. This is followed by an overview of the course 
modules undertaken and their application to clinical practice and research.  The paper 
concludes by providing a summary of the key components of my professional and personal 
development and dissemination of the research findings. 
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10.1 Table 1: SWOT analysis 
 
 
Strengths 
 Committed to improving clinical care 
 Effective professional networks 
 Support of family and friends 
 Experience of research at MSc level 
 Experience of writing for publication 
 Determination 
 Integrity 
 Sensitivity to needs of others 
 
Opportunities 
 To carry out research 
 Networking 
 Communities of practice 
 Peer support 
 Academic support 
 Educational development 
 Learn new skills 
 Increase knowledge 
 Build relationships within new organisations 
through research process 
 Use software package to manage data for 
analysis 
 Improve writing ability 
 Present research findings 
 
Weaknesses 
 Self doubt 
 Time taken to define research question 
 Limited experience of undertaking researc
 Limited in depth knowledge of research 
methodologies 
 
Threats 
 Resources e.g. balancing work pressures 
 Life events 
 
Course Modules 
10.2 Introduction to Doctoral Studies 
This module set the scene for the four year study period both in conveying the expectations 
of Doctoral level study and developing the foundation of core competencies in order to 
achieve these. The module is supported by an e-learning facility enabling on-line discussion 
with fellow students and lecturers. Students were encouraged to articulate their area of 
interest for the research thesis at an early stage to begin to formulate ideas and express 
these to colleagues in a range of healthcare disciplines. I found that this cemented my topic 
of interest though narrowing this down to a more defined research question was dependent 
on a depth and breadth of reading on the subject. 
 
10.3 Communities of Practice Module 
The development and synthesis of professional knowledge forms the basis of this module 
considering historical, cultural and political influences. Exploration of the links between 
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philosophy of science and knowledge encouraged me to consider my stance on how 
learning and understanding is best advanced in contemporary practice. Further reading and 
examination of philosophical approaches led me to consider interpretive phenomenology as 
a possible way to investigate patients’ experiences in my chosen area of interest. I found the 
module particularly helpful in considering ways in which to transfer and disseminate new 
knowledge between disciplines and across organisational boundaries.   
 
10.3.1 Application to Clinical Practice and Research 
This taught element reinforced the importance of professional networks in clinical practice 
and was of great benefit in carrying out the research.  When the research was first 
visualised, the stem cell transplant programme was based in my hospital. During the project 
however, the SCT services at two hospitals merged and whilst colleagues moved with the 
speciality this served to extend the community of practice further. Introductions to clinical 
staff at the new facility provided excellent opportunities for discussion about my research, 
advice and access to the study participants. Consultant haematologists agreed to support 
the project in line with requirements of the Research & Development. Meeting relevant staff 
at the second specialist centre was made easy by having a wide network of colleagues who 
provided links and could facilitate introductions. This aspect was particularly rewarding since 
old and new haematology colleagues generously gave me their time, the benefit of their 
expertise and welcomed me into their clinical teams during the period of identifying and 
interviewing participants.   
 
10.4 Advanced Research Methods Module 
This module incorporated in depth training in a range of quantitative and qualitative 
methodologies. The assignment challenged students to defend a methodology, design and 
methods suited to specific research questions and contributed significantly to my knowledge 
of research approaches in addition to extremely interesting and challenging areas for 
inquiry.  I gained greater knowledge of ethical issues which I could apply to my own study as 
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it took shape. These were particularly in relation to involvement of vulnerable patients, 
professional gate-keeping and gaining access, patient illness and attrition. Other 
considerations include engaging with participants in a way which minimises power 
differentiation between interviewer and interviewee and allows both to interpret events in 
order to gain greater depth of understanding.  
 
10.4.1 Application to Clinical Practice and Research 
On a practical level, the breadth and depth of reading involved in this module was invaluable 
for a number of reasons. Firstly, it provided an overview of current research in cancer and 
other specialties and how clinical practice was developing, for example the use of 
telemedicine and new approaches to patient follow up. Secondly, in parallel with the 
philosophy of science introduced in the earlier module it gave me an insight into interpretive  
phenomenological methodology which proved so valuable in exploring patients lived 
experience.  Thirdly, as mentioned reading and learning from other researcher’s 
experiences was extremely helpful from both patient access and ethical considerations. 
Studies involving vulnerable patients highlighted issues related to professional gate-keeping 
and subsequent lack of access to study participants and also attrition due to ill health or 
death. This was the reason that two specialist centres were chosen to ensure a sufficient 
cohort of patients for the study.    
 
10.5 Policy Politics and Power 
This module directed me to the review and analysis of the Cancer Reform Strategy which 
has major significance for my chosen area of study. Contribution to my personal and 
professional growth includes an enhanced awareness of the critical factors influencing policy 
development, dissemination and implementation.  
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10.5.1 Application to Clinical Practice and Research 
With a greater awareness of policy development, policy drivers and ‘policy windows’ I have 
been able to influence a number of changes in clinical practice with greater confidence and 
evidence. An example has been the development of a local policy to allow nurses to 
authorise blood within our organisation. Although awaiting finalisation of the National Blood 
Transfusion Policy to allow its implementation we have been able to adapt the competencies 
and agree a robust training programme to support two named nurses to take this forward. 
Authorisation of blood by nurses was a recommendation by my former manager and 
Doctoral student at Surrey University and evidence from her thesis supports potential patient 
benefits relating to the effective treatment of anaemia in haematology. 
 
10.6 Service Evaluation and Leadership in Healthcare Organisations 
This module served to increase my awareness of quantitative methods since I chose to 
examine a service development through a randomised control methodology. The area 
studied is concerned with the main research topic though touched on different but relevant 
aspects of service delivery including economic evaluation. This was particularly useful 
because it challenged me to defend a qualitative methodology for the thesis in order to gain 
a greater depth of understanding from participants’ experiences.  Both the service evaluation 
and leadership in healthcare organisations modules came at a time of major political and 
organisational change in the National Health Service thereby providing opportunity to 
engage in lively debates regarding contemporary theory and practice. 
 
10.6.1 Application to Clinical Practice and Research 
The theory learned within these modules and associated discussions with doctoral students 
and academic staff have influenced the way in which I view the clinical services within my 
remit at work. I actively seek opportunities to innovate and lead change and have a greater 
knowledge base on which to base decisions.  Continuing to work in clinical practice 
combined with the theoretical underpinnings of the Doctoral Programme have provided me 
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with the increased knowledge, skills and experience with which to carry out my own 
research study. I have been able to share much of the knowledge I have gained and used it 
to inspire others in their professional and academic pursuits, whilst feeling personally 
motivated and enthusiastic. A summary of the key components of my professional and 
personal development are listed below: 
 
 Gaining sufficient knowledge to undertake a research study at this academic level by 
learning, reading a wide range and volume of literature and an improved ability to 
think critically.  
 An increased understanding of the extensive portfolio of research methodologies 
ethical considerations and practicalities of conducting research. 
 The value of discussion with academic supervisors and others (a verbal or written 
exchange regarding specific and difficult issues can move you miles) 
 Development of a greater ability to negotiate, challenge and influence practice within 
multidisciplinary teams and across organisational boundaries. 
 An appreciation of the many colleagues and friends who have contributed to my 
professional and personal development in so many different ways. 
10.7 Dissemination 
Receiving a travel scholarship to attend the European Bone Marrow Transplant (EBMT) 
meeting in 2011 provided a great opportunity to meet and listen to many experts in stem cell 
transplantation. Being relatively new to the specialist field myself this proved to be an 
invaluable experience of learning and developing links for my research. During the course of 
study, I have been able to discuss the development of my research proposal with academic 
and clinical staff. Presenting preliminary findings to the doctoral student group was very 
helpful both in focussing my thoughts at that time and in presenting within this specialised 
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field of haematology. Students contributed by commenting on the development of themes 
from some of the data extracts from participant narratives which were followed up 
subsequently. I had the opportunity to present a poster at the University of Surrey Post 
Graduate Research conference where I met a fellow student from the sociology discipline. 
Our shared interest in patient’s experience in the oncology setting will continue as our 
research pursuits continue. An abstract has been accepted for presentation at the British 
Sociological Association Conference in September 2014 and will be another opportunity to 
network with people outside the medical discipline.  The findings will be shared with 
colleagues and patients in the stem cell transplant community and I have been invited to 
present at one of the EBMT meetings on completion.   
 
10.8 Conclusion 
In conclusion, undertaking the Doctorate in Clinical Practice has provided me with an 
unparalleled opportunity to extend my knowledge base in a highly specialised area and to 
enable me to carry out this research. Some of the most difficult times faced as I have strived 
to achieve this higher level of academic work have been the most developmental and of 
significant personal gain. I feel that I have developed the ability to juggle more complex 
tasks than previously and the resilience to face the inevitable self-doubt associated with 
research and operating outside of one’s usual ‘comfort zone’.  
 
 
 
